Page last updated: 2024-12-05

sodium fluoride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Sodium fluoride (NaF) is an ionic compound composed of sodium and fluoride ions. It is a white, crystalline solid that is commonly used in toothpaste, drinking water fluoridation, and industrial processes. It is synthesized by reacting sodium hydroxide with hydrofluoric acid. Sodium fluoride is an effective antibacterial agent and helps to prevent dental cavities by strengthening tooth enamel. The addition of fluoride to public water supplies has been widely credited with reducing tooth decay rates. Sodium fluoride is also used in the manufacture of ceramics, glass, and pesticides. It is studied for its potential applications in treating osteoporosis and other bone diseases. While sodium fluoride is generally safe at low doses, excessive intake can be toxic.'
```

Cross-References

ID SourceID
PubMed CID5235
CHEMBL ID1528
CHEBI ID28741
MeSH IDM0020103

Synonyms (1191)

Synonym
NAF ,
CHEBI:28741 ,
P00019
fluonatril
osteopor-f
sodium fluoride (na2f2)
luride
fluorol
ossalin
fluorid sodny
zymafluor
sodium fluoride (naf)
sodium flouride
flurexal
fda 0101
karidium
liquiflur
wln: na f
florocid
sodium hydrofluoride
alcoa sodium fluoride
les-cav
flura
xaridium
ossin
roach salt
antibulit
flursol
flura drops
villiaumite
t-fluoride
fluorident
sodium monofluoride
flux
sodium fluoride cyclic dimer
fluoraday
nci-c55221
pergantene
sodium fluorure
pediaflor
sodium fluoride, solid
fluoride, sodium
koreberon
fungol b
floridine
nsc77385
fluorure de sodium
nsc-77385
luride sf
rafluor
natrium fluoride
flura-gel
rescue squad
ai3-01500
flura-loz
sodium fluorure [french]
duraphat
na frinse
fluorocid
thera-flur
sodium fluoride [iso]
lemoflur
osteofluor
pedident
fluorure de sodium [french]
ccris 1573
thera-flur-n
epa pesticide chemical code 075202
gleem
einecs 231-667-8
nafpak
flurcare
flozenges
super-dent
minute-gel
fluorineed
point two
caswell no. 769
kari-rinse
pennwhite
sodium fluoride, solid (dot)
iradicav
gel ii
gelution
trisodium trifluoride
f1-tabs
luride-sf
fluoros
fluorid sodny [czech]
luride lozi-tabs
chemifluor
stay-flo
so-flo
fluorinse
un1690
fluorigard
karigel
hsdb 1766
fluoritab
nsc 77385
nufluor
phos-flur
credo
studafluor
cavi-trol
fluor-o-kote
neutra care
lea-cov
fluorure de sodium [iso-french]
nafeen
predent
7681-49-4
sodium fluoride ,
C08142
fluorinse (tn)
sodium fluoride (jan/usp)
D00943
sodium fluorides
fluorides, sodium
chembl1528 ,
fluoride (as sodium)
natrii fluoridum
natrum fluoratum
dentalfluoro
fluoride (as sodium fluoride)
A838842
apoflux
ec 231-667-8
prevident 5000 plus
zooby
sodium fluoride [un1690] [poison]
fluor-a-day
sodium fluoride [usp:jan]
unii-8zyq1474w7
8zyq1474w7 ,
fludent
ethedent
duofluorid
FT-0688141
FT-0645095
fluoride (as sodium) [vandf]
sodium fluoride [ep monograph]
sodium fluoride [hsdb]
sodium fluoride [who-ip]
sodium fluoride [vandf]
sodium fluoride [mi]
sodium fluoride [mart.]
sodium fluoride [inci]
neutral sodium fluoride
colgate total component sodium fluoride
fluoride (as sodium fluoride) [vandf]
natrum fluoratum [hpus]
sodium fluoride [jan]
sodium fluoride [who-dd]
sodium fluoride [usp-rs]
natrii fluoridum [who-ip latin]
sodium fluoride component of colgate total
sodium fluoride [orange book]
sodium fluoride [usp monograph]
HY-B1766
CS-5131
PUZPDOWCWNUUKD-UHFFFAOYSA-M
sodium fiuoride
pediaflor; zymafluor
AKOS024438093
DTXSID2020630 ,
sodium fluoride, 99.99% (metals basis), 3-6mm pieces
mfcd00003524
DB09325
sodium fluoride, 99.995% (metals basis)
colgate
sodium;fluoride
nafril ret
fluorigard weekly
en-de-kay
bdbm50209223
fluorigard daily
fluor ret
point-two
dentiplus
sodium fluoride, trace metals grade, 99.99%
sodium fluoride acs grade
Q407520
AMY37012
crest complete multi-benefitplus scope
kindfill
topex 60 second fluoride foam
gel 1100grape
crest 3d white whitening therapycharcoal with coconut oil
adoptaplatoon
pcxx one minte gel rootbeer
therabreath for kids anticavity wacky watermelon
oral fusion anticavity
colgate 2in1icy blast
colgate kids unicorn alcohol free
colgate re revive
nafrinse packets mint
pcxx cappuccino apf f
colgate kids space jammild bubble fruit flavor
closysfluoride rinse
crest scopeadvanced
nafrinse unit dose mint flavor
smart senseanticavity
dinosaur
maintenance rinse
aquafreshextra fresh plus whitening
sdoium fluoride
oral b minute-foamgrape
pcxx neutral rns peppermint
kaylaan
topex 60 second fluoride foambubble fun
crest complete multi benefit
pcxx neutral rns grape
pcxx bubblegum apf f
laura lynn anticavity
colgate kids sloth
kids crest cavity protectionsparkle fun
oral antivavity
the natural dentistwhitening
freshmint premium anticavity gel
dentree
iodent animal kingdom fruity
aquafreshextreme clean deep action
crest anti-cavityregular
ortho guard
burts bees
previddent 5000 booster plus spearmint
crest anti-cavity
ctx3 rinse
prevident5000 plus fruitastic
crest cavity protection
hoo gargle (apple spearmint flavoring)
zero waste refill for toothpaste
colgate maximum cavity protection
topex neutral fluoride foam
fluoride gel
iris 60 second apf
pine salt 170g
therabreath healthy smile oral rinse
jason powersmile fluoride peppermint anticavity
dental care advance cleaningmaximun baking soda
pcxx vanilla orange neutral f
burts beeskids strawberry splash
denti whoo cts germ free
dentek kids anticavity fluoridelooney tunes bubblegum blast
0.243% sodium fluoride toothpaste
act anticavity fluoride mint
kroger kids anticavity fluoride
colgate maxfresh charcoal
hismile mango sorbet flavor anticavity
emmi dent sodium fluoride anticavity mild
cavity protection fresh mint anticavity mouthwash
crest 3d whiteradiant mint
tm-c7 oral care
heb gleaming whitefresh mint
pepsodent complete careenamel-safe whitening
maintenance rinsegrape
hellojuicy grape fluoride
hanip gargle apple fragrance
nafrinse unit dose verry berry
pcxx remin 0.4
crest complete pluswhitening intense freshness
autobrush watermelon
take home fluoridecool mint
2080 k original
discount drug martanticavity fluoride rinse mint flavor
pcxx cool peppermint apf g
killfire mouthwash
ionite apf
pcxx bubblegum neutral f
oral-b minute-foam strawberry
the natural dentist
western family whitening plus minty fresh mouthwash anticavity
oral b cavity protection
hanip gargle pine fragrance
plak smackermint blast
colgate you blue fresh mint
crest premium plusactive foam whitening scope
amerfresh fluoride gel
the humble co. anticavity mouthwash strawberry
hyveecomplete care fresh mint
pcxx grape apf f
colgate phos-flur ortho defense alcohol free anticavity gushing grape fluoride
crest 3d whitebrilliance ultra
darby apf mint
aquafreshmulti action whitening
perioe pop advanced whitening prebiotic
up and up anticavity toothpaste whitening
firefly bubble blast
biotenefresh mint original
sodium fluoride (ep monograph)
colgate kids watermelon flavor
nativewhitening
kroger kids anticavity fluoridemixed berry
listerine total care zero alcohol anticavity
colgate enamel strength mouthwash
denti-care denti-rinseneutral sodium fluoride oral rinse berry
listerine total care fresh mint anticavity fluoride
sodium floride
mi paste one kids blue raspberry
colgatecavity protection
zoobyspearmint safari
mint dentistry
crestmoisturizing
smile direct club
theoryfreshness care essential mint
spotlight pregnancy
humble brush bamboo with fresh mint flouride
t-series
universal charcoal with aloe vera anti-cavity fluoride
advance white extreme whitening
crestsplash
prevident5000 plus spearmint
koala pals
walgreens sensitive extra whitening
crest expressions scope
sodium fluoride 1.1% gel
dr dental care 250ml
emmi-dent kids
freshmint anticavity fluoride gel toothpaste
oral b minute-foammellow mint
zoobyturtle melon
anticavity and antigingivitis whitening fluoride
botao kids strawberry flavored with fluoride
zero waste fluoride mint tooth tabs
medichoice premium anticavity fluoride
maintenance rinsecitrus
synedent flx
rain breeze toothpaste
nupro fluorides naf oral solutionmint
ph7 gel mint
anticavity
pcxx neutral gel vanilla orange
oral b neutra foam
natural fluoride fresh mint
essentials healthy teeth and gums
burts beesfor kids
primo apf
pcxx apf rns mint
1.1% sodium fluoride
nupro fluoridespeach
pcxx bubblegum apf g
acclean foam fluoride 60 second application
dr. 9020 dental clinic
listerine healthy white restoring anticavity fluoride clean mint
crest 3d white whitening therapydeep clean charcoal
burts beesextra white zen peppermint
pine salt 140g
colgate junior bubble fruit
neutrarinse 2% neutral sodium floride oral rinse raspberry splash
handy solutions crest complete multi-benefit whitening plus scope
auraglow daily
smile active pro tartar control fluoride
hello magical mermaid
pcxx one minte gel raspberry blast
mipaste plus vanilla
perioe microbiome whitening
topical 60 sec sodium fluoridestrawberry
oral-b neutracare mint
soom green mouthwash
crest kidscavity protection
act restoring anticavity fluoride mint burst
walgreens anticavity and antigingivitis whitening
fluoride anticavity toothpaste
oral defense fluoride rinse
scotts select neutral apf fluoride
gel 1100citrus
gargle dam
clarben
sodium fluoride 5000 plus
colgate re reenergize
aim whiteningwith baking soda
anticavity fluoride rinse
listerine total care zero alcohol anticavityfresh mint
shopkins mouth wash
dentalux charcoal
anticavity fluoride
colgate kids trolls alcohol free anti-cavity sparkle time bubble fruit
kangaroooralcaretoothpaste
assured anticavity fluoride kids bubblegum
emmi-dent fresh
quip anticavity fluorideconcentrate
walgreens anticavity and antigingivits whitening fluoride toothpaste
treatment rinse
colgate junior kids batman mild bubble fruit fluoride
dr plus dental daily care
the humble co. anticavity kids strawberry flavor
maximum security
gelo-x
freshdent kids strawberry anticavity tooth
perioe pop advanced whitening prebioticcool mint
purelife apf
pcxx strawberry neutral f
60-second fluorideorange cream
perioe microbiome total care
nupro fluorides naf oral solutionapple cinnamon
ionite apffoam
pcxx one minte gel creme de menthe
sodium fluoirde
pcxx bugglegum neutral gl
dentalux coconut minerals
colgate cavity protection fresh mint
denti-care denti-foamtopical sodium fluoride strawberry
sprinjenewhite boost
oral-banticavity
pcxx peppermint neutral gl
cvs pharmacydry mouth
pcxx one minte gel mocha cappuccino
dentisse
crest puregentle whitening
kolorz neutral fluoride foamtriple mint
neutragard gel mint
natural fluoride fresh mintcavity protection whitening fresh breath
upc 801803 00211 megafresh gel fluoride tooth
colgate maxfresh with mini breath clean mint
aim tartar control
crest 3d whiteenamel protect
firefly strawberry smoothie
doctor 9020 dental clinic
the natural dentistpeppermint twist
60 second taste mint
denti whoo cts germ free-f
crest pro healthdensify rinse
colgate max cleanspearmint blast
zero waste replacement for toothpaste
crestfresh and white
aquapick whitening tooth foam
dr.pik oral care gargle
astonea-sodium fluoride
pcxx one minte gel luscious lime
prevident5000 dry mouth
colgate maximum cavity protection wonder woman
listerine smart rinse anticavity fluoride rinse-mint shield
delta one 2019 tumi collins amenity with crest complete whitening scope
close upfreshening with mouthwash
colgate trilple accion
pcxx minute fm lime
down toothpaste,gingersnap
pcxx peppermint neutral f
close up anticavity toothpaste
made by dentists whitening
pcxx neutral gel raspberry blast
prevident 5000 booster plus fruitastic
luster nowinstant whitening
arcwhitening
the white toothbrush
fluoritab chewablecherry
fluoride mouth rinse anticavity
sodium fluoride (usp-rs)
kids flouride rinse
quip
oral b minute-foam
crest 3d whiteadvanced stain shield
crest pureall around clean
up and up anticavity toothpaste whitening plus mouthwash
aquafreshextreme clean pure breath action
crest complete pluswhitening cinnamon expressions
restoring anticavity
ms apf
nupro fluorideswild cherry
hello unicorn
dollar shave club
hoo gargle jasmine mint flavor
pepsodent complete careoriginal
aimbubble berry
pcxx strawberry apf f
dr.noah toothpaste tablets
colgate max fresh
hello wild strawberry
topex 60 second fluoride foamspearmint
gel 1100mint
pcxx one minte bazooka bubblegum
anticavity toothpaste
kolorz sixty second fluoridecherry cheesecake
sprinjenefresh boost
hismile grape bubblegum flavor anticavity
hismile peach iced tea flavor anticavity
listerine naturals enamel repair anticavity fluoride, herbal mint
pcxx cherry apf g
60 second gel bubblegum
family wellnessanticavity fresh mint
colgate triple action original mint fluoride
crest premium plusadvanced whitening active foam
phocal phn
pcxx marshmallow apf g
the blue toothbrush
perioe pop complete protection prebioticmint blast
creststrawberry
plaque hd anticavity fresh mint flavorprofessional plaque-identifying
60 second taste strawberry
orajel
zap neutral
kolorz neutral fluoride foam
sea salt anticavity salt47gently scrubs away surface stains / fights bad breath germs / strengthens enamel
60-second fluoridepina colada
kolorz sixty second fluoridetriple mint
nafrinse packetskit grape
colgate kids maximum cavity protection batman
ludent
crest 3d white luxediamond strong
crest 3d whiteadvanced radiant mint
auraglow whitening
dr tichenors with extra whitening and tartar control
aquafreshcavity protection
60-second fluoridemarshmallow
dr. dental care
truly radiant rejuvenating
act total care anticavity fluoride icy clean mint
luster premium white
oral-b minute-foam banana splitz
oral b minute-foamorange-a-tangy
electrifying blue polish
doctor-clean
hismile smooth mint flavor anticavity
western family complete whitening
floam topical floam fluoride
clbio dental clear
kolorz sixty second fluoride foamblue raspberry
amerfresh tooth
pcxx neutral rns strawberry
60 second gel strawberry
fluoride treatment
advance white
made by dentists, inc. monster slime
crest 3d whiteluxe diamond strong
botao kids strawberry flavored toothpaste with fluoride
mouthwash for total care
crest complete pluswhitening plus scope
oralline secure
pcxx watermelon neutral gl
close upwhitening with mouthwash
maesa-hey human
nupro fluoridesberry cherry
o bits xylitol toothpaste yuja mint flavor
crest complete plus3 in 1
linhart
sodium fluoride drops
burts beescharcoal peppermint
fluorishield
pcxx one minte gel strawberry blast
neutragel
pcxx raspberry apf f
crest complete multi benefitwhitening plus scope outlast
nafrinse packetskit very berry
neutramaxx 5000
colgatejr littlest pet shop
sodium fluoride 0.02%
colgatejunior sponge bob
mintblast
colgate luminous crystal fluoride
nafrinse packetskit mint
crest braces careanticavity fluoride rinse
hello
natural whiteradiant white
orajel fluoride
dental clear premium
topex 60 second fluoride foamorange cream
crest 3d whitearctic fresh
oral-b minute-foam mellow mint
doctrust doublex tooth
the humble co anticavity mouthwash fresh mint
pcxx rootbeer apf f
crest kids
colgate2in1 whitening stain lifters
crest 3d whiteluminous mint
colgate junior mixed kids bubble fruit fluoride
crest 3d whiteadvanced glamorous white
tidalove smile more oral care
crest complete multi-benefitwhitening scope outlast
sodium fluoride (usp monograph)
sodium fluoride gel
nativewhitening candy cane
avon whitening essentials10x charcoal black clean mint
opalescence whitening
soom mouthwash
tanners tasty cha cha chocolate
flouride mouthwash strong mint
denticare pro-gelneutral sodium fluoride
1.1% sodium fluoride prescription dental cream
crest complete multi-benefitwhitening plus cinnamon expressions
haring b detox mouthwash
just right
crest 3d whiteadvanced express white
aim tartar controlplus mouthwash and whitening
shopkins brush buddies
crest pure
firefly anticavity fluoride
crest mysticenchanted strawberry
gelato apf
made by dentists, inc. whitening
maintenance rinsemint
essentials whiten and strengthen
hellodragon dazzle fluoride
crest 3d whitebrilliance charcoal
hismile banana flavor anticavity
alcohol-free anticavity
topex 60 second fluoride foamgrape
hoo gargle apple spearmint flavor
60 second fluoride gel
colgate optic white stain fighter clean mint
kolorz sixty second fluoride foamcherry cheesecake
crest 3d white brilliancepro enamel protect
colgate kids slothmild bubble fruit flavor
fluorure de sodium (iso-french)
colgate kids ryans world
aquapick whitening bubblepick
simply white
peroxie care tartar control
cresttartar protection whitening
enamel defense
truly radiant rejuvenatingwhitening
nativecharcoal
act anticavity fluoride arctic blast
simply whitesweet mint
x-pur opti-rinse plus
autobrush bubblegum
nafrinse packets very berry
dr dental care 750ml
cinnafresh
cinnamon toothpaste tablets
denta 5000 plus
koala palsberrylicious
closeup travel
sensitivity toothpaste
sodium fluoride tablet
crest 3d whiteenamel renewal
crest pro-health advanced complete care
clean mint rush
neutramaxx 5000 tcp
act kids anticavity fluoride groovy grape
pcxx neutral gel creme de menthe
crest complete plusscope advanced active foam
clear qq
kids crestbubblegum rush
sorbet apf
colgate you white vanilla
crest 3d white whitening therapyenamel care
burts beesenamel care
toms natural enamel strength peppermintstrengthens enamel / whitening / fights cavities / freshens breath / no artificial dyes or sweeteners
tanners tasty vanilla bling
plaque hd anticavity fresh mint flavor
kill firetoothpaste
goby peppermint
brisatropical fresh
colgate maximum cavity protectionbubble fruit flavor
giant eagle wintermint zero alcohol
anticaries
denpocavity prevention
colgate kids llama
colgate zero clear spearmint
unpaste tooth tabs
crest pro-healthrestore enamel
advance white extreme whiteningtartar control
scotts select apf foam fluoride
hyveeanticavity mint
topical 60 sec sodium fluoridemint
kids crest cavity protection
crest complete plus whitening
ionite apfneutral
crest pro-healthadvanced w/extra deep clean
ctx3 rinsemint
60 second gel mint
crest aligner care
dentagel
pcxx one minte gel banana berry
cool sense care plus mouthwash
pcxx lime apf f
colgatejunior transformers
denti-care denti-protopical sodium fluoride 60 second
crest mysticmagical bubblegum
truly radiantwhitening and strengthening rinse clean and fresh
charm-tex fluoride gel
60-second fluoridestrawberry
crest cavity protectionregular
whiteningtooth polish
neutrarinse 2% neutral sodium floride oral rinse refreshmint
colgate re repair
airline dental products with crest and manual toothbrush
the humble co. anticavity charcoal
listerine healthywhite vibrant clean mint
pcxx neutral gel pina colada
neutrarinse 2% neutral sodium floride oral rinse white grape
60 second taste groovy grape
anticavity rinse
crest 3d whiteadvanced luminous mint
the humble co. anticavity mouthwash strawberry kids
maxixum security gel toothpaste
aquafreshextreme clean whitening action
plak smacker anti-cavity fluoride gel
60-second fluoridegrape
maesa-hey humans
sodium fluoride toothpaste
colgate fluoride-trolls-mild bubble fruit
crest 3d white whitening therapycharcoal with tea tree oil
gel 1100
act total care anticavity fluoride fresh mint
therabreath for kids anticavity grapes galore
dawnmist fluoride
crest 3d white whitening therapy charcoal
2080 k herbal mint
ctx3 rinsegrape
pcxx raspberry neutral gl
pcxx neutral rms bubblegum
crest 3d white whitening therapycharcoal with ginger oil
colgate maxclean with whitening smartfoam
jason healthy mouth fluoride cinnamon anticavity
act kids anticavity fluoride
treatment rinsemint
kolorz sixty second fluoride
cardinal health fluoride anticavity
autobrush mint
topex 60 second fluoride foamstrawberry
crest complete pluswhitening plus scope outlast
neutral rinse
pcxx cherry apf f
kolorz sixty second fluoride foam
toms kids grape save the animals
act total care sensitive anticavity mint mouth
dental care advance cleaning
crest cavity protection regular
colgate you blue vanilla
theoryenamel care wild peppermint
listerine total care fresh mintanticavity
tradition salt caretoothpaste
hello unicorn sparkle
topical neutral fluoride gel
colgate cavity protection
colgate maxfresh knockout
hello unicorn splash
orajel paw patrol
prevident very berry
colgatejunior bubblefruit
colgate maxfresh with whitening knockout fluoride
crest pro-health advancedwith extra tartar protection
nafrinse packets grape
crest 3d whiteultra
perioe whitening essentialsfresh aloe green mint
hey humans whitening clean mint rush
farmasi whitening
pcxx one minte gel watermelon splash
pcxx neutral gel cool peppermint
colgate kids llamamild bubble fruit flavor
oral b neutracaremint menthe
mipaste one kids cotton candy
goglama naf rns mint
colgate re refresh
rite aid radiant white
made by dentists, inc. total care
maximum security anticavity
colgate enamel health mouthwash
colgate triple action
colgate ultra brite advanced whitening all in one clean mint
pepsodent complete care
beanguard gargle plus
pcxx creme de menthe neutral gl
crest complete multi-benefitextra whitening plus scope advanced freshness
mipasteplus
crest 3d whitebrilliance blast
neutra maxx 5000
kolorz sixty second fluoride foamcotton candy
colgate optic white charcoal
toms natural anticavity peppermintfights cavities freshens breath strengthens enamel
peppermint charcoal anticavity pcft6gently whitens teeth / fights cavities / safe for enamel / safe for everyday use
dtxcid20630
fluorimax 5000
ap-24
the humble co. anticavity fresh mint
pcxx raspberry apf g
chewpaste with fluoride
cinnafresh anticavity
colgate optic white stain fighter
orthocare
pro gel 5000mint
crest premium plusdeep clean active foam
crest tartar protection
pro care flouride
hello dragon dazzle
kids anticavity fluoride
sodium fluoride (mart.)
crest cavity protectioncool mint gel
colgate proclinical-sparkling mint
cavity protection fresh mint
colgate kids ryans toy world alcohol free anticavity ryans bubble fruit
sf 5000 plus
doctrust k
hismile watermelon flavor anticavity
hebdry mouth
hoo gargle (apple spearmint flavor)
sodium fluoride, (solid)
colgate sparkling white cinnamint
crest 3d whitestain eraser fresh mint
wintermint mint chill
crestsensi-care
pcxx grape apf g
crest 3d white
toms childrens anticavity mouthwash silly strawberry
gleemwhitening
crest 3d whitestain eraser icy clean mint
ionite r
rite aid radiant whitearctic mint
arcafter whitening rinse
cleanafnaturalanticavitytoothpaste
listerine total care stain remover anticavity fluoride fresh mint
act anticavity fluoride kids groovy grape
crest complete deep clean
mastic dent oulo action
act kids anticavity fluoridewild watermelon
burstwonderfully whitening anti cavity
pcxx neutral gel mocha capuccino
burts beesdeep clean plus whitening
sodium fluoride 5000 ppm
crest complete pluswhitening deep clean
mipaste one kids blue raspberry
zap apf
aimcavity protection with whitening
kolorz sixty second fluoridecotton candy
thomas and friends
charcoal spearmint
pcxx one minte gel grape explosion
dental clear natural
burkhart neutral
crest 24g and toothbrush dental kit
saltrain clean breath
listerine smart rinse anticavity fluoride rinse-berry splash
nrg apf
therabreath for kids anti cavity oral rinse
kids crestbubblegum flavor
kids creststrawberry rush
orajelkids my way anticavity toothpaste
pine salt
toothpowder
pcxx naf rns mint
colgate ultra fresh
therabreath fresh breath
crest premium plusscope outlast active foam
clinpro 5000
colgate kids maximum cavity protection
colgatemax fresh cool mint
kolorz sixty second fluoridepina colada
colgate maxfresh with mini breath cool mint
sorbet neutral
clinpro tooth creme
amerfresh fluoride
kolorz
denti-care denti-foam
mint fluoride tooth
60 second taste orange twist
oral-b neutra-foam mint
medichoice anticavity fluoride
crest 3d whiteadvanced charcoal
therabreath anticavity
colgate you blue coconut
advance whitetartar control breath freshening
burkhart neutral ph
perioe whitening essentials
hellotis mouthwash
zoobychocolate chow
the humble co anticavity mouthwash charcoal
sodium fluoride 0.243%
amhealer
fluoride drops
kids healthy teeth
pcxx
hebhebuddy
pcxx vanilla orange one minute fm
crest 3d whitebrilliance
theory
crest premium plusscope dual blast active foam
colgate kids space jam
colgate ultra white charcoal
colgate kids trolls
glowing white
dental clinic 2080 k citrus cool mint
60 second taste chocolate vanilla
mojito mint dentistry
crest 3d whiteglamorous white
mintblast anti cavity fluoride
colgate ultra protect
oral-b minute-foam grape punch
pcxx one minte gel marshmallow float
pcxx banana berry apf g
prevident fresh mint
colgate optic white stain fighter fresh mint
total daily repair
treatment rinseapple
giant eagle wintermint with fluoride
crest braces care
made by dentists, inc. alien blood
closys
periosciences white care ao pro
peppermint charcoal anticavity pcft6
neutragard gel strawberry
sodium fluoride 0.24%
crest complete plus
close up
mastic dent whitening
perioe microbiome whiteningcool mint
oralline kids
denticare pro-gel
crest complete pluswhitening herbal mint expressions
western family cavity control
periotherapy healthy gums
pcxx neutral gel watermelon splash
the natural dentistcharcoal whitening fluoride
heb gleaming whitearctic mint
nupro fluoridesmint
perioe microbiome total carestrong mint
listerine total care fresh mint
freshmint premium anticavity
fluoridex
crestbubblegum
crest4in1
prevident orthodefense
made by dentists total care
prevident
alcohol free refreshing mint
crest 3d whitestain eraser polishing mint
mipaste plus strawberry
colgate max clean
fluoride mouthwash soft mint
colgate max fresh cool mint
crest 3d whitestain shield
western family tartar control
spotlight oral care for whitening teeth
act restoring anticavity fluoride cool mint
crest pro-healthadvanced w/extra whitening
luminous white with activated charcoal cwlt
charcoal mint dentistry
zoobygrowlin grrrape
mipaste plus melon
hismile vanilla flavor anticavity
flor-opal sustained-release fluoride
sodium fluoride 5000 ppm dry mouth
jason sea fresh anticavity spearmint
sodium fluroide paste, dentrifice
crest 3d whitedeep clean
country gent
colgate re variety pack
perioe whitening essentials10x charcoal black clean mint
pcxx one minte gel vanilla orange
pcxx neutral foam bazooka bubblegum
brushbuddies shopkins anticavity fluoride
autobrush strawberry
crest 3d white luxe
pure mouth liquid
colgatemax white with mini bright strips crystal mint
colgate enamel health whitening
alorawhitening
mipasteone kids blue raspberry
tropical mint dentistry
zoobyhappy hippo cake
prevident 5000 kids
act anticavity fluoride kids wild watermelon
pcxx strawberry apf g
colgate kids wonder woman alcohol free anticavity bubble fruit
colgate kids
walgreen anticavity whitening
crest complete multi benefitwhitening plus scope minty fresh gel
pcxx anticaries no flavor ne g
detox dr. oral clean care
pcxx no flavor neutral f
60 second gel orange cream
act anticavity fluoride cinnamon
mintblast cool mint flavor anti cavity fluoride tooth
pcxx apf rns strawberry
tanda pearl professional whitening
nafrinse unit dose fluoride
colgate kidsmild bubble fruit flavor
tiger supply inc apf
pcxx mocha cappuccino apf g
kids crestpure strawberry
usepa/opp pesticide code: 75202
nupro fluoridestropical
crest 3d whiteadvanced triple whitening
olidental gargle
plak smacker anti cavity fluoride
colgate kids minions
close up travel
cool sense care plus
wentworth alcohol free
ultrabrite
delixir g toothpaste
crest scope
60 second gel grape
crestsimply clean
mint toothpaste tablets
delta one 2019 tumi collins and tumi collins bombas amenity with crest 3d white brilliance
reach anti cavity fluoride
zero waste fluoride cinnamon tooth tabs
the humble co. kit
colgate 2in1
crestminty breeze
tanners tasty ooh la la orange
western family whitening
the gargle
meijerdry mouth
walgreens scooby doo fluoride gel toothpaste
crest pro-health advanced complete careanticavity fluoride
perioe pop complete protection prebiotic
dr dental care 80ml
colgate you white coconut
sodium fluoride 5000 ppm fruit
2080 k ginger mint
crest 3d whiteultra vivid mint
mipaste plus mint
topical 60 sec sodium fluorideorange cream
heb gleaming white
listerine total care anticavitycinnamint
denti-care denti-foamtopical sodium fluoride mint
crest complete plusextra whitening with tartar protection
pcxx one minte gel cool peppermint
plak smacker great white shark
crest complete pluswhitening scope candy cane
spearmint and peppermint plaque a way fluoride anticavitygentle formulagentle formula
pcxx neutral rns watermelon
aim cavity protectionmulti benefit
60 second taste marshmallow
pure snow whitening
listerine smart rinse anticavity fluoride rinse-pink lemonade flavor
megafresh
quip anticavity
the natural dentistgroovy grape
biotenegentle mint
brisaluminous whitening
colgate max freshadvanced whitening
crest complete multi-benefitwhitening plus scope
act total care dry mouth anticavity mouth
therabreath for kids anticavity strawberry splash
ctx3 rinsecitrus
the humbleco natural fresh mint
dentalux kids mixed berry
unpaste
crest baking soda and peroxidewhitening with tartar protection
vividsensiguard
oral rinses
pcxx watermelon apf g
pcxx vanilla orange neutral gl
colgatetartar control whitening crisp mint
colgate kids hummild bubble fruit flavor
bon scent sparkling tooth wash
glister multi-action
fluoride dental treatment rinse
avon whitening essentialsoriginal cool mint
doctortibletkereale
crest mystic
laura lynn anticavity whitening plus mouthwash
colgate re renew
colgate kids-bubblefruit
orabrite
orajel kidstoothpaste
allday 5000
therabreath plus fresh breath
listerine smart rinse berry splash
crest 3d whitevibrant mint
act whitening anticavity gentle mint
aim cavity protection
pcxx vanilla orange apf g
oral b minute-foamstrawberry
crest 3d white whitening therapygentle care coconut oil
nateanclean and whiten
just right 5000
complete care tartar control
denti-care denti-pro
listerine smart rinse anticavity fluoride rinse-bubble blast
1.1% sodium fluoride toothpaste
scopestay strong
colgate you white fresh mint
denticare denti-pro
hellounicorn splash anticavity fluoride rinse
pcxx one minute cool peppermint
eversmile alignerfresh enamel guard
sherbet
professional whitening system whitening mouth wash
3seconds magic gargle peach
gelato neutral ph
pro gel 5000citrus
peppermint twist
crest 3d whitecharcoal
rembrandt intense stain
acclean plus
hellowild strawberry
oral b neutracare
pcxx mocha cappuccino neutral gl
topical 60 sec sodium fluoridegrape
kit 2
sodium fluoride chewable
topical apf fluoride gel
crest complete multi-benefit
pcxx rootbeer apf g
simply whiteclean mint
burts beescharcoal mint medley
denti-care denti-rinseneutral sodium fluoride oral rinse
kolorz sixty second fluorideblue raspberry
avon whitening essentialsblanc charcoal fresh mint
crest complete plusscope outlast
nupro fluorides naf oral solutionmandarin orange
colgatejunior fresh protect
prevident alcohol free
crest premium plus
mipaste plus tutti frutti
gel 7 neutral topical fluoride gel strawberry
crest 3d white whitening therapy
povi dental care
therabreath toothpaste
soonsoo gargle
avon whitening essentials
aquafreshultimate white
oral b cavity protectionspecial care rinse
crest complete plusactive fresh plus whitening scope
plaque refresh remineralizing rinse fresh mint
colgate max fresh clean mint
handy solutions mint fluoride tooth
60-second fluoridecherry
pcxx wild cherry apf g
pcxx peppermint apf f
hey humans whitening wintermint chill
colgate deep clean fluoride
the humble co natural charcoal
dentalux total care
pcxx pina colada apf g
sorbet rinse
nupro fluorides
colgate phos-flur ortho defense alcohol free anticavity mint fluoride
pcxx apf rns grape
crest 3d white stain eraser
hismile coconut whip flavor anticavity
oralline
crest aligner carecavity defense rinse
brisaawaken refreshed
dental pro
glister multi-action fluoride
smilebar whitening
emmi-dent whitening
gerigentle-good morning
pro gel 5000
luster premium whitenow
crest 3d whiteadvanced whitening
hoo gargle rooibos tea flavor
act kids anticavity fluoride fruit punch
biomin restore plus
crest3d white brilliance luminous purple
crest tartar protectionfresh mint gel
sodium fluoride 1.1%
amerfresh clear
o bits xylitol toothpaste fresh mint flavor
60-second fluoridemint
colgate kids batman alcohol free anticavity mouthwash bat-signal bubble fruit
toms luminous white fluoride clean mintcavity protection / whitening
equate anticavity oral rinse
oral b neutra foammint menthe
gel 7 neutral topical fluoride gel mint
colgate kids hum
neutramaxx 5000 plus turbo
orajel jojo siwa
dental clinic 2080 k strong winter green
arcenamel protection
greenco
sodium fluoride (usp:jan)
amaradvanced whitening
acclean
the humble co. anticavity mouthwash coconut
darby apf strawberry
zero waste fluoride tooth tabs
burts beesextra white
toms luminous white fluoride clean mint
pcxx homegel nf g
eurofresh whitening
dentek looney tunes kidsbubblegum blast
hello kids wild strawberry
crest complete plusscope outlast ultra
whitening plus
act kids anticavity fluoride pineapple punch
kids anticavity
act braces care anticavity
xerostom
professional whitening system whitening
crest complete multi-benefittartar control whitening plus scope
pcxx apf rns bubblegum
colgate double fresh
beyond activated coconut charcoal and sea salt
hismile strawberry flavor anticavity
colgate kids minions mouthwash
spotlight oral care for total care
pcxx creme de menthe apf g
spotlight mouthwash for whitening teeth
kolorz sixty second fluoride foamtriple mint
colgate optic white stain fighterwith baking soda
colgatemax clean effervescent mint
act anticavity fluoride kids bubblegum
sodium fluoride 5000 ppm spearmint
60 second taste bubblegum

Research Excerpts

Overview

18F-sodium fluoride (NaF) is a radiotracer used in PET that reflects calcium metabolism and osteoblastic activity. 18F sodium fluoride PET/CT proves to be a useful tool in the diagnosis of complex spine pathology.

ExcerptReferenceRelevance
"18F- Sodium Fluoride (NaF) is an excellent bone imaging agent used for skeletal staging but can also be localized in extra osseous calcifying lesions. "( Incidental brain metastasis of breast cancer detected on 18F-Sodium Fluoride (NaF) PET-CT.
Ahmed, N; Kandari, FA; Muzaffar, S; Usmani, S, 2020
)
1.31
"18F-sodium fluoride (NaF) is a radiotracer used in PET that reflects calcium metabolism and osteoblastic activity. "( Magnetic resonance imaging-based partial volume-corrected 18F-sodium fluoride positron emission tomography in the femoral neck.
Alavi, A; Ayubcha, C; Borja, AJ; Rajapakse, CS; Raynor, WY; Revheim, ME; Rojulpote, C; Seraj, SM; Werner, TJ, 2021
)
1.42
"F-sodium fluoride (NaF) is a bone-seeking agent that can also localize extraosseous calcifying lesions."( Unsuspected Metastases to Muscles in Osteosarcoma Detected on 18F-Sodium Fluoride PET-CT.
Al Kandari, F; Al Maraghy, M; Bakiratharajan, D; Marafi, F; Rasheed, R; Usmani, S, 2018
)
1.28
"18F-Sodium fluoride is a bone tracer with a high signal-to-noise ratio, but its dosimetry is higher than that of 99mTc-labeled phosphonates at the recommended activities. "( Can we achieve a radionuclide radiation dose equal to or less than that of 99mTc-hydroxymethane diphosphonate bone scintigraphy with a low-dose 18F-sodium fluoride time-of-flight PET of diagnostic quality?
Balogova, S; Chauchat, P; Kerrou, K; Michaud, L; Nataf, V; Ohnona, J; Paycha, F; Talbot, JN, 2013
)
1.15
"Sodium fluoride (Na-F) PET/CT is an imaging technique which allows radiolabeled fluoride to help detect areas of bone turnover. "( Role of sodium fluoride PET imaging for identification of bony metastases in prostate cancer patients.
Hughes, CT; Nix, JW, 2015
)
2.29
"Sodium fluoride (NaF) is a wood preservative with fungicidal activity and antifeedant activity against termites. "( Sodium Fluoride for Protection of Wood Against Field Populations of Subterranean Termites.
Pan, C; Wang, C, 2015
)
3.3
"Sodium fluoride (NaF) is a source of fluoride ions used in many applications. "( The Effect of Sodium Fluoride on Cell Apoptosis and the Mechanism of Human Lung BEAS-2B Cells In Vitro.
Bao, Q; Li, P; Li, S; Liang, J; Lin, S; Mao, Z; Pan, R; Shen, L; Xu, J; Yan, C; Ying, J; Yu, X, 2017
)
2.26
"18F sodium fluoride PET/CT proves to be a useful tool in the diagnosis of complex spine pathology of the postoperative patients. "( Utility of 18F sodium fluoride PET/CT imaging in the evaluation of postoperative pain following surgical spine fusion.
Bakshian, S; Dardashti, S; Manzano, M; Matthews, R; Pouldar, D; Rao, V, 2017
)
1.37
"Sodium fluoride (NaF) is a bone-seeking positron-emitting tracer with high sensitivity and specificity for detection of osseous lesions, particularly osteolytic lesions. "( Atlas of sodium fluoride PET bone scans: atlas of NaF PET bone scans.
Colletti, PM; Sheth, S, 2012
)
2.24
"Sodium fluoride (NaF) is an anion that has been previously shown to block the moulting process of Ascaris suum larvae. "( Fluoride exposure inhibits protein expression and enzyme activity in the lung-stage larvae of Ascaris suum.
Alim, MA; Huang, X; Islam, MK; Miyoshi, T; Motobu, M; Tsuji, N; Yamada, M, 2006
)
1.78
"Sodium fluoride is an enzyme inhibitor and reduces osteoclastic bone resorption and, if the dosage is more than 60 mg a day, may rebuild pseudohaversian bone."( Sodium fluoride therapy.
Berges, J; Bretlau, P; Causse, JB; Causse, JR; Shambaugh, GE; Uriel, J, 1993
)
2.45

Effects

Sodium fluoride treatment has a role to play in preventing the onset and progression of hearing loss in patients suffering from otosclerosis.

Sodium fluoride (NaF) has been used to fluoridate drinking water in the United States since the mid 1940s. Sodium fluoride has been shown to be effective therapy for some patients with vertebral osteoporosis.

ExcerptReferenceRelevance
"Sodium fluoride treatment has a role to play in preventing the onset and progression of hearing loss in patients suffering from otosclerosis."( Otosclerosis 2: the medical management of otosclerosis.
Bajaj, Y; Coatesworth, AP; Uppal, S, 2010
)
1.08
"Sodium fluoride has a similar effect in blood taken from rats to which soman was administered intravenously."( Formation of soman (1,2,2-trimethylpropyl methylphosphonofluoridate) via fluoride-induced reactivation of soman-inhibited aliesterase in rat plasma.
de Jong, LP; van Dijk, C, 1984
)
0.99
"18F-sodium fluoride (18F-NaF) has been used to access aortic stenosis in clinical research setting. "( Aortic valve microcalcification and cardiovascular risk: an exploratory study using sodium fluoride in high cardiovascular risk patients.
Abrunhosa, A; Castelo-Branco, M; Chichorro, N; de Lima, JP; Domingues, C; Gonçalves, L; João Ferreira, M; Oliveira-Santos, M; Silva, R, 2020
)
1.34
"Sodium fluoride (NaF) has been applied to inhibit glycolysis in venous specimens for decades. "( Effect of Addition of WZB117 as an Inhibitor of Glucose Transporter 1 for Venous Blood Glucose Determination.
Ran, Y; Zhang, L; Zhen, Q; Zhu, Y, 2021
)
2.06
"Sodium fluoride (NaF) has been found to interfere with the reproductive system of animals. "( The antagonism of aluminum against fluoride-induced oxidative stress and c-Fos overexpression in rat testes.
Wang, J; Xu, F; Zhang, H; Zhang, K; Zhang, Y, 2014
)
1.85
"Sodium fluoride PET (18F-NaF) has recently reemerged as a valuable method for detection of osseous metastasis, with recent work highlighting the potential of coadministered 18F-NaF and 18F-FDG PET/CT in a single combined imaging examination. "( Detection of osseous metastasis by 18F-NaF/18F-FDG PET/CT versus CT alone.
Gambhir, SS; Iagaru, A; Lutz, AM; Mittra, ES; Mosci, C; Sampath, SC; Willmann, JK, 2015
)
1.86
"Sodium fluoride (NaF) has previously been shown to inhibit recombinant MMP-2 and MMP-9."( NaF Inhibits Matrix-Bound Cathepsin-Mediated Dentin Matrix Degradation.
Altinci, P; Mutluay, M; Pashley, D; Seseogullari-Dirihan, R; Tezvergil-Mutluay, A; Tjäderhane, L, 2016
)
1.16
"F-18 sodium fluoride (NaF) has been used to image inflammation in coronary artery plaques and has low background myocardial uptake."( F-18 sodium fluoride PET/CT does not effectively image myocardial inflammation due to suspected cardiac sarcoidosis.
Bokhari, S; Chen, J; DeLuca, A; Morgenstern, R; Weinberg, RL, 2017
)
1.42
"Sodium fluoride treatment has a role to play in preventing the onset and progression of hearing loss in patients suffering from otosclerosis."( Otosclerosis 2: the medical management of otosclerosis.
Bajaj, Y; Coatesworth, AP; Uppal, S, 2010
)
1.08
"Sodium fluoride (NaF) has been shown to be cytotoxic and produces inflammatory responses in humans. "( Effects of NaF on the expression of intracellular Ca2+ fluxes and apoptosis and the antagonism of taurine in murine neuron.
Haojun, Z; Jin, L; Junling, W; Ke, Z; Yaoling, W, 2012
)
1.82
"Sodium fluoride (NaF) has been shown to be cytotoxic and produces inflammatory responses in humans. "( Involvement of both mitochondrial- and death receptor-dependent apoptotic pathways regulated by Bcl-2 family in sodium fluoride-induced apoptosis of the human gingival fibroblasts.
Choi, NK; Jeong, YJ; Jung, JY; Kim, SH; Kim, WJ; Lee, JH; Park, JH; Yang, KH, 2008
)
2
"Sodium fluoride has a similar effect in blood taken from rats to which soman was administered intravenously."( Formation of soman (1,2,2-trimethylpropyl methylphosphonofluoridate) via fluoride-induced reactivation of soman-inhibited aliesterase in rat plasma.
de Jong, LP; van Dijk, C, 1984
)
0.99
"Sodium fluoride has been demonstrated by spectrophotometric experiment to have an inhibitory effect on the hydrolyzing action of alpha-chymotrypsin. "( Effect of fluoride on alpha-chymotrypsin.
Kacker, SK; Shambaugh, GE, 1980
)
1.7
"Sodium fluoride has for more than 2 decades been a commonly used therapeutic agent for established osteoporosis because of a repeatedly documented anabolic effect on trabecular bone mass. "( Marked decrease in trabecular bone quality after five years of sodium fluoride therapy--assessed by biomechanical testing of iliac crest bone biopsies in osteoporotic patients.
Mosekilde, L; Richards, A; Søgaard, CH,
)
1.81
"Sodium fluoride has been used to treat established osteoporosis for nearly 30 years."( Water fluoridation and osteoporotic fracture.
Coggon, D; Cooper, C; Hillier, S; Inskip, H, 1996
)
1.02
"Sodium fluoride (NaF) has been used to fluoridate drinking water in the United States since the mid 1940s. "( Developmental toxicity of sodium fluoride measured during multiple generations.
Ames, MJ; Black, TN; Collins, TF; Olejnik, N; Rorie, JI; Ruggles, DI; Shackelford, ME; Sprando, RL, 2001
)
2.05
"Sodium fluoride (NaF) has previously been reported to induce a strong IL-8 response in human epithelial lung cells (A549) via mechanisms that seem to involve the activation of G proteins. "( Mechanisms in fluoride-induced interleukin-8 synthesis in human lung epithelial cells.
Låg, M; Refsnes, M; Schwarze, PE; Thoresen, GH; Thrane, EV, 2001
)
1.75
"Sodium fluoride has been shown to be effective therapy for some patients with vertebral osteoporosis. "( Sodium fluoride lacks mitogenic activity for fetal human bone cells in vitro.
Kopp, JB; Robey, PG, 1990
)
3.16
"Sodium fluoride has now been used for 24 years in an effort to slow down or arrest sensorineural hearing nerve deterioration in patients with stapedial otosclerosis or after stapedectomy, as well as in patients with pure cochlear otosclerosis. "( How and when to prescribe sodium fluoride.
Shambaugh, GE, 1989
)
2.02
"Sodium fluoride (NaF) has previously been shown to be clastogenic in vitro in Syrian hamster cells and human fibroblasts."( Extrapolation from in vitro tests to human risk: experience with sodium fluoride clastogenicity.
Roberts, SA; Scott, D, 1987
)
1.23

Actions

Sodium fluoride (NaF) plays an important role in preventing dental caries. It promotes remineralisation and silver nitrate has a profound antimicrobial effect.

ExcerptReferenceRelevance
"Sodium fluoride (NaF) plays an important role in preventing dental caries. "( Micromolar sodium fluoride promotes osteo/odontogenic differentiation in dental pulp stem cells by inhibiting PI3K/AKT pathway.
Li, C; Liu, Z; Xie, X; Xu, S; Zuo, D, 2021
)
2.45
"Sodium fluoride promotes remineralisation and silver nitrate has a profound antimicrobial effect."( Revitalising Silver Nitrate for Caries Management.
Chu, CH; Duangthip, D; Duffin, S; Gao, SS; Lo, ECM; Zhao, IS, 2018
)
1.2
"Sodium fluoride probably promotes oxidative stress in macrophages, which is manifested by a strong increase in ROS synthesis and a decrease in ATP."( Fluoride as a pro-inflammatory factor and inhibitor of ATP bioavailability in differentiated human THP1 monocytic cells.
Baranowska-Bosiacka, I; Baśkiewicz, M; Gutowska, I; Machaliński, B; Marchlewicz, M; Milo, B; Siennicka, A; Stachowska, E; Wiszniewska, B, 2010
)
1.08
"Sodium fluoride and EDTA cause similar depressions in the cell walls but do not reduce budding as much as nystatin."( Calcium, sequestering agents and nystatin--interactions on cell wall morphology and fungistasis of Candida albicans.
Cawson, RA; Pugh, D, 1980
)
0.98
"Sodium fluoride did not inhibit H+ ion secretion induced by histamine."( Stimulation of H+ ion secretion from the isolated mouse stomach by sodium fluoride.
Assem, ES; Wan, BY, 1982
)
1.22
"Sodium fluoride did not inhibit the incorporation of [U-14 C]myo-inositol into inositol-P5."( Studies on avian erythrocyte metabolism. XII. The synthesis and degradation of inositol pentakis (dihydrogen phosphate).
Goldman, PH; Harkness, DR; Isaacks, RE; Johnson, AE; Kim, CY, 1982
)
0.99
"Sodium fluoride promotes the development of significant changes in hepatocytes ultrastructure."( [Morphofunctional characteristics of certain rat liver hepatocytic ultrastructures during prolonged exposure to sodium fluoride].
Lavrushenko, LF; Okunev, VN; Trunov, VI,
)
1.06
"Sodium fluoride was found to inhibit completely the formation of CP."( Cocapropylene (propylcocaine) formation by human liver in vitro.
Bailey, DN,
)
0.85
"Sodium fluoride promotes bone formation."( Radiopacity and fatigue characterization of a novel acrylic bone cement with sodium fluoride.
Baruffaldi, F; Cristofolini, L; Minari, C; Pierotti, L, 2000
)
1.26

Treatment

Sodium fluoride treatment has a role to play in preventing the onset and progression of hearing loss in patients suffering from otosclerosis. Treatment with sodium fluoride inhibited osteoblast proliferation in a dose-dependent fashion and effects were maximal after 120 h incubation.

ExcerptReferenceRelevance
"Sodium fluoride-treated animals showed morphometric and skeletal changes which were more pronounced in the high-dose group showing significantly decreased body weight gain in pregnant mothers and dead/immature fetuses."( Aloe vera protects against fluoride-induced teratogenic effects during pre- and postnatal development in mice.
Bhatnagar, P; Choudhary, S; Mathur, P, 2022
)
1.44
"Sodium fluoride treatment has a role to play in preventing the onset and progression of hearing loss in patients suffering from otosclerosis."( Otosclerosis 2: the medical management of otosclerosis.
Bajaj, Y; Coatesworth, AP; Uppal, S, 2010
)
1.08
"Sodium fluoride treatment at 20mg/kg/day for 29 days by oral gavage resulted in significant diminution in the relative wet weight of the testis, prostate, and seminal vesicle without alteration in the body weight gain."( Testicular toxicity in sodium fluoride treated rats: association with oxidative stress.
Das Sarkar, S; Das, UB; Ghosh, D; Jana, D; Maiti, R,
)
1.16
"Sodium fluoride treatment of osteoporosis is known to stimulate bone formation and to increase bone mass, but recent clinical trials failed to prove its antifracture effectiveness. "( Abnormal bone mineralization after fluoride treatment in osteoporosis: a small-angle x-ray-scattering study.
Abendroth, B; Eschberger, J; Fratzl, P; Klaushofer, K; Roschger, P, 1994
)
1.73
"The sodium fluoride treatment associated to the lack of adrenal androgens are responsible for the onset of pelvic stress fractures which usually occur in elderly subjects."( [Bone complications of fluorotherapy: influence of androgen deficiency].
Aghassian, C; Hartemann, P; Leclère, J; Morel, J; Weryha, G, 1990
)
0.76
"The treatment of sodium fluoride led to different mechanical properties."( In situ structural modification of bacterial cellulose by sodium fluoride.
Al-Ammari, A; Chen, C; Li, W; Lin, J; Sun, B; Sun, D; Wei, F; Xu, X; Zhang, H; Zhang, L, 2020
)
1.13
"Treatment with sodium fluoride inhibited osteoblast proliferation in a dose-dependent fashion and effects were maximal after 120 h incubation."( Effects of sodium fluoride treatment in vitro on cell proliferation, apoptosis and caspase-3 and caspase-9 mRNA expression by neonatal rat osteoblasts.
Chen, Q; Feng, C; Li, W; Lv, L; Smith, GW; Wang, H; Wang, J; Yan, X, 2009
)
1.08
"Treatment with sodium fluoride (orally) together with rational oral hygiene decreases salivary viscosity, values of enamel resistance test, modifies the rate of enamel remineralization, increases the Ca/P coefficient at the expense of decrease in the concentration of inorganic phosphorus, and increases fluorine concentration in the oral fluid."( [The composition and properties of the oral fluid in children taking sodium fluoride tablets who have different levels of oral hygiene].
Satygo, EA, 2000
)
0.88
"Treatment with sodium fluoride did not impair liver function or cholestasis in PBC."( Sodium fluoride prevents bone loss in primary biliary cirrhosis.
del Rio, L; Gómez, R; Guañabens, N; Muñoz, J; Parés, A; Roca, M; Rodés, J, 1992
)
2.07
"Treatment with sodium fluoride increases bone density, but its effect on the incidence of fractures remains uncertain."( Osteoporosis.
MacLennan, WJ, 1990
)
0.62
"Treatment with sodium fluoride, synthetic salmon calcitonin, and 24,25-dihydroxyvitamin D did not result in any apparent benefit."( Fibrogenesis imperfecta ossium with early onset: observations after 20 years of illness.
Jensen, PS; Lang, R; Vignery, AM, 1986
)
0.61

Toxicity

The aims of this study were to: (i) examine the toxic effects of sodium fluoride (NaF) in blood, liver, spleen, and brain cells of Wistar rats after the subacute exposure; (ii) explore the potential protective properties of selenium (Se) against fluoride toxicity.

ExcerptReferenceRelevance
" The other fluorides tested showed no toxic effects in dosages relevant for caries prophylaxis and with oral application."( [Comparison of embryotoxic effects of inorganic fluorides].
Stratmann, KR, 1979
)
0.26
" The results showed that the addition of 10-150 micrograms of NaF per ml of culture medium induced 10-75% cytotoxic effect on hamster V79 cells but had no toxic effect on human EUE cells."( Cytotoxicity and genotoxicity testing of sodium fluoride on Chinese hamster V79 cells and human EUE cells.
Gábelová, A; Ruppová, K; Slamenová, D, 1992
)
0.55
"The LD50 for fluoride was elevated from less than 60 mg F/kg body weight to 172 mg F/kg when magnesium (as MgCl2), equivalent to 3 times that of F, was administered by gavage 30 min after the F dose."( The LD50, excretion and serum and bone levels of F after a high single F and F + Mg dose in rats with findings on cardiac Ca and Mg.
Koskinen-Kainulainen, M; Luoma, H; Tuomisto, J, 1990
)
0.28
"Fasted Sprague-Dawley male rats were used in three experiments to determine the acute LD50 values of fluoride when it was administered intragastrically as NaF, disodium monofluorophosphate (Na2PO3F, MFP) or NaF and MFP."( Acute oral toxicity of sodium fluoride and monofluorophosphate separately or in combination in rats.
Birdsong-Whitford, NL; Finidori, C; Whitford, GM, 1990
)
0.59
" We conclude that intermittent sodium fluoride treatment without 1,25-(OH)2D provides safe and effective treatment of osteoporosis, marked by formation of new adequately mineralized bone, a rise in vertebral bone mass, and reduced frequency of vertebral fractures."( Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures.
Johnson, K; Pak, CY; Parcel, C; Peterson, R; Sakhaee, K; Zerwekh, JE, 1989
)
0.79
" The F treatments had no measurable adverse effects on breeding, gestation, whelping or lactation, although only 14% of the kits whelped by females fed 350 ppm F survived to 3 wk of age."( Chronic toxicity of dietary fluorine to mink.
Aulerich, RJ; Bursian, SJ; Hochstein, JR; Napolitano, AC; Olson, BA, 1987
)
0.27
"In a prospective case controlled study, we evaluated the adverse effects of long-term fluoride ingestion on the gastrointestinal tract."( Toxic effects of chronic fluoride ingestion on the upper gastrointestinal tract.
Das, TK; Dasarathy, S; Gupta, IP; Susheela, AK; Tandon, RK, 1994
)
0.29
" Abundant scientific data accumulated over the years have demonstrated that other than dental fluorosis, there are no known adverse effects of long-term fluoride ingestion for caries prevention."( Fluoride: safety issues.
Li, Y,
)
0.13
" From the results of this study we suggest that an acid environment which supports formation of hydrogen fluoride increases toxic but not mutagenic potencies of sodium fluoride."( Evaluation of mutagenic and cytotoxic effects of sodium fluoride on mammalian cells influenced by an acid environment.
Gábelová, A; Ruppová, K; Slamenová, D; Wsólová, L, 1996
)
0.74
" Our results suggest that the toxic effect of F- on the kidney may be more pronounced in the proximal tubule than the glomeruli region, and that the disorder of the proximal tubule is more serious in the S3 segment than S1 or S2 segment."( Urinary biomarkers monitoring for experimental fluoride nephrotoxicity.
Dote, T; Kono, K; Miyata, K; Nishiura, H; Nishiura, K; Shimahara, M; Sugimoto, K; Usuda, K, 1998
)
0.3
" Over the six-month observation period, the experimental tartar control and the marketed tartar control dentifrices were comparable on adverse event frequency, type or severity, and no subject discontinued treatment due to an oral soft tissue adverse event."( Safety and efficacy of a novel tartar control dentifrice containing 3.3% pyrophosphate: a controlled six-month clinical trial.
Fortna, RH; Gerlach, RW; Schulte, MC; Segreto, VA; Stevens, DP, 1998
)
0.3
" These results indicate that NaF can be toxic to oral mucosal fibroblasts in vitro by its inhibition of protein synthesis, mitochondrial function and depletion of cellular ATP."( Cytotoxicity of sodium fluoride on human oral mucosal fibroblasts and its mechanisms.
Chang, MC; Hahn, LJ; Hsieh, CC; Jeng, JH; Kuo, MY; Lan, WH; Lin, SK, 1998
)
0.65
" Over the 6-month observation period, the sodium hexametaphosphate and the marketed control dentifrices were comparable in terms of adverse event type and severity, and no subject discontinued treatment due to an oral soft tissue adverse event."( Anticalculus efficacy and safety of a novel whitening dentifrice containing sodium hexametaphosphate: a controlled six-month clinical trial.
Baker, R; Gerlach, R; Liu, H; Ramsey, L; Segreto, V; Vastola, K, 2002
)
0.31
" All the toothbrushes tested in this investigation were found to be safe with no evidence of hard or soft tissue trauma."( A 3-month comparative investigation of the safety and efficacy of a new toothbrush: results from two independent clinical studies.
Galustians, HJ; Jacobs, DM; King, DW; Low, MA; Qaqish, JG; Sharma, NC; Weber, DA, 2000
)
0.31
"In order to assess the effect of calcium on the toxic effects of fluoride, adult female Wistar rats were treated with sodium fluoride (NaF, 500 ppm in drinking water) alone or in combination with calcium carbonate (CaCO3, 50 mg/ kg by oral intubation) daily for 60 days."( Modulation of fluoride toxicity in rats by calcium carbonate and by withdrawal of fluoride exposure.
Ekambaram, P; Paul, V, 2002
)
0.52
" The results of this experiment indicate that fluoride at a dose encountered in drinking water in contaminated areas exerts an adverse effect on the male reproductive system and this effect is associated with indicators of oxidative stress."( Testicular toxicity in sodium fluoride treated rats: association with oxidative stress.
Das Sarkar, S; Das, UB; Ghosh, D; Jana, D; Maiti, R,
)
0.44
" Conclusion Fluoride-arsenic exposure has adverse effects on the reproductive system and the development of rats' offspring."( [Toxic effect of fluoride-arsenic on the reproduction and development of rats].
Ling, B; Liu, J; Wang, G; Zhang, C, 2000
)
0.31
" Form Cresol and Cam Phenic reduced the glucose consumption at early stage, possibly due to their toxic effect."( Effect of endodontic agents on cytotoxicity induction by sodium fluoride.
Akahane, K; Hashimoto, K; Kashimata, M; Morshed, SR; Nakamura, Y; Nishikawa, H; Otsuki, S; Sakagami, H; Takayama, F; Tokunaga, T; Yasui, T; Yokote, Y,
)
0.38
" The toxic effect of antibacterial agents was in the order: AgF>JJZ>NaF."( Cytotoxicity of direct current with antibacterial agents against host cells in vitro.
Nakamura, Y; Nishikawa, H; Sakagami, H; Shimetani, A; Takahashi, K, 2005
)
0.33
" Fluoride is one of many methoxyflurane metabolites and may itself cause toxicity and/or reflect formation of other toxic metabolite(s)."( New insights into the mechanism of methoxyflurane nephrotoxicity and implications for anesthetic development (part 2): Identification of nephrotoxic metabolites.
Ensign, D; Kharasch, ED; Liggitt, HD; Schroeder, JL; Whittington, D, 2006
)
0.33
" Because their co-formation is unique to methoxyflurane compared with other volatile anesthetics and they are more toxic than fluoride alone, this suggests a new hypothesis of methoxyflurane nephrotoxicity."( New insights into the mechanism of methoxyflurane nephrotoxicity and implications for anesthetic development (part 2): Identification of nephrotoxic metabolites.
Ensign, D; Kharasch, ED; Liggitt, HD; Schroeder, JL; Whittington, D, 2006
)
0.33
"Toxicity of sodium fluoride added to nutrition products is assessed through peculiarities of kidney tissue culture growth in vitro--over 75% inhibition of cell clumps growth supports high toxic influence of sodium fluoride, the growth decrease from 63% to 74% signifies lower degree, the growth inhibition less than 62% demonstrates very low toxicity of the chemical."( [Justifying the use of primary tissue culture method for evaluation of sodium fluoride safety in nutrition products].
Degteva, GN; Gromova, LE; Nazarenko, NA; Pashchenko, VP, 2007
)
0.95
" Results revealed that curcumin efficiently ameliorates the toxic effect of As and F by reducing the frequency of structural aberrations (>60%), hypoploidy (>50%) and primary DNA damage."( Curcumin supplementation protects from genotoxic effects of arsenic and fluoride.
Rao, MV; Tiwari, H, 2010
)
0.36
"Lycopene administration could minimize the toxic effects of fluoride indicating its free-radical scavenging and powerful anti-oxidant activities."( Efficacy of lycopene against fluoride toxicity in rats.
Mansour, HH; Tawfik, SS, 2012
)
0.38
"To investigate the toxic effect of sodium fluoride (NaF) on the nematode Caenorhabditis elegans (C."( Toxicity of sodium fluoride to Caenorhabditis elegans.
Guan, SW; Li, PF; Li, Q; Wang, LP; Yu, YH; Zhang, SH, 2012
)
1.03
"Long-term excessive fluoride intake is known to be toxic and can damage a variety of organs and tissues in the human body."( Fluoride-elicited developmental testicular toxicity in rats: roles of endoplasmic reticulum stress and inflammatory response.
Chen, Y; Cui, Y; Gao, H; Guan, Z; Jiang, C; Lei, R; Liu, H; Wang, A; Wang, Z; Wu, X; Xia, T; Yang, L; Yu, L; Zeng, Q; Zhang, C; Zhang, S; Zhang, X, 2013
)
0.39
" These findings suggest that fluoride mediate its toxic effects on intestine through oxidative stress and mitochondrial dysfunctions which are further augmented with alcohol consumption and advancing age."( Ethanol and age enhances fluoride toxicity through oxidative stress and mitochondrial dysfunctions in rat intestine.
Chauhan, SS; Mahmood, A; Ojha, S, 2013
)
0.39
"We aimed to investigate of protective role of proanthocyanidin (PA) and vitamin E (vit E) against to toxic effect of formaldehyde (FA)."( Investigation of the protective effects of proanthocyanidin and vitamin E against the toxic effect caused by formaldehyde on the liver tissue.
Bakar, E; Cerkezkayabekir, A; Ulucam, E, 2015
)
0.42
"1 LD50 three times a week up to 18 injections."( Applying theoretical premises of binary toxicity mathematical modeling to combined impacts of chemical plus physical agents (A case study of moderate subchronic exposures to fluoride and static magnetic field).
Gurvich, VB; Katsnelson, BA; Makeyev, OH; Meshtcheryakova, EY; Minigalieva, IA; Panov, VG; Sutunkova, MP; Tsepilov, NA; Valamina, IE; Varaksin, AN, 2016
)
0.43
"At present, very limited studies focus on the toxic effect of sodium fluoride (NaF) on splenic development of human and animals in vivo."( Sodium fluoride (NaF) causes toxic effects on splenic development in mice.
Chen, L; Cui, H; Deng, H; Deng, J; Fang, J; Kuang, P; Wang, X; Zhao, L; Zuo, Z, 2017
)
2.14
" A random-effects model within a Bayesian framework was applied to compare treatment effects as standardized mean difference (SMD) with their corresponding 95% credible interval (CrI), while odds ratio (OR) was applied to compare adverse events with 95% CrI."( Efficacy and safety of medical therapy for low bone mineral density in patients with Crohn disease: A systematic review with network meta-analysis.
Chen, H; Ma, H; Ma, J; Wang, P; Zhang, H; Zhang, Y; Zhao, X; Zhou, C; Zhu, Y, 2017
)
0.46
" For safety assessment, the incidence of adverse events (AEs) demonstrated no statistical difference between agents and placebo."( Efficacy and safety of medical therapy for low bone mineral density in patients with Crohn disease: A systematic review with network meta-analysis.
Chen, H; Ma, H; Ma, J; Wang, P; Zhang, H; Zhang, Y; Zhao, X; Zhou, C; Zhu, Y, 2017
)
0.46
" However, limited information is available on the toxic effects of fluoride exposure on the female reproductive system, especially oocyte maturation."( Sodium fluoride exposure exerts toxic effects on porcine oocyte maturation.
Cui, XS; Liang, S; Nie, ZW; Niu, YJ; Shin, KT; Zhao, M, 2017
)
1.9
" Safety was assessed as adverse events from clinical examination and interview."( Safety and effectiveness of a two-step dentifrice/gel sequence with medication-associated hyposalivation: A randomized controlled trial in a vulnerable population.
Gerlach, RW; Papas, A; Singh, M, 2018
)
0.48
"Excessive exposure to fluoride has adverse effects on neurodevelopment, but the mechanisms remain unclear."( ERK1/2-mediated disruption of BDNF-TrkB signaling causes synaptic impairment contributing to fluoride-induced developmental neurotoxicity.
Chen, J; Dong, L; Li, P; Niu, Q; Wang, A; Xia, T; Xu, C; Zhang, S; Zhao, Q; Zhou, G, 2018
)
0.48
"The present study was undertaken to investigate the toxic effect of sodium fluoride (NaF)- and fluoride (F)-contaminated groundwater on male reproduction and it's reversibility in male rats."( A Comparative Analysis of Fluoride-Contaminated Groundwater and Sodium Fluoride-Induced Reproductive Toxicity and Its Reversibility in Male Rats.
Chaithra, B; Sarjan, HN, 2020
)
1.03
"Exposure of neural cells to harmful and toxic factors promotes oxidative stress, resulting in disorders of metabolism, cell differentiation, and maturation."( Chronic Exposure to Fluoride Affects GSH Level and NOX4 Expression in Rat Model of This Element of Neurotoxicity.
Baranowska-Bosiacka, I; Dec, K; Gutowska, I; Jakubczyk, K; Lubkowska, A; Maciejewska, D; Skonieczna-Żydecka, K; Skórka-Majewicz, M; Styburski, D; Tarnowski, M; Łukomska, A, 2020
)
0.56
"The aims of this study were to: (i) examine the toxic effects of sodium fluoride (NaF) in blood, liver, spleen, and brain cells of Wistar rats after the subacute exposure; (ii) explore the potential protective properties of selenium (Se) against fluoride toxicity after the simultaneous administration."( Genotoxicity of fluoride subacute exposure in rats and selenium intervention.
Antonijević, B; Antonijević-Miljaković, E; Baralić, K; Bulat, Z; Ćurčić, M; Djordjevic, AB; Javorac, D; Kolarević, S; Kostić-Vuković, J; Kračun-Kolarević, M; Mandić, J; Mandinić, Z; Marić, JJ; Milutinović-Smiljanić, S; Radovanović, J; Sunjog, K; Vuković-Gačić, B; Đukić-Ćosić, D, 2021
)
0.86
"High dose of fluoride intake is associated with toxic effects on liver and kidney tissues."( Hesperidin protects liver and kidney against sodium fluoride-induced toxicity through anti-apoptotic and anti-autophagic mechanisms.
Ayna, A; Caglayan, C; Darendelioğlu, E; Kandemir, FM; Küçükler, S, 2021
)
0.88
" Fluoride generates reactive oxygen species and free radicals which induce oxidative stress in target cells and mediate its toxic effects."( 3,4-Dihydroxybenzaldehyde mitigates fluoride-induced cytotoxicity and oxidative damage in human RBC.
Anjum, R; Maheshwari, N; Mahmood, R, 2022
)
0.72
"Fluoride is an element with toxic properties and has been proven to have some adverse effects on many soft tissues, including brain tissue."( Neuromodulatory effects of hesperidin against sodium fluoride-induced neurotoxicity in rats: Involvement of neuroinflammation, endoplasmic reticulum stress, apoptosis and autophagy.
Bayav, İ; Caglayan, C; Çelik, H; Genç, A; Gür, C; Kandemir, FM; Kandemir, Ö; Yıldız, MO, 2022
)
0.98
" Products that pass the non-inferiority test in ACD (surface softening) are proposed as safe for enamel as there is no suggestion from this data that teeth are at risk of tissue loss due to these products."( Application of non-inferiority testing in microhardness and its relationship to erosion: Relevance for hard tissue safety evaluations.
Chen, H; Grender, J; Hornsby, A; Moore, J; Schneiderman, E; St John, S; White, DJ, 2022
)
0.72
" Presently, the studies focusing on the toxic effects of sodium fluoride (NaF) on heart tissue at biochemical and molecular level are limited."( Hesperidin Attenuates Oxidative Stress, Inflammation, Apoptosis, and Cardiac Dysfunction in Sodium Fluoride-Induced Cardiotoxicity in Rats.
Ayna, A; Caglayan, C; Darendelioğlu, E; Genç, A; Kandemir, FM; Kandemir, Ö; Varışlı, B, 2022
)
1.19

Pharmacokinetics

ExcerptReferenceRelevance
" It is suggested that improvements of the clinical benefit of fluoride therapy in osteoporosis might be achieved if the dosage regimen were based on the pharmacokinetic properties of the fluoride preparation used as well as plasma fluoride monitoring."( Fluoride pharmacokinetics: its implications in the fluoride treatment of osteoporosis.
Ekstrand, J; Spak, CJ, 1990
)
0.28
" Pharmacokinetic data should, therefore, form part of the basis for the optimal and safe use of fluoride products."( Pharmacokinetic aspects of topical fluorides.
Ekstrand, J, 1987
)
0.27
"The pharmacokinetic parameters of fluoride have been studied, after a single oral administration to human volunteers of two fluoridated compounds: sodium fluoride, and a new organic fluoride salt, nicomethanol hydrofluoride."( [Blood pharmacokinetics of fluorine in man after the oral administration of nicomethanol hydrofluoride].
Cheymol, G; Mahuzier, G; Poitou, P; Souleau, M, 1984
)
0.47
"9 l/kg, mean resident time (MRT) was 42 and 57 min, and elimination half-life was 34 and 49 min at the 2 and 4 mg/kg dose of COC, respectively."( Pharmacokinetics and metabolism of cocaine in maternal and fetal guinea pigs.
Murphey, LJ; Olsen, GD; Sandberg, JA, 1995
)
0.29
" There were some significant differences in the maximum F concentration, the area under the salivary fluoride concentration curve (AUC) when plotted against time, and the salivary stimulating effect among the four products, but as a whole they were small and probably of minor clinical importance."( Salivary fluoride clearance after a single intake of fluoride tablets and chewing gums in children, adults, and dry mouth patients.
Birkhed, D; Norén, JG; Persson, LG; Sjögren, K, 1993
)
0.29
" The validated method was successfully applied to a pharmacokinetic study in rats after the intratracheal administration of zeylenone in free drug or polymeric micellar solutions."( Stabilization of zeylenone in rat plasma by the presence of esterase inhibitors and its LC-MS/MS assay for pharmacokinetic study.
Chang, Q; Han, R; Hu, X; Liao, YH; Liu, CY; Quan, LH; Wei, XL, 2013
)
0.39

Compound-Compound Interactions

Sodium fluoride tooth protector combined with pit and fissure sealing has better anti-caries effect than the use of pit andfissure sealant alone in preschool children.

ExcerptReferenceRelevance
"The aim was to study the effect of substitution of invert sugar for sucrose, in combination with fluoride varnish (Duraphat) treatment twice a year, on caries development in preschool children."( Effect of partial substitution of invert sugar for sucrose in combination with Duraphat treatment on caries development in preschool children: the Malmö Study.
Birkhed, D; Edwardsson, S; Frostell, G; Goldberg, P; Petersson, LG; Priwe, C; Winholt, AS, 1991
)
0.28
"Clinical pharmacology of slow-release sodium fluoride given with calcium citrate was examined in acute and long-term studies."( Fluoride bioavailability from slow-release sodium fluoride given with calcium citrate.
Adams, B; Bahar, A; Beckley, R; Pak, CY; Parcel, C; Poindexter, J; Sakhaee, K, 1990
)
0.81
"To assess whether an interval of a few hours would be advisable between an intake of sodium fluoride (NaF) and that of calcium salts when treating osteoporotic patients with vertebral collapse, we carried out three pharmacokinetic studies in 12 healthy fasting volunteer subjects to compare the fluoride bioavailability provided by NaF alone and NaF combined with two calcium salts."( Comparative study of fluoride bioavailability following the administration of sodium fluoride alone and in combination with different calcium salts.
Arlot, M; Briançon, D; Chapuy, MC; D'Aranda, P; Duplan, B; Meunier, PJ; Quillet, P, 1990
)
0.73
"76 years, were treated in the course of one year with sodium fluoride (Fluosen) in a dose of 45 mg/24 h in combination with calcium gluconate (2 g/24 h) and oil solution of vit D2 (2 mg/week)."( [Treatment of patients with postmenopausal and steroid-induced osteoporosis using sodium fluoride combined with vitamin D2 and calcium gluconate].
Andreeva, M; Diankova, L; Kamenova, P; Khristova, D; Todorova, S; Tsachev, K, 1990
)
0.75
" The present aim was to study the effects of mouthrinses with CHX and Zn ions combined with fluoride on the viability and glycolytic activity of dental plaque in order to assess the bacteriostatic versus possible bactericidal effects."( Effects of mouthrinses with chlorhexidine and zinc ions combined with fluoride on the viability and glycolytic activity of dental plaque.
Giertsen, E; Scheie, AA, 1995
)
0.29
" The results indicate that mucin in combination with various fluorides seems to affect enamel remineralization significantly."( Effect of mucin alone and in combination with various dentifrices on in vitro Remineralization.
Hopfenmuller, W; Kielbassa, AM; Meyer-Lueckel, H; Umland, N,
)
0.13
"The aim of this in vitro study was to assess the effects of saliva substitutes (modified with respect to calcium, phosphates, and fluorides) in combination with a high-concentrated fluoride toothpaste on demineralised dentin."( Saliva substitute in combination with high-concentrated fluoride toothpaste: effects on demineralised dentin in vitro.
Kielbassa, AM; Sampaio, JE; Tschoppe, P; Zandim, DL, 2010
)
0.36
"Under the conditions of this limited protocol, the combination of Saliva natura solutions slightly saturated with respect to OCP in combination with a high-concentrated fluoride toothpaste enabled remineralisation of dentin in vitro."( Saliva substitute in combination with high-concentrated fluoride toothpaste: effects on demineralised dentin in vitro.
Kielbassa, AM; Sampaio, JE; Tschoppe, P; Zandim, DL, 2010
)
0.36
"To test if a novel dual-phase gel system (calcium silicate and phosphate with 1450 ppmF, as NaF/MFP; TG) combined with a toothpaste (calcium silicate and sodium phosphate with 1450 ppmF, as MFP; TG) was able to re-harden previously acid-challenged enamel to a greater extent than other toothpastes."( Remineralisation effect of a dual-phase calcium silicate/phosphate gel combined with calcium silicate/phosphate toothpaste on acid-challenged enamel in situ.
Gupta, AK; Joiner, A; Naeeni, MM; Schäfer, F; Zero, DT, 2014
)
0.4
"It is concluded that the test regimen based on the novel dual-phase gel system combined with toothpaste was able to re-harden acid-challenged tooth enamel to a greater extent than a normal fluoride toothpaste."( Remineralisation effect of a dual-phase calcium silicate/phosphate gel combined with calcium silicate/phosphate toothpaste on acid-challenged enamel in situ.
Gupta, AK; Joiner, A; Naeeni, MM; Schäfer, F; Zero, DT, 2014
)
0.4
"The objective of this study was to investigate the antibacterial effects on a cariogenic biofilm of a bioactive glass (BAG) combined with either sodium fluoride (NaF) or triclosan (TCS)."( Antimicrobial effects of a bioactive glass combined with fluoride or triclosan on Streptococcus mutans biofilm.
Chen, YM; Shi, SY; Smales, RJ; Wang, MT; Wu, Q; Xu, YT, 2015
)
0.62
"To explore the effect of sodium fluoride tooth protector combined with pit and fissure sealing to prevent caries in preschool children."( [Evaluation of the efficacy of sodium fluoride dental protective agent combined with pit and fissure sealant in prevention of dental caries in preschool children].
Li, J; Zhang, AH, 2019
)
1.1
" Children in the control group were treated with pit and fissure sealant for prevention of caries, while children in the combined group were treated with sodium fluoride tooth protector combined with pit and fissure sealant for caries prevention."( [Evaluation of the efficacy of sodium fluoride dental protective agent combined with pit and fissure sealant in prevention of dental caries in preschool children].
Li, J; Zhang, AH, 2019
)
1
"Sodium fluoride tooth protector combined with pit and fissure sealing has better anti-caries effect than the use of pit and fissure sealant alone in preschool children."( [Evaluation of the efficacy of sodium fluoride dental protective agent combined with pit and fissure sealant in prevention of dental caries in preschool children].
Li, J; Zhang, AH, 2019
)
2.24
"3 µm) irradiation combined with AmF/NaF/SnCl2 solution on prevention and control of erosive tooth wear (ETW) in human enamel."( In situ Effect of CO2 Laser (9.3 μm) Irradiation Combined with AmF/NaF/SnCl2 Solution in Prevention and Control of Erosive Tooth Wear in Human Enamel.
da Silva, CV; de Freitas, PM; Engel, Y; Rechmann, P; Tavares, JP, 2021
)
0.62
"3-µm laser application prevented and controlled ETW progression in human enamel, with greater efficiency when combined with AmF/NaF/SnCl2 solution application."( In situ Effect of CO2 Laser (9.3 μm) Irradiation Combined with AmF/NaF/SnCl2 Solution in Prevention and Control of Erosive Tooth Wear in Human Enamel.
da Silva, CV; de Freitas, PM; Engel, Y; Rechmann, P; Tavares, JP, 2021
)
0.62
"6 μm) combined with a stannous/fluoride-containing solution for preventing erosion in human/bovine enamel."( Effect of CO2 laser combined with AmF/NaF/SnCl2 solution on the prevention of human and bovine enamel erosion.
Engel, Y; Freitas, PM; Mantilla, TF; Ramos-Oliveira, TM; Silva, CVD; Tavares, JP, 2022
)
0.72
" A possible affordable alternative may be Sodium Fluoride (NaF) varnish combined with good oral hygiene promoted by parental Motivational Interviewing (MI)."( Effectiveness of silver diamine fluoride versus sodium fluoride varnish combined with mother's motivational interviewing for arresting early childhood caries: a randomized clinical trial.
Amer, H; Tantawi, ME; Yassin, R, 2023
)
1.43

Bioavailability

The relative bioavailability of enteric-coated sodium fluoride (NaF) tablets (10 mg F-) has been assessed following administration with a standard calcium-rich breakfast or calcium-poor lunch, and 2 h before or s before. The purpose of the present work was to compare the bio availability of structural fluorine contained in sepiolite and in sodium fluoride for laying hens.

ExcerptReferenceRelevance
"The bioavailability of Ossin, a drug for the treatment of osteoporosis, containing 40 mg of NaF, was investigated."( [Biological availability of Ossin, a sodium-fluoride dragee for osteoporosis therapy].
Becker, R, 1979
)
0.26
" This concluded that if efficacy or safety are related to the bioavailability of fluoride, it may be valuable to adjust the dosage of fluoride accordingly to the GFR and BSA."( Effect of age on the disposition of sodium fluoride.
Bannwarth, B; Cuny, G; Gillet, P; Guillaume, M; Jeandel, C; Lapicque, F; Monot, C; Netter, P; Payan, E, 1992
)
0.56
"The aims of this work were (a) to assess the oral bioavailability of fluoride delivered from dentifrices and (b) to test for a possible link between the results and clinical data obtained with the same dentifrices."( Oral fluoride measurements for estimation of the anti-caries efficacy of fluoride treatments.
Duckworth, RM; Gilbert, RJ; Morgan, SN, 1992
)
0.28
" As the bioavailability of sodium fluoride (NaF) can be impaired by concomitant absorption of calcium, both drugs have to be ingested separately."( Bioavailability of fluoride in postmenopausal women: comparative study between sodium fluoride and disodium monofluorophosphate-calcium carbonate.
Bardin, C; Brouard, A; Kuntz, D; Lioté, F; Liou, A; Terrier, JL, 1992
)
0.81
" Fluoride was measured in plasma and urine with a specific electrode and fluoride bioavailability from the three drugs was compared."( [Fluoride bioavailability from sodium fluoride alone or in association with different calcium salts].
Bellony, R; Brazier, M; Desmet, G; Fardelonne, P; Sebert, JL, 1991
)
0.57
" Compared with fluoride from NaF, the relative bioavailability of fluoride from sepiolite was found to be very weak."( Bioavailability of fluoride from dietary sepiolite in the lamb.
Chaso, A; Madrid, JA; Pascual, R; Salido, GM, 1991
)
0.28
" The bioavailability of fluorine was evaluated on the basis of the plasma levels and of the urinary excretion of fluoride."( Bioequivalence of sodium monofluorophosphate with sodium fluoride and compatibility with calcium.
Maurer, H; Setnikar, I, 1990
)
0.53
"The purpose of the present work was to compare the bioavailability of structural fluorine contained in sepiolite and in sodium fluoride for laying hens."( Bioavailability of fluorine in sepiolite for laying hens.
Almirall, M; Angulo, E; Brufau, J; Esteve-Garcia, E; Nogareda, C; Pérez-Vendrell, A, 1990
)
0.49
" It was concluded that a single intravascular fluoride administration (bolus) may be used to evaluate oral bioavailability of fluoride in sheep in toxicity studies."( Fluoride pharmacokinetics in the ewe: a linear pharmacokinetics model.
Charles, E; Joseph-Enriquez, B; Kolf-Clauw, M; Milhaud, G; Toutain, PL, 1990
)
0.28
"003), suggesting that this difference in efficacy and tolerance is related to a better bioavailability of fluoride provided by MFP than by NaF."( Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride.
Chapuy, MC; Delmas, PD; Duboeuf, F; Dupuis, J; Meunier, PJ, 1990
)
0.5
" The bioavailability of conventional plain NaF tablets has been shown to be close to 100, for sustained-release NaF tablets close to 90%, and for enteric-coated NaF tablets 65%."( Fluoride pharmacokinetics: its implications in the fluoride treatment of osteoporosis.
Ekstrand, J; Spak, CJ, 1990
)
0.28
"To assess whether an interval of a few hours would be advisable between an intake of sodium fluoride (NaF) and that of calcium salts when treating osteoporotic patients with vertebral collapse, we carried out three pharmacokinetic studies in 12 healthy fasting volunteer subjects to compare the fluoride bioavailability provided by NaF alone and NaF combined with two calcium salts."( Comparative study of fluoride bioavailability following the administration of sodium fluoride alone and in combination with different calcium salts.
Arlot, M; Briançon, D; Chapuy, MC; D'Aranda, P; Duplan, B; Meunier, PJ; Quillet, P, 1990
)
0.73
" The calcium was also well absorbed as shown by the rise in serum ionized calcium concentration."( Bioavailability of enteric-coated sodium fluoride tablets as affected by the administration of calcium supplements at different time intervals.
Devogelaer, JP; Nagant de Deuxchaisnes, C; Stein, F, 1990
)
0.56
" The bioavailability was evaluated on the basis of the plasma levels and of the urinary excretion of fluoride."( Relative bioavailability of fluoride from monofluorophosphate tablets after single oral administration.
Maurer, H; Setnikar, I, 1990
)
0.28
" These data show that iodine released by amiodarone has a bioavailability different from that of NaI."( Changes in 127I mice thyroid follicle studied by analytical ion microscopy: a key for the comprehension of amiodarone-induced thyroid diseases.
Briançon, C; Fragu, P; Halpern, S; Telenczak, P, 1990
)
0.28
"The relative bioavailability of enteric-coated sodium fluoride (NaF) tablets (10 mg F-) has been assessed following administration with a standard calcium-rich breakfast or calcium-poor lunch, and 2 h before or simultaneously with antacid administration (2."( Influence of food and antacid administration on fluoride bioavailability from enteric-coated sodium fluoride tablets.
Arnold, P; Biollaz, J; Chapuy, MC; Grandjean, EM; Meunier, PJ; Schelling, JL; Wermeille, M, 1989
)
0.75
"3% triclosan/PVM/MA copolymer/NaF test dentifrice provided effective delivery and bioavailability of the antiplaque agent, triclosan."( Salivary and plaque triclosan levels after brushing with a 0.3% triclosan/copolymer/NaF dentifrice.
Afflitto, J; Fakhry-Smith, S; Gaffar, A, 1989
)
0.28
"The aim of the present work was to study the usefulness of disodium monofluorophosphate (MFP) as a milk-fluoridating agent by measuring the bioavailability of F from MFP in milk relative to that of F from NaF in water."( Fluoride bioavailability from disodium monofluorophosphate fluoridated milk in children and rats.
Cisternas, P; Guerrero, S; Monckeberg, F; Villa, A, 1989
)
0.28
" Bioavailability of F from bone-meal, calcium and CaF2 tablets was evaluated in relation to that of NaF."( Factors influencing the bioavailability of fluoride from calcium-rich, health-food products and CaF2 in man.
Einwag, J; Trautner, K, 1987
)
0.27
" The results showed a less-than-20% bioavailability of fluoride when administered with calcium-rich food."( Fluoride pharmacokinetics in the domestic pig.
Ekstrand, J; Fejerskov, O; Richards, A, 1982
)
0.26
" In contrast, there was no difference in the areas under the curves, indicating that the relative bioavailability of fluoride is the same in all preparations."( [Bioavailability of monofluoride preparations for dental caries prophylaxis (author's transl)].
Férault-Larue, DH; Fuchs, C; Heimann, G, 1980
)
0.26
"This investigation was done to determine the bioavailability of fluoride (F) after toothbrushing associated with different water rinsing procedures."( Effect of water rinsing after toothbrushing on fluoride ingestion and absorption.
Birkhed, D; Ekstrand, J; Sjögren, K, 1994
)
0.29
" The authors cannot conclude as to which of the two types of fluoride exhibits the best bioavailability because their absorption coefficients have not been determined."( [Pharmacokinetics of fluorine contained in the Royale Saint-Yorre mineral water].
Barbey, E; Chevrel, G; Meunier, PJ, 1993
)
0.29
"Since fluoride dentifrices first became available over 30 years ago many formulation changes regarding fluoride type, concentration and abrasive systems have occurred to improve stability, compatibility, and also bioavailability of active ingredients."( Dentifrices: recent clinical findings and implications for use.
Stephen, KW, 1993
)
0.29
" Thus, it may be hypothesized that the high bone fluoride uptake is due to different individual responses from one patient to another concerning the bioavailability of the same dose of fluoride."( Relationship between bone fluoride content and histological evidence of calcification defects in osteoporotic women treated long term with sodium fluoride.
Boivin, G; Chapuy, MC; Duriez, J; Flautre, B; Hardouin, P; Meunier, PJ, 1993
)
0.49
" Since the rate of absorption is also strongly influenced by the rapidity of gastric emptying, we have compared the relative importance of gastric acidity and gastric emptying in overall F absorption."( Influence of gastric acidity on fluoride absorption in rats.
Messer, HH; Ophaug, RH, 1993
)
0.29
"This paper reports a reassessment of the bioavailability of fluoride from monofluorophosphate (MFP, CAS 10163-15-2)."( Bioavailability of fluoride administered as sodium fluoride or sodium monofluorophosphate to human volunteers.
Morosano, M; Puche, RC; Rigalli, A, 1996
)
0.56
"The absolute bioavailability and other pharmacokinetic parameters of two fluoride formulations were investigated in 13 healthy volunteers, aged 61-70 years."( Absolute bioavailability of fluoride from disodium monofluorophosphate and enteric-coated sodium fluoride tablets.
Duursma, SA; Glerum, JH; van Asten, P; van Dijk, A; van Rijn, HJ; Ververs, FF, 1996
)
0.52
" MFP had significantly higher bioavailability [102."( Absolute bioavailability of fluoride from disodium monofluorophosphate and enteric-coated sodium fluoride tablets.
Duursma, SA; Glerum, JH; van Asten, P; van Dijk, A; van Rijn, HJ; Ververs, FF, 1996
)
0.52
"The MFP formulation showed higher bioavailability with smaller variation than the NaFor formulation."( Absolute bioavailability of fluoride from disodium monofluorophosphate and enteric-coated sodium fluoride tablets.
Duursma, SA; Glerum, JH; van Asten, P; van Dijk, A; van Rijn, HJ; Ververs, FF, 1996
)
0.52
" With this in mind, the bioavailability of the drug has to be taken into account, particularly its gastrointestinal absorption which is dramatically enhanced if a plain non entericoated (EC) capsule is used, as compared to that of an EC tablet with the same face value."( Fluoride therapy of type I osteoporosis.
Devogelaer, JP; Nagant de Deuxchaisnes, C, 1995
)
0.29
" This study attempts to add to the understanding of the systemic bioavailability of fluoride ingested with milk compared with water, by measuring its uptake into developing incisors of sheep."( Fluoride uptake into the developing enamel and dentine of sheep incisors following daily ingestion of fluoridated milk or water.
Coote, GE; Cutress, TW; Gao, J; Suckling, GW, 1996
)
0.29
" The results of the present studies demonstrated that salifluor is an effective antiplaque agent in mouthrinse and dentifrice when carefully formulated to maximize its delivery and bioavailability on oral surfaces."( In vitro and in vivo studies on salifluor/PVM/MA copolymer/NaF combination as an antiplaque agent.
Afflitto, J; Furuichi, Y; Gaffar, A; Kashuba, B; Lucchesi, S; Nabi, N, 1996
)
0.29
"According to previous pharmacokinetic studies the bioavailability of fluorine (F) from sodium monofluorophosphate (MFP) doubles that of sodium fluoride (NaF)."( In postmenopausal osteoporosis the bone increasing effect of monofluorophosphate is not dependent on serum fluoride.
Bocanera, R; Masoni, A; Morosano, M; Pera, L; Puche, RC; Rigalli, A; Tozzini, R, 1999
)
0.51
" MFP and P-NaF showed greater bioavailability than Neosten and much higher Cmax that exceeded the toxic threshold of Fser (190 ng/ml)."( A comparison of fluoride bioavailability from a sustained-release NaF preparation (Neosten) and other fluoride preparations.
Gitomer, WL; Pak, CY; Sakhaee, K, 2000
)
0.31
" The beneficial effect observed in the T group compared with the C group was apparently mostly due to the administration mode via FAP, which could prolong the intra-oral bioavailability of the prophylactic preparation."( Efficacy of a slow-release device containing fluoride, xylitol and sorbitol in preventing infant caries.
Aaltonen, AS; Inkilä-Saari, I; Suhonen, JT; Tenovuo, J, 2000
)
0.31
" The bioavailability of fluoride from these diets was evaluated in relation to that of sodium fluoride in solution form."( Bioavailability of fluoride in humans from commonly consumed diets in India.
Gauba, K; Goyal, A; Tewari, A, 1998
)
0.52
" It is therefore conceivable that any alteration of the gastrointestinal motility can affect the rate of absorption of fluoride and leads to aggravation of its toxic effects."( Effect of sodium fluoride on gastric emptying and intestinal transit in mice.
Amira, S; Gharzouli, K; Soufane, S, 2005
)
0.73
"This work presents a study of the bioavailability and distribution of fluoride in tissues of animals (Wistar rats) which were fed with a poultry feeding that contains sepiolite as an additive."( Determination of bioavailable fluoride from sepiolite by "in vivo" digestibility assays.
Hernández, L; Quintana, MC; Suárez, P, 2008
)
0.35
"Post-brushing water rinsing may reduce the risk of fluoride (F) ingestion from dentifrice, however the decreased salivary F bioavailability may compromise any consequent anticaries benefits."( Low-fluoride dentifrice and the effect of postbrushing rinsing on fluoride availability in saliva.
Cury, JA; Tenuta, LM; Zamataro, CB, 2008
)
0.35
"This study evaluated the bioavailability of fluoride after topical application of a dual-fluoride varnish commercially available in Brazil, when compared to Duraphat."( Urinary fluoride output in children following the use of a dual-fluoride varnish formulation.
Bijella, MF; Buzalaf, MA; Cardoso, VE; Delbem, AC; Olympio, KP; Pessan, JP,
)
0.13
" According to the highly individual profile of fluoride in saliva and plaque, both levels of bioavailability correlated for the first 30 minutes, and the fluoride content of saliva and plaque was back to baseline after 6 hours."( Fluoride bioavailability in saliva and plaque.
Arnold, WH; Gaengler, P; Hertenstein, P; Jordan, RA; Kuehnl, P; Markovic, L; Naumova, EA, 2012
)
0.38
" However, no significant difference in bioavailability between NaF and amine fluoride, in saliva, or in plaque was found."( Fluoride bioavailability in saliva and plaque.
Arnold, WH; Gaengler, P; Hertenstein, P; Jordan, RA; Kuehnl, P; Markovic, L; Naumova, EA, 2012
)
0.38
" High-F dentifrice enhanced the bioavailability of salivary F, being an option for caries management in patients with high caries risk."( Salivary fluoride levels after use of high-fluoride dentifrice.
Bohn, AC; Cruz, PF; de Moura, MS; Vale, GC, 2015
)
0.42
"It was the aim of this study to investigate differences in fluoride bioavailability in different oral areas after the application of amine fluoride (AmF) and sodium fluoride (NaF)."( Dynamics of Fluoride Bioavailability in the Biofilms of Different Oral Surfaces after Amine Fluoride and Sodium Fluoride Application.
Arnold, WH; Dickten, C; Jung, R; Krauss, F; Naumova, EA; Rübesamen, H; Sandulescu, T; Schmütsch, K; Zimmer, S, 2016
)
0.85
" In salivary sediment bioavailability of fluoride lasted longer after application of fluoridated bioactive glass."( Randomized investigation of the bioavailability of fluoride in saliva after administration of sodium fluoride, amine fluoride and fluoride containing bioactive glass dentifrices.
Arnold, WH; Hill, RG; Kouji, O; Modric, J; Naumova, EA; Pierchalla, T; Rybka, M; Staiger, M, 2019
)
0.73
"Toothbrushing with the fluoride containing bioactive glass dentifrices had positive effects on the fluoride bioavailability within two hours."( Randomized investigation of the bioavailability of fluoride in saliva after administration of sodium fluoride, amine fluoride and fluoride containing bioactive glass dentifrices.
Arnold, WH; Hill, RG; Kouji, O; Modric, J; Naumova, EA; Pierchalla, T; Rybka, M; Staiger, M, 2019
)
0.73
" TSF concentration (µg F/mL) in TR was determined as an indicator of fluoride bioavailability during toothbrushing and the areas under curves of saliva fluoride concentration versus time (area under the curve, AUC = µg F/mL × min) were calculated as an indicator of fluoride bioavailability after toothbrushing."( Chemically Soluble Fluoride in Na2FPO3/CaCO3-Based Toothpaste as an Indicator of Fluoride Bioavailability in Saliva during and after Toothbrushing.
Coelho, CSS; Cury, JA; Tabchoury, CPM, 2020
)
0.56
"The aim of this in vitro study was to determine the fluoride concentration in silver diamine fluoride (SDF) products and their bioavailability with demineralized dentine."( Fluoride Concentration in SDF Commercial Products and Their Bioavailability with Demineralized Dentine.
Cury, JA; Soares-Yoshikawa, AL; Tabchoury, CPM, 2020
)
0.56
"HCl significantly improved the fluoride bioavailability in CFDs (p<0."( Enhanced Fluoride Bioavailability with Incorporation of Arginine in Child Dentifrices.
Bijle, MN; Carey, CM; Ekambaram, M; Lo, ECM; Tsoi, J; Yiu, CKY, 2020
)
0.56
" Incorporating arginine (L-arginine or L-arginine monohydrochloride) at 2% w/w improves fluoride bioavailability of the child formula dentifrices."( Enhanced Fluoride Bioavailability with Incorporation of Arginine in Child Dentifrices.
Bijle, MN; Carey, CM; Ekambaram, M; Lo, ECM; Tsoi, J; Yiu, CKY, 2020
)
0.56
"The use of fluoridated dentifrices is recognized as the main reason for the decline of dental caries and its effect is associated with the bioavailability of fluoride (F) in the oral cavity."( Nocturnal Salivary Fluoride Bioavailability After Brushing with a High-fluoride Dentifrice.
Carvalho, GAO; de Sousa Lopes, MS; Macena, NS; Mota, BIS; Prado, VLG; Santana, GB; Vale, GC, 2022
)
0.72
" Mouth rinses with 226 ppm F as NaF and low pH presented significantly greater bioavailability of fluoride on enamel than those with higher pH or lower NaF concentration."( Fluoride bioavailability on demineralized enamel by commercial mouth rinses.
Botelho, JN; Cury, JA; Giacaman, RA; Pedro Ricomini-Filho, A; Tabchoury, CPM; Valdivia-Tapia, AC,
)
0.13
" This finding was concurrent with significantly increased serum bioavailability of nitric oxide in the hypertensive rats treated with L-arginine and lisinopril."( L-arginine and lisinopril supplementation protects against sodium fluoride-induced nephrotoxicity and hypertension by suppressing mineralocorticoid receptor and angiotensin-converting enzyme 3 activity.
Adedapo, AA; Adedapo, AD; Adejumobi, OA; Adetona, MO; Ajibade, TO; Aro, AO; Awodele, OA; Kayoka-Kabongo, PN; McGaw, LJ; Nkadimeng, SM; Oguntibeju, OO; Ola-Davies, OE; Omobowale, TO; Oyagbemi, AA; Saba, AB; Tijani, MO; Yakubu, MA, 2023
)
1.15

Dosage Studied

Sodium fluoride (NaF), activator of G-binding proteins, and ouabain, inhibitor of Na+/H+ pump, increased levels of IL-6 mRNA. Sodium fluoride is an enzyme inhibitor and reduces osteoclastic bone resorption.

ExcerptRelevanceReference
" In the described series of investigations this compound, with which treatment by gradual dosage is possible, has proved its effectiveness."( [Sodium fluoride in the therapy of osteoporosis].
Krokowski, E, 1979
)
1.17
" Less fluoride was deposited in teeth and bone from AIF6, than from NaF at all dosage levels."( Dental fluorosis as related to the concentration of fluoride in teeth and bone.
Aasenden, R; Bakhos, Y; Brudevold, F, 1978
)
0.26
" Daily dosage was 50-100 mg."( [Treatment of osteoporosis with a delayed-action sodium fluoride preparation].
Chlud, K,
)
0.39
" Older tooth germs were less affected overal when incubated at the same fluoride dosage and time of treatment."( Regeneration of tooth development in vitro following sodium fluoride treatment.
Kerley, MA; Kollar, EJ, 1977
)
0.51
" The in vitro dose-response curves of norepinephrine and dopamine were similar in both groups of animals."( Adenylate cyclase activity in corpus striatum of rats with porto-caval anastomosis.
Geisler, A; Klysner, R; Laursen, H, 1977
)
0.26
" This concluded that if efficacy or safety are related to the bioavailability of fluoride, it may be valuable to adjust the dosage of fluoride accordingly to the GFR and BSA."( Effect of age on the disposition of sodium fluoride.
Bannwarth, B; Cuny, G; Gillet, P; Guillaume, M; Jeandel, C; Lapicque, F; Monot, C; Netter, P; Payan, E, 1992
)
0.56
" The results of this study suggest that the new rinse may provide a greater cariostatic effect at the same fluoride dosage than does a NaF rinse."( In vivo fluoride concentrations measured for two hours after a NaF or a novel two-solution rinse.
Carey, CM; Chow, LC; Mao, Y; Takagi, S; Vogel, GL, 1992
)
0.28
", dose-response effects."( Sample size considerations in designing studies with intra-oral models.
Beiswanger, BB; Dunipace, AJ; Katz, BP; Stookey, GK, 1992
)
0.28
" Plaque fluoride measured after four weeks' daily use of the dentifrices exhibited similar dose-response behavior."( Oral fluoride measurements for estimation of the anti-caries efficacy of fluoride treatments.
Duckworth, RM; Gilbert, RJ; Morgan, SN, 1992
)
0.28
" Further, dose-response studies showed that sodium fluoride (NaF), activator of G-binding proteins, and ouabain, inhibitor of Na+/H+ pump, increased levels of IL-6 mRNA."( Role of lymphotoxin in expression of interleukin 6 in human fibroblasts. Stimulation and regulation.
Adelman, DC; Akashi, M; Koeffler, HP; Loussararian, AH; Saito, M, 1990
)
0.54
" The lipopeptides N-palmitoyl-(S)-[2,3-bis(palmitoyloxy)-(2RS)- propyl]-(R)-cysteinylalanylglycine, N-palmitoyl-(S)-[2,3-bis(palmitoyloxy)- (2RS)-propyl]-(R)-cysteinylseryl-lysyl-lysyl-lysine and (S)-(1,2- dicarboxyhexadecyl)ethyl-N-palmitoylcysteinylseryl-lysyl-lys yl-lysine stimulated both parameters, but the maximal effects on nitrite formation and the shape of the dose-response curves did not parallel the effects on [Ca2+]i."( Induction and activity of NO synthase in bone-marrow-derived macrophages are independent of Ca2+.
Bessler, W; Busse, R; Hauschildt, S; Kohler, J; Lückhoff, A; Mülsch, A, 1990
)
0.28
"Relationships between the fluoride dosage administered to weanling New Zealand white male rabbits and some mechanical properties of the compact bone were investigated for a wide range of dosages."( Effect of fluoride dosage on bone density, sonic velocity, and longitudinal modulus of rabbit femurs.
Hanson, DB; Lees, S, 1992
)
0.28
" PGF2 alpha also increased inositol phosphate formation, with a time course and dose-response consistent with its ability to increase [Ca2+]i."( Mobilization of extracellular Ca2+ by prostaglandin F2 alpha can be modulated by fluoride in 3T3-L1 fibroblasts.
Crooke, ST; Nakada, MT; Stadel, JM, 1990
)
0.28
" It is suggested that improvements of the clinical benefit of fluoride therapy in osteoporosis might be achieved if the dosage regimen were based on the pharmacokinetic properties of the fluoride preparation used as well as plasma fluoride monitoring."( Fluoride pharmacokinetics: its implications in the fluoride treatment of osteoporosis.
Ekstrand, J; Spak, CJ, 1990
)
0.28
" The correct dosage must be determined based on patient age and fluoride content of the patient's main water source(s)."( Dietary fluoride supplements for Ohio children--the role of the physician.
Benninger, G; Kuthy, RA; Levy, SM; Quilty, JF, 1990
)
0.28
" DA was less potent than VIP, and stimulated cyclase activity with a monophasic dose-response curve."( Interactions between vasoactive intestinal peptide and dopamine in the rabbit retina: stimulation of a common adenylate cyclase.
Lam, DM; Pachter, JA, 1986
)
0.27
" At 6 h post DE, there were no differences between the dose-response curves obtained from aortic rings with or without endothelium."( Effect of endothelium removal on stimulatory and inhibitory modulation of rat aortic prostacyclin synthesis.
Dandona, P; Jeremy, JY, 1989
)
0.28
" BGP was determined before and after administering sodium fluoride at a dosage of 50 mg/day/15 days to three groups: 14 patients with insulin-dependent diabetes, 16 diabetics on oral antidiabetic treatment, and 25 controls, all of similar age, sex, and characteristics."( Suggestion of a deficient osteoblastic function in diabetes mellitus: the possible cause of osteopenia in diabetics.
Cabranes, JA; Gomez-Castresana, F; Hernandez, ER; Rico, H, 1989
)
0.53
" Dose-response curves to carbachol and 5-HT showed that lithium treatment reduced the maximal agonist response without altering the EC50 value."( Subacute and chronic in vivo lithium treatment inhibits agonist- and sodium fluoride-stimulated inositol phosphate production in rat cortex.
Godfrey, PP; Grahame-Smith, DG; McClue, SJ; White, AM; Wood, AJ, 1989
)
0.51
" Dose-response studies revealed a dose-dependent increase in beta-adrenergic receptor-stimulated cAMP production."( Glucocorticoid administration increases receptor-mediated and forskolin-stimulated cyclic AMP accumulation in rat brain cerebral cortical slices.
Duman, RS; Enna, SJ; Strada, SJ, 1989
)
0.28
" Ethanol (300 mM) reduced the lag period for [3H]inositol phosphate accumulation at submaximal GTP[S] concentrations and caused a shift to the left (3-fold) in the dose-response curve."( Short chain alcohols activate guanine nucleotide-dependent phosphoinositidase C in turkey erythrocyte membranes.
Hager, R; Rooney, TA; Rubin, E; Thomas, AP, 1989
)
0.28
" A dose of 5 mg/kg of AMPH, but not 1 mg/kg of AMPH, caused a 2-fold shift to the right in the dose-response curve for DA in stimulating AC activity when compared with saline controls."( Desensitization of rat striatal dopamine-stimulated adenylate cyclase after acute amphetamine administration.
Barnett, JV; Kuczenski, R, 1986
)
0.27
" At the agonal stage, the isoproterenol dose-response curve was shifted significantly to the right in myocardial membranes from endotoxic rats, but there was no significant decrease in maximum stimulated activity."( Alterations in beta-adrenergic stimulation of myocardial adenylate cyclase in endotoxic rats.
Jones, SB; Romano, FD, 1986
)
0.27
" The link between phospholipase C activation and these early events of the mitogenic response is demonstrated by the similarity of all dose-response curves for NaF and AlCl3 and by the common sensitivity of the four events to pertussis toxin."( Coupling between phosphoinositide breakdown and early mitogenic events in fibroblasts. Studies with fluoroaluminate, vanadate, and pertussis toxin.
Chambard, JC; Paris, S; Pouysségur, J, 1987
)
0.27
" The dose-response profiles for the effects of the beta gamma T complex on the rate and extent of the GTP gamma S-stimulated fluorescence enhancement of alpha T have also been examined."( The intrinsic fluorescence of the alpha subunit of transducin. Measurement of receptor-dependent guanine nucleotide exchange.
Cerione, RA; Phillips, WJ, 1988
)
0.27
" Moreover, the dose-response effects of NaF on arachidonate release and DG formation were different."( Differential sensitivity of arachidonic acid release and 1,2-diacylglycerol formation to pertussis toxin, GDP beta S and NaF in saponin-permeabilized human platelets: possible evidence for distinct GTP-binding proteins involving phospholipase C and A2 act
Hattori, H; Nakashima, S; Nozawa, Y; Shirato, L; Takenaka, A, 1987
)
0.27
" The NaF-PGI2 dose-response curve was moved to the left by the presence of adrenaline, phorbol 12,13-dibutyrate (PDBU) and the Ca2+ ionophore A23187 in the incubation media."( Fluoride stimulates in vitro vascular prostacyclin synthesis: interrelationship of G proteins and protein kinase C.
Dandona, P; Jeremy, JY, 1988
)
0.27
" However, the incidence of micronucleated polychromatic erythrocytes in male AP rats dosed 1000 mg/kg NaF (the maximum tolerated dose over 24 h) or 500 mg/kg NaF was similar to that in the animals dosed distilled water (vehicle control)."( Sodium fluoride and chromosome damage (in vitro human lymphocyte and in vivo micronucleus assays).
Albanese, R, 1987
)
1.72
" Sixteen hours of treatment with high concentrations of sodium fluoride did not induce resistance to ouabain, but resulted in some significant induction of 6-thioguanine, 1-beta-D-arabinofuranosyl cytosine and methotrexate resistance, although the results were variable between experiments and no dose-response was observed."( The mutagenicity of sodium fluoride to L5178Y [wild-type and TK+/- (3.7.2c)] mouse lymphoma cells.
Bridges, BA; Cole, J; Muriel, WJ, 1986
)
0.84
" The structural manifestations in pulmonary tissue were more progressive with the subsequent increase in the dosage of fluoride."( Pulmonary damage caused by fluoride in rabbits during experimental fluorosis.
Singh, JP; Thapar, SP, 1988
)
0.27
" Further analysis of the effects of low mol wt fraction on hCG stimulation of adenylyl cyclase indicated that enzyme inhibition was not accompanied by a shift in the hCG concentration required for half-maximal stimulation (the apparent activation constant) compared to dose-response curves obtained in the absence of added fraction."( Inhibition of luteinizing hormone/human chorionic gonadotropin-stimulable adenylyl cyclase activity in rat luteal membranes by nonsteroidal component(s) in human follicular fluid.
Asch, RH; Cammack, JT; Ellsworth, LR; Rojas, FJ; Ruetzel, C, 1986
)
0.27
" Rabbits were dosed orally, for 30 days, with fluoride at 2, 10 or 20 mg per kg body weight as sodium fluoride."( Levels of lactate dehydrogenase and creatine kinase in plasma of fluoride-treated rabbits.
Matović, V; Nedeljković, M; Soldatović, D, 1985
)
0.49
" However, the dose-response curve for the GppNHp-dependent increase in [3H]forskolin binding sites is shifted to lower concentrations in the presence of prostaglandin E1."( Regulation of [3H]forskolin binding to human platelet membranes by GppNHp, NaF, and prostaglandin E1.
Nelson, CA; Seamon, KB, 1985
)
0.27
"In view of controversial findings regarding the mechanism for the increased intracellular hepatic cyclic 3':5' adenosine monophosphate levels in diabetic rats, we studied the dose-response relationship of the adenylate cyclase to glucagon stimulation in severely diabetic and in diabetic, insulin-treated rats."( Increased dose-response relationship of liver plasma membrane adenylate cyclase to glucagon stimulation in diabetic rats. A possible role of the guanyl nucleotide-binding regulatory protein.
Allgayer, H; Bachmann, W; Hepp, KD, 1982
)
0.26
"Three types of sustained and controlled release dosage forms of sodium fluoride (NaF) for the prevention of dental caries are reviewed."( The use of controlled and sustained release agents in dentistry: a review of applications for the control of dental caries.
Mirth, DB, 1980
)
0.5
"Fifteen patients with multiple myeloma were treated with sodium fluoride (50 mg twice daily) plus calcium carbonate (1 g four times daily) or with the same fluoride-calcium dosage plus vitamin D (50,000 U twice weekly)."( Effect of sodium fluoride, calcium carbonate, and vitamin D on the skeleton in multiple myeloma.
Jowsey, J; Kyle, RA, 1980
)
0.91
" From this information and the dose-response relationship for survival of NF and repair deficient cells we can determine the mean number of adducts required to produce a potentially lethal lesion and the effective time available for repair."( A model for the effect of excision repair on the survival of human cells exposed to chemical carcinogens.
Heflich, RH; Miller, JH, 1982
)
0.26
" Based on the available data an advice was given for the dosage of NaF in patients with osteoporosis."( Fluoride in serum and bone during treatment of osteoporosis with sodium fluoride, calcium and vitamin D.
Backer Dirks, O; Duursma, SA; van der Sluys Veer, J; van Kesteren, RG; Visser, WJ, 1982
)
0.5
" The dose-response curve for ethanol activation of basal adenylate cyclase activity was shifted to the right for enzyme obtained from mice chronically treated with ethanol."( Effects of ethanol on Arrhenius parameters and activity of mouse striatal adenylate cyclase.
Hoffman, PL; Tabakoff, B, 1982
)
0.26
" Sodium fluoride in moderate therapeutic dosage possibly can retard or completely inhibit the activity of bone-resorbing enzymes in the otospongiotic focus, thus retarding or arresting active expansion of a focus and resulting in stabilizing or arresting the progression of sensorineural hearing loss that is associated with otospongiosis."( Effect of fluoride on alpha-chymotrypsin.
Kacker, SK; Shambaugh, GE, 1980
)
1.17
" The dosage of 500 mg daily is much less than that which produces fluorosis after prolonged treatment; it suggests a trial of niflumic acid in the treatment of osteoporosis, respecting naturally the contra-indications, and supervising the digestive tract as always with anti-inflammatory drugs."( [Change in the plasma and urine levels of ionized fluorine under the influence of low doses of niflumic acid. Possible application to the treatment of osteoporosis].
Audran, M; Boiteau, HL; Caumon, JP; Prost, A; Rossel-Renac, F, 1980
)
0.26
" Increasing concentrations of NaF (5, 10, 15 ppm F), Na-Silicofluoride, or NaMFP showed similar caries-inhibiting effects without remarkable influence of the fluoride dosage used."( The effects of non-fluoridated and fluoridated milk on experimental caries in rats.
Grosser, W; Kneist, S; Stösser, L, 1995
)
0.29
" They were dosed by drinking water to mimic human exposure to fluoridated water."( Developmental toxicity of sodium fluoride in rats.
Ames, MJ; Balmer, MF; Black, TN; Collins, TF; Olejnik, N; Ruggles, DI; Shackelford, ME; Sprando, RL; Welsh, JJ, 1995
)
0.59
" Exposure of transfected cells to human chorionic gonadotropin (hCG) resulted in a dose-dependent loss of maximal hCG-stimulable adenylyl cyclase activity without a significant shift to the right of the dose-response curve to hCG."( Homologous desensitization of the murine luteinizing hormone receptor expressed in L cells.
Birnbaumer, L; Birnbaumer, M; Gudermann, T, 1995
)
0.29
" Impregnation of birch toothpicks in 1, 2 or 3% NaF resulted in lower F concentrations both in vitro and in vivo, with a clear dose-response effect."( Uptake and release of fluoride from birch and lime toothpicks.
Birkhed, D; Kashani, H; Petersson, LG, 1995
)
0.29
" beta-Aminopropionitrile (BAPN) induced monotonic degradation of all properties at all dose levels, corresponding to the decreasing density with dosage level."( Comparison of dosage-dependent effects of beta-aminopropionitrile, sodium fluoride, and hydrocortisone on selected physical properties of cortical bone.
Hanson, D; Lees, S; Mook, HA; Page, E, 1994
)
0.52
" When adenine and benzyladenine, a similar substance of adenine, was microinjected into the germinal vesicle of oocytes, the meiotic maturation of oocytes could be obviously arrested depending on the dosage of injection."( [The meiosis arrest of mouse oocytes induced by adenine].
Fan, BQ; Li, CJ; Wang, B, 1994
)
0.29
" Four studies examined the effects of different concentrations of fluoride, established dose-response profiles with NaF and Na2PO3F, and tested commercial dentifrices."( An in vitro model for studying the efficacy of fluoride dentifrices in preventing root caries.
Beiswanger, AJ; Dunipace, AJ; Stookey, GK; Zhang, W, 1994
)
0.29
" Sodium fluoride is an enzyme inhibitor and reduces osteoclastic bone resorption and, if the dosage is more than 60 mg a day, may rebuild pseudohaversian bone."( Sodium fluoride therapy.
Berges, J; Bretlau, P; Causse, JB; Causse, JR; Shambaugh, GE; Uriel, J, 1993
)
2.64
" As a result, it is now established that from 1000-2800 ppm F, there is a dose-response relationship."( Dentifrices: recent clinical findings and implications for use.
Stephen, KW, 1993
)
0.29
" Because during the 4 year trial the NaF dosage was decreased (because of side effects) in 54 of the 101 women randomized to NaF, dose-response relationships could be evaluated."( Clinical trial of fluoride therapy in postmenopausal osteoporotic women: extended observations and additional analysis.
Chao, E; Hodgson, SF; Lane, A; Melton, LJ; Muhs, J; O'Fallon, WM; Riggs, BL; Wahner, HW, 1994
)
0.29
" The dose-response curve for stimulation of [Ca2+]i elicited by sodium fluoride was similar to that for suppression of neurite outgrowth."( Fluoride causes suppression of neurite outgrowth in human neuroblastoma via an influx of extracellular calcium.
Fujisawa, E; Kitoh, N; Nakagawa-Yagi, Y; Nakamura, H; Ogane, N; Saito, Y, 1993
)
0.52
" Australian randomized study of 50 patients is described where NaF dosage is varied proportional to the osteoblast response, and duration is dependent on densitometric and radiographic response."( Fluoride treatment of osteoporosis: cyclical non-blinded or continuous blinded studies?
Bhagat, CI; Gutteridge, DH; Jones, CE; Kent, GN; Nicholson, GC; Prince, RL; Retallack, RW; Stewart, GO; Stuckey, BG, 1993
)
0.29
" These compounds are the most widely used sources of fluoride in dentifrices, and dose-response clinical standards are available for both."( The application of in situ models for evaluation of new fluoride-containing systems.
Faller, RV, 1995
)
0.29
" A study was conducted on interference with complexing anions of Fe(III), cations that react with fluoride ions and with common ingredients of dosage forms and dental preparations."( Spectrophotometric determination of fluoride in dosage forms and dental preparations.
Florean, E; Mirel, S; Oprean, R; Roman, L; Săndulescu, R; Suciu, P, 1996
)
0.29
" Dose-response curves to acetylcholine (0."( Modification of aortic contractility in the cardiomyopathic hamster.
Dumont, EC; Lambert, C; Lamontagne, D, 1996
)
0.29
" They were dosed orally each day for 22 weeks with fluoride as sodium fluoride in water or bovine milk."( Fluoride uptake into the developing enamel and dentine of sheep incisors following daily ingestion of fluoridated milk or water.
Coote, GE; Cutress, TW; Gao, J; Suckling, GW, 1996
)
0.53
"0% pyrophosphate dentifrice was observed to be almost twice as effective on a percentage basis as the lower dosage pyrophosphate dentifrice in facilitating easier calculus removal."( The comparative efficacy of two commercial tartar control dentifrices in preventing calculus development and facilitating easier dental cleanings.
Bacca, L; Campbell, SL; Cox, ER; Lanzalaco, AC; McClanahan, SF; Perlich, MA; Schiff, T; Stains, A; White, DJ, 1996
)
0.29
"Chewable tablets containing low dosage fluoride content were prepared using two varieties of celluloses and their in vitro parameters were evaluated."( Clinical evaluation of sodium fluoride chewable tablets in dental caries.
Aithal, KS; Tandon, S; Udupa, DN,
)
0.44
" Perifusion of young and senescent AP cells with thymulin doses, ranging from 10(-8) to 10(-5) M, gave a logarithmic dose-response pattern of GH."( Growth hormone-releasing activity of thymulin on pituitary somatotropes is age dependent.
Brown, OA; Dardenne, M; Goya, RG; Pléau, J; Sosa, YE, 1999
)
0.3
" Dose-response experiments showed a maximal release of IL-6 and IL-8 at a concentration of 5 mM NaF 24 h after addition."( Fluoride-induced interleukin-6 and interleukin-8 synthesis in human epithelial lung cells.
Becher, R; Lâg, M; Refsnes, M; Schwarze, PE; Skuland, T, 1999
)
0.3
"Chewable tablets containing low dosage flouride content were prepared using two varities of celluloses and their in vitro parameters were evaluated."( Clinical evaluation of sodium flouride chewable tablets in dental caries.
Aithal, KS; Maddi, SS; Tandon, S,
)
0.13
" Following a baseline plaque examination and complete plaque removal at the start of the first 4-day treatment period, subjects initiated a twice-daily supervised dosing regimen, during which they rinsed with their first assigned dentifrice in slurry form while refraining from tooth-brushing and all other oral hygiene procedures."( Plaque regrowth effects of a triclosan/pyrophosphate dentifrice in a 4-day non-brushing model.
Beiswanger, BB; Bollmer, BW; Court, LK; Crisanti, MM; Majeti, S; Mau, MS; McClanahan, SF; McClary, JM, 2000
)
0.31
" The results indicate that supplementation of the mouse drinking water with calcium salts prevents bone changes induced by short-term suspension, while calcium salts in combination with fluoride are less effective as fluoride dosage increases."( Effect of oral calcium and calcium + fluoride treatments on mouse bone properties during suspension.
Allen, KA; Luttges, MW; Simske, SJ, 1992
)
0.28
" The results of these experiments indicate that sodium fluoride administered at higher concentrations than the usual caries preventive dosage made the generation time of cariogenic oral bacteria and fungi longer, slowing down their multiplication."( Effect of fluoride on cariogenic oral microorganisms (an in vitro study).
Bánóczy, J; Gintner, Z; Herczegh, A; Kamotsay, K; Nász, I; Rozgonyi, F, 2002
)
0.57
"Wistar rats were provided with distilled water containing NaF (50 mg/L) and administered by gavage with different dosed of Se-Zn for six months."( [Effects of selenium and zinc on rat renal apoptosis and change of cell cycle induced by fluoride].
Chen, X; Wang, A; Xia, T; Yu, R, 2002
)
0.31
" Amiodarone also demonstrated a J-shaped dose-response effect, with statistical significance at A(1), A(2), and A(3) versus tube 9 (control)."( Amiodarone attenuates fluoride-induced hyperkalemia in vitro.
Chu, J; Hoffman, RS; Howland, MA; Nelson, LS; Su, M, 2003
)
0.32
"A controlled fluoride (F) dose-response study was conducted in concurrence with a supervised school oral hygiene regimen to assess whether dentifrices with increasing fluoride levels could be differentiated with small sample sizes in short time frames."( Effect of three concentrations of sodium fluoride dentifrices on clinical caries.
Archila, L; Bartizek, RD; Biesbrock, AR; Gerlach, RW; Jacobs, SA, 2003
)
0.6
" Uses include screening compounds for gross metabolic effects in mammalian cell lines, determining preliminary metabolic dose-response curves for guiding further research, and designing and optimizing media for in vitro systems utilizing cell cultures."( 24-well plate spectrophotometric assay for preliminary screening of metabolic activity.
Balcarcel, RR; Yang, Y, 2003
)
0.32
" However, no current marketed dosage forms deliver fluoride for an extended period."( Development and evaluation of extended release bioadhesive sodium fluoride tablets.
Dansereau, RJ; Owens, TS; Sakr, A, 2005
)
0.57
" More work is needed to validate the model by means of a fluoride dose-response study."( Development of an in situ root caries model B. In situ investigations.
Higham, SM; Preston, KP; Smith, PW, 2005
)
0.33
" A comparable number of teeth required repeat dosage in both groups."( 2% sodium fluoride-iontophoresis compared to a commercially available desensitizing agent.
Gupta, R; Pandit, N; Singal, P, 2005
)
0.95
" Bovine enamel blocks were subjected to the models and treated with F solutions containing from 70 to 280 microg F/mL in order to validate them in terms of dose-response effect."( pH-cycling models to evaluate the effect of low fluoride dentifrice on enamel de- and remineralization.
Cury, JA; Hara, AT; Paes Leme, AF; Queiroz, CS, 2008
)
0.35
" The conducted studies proved that cholesterol in the applied dosage (500 mg cholesterol per rabbit per 24 h) has an atherogenic action."( The influence of fluoride ions upon selected enzymes of protein metabolism in blood plasma of rabbits with hypercholesterolemia.
Birkner, B; Birkner, E; Grucka-Mamczar, E; Kasperczyk, A; Kasperczyk, S; Stawiarska-Pieta, B; Zalejska-Fiolka, J, 2008
)
0.35
" There was a dose-response effect with respect to both impregnation time and the concentration of the F solution."( Uptake and release of fluoride from fluoride-impregnated chewing sticks (miswaks) in vitro and in vivo.
Baeshen, HA; Birkhed, D; Kjellberg, H; Lingström, P, 2008
)
0.35
" The authors offer an accompanying rationale based on dosage reduction and efficacy, that fluoride varnish should be the topical fluoride of choice for children ages 6-12."( The use of fluoride varnish in children: a critical review with treatment recommendations.
Miller, EK; Vann, WF, 2008
)
0.35
"Test products were: new dentifrice formulation in a fluoride dose-response (0; 675; 1426 ppm F as sodium fluoride [NaF-0; NaF-675; NaF]); Elmex Kariesschutz (1400 ppm F as amine fluoride [AmF]); and Oral-B Pro-Expert (1450 ppm F-1100 ppm F as stannous fluoride and 350 ppm F as sodium fluoride [SnNaF])."( Laboratory assessment of the anticaries potential of a new dentifrice.
Chauhan, VK; Lippert, F; Lynch, RJ; Newby, EE; Schemehorn, BR, 2009
)
0.57
"05) as compared to a benchmark commercial desensitizing toothpaste containing 2% potassium ion, dosed as potassium nitrate, after two weeks, four weeks, and eight weeks of product use."( Comparing the efficacy in reducing dentin hypersensitivity of a new toothpaste containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride to a benchmark commercial desensitizing toothpaste containing 2% potassium ion: an eight-week clinical study
Bartolino, M; Costacurta, M; Cummins, D; Delgado, E; DeVizio, W; Dibart, S; Docimo, R; Mateo, LR; Maturo, P; Montesani, L; Zhang, YP, 2009
)
0.35
" mutans biofilm formation, which simulated 'feast-famine' episodes of exposure to sucrose that occur in the oral cavity, showed dose-response susceptibility to antimicrobials and allowed the evaluation of substances with anticaries potential."( S. mutans biofilm model to evaluate antimicrobial substances and enamel demineralization.
Ccahuana-Vásquez, RA; Cury, JA,
)
0.13
" Oral examinations were conducted before radiotherapy, after dosage of 2000 cGy irradiation, immediately after the termination of radiotherapy, and 1 month and 6 months after termination of the radiotherapy."( Progress of oral sequelae during head-neck radiotherapy.
Deng, J; Gao, XJ; Li, NY; Lu, HJ; Sun, HB, 2010
)
0.36
"Salivary flow rate decreased significantly after the first dosage of 2000 cGy, and was aggravated with the increase in irradiation dosage until the termination of radiotherapy."( Progress of oral sequelae during head-neck radiotherapy.
Deng, J; Gao, XJ; Li, NY; Lu, HJ; Sun, HB, 2010
)
0.36
"4 g/kg×d) and low dosage (0."( [The influence of fluoride on expression of OPGL and M-CSF genes and their proteins in rats with experimental fluorosis and the therapeutic effect of Danlan Xianpeng Liaofu caspule].
Sun, XJ; Xiao, YM; Yu, YN, 2010
)
0.36
" (4) Compared with that of the fluoride group animals, the expression intensity of OPGL mRNA decreased in animals of the control group, the high, mid- and low- dosage medication groups and the borax group."( [The influence of fluoride on expression of OPGL and M-CSF genes and their proteins in rats with experimental fluorosis and the therapeutic effect of Danlan Xianpeng Liaofu caspule].
Sun, XJ; Xiao, YM; Yu, YN, 2010
)
0.36
"This study was conducted to further explore the effects of selenium on the blood antioxidant capacity in rats exposed to fluoride to find out the optimal dosage level of selenium."( Intervention of selenium on chronic fluorosis-induced injury of blood antioxidant capacity in rats.
Feng, P; Wei, J; Zhang, Z, 2011
)
0.37
" A dosing regimen of 10 mmol/L sodium fluoride over 8 days was followed, during which time larvae developed to Stage 58, when the process of progressive ossification takes place in the vertebral column and membranous bones of the skull, pelvic, and pectoral girdles and portions of the appendicular skeleton."( Effects of fluoride on expression of bone-specific genes in developing Xenopus laevis larvae.
Belak, ZR; Nair, M; Ovsenek, N, 2011
)
0.66
"For aqueous solutions and mouthrinses, a fluoride dose-response was observed with a plateau around 100 μg/g F(-) for both HA substrates, with or without pellicle."( Inhibition of erosive dissolution by sodium fluoride: evidence for a dose-response.
Barbour, ME; Churchley, DR; Gracia, LH; Jones, SB; Rees, GD; White, AJ, 2012
)
0.65
" A fluoride dose-response was seen at low concentrations."( Inhibition of erosive dissolution by sodium fluoride: evidence for a dose-response.
Barbour, ME; Churchley, DR; Gracia, LH; Jones, SB; Rees, GD; White, AJ, 2012
)
0.65
"To determine the effect of relatively low strontium concentrations on enamel remineralization and investigate the dose-response effects of strontium and fluoride combinations on the remineralization of artificial caries lesions in vitro."( The effect of strontium and combinations of strontium and fluoride on the remineralization of artificial caries lesions in vitro.
Eckert, G; Eder, J; Lippert, F; Yassen, GH; Zandoná, AF,
)
0.13
"To investigate the relative fluoride dose-response of human and bovine enamel caries lesions under remineralizing conditions and utilizing an established pH cycling model."( Fluoride dose-response of human and bovine enamel caries lesions under remineralizing conditions.
Hara, AT; Lippert, F, 2012
)
0.38
" Human and bovine enamel showed a good fluoride dose-response for REM and correlated well."( Fluoride dose-response of human and bovine enamel caries lesions under remineralizing conditions.
Hara, AT; Lippert, F, 2012
)
0.38
" Unlike UC nanocrystals previously reported in the literature with multicolor emission obtained by varying the rare-earth dopants, the current work developed a new approach to tune the UC emission color by controlling the NaF concentration without changing the ratio and dosage of rare-earth ions."( Controllable multicolor upconversion luminescence by tuning the NaF dosage.
Li, H; Wang, L, 2014
)
0.4
" F decreased the activities of pro- and active forms of salivary and purified human MMPs in a dose-response manner."( Sodium fluoride inhibits MMP-2 and MMP-9.
Bolanho, A; Buzalaf, MA; Kato, MT; Salo, T; Tjäderhane, L; Zarella, BL, 2014
)
1.85
"A linear fluoride dose-response was observed for all study variables which exhibited similar overall patterns."( An in situ caries study on the interplay between fluoride dose and concentration in milk.
Lippert, F; Martinez-Mier, EA; Zero, DT, 2014
)
0.4
" A dose-response relationship was observed between fluoride concentrations in the varnishes and %SHR."( In vitro remineralizing effect of fluoride varnishes containing sodium trimetaphosphate.
Castilho, FC; Delbem, AC; Lima, TM; Manarelli, MM; Pessan, JP, 2014
)
0.4
" There was a better dose-response relationship among the varnishes exposed to water than to artificial saliva."( Evaluation of fluoride release from experimental TiF4 and NaF varnishes in vitro.
Buzalaf, MA; Comar, LP; Grizzo, LT; Magalhães, AC; Souza, BM, 2014
)
0.4
" Our results demonstrated that high dosage of NaF could inhibit cell proliferation by stress-induced apoptosis, which was confirmed by cellular and molecular evidences."( Toxic effects of sodium fluoride on cell proliferation and apoptosis of Leydig cells from young mice.
Chen, ZY; Gao, JP; Liu, ML; Song, Gh; Wang, HL; Wang, RL; Yan, XY; Zhang, B, 2014
)
0.74
" No clear dose-response effect was observed."( Hydrophobic sodium fluoride-based nanocrystals doped with lanthanide ions: assessment of in vitro toxicity to human blood lymphocytes and phagocytes.
Banski, M; Bartusova, M; Dusinska, M; Horvathova, M; Ilavska, S; Jahnova, E; Kuricova, M; Liskova, A; Misiewicz, J; Podhorodecki, A; Rollerova, E; Sojka, B; Szabova, M; Tulinska, J, 2014
)
0.78
" Dose-response curves of 72 h continuously cultured BmN treated with NaF showed that the half inhibitory concentration (IC50) value was 56."( The toxicity of NaF on BmN cells and a comparative proteomics approach to identify protein expression changes in cells under NaF-stress: impact of NaF on BmN cells.
Chang, C; Chen, H; Chen, K; Chen, L; Xia, H; Yao, C; Yao, Q; Zhang, C; Zhou, Y, 2015
)
0.42
"Highly significant linear and, with the exception of SMHR, quadratic dose-response relationships were observed between all efficacy variables and fluoride concentration."( Dose-response effect of fluoride dentifrice on remineralisation and further demineralisation of erosive lesions: A randomised in situ clinical study.
Bosma, ML; Butler, A; Creeth, JE; Hara, AT; Kelly, SA; Lynch, RJ; Martinez-Mier, EA; Zero, DT, 2015
)
0.42
"The aim of this exploratory double-blinded, randomized, cross-over, in situ study was to compare the effects of various model parameters ('intervention', 'brushing', 'position') on enamel caries lesions in a dose-response model."( The effect of various model parameters on enamel caries lesions in a dose-response model in situ.
Dörfer, CE; Gninka, B; Heldmann, P; Meyer-Lueckel, H; Paris, S; Wierichs, RJ, 2015
)
0.42
" Values for NaF1450 revealed a similar dose-response as LA1360."( The effect of various model parameters on enamel caries lesions in a dose-response model in situ.
Dörfer, CE; Gninka, B; Heldmann, P; Meyer-Lueckel, H; Paris, S; Wierichs, RJ, 2015
)
0.42
"The design of the present in situ study was able to reveal a fluoride dose-response to hamper further demineralization of enamel specimens for 'easily cleanable' and 'plaque-retaining' sites being brushed or not."( The effect of various model parameters on enamel caries lesions in a dose-response model in situ.
Dörfer, CE; Gninka, B; Heldmann, P; Meyer-Lueckel, H; Paris, S; Wierichs, RJ, 2015
)
0.42
" The pregnant wistar rats were dosed with 20 ppm sodium fluoride (NaF) from day one of pregnancy till the pups were aged day 30."( Vitamin A deficiency: An oxidative stress marker in sodium fluoride (NaF) induced oxidative damage in developing rat brain.
Banala, RR; Karnati, PR, 2015
)
0.92
" All three fluoride toothpastes were more efficacious than placebo, and there were no safety concerns following single dosing in this short-term in situ model."( Erosion Remineralization Efficacy of Gel-to-Foam Fluoride Toothpastes in situ: A Randomized Clinical Trial.
Hara, AT; Jeffery, P; Lippert, F; Mason, S; Nehme, M; Zero, DT, 2016
)
0.43
" A clear dose-response relationship was seen between F concentration/amount of dentifrice applied and the mean area under the curve (AUC) of salivary F concentrations (P<0."( Influence of the Amount of Dentifrice and Fluoride Concentrations on Salivary Fluoride Levels in Children.
Cunha, RF; Danelon, M; de Moraes, FR; Delbem, AC; Hall, KB; Hosida, TY; Nagata, ME; Pessan, JP, 2016
)
0.43
"To compare and explore the dose-response of phytate-containing 1150 ppm fluoride toothpastes on model caries lesions and to determine the impact of zinc ions."( Effect of phytate and zinc ions on fluoride toothpaste efficacy using an in situ caries model.
Budhawant, C; Burnett, GR; Creeth, JE; Hara, AT; Lippert, F; Lynch, RJM; Parkinson, CR; Zero, DT, 2018
)
0.48
" No differences between fluoride toothpastes were observed for any measure with little evidence of a dose-response for phytate."( Effect of phytate and zinc ions on fluoride toothpaste efficacy using an in situ caries model.
Budhawant, C; Burnett, GR; Creeth, JE; Hara, AT; Lippert, F; Lynch, RJM; Parkinson, CR; Zero, DT, 2018
)
0.48
" In general, the effect on OIIRR increased with higher dosage and/or exposure time."( The effect of biologic factors and adjunctive therapies on orthodontically induced inflammatory root resorption: a systematic review and meta-analysis.
Haugland, L; Kristensen, KD; Lie, SA; Vandevska-Radunovic, V, 2018
)
0.48
" Simultaneously, the autophagy marker LC3 brown punctate staining was increased with NaF dosage increase."( Sodium fluoride induces splenocyte autophagy via the mammalian targets of rapamycin (mTOR) signaling pathway in growing mice.
Cui, H; Deng, H; Deng, J; Fang, J; Kuang, P; Li, Y; Liu, H; Wang, X; Zhao, L; Zuo, Z, 2018
)
1.92
" Group A was the control group and received normal saline, Group B was exposed to NaF at 300 ppm (300 mg/L) in drinking water daily for a week, Groups C and D were exposed to 300 ppm (300 mg/L) of NaF and coadministered with Luteolin orally daily at a dosage of 100 mg/kg and 200 mg/kg for the same time point."( Luteolin-mediated Kim-1/NF-kB/Nrf2 signaling pathways protects sodium fluoride-induced hypertension and cardiovascular complications.
Adedapo, AA; Adejumobi, OA; Afolabi, JM; Ajibade, TO; Asenuga, ER; Falayi, OO; Ogunpolu, BS; Ola-Davies, OE; Omobowale, TO; Oyagbemi, AA; Saba, AB; Yakubu, MA, 2018
)
0.72
" Dose-response relationships were observed for both variables for fluoride concentration and treatment time."( The Effects of Fluoride Treatment Time and Concentration on In Vitro Caries Lesion Demineralisation and Remineralisation.
Chu, TG; Eckert, GJ; Hara, AT; Levon, JA; Lippert, F; Maarafi, AJ,
)
0.13
" The efficacy of MMF as an immunosuppressant and long-term safety in cats of this dosage regimen is unknown."(
Abrams, G; Adolfsson, E; Agarwal, PK; Akkan, AG; Al Alhareth, NS; Alves, VGL; Armentano, R; Bahroos, E; Baig, M; Baldridge, KK; Barman, S; Bartolucci, C; Basit, A; Bertoli, SV; Bian, L; Bigatti, G; Bobenko, AI; Boix, PP; Bokulic, T; Bolink, HJ; Borowiec, J; Bulski, W; Burciaga, J; Butt, NS; Cai, AL; Campos, AM; Cao, G; Cao, Y; Čapo, I; Caruso, ML; Chao, CT; Cheatum, CM; Chelminski, K; Chen, AJW; Chen, C; Chen, CH; Chen, D; Chen, G; Chen, H; Chen, LH; Chen, R; Chen, RX; Chen, X; Cherdtrakulkiat, R; Chirvony, VS; Cho, JG; Chu, K; Ciurlino, D; Coletta, S; Contaldo, G; Crispi, F; Cui, JF; D'Esposito, M; de Biase, S; Demir, B; Deng, W; Deng, Z; Di Pinto, F; Domenech-Ximenos, B; Dong, G; Drácz, L; Du, XJ; Duan, LJ; Duan, Y; Ekendahl, D; Fan, W; Fang, L; Feng, C; Followill, DS; Foreman, SC; Fortunato, G; Frew, R; Fu, M; Gaál, V; Ganzevoort, W; Gao, DM; Gao, X; Gao, ZW; Garcia-Alvarez, A; Garza, MS; Gauthier, L; Gazzaz, ZJ; Ge, RS; Geng, Y; Genovesi, S; Geoffroy, V; Georg, D; Gigli, GL; Gong, J; Gong, Q; Groeneveld, J; Guerra, V; Guo, Q; Guo, X; Güttinger, R; Guyo, U; Haldar, J; Han, DS; Han, S; Hao, W; Hayman, A; He, D; Heidari, A; Heller, S; Ho, CT; Ho, SL; Hong, SN; Hou, YJ; Hu, D; Hu, X; Hu, ZY; Huang, JW; Huang, KC; Huang, Q; Huang, T; Hwang, JK; Izewska, J; Jablonski, CL; Jameel, T; Jeong, HK; Ji, J; Jia, Z; Jiang, W; Jiang, Y; Kalumpha, M; Kang, JH; Kazantsev, P; Kazemier, BM; Kebede, B; Khan, SA; Kiss, J; Kohen, A; Kolbenheyer, E; Konai, MM; Koniarova, I; Kornblith, E; Krawetz, RJ; Kreouzis, T; Kry, SF; Laepple, T; Lalošević, D; Lan, Y; Lawung, R; Lechner, W; Lee, KH; Lee, YH; Leonard, C; Li, C; Li, CF; Li, CM; Li, F; Li, J; Li, L; Li, S; Li, X; Li, Y; Li, YB; Li, Z; Liang, C; Lin, J; Lin, XH; Ling, M; Link, TM; Liu, HH; Liu, J; Liu, M; Liu, W; Liu, YP; Lou, H; Lu, G; Lu, M; Lun, SM; Ma, Z; Mackensen, A; Majumdar, S; Martineau, C; Martínez-Pastor, JP; McQuaid, JR; Mehrabian, H; Meng, Y; Miao, T; Miljković, D; Mo, J; Mohamed, HSH; Mohtadi, M; Mol, BWJ; Moosavi, L; Mosdósi, B; Nabu, S; Nava, E; Ni, L; Novakovic-Agopian, T; Nyamunda, BC; Nyul, Z; Önal, B; Özen, D; Özyazgan, S; Pajkrt, E; Palazon, F; Park, HW; Patai, Á; Patai, ÁV; Patzke, GR; Payette, G; Pedoia, V; Peelen, MJCS; Pellitteri, G; Peng, J; Perea, RJ; Pérez-Del-Rey, D; Popović, DJ; Popović, JK; Popović, KJ; Posecion, L; Povall, J; Prachayasittikul, S; Prachayasittikul, V; Prat-González, S; Qi, B; Qu, B; Rakshit, S; Ravelli, ACJ; Ren, ZG; Rivera, SM; Salo, P; Samaddar, S; Samper, JLA; Samy El Gendy, NM; Schmitt, N; Sekerbayev, KS; Sepúlveda-Martínez, Á; Sessolo, M; Severi, S; Sha, Y; Shen, FF; Shen, X; Shen, Y; Singh, P; Sinthupoom, N; Siri, S; Sitges, M; Slovak, JE; Solymosi, N; Song, H; Song, J; Song, M; Spingler, B; Stewart, I; Su, BL; Su, JF; Suming, L; Sun, JX; Tantimavanich, S; Tashkandi, JM; Taurbayev, TI; Tedgren, AC; Tenhunen, M; Thwaites, DI; Tibrewala, R; Tomsejm, M; Triana, CA; Vakira, FM; Valdez, M; Valente, M; Valentini, AM; Van de Winckel, A; van der Lee, R; Varga, F; Varga, M; Villarino, NF; Villemur, R; Vinatha, SP; Vincenti, A; Voskamp, BJ; Wang, B; Wang, C; Wang, H; Wang, HT; Wang, J; Wang, M; Wang, N; Wang, NC; Wang, Q; Wang, S; Wang, X; Wang, Y; Wang, Z; Wen, N; Wesolowska, P; Willis, M; Wu, C; Wu, D; Wu, L; Wu, X; Wu, Z; Xia, JM; Xia, X; Xia, Y; Xiao, J; Xiao, Y; Xie, CL; Xie, LM; Xie, S; Xing, Z; Xu, C; Xu, J; Yan, D; Yan, K; Yang, S; Yang, X; Yang, XW; Ye, M; Yin, Z; Yoon, N; Yoon, Y; Yu, H; Yu, K; Yu, ZY; Zhang, B; Zhang, GY; Zhang, H; Zhang, J; Zhang, M; Zhang, Q; Zhang, S; Zhang, W; Zhang, X; Zhang, Y; Zhang, YW; Zhang, Z; Zhao, D; Zhao, F; Zhao, P; Zhao, W; Zhao, Z; Zheng, C; Zhi, D; Zhou, C; Zhou, FY; Zhu, D; Zhu, J; Zhu, Q; Zinyama, NP; Zou, M; Zou, Z, 2019
)
0.51
"001) for the lowly cariogenic model, indicating a fluoride dose-response for both."( Effects of Dentifrices Differing in Fluoride Content on Remineralization Characteristics of Dentin in vitro.
Apel, C; Esteves-Oliveira, M; Meyer-Lueckel, H; Rupp, K; Wierichs, RJ, 2020
)
0.56
"For both pH-cycling conditions a dose-response for fluoride could be revealed."( Effects of Dentifrices Differing in Fluoride Content on Remineralization Characteristics of Dentin in vitro.
Apel, C; Esteves-Oliveira, M; Meyer-Lueckel, H; Rupp, K; Wierichs, RJ, 2020
)
0.56
" However, to delineate its exact formulation, dosage or frequency, there is need for more well conducted randomised controlled trials."( Effectiveness of topical fluorides in prevention of radiation caries in adults: A systematic review and meta- analysis.
Agarwal, D; Kumar, V; Priya, H; Purohit, B; Ravi, P, 2022
)
0.72
" Further studies are necessary to examine the extended effect of Resveratrol with increased dosage or time of treatment."( Resveratrol thyro-protective role in fluorosis rat model (histo-morphometric, biochemical and ultrastructural study).
Amin, MA; Hassan, NH, 2023
)
0.91
" Twenty-eight adult Wistar rats were divided equally and randomly into four groups: group one received distilled water; group two received NMO at a dosage of 250 mg/kg/body weight; group three received NaF at a dosage of 10 mg/kg/body weight; and group four received NaF and NMO."( Ameliorative effects of nano Moringa on fluoride-induced testicular damage via down regulation of the StAR gene and altered steroid hormones.
Abd-Allah, ER; El-Rahman, HAA, 2023
)
0.91
"We observed a dose-response relation between F concentrations in the gels without TMP for %SHR and ΔKHN."( Effect of fluoride gels with nano-sized sodium trimetaphosphate on the in vitro remineralization of caries lesions.
Báez-Quintero, LC; Danelon, M; Delbem, ACB; Monteiro, DR; Nagata, ME; Pessan, JP; Sampaio, C; Wiegand, A, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (2 Product(s))

Product Categories

Product CategoryProducts
Other1
Imbiss, Salzige Snacks, Vorspeisen, Chips und Pommes Frites, Fertiggerichte, Chips1

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved

Roles (1)

RoleDescription
mutagenAn agent that increases the frequency of mutations above the normal background level, usually by interacting directly with DNA and causing it damage, including base substitution.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
fluoride salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (7)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Carbonic anhydrase Astrosclera willeyanaKi940.00000.03201.51729.6000AID647373
Carbonic anhydrase 1Homo sapiens (human)Ki300,000.00000.00001.372610.0000AID1161930; AID587130; AID598726; AID714401; AID724722; AID730754; AID763569
Carbonic anhydrase 2Homo sapiens (human)Ki288,235.29410.00000.72369.9200AID1058395; AID1070020; AID1161931; AID1161950; AID1235241; AID1237475; AID1336557; AID1430526; AID1461934; AID587131; AID598728; AID714400; AID724721; AID730373; AID730753; AID758952; AID763568
Mu-type opioid receptorRattus norvegicus (Norway rat)Ki300,000.00000.00000.38458.6000AID1161931
Carbonic anhydraseMethanosarcina thermophilaKi200,000.00000.06000.97148.5000AID1235242; AID1336558; AID758950
Carbonic anhydrase Pseudomonas aeruginosa PAO1Ki100,000.00000.07596.26909.0000AID1237477
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (22)

Processvia Protein(s)Taxonomy
DNA repairEyes absent homolog 2Homo sapiens (human)
chromatin remodelingEyes absent homolog 2Homo sapiens (human)
mesodermal cell fate specificationEyes absent homolog 2Homo sapiens (human)
striated muscle tissue developmentEyes absent homolog 2Homo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandEyes absent homolog 2Homo sapiens (human)
mitochondrial outer membrane permeabilizationEyes absent homolog 2Homo sapiens (human)
anatomical structure developmentEyes absent homolog 2Homo sapiens (human)
positive regulation of DNA repairEyes absent homolog 2Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway in absence of ligandEyes absent homolog 2Homo sapiens (human)
cell differentiationEyes absent homolog 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 1Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (9)

Processvia Protein(s)Taxonomy
magnesium ion bindingEyes absent homolog 2Homo sapiens (human)
protein bindingEyes absent homolog 2Homo sapiens (human)
histone H2AXY142 phosphatase activityEyes absent homolog 2Homo sapiens (human)
protein tyrosine phosphatase activityEyes absent homolog 2Homo sapiens (human)
arylesterase activityCarbonic anhydrase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 1Homo sapiens (human)
protein bindingCarbonic anhydrase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 1Homo sapiens (human)
hydro-lyase activityCarbonic anhydrase 1Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 1Homo sapiens (human)
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (9)

Processvia Protein(s)Taxonomy
nucleoplasmEyes absent homolog 2Homo sapiens (human)
mitochondrionEyes absent homolog 2Homo sapiens (human)
cytosolEyes absent homolog 2Homo sapiens (human)
nucleusEyes absent homolog 2Homo sapiens (human)
cytosolCarbonic anhydrase 1Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 1Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (78)

Assay IDTitleYearJournalArticle
AID1430526Inhibition of recombinant human carbonic anhydrase 2 assessed as inhibition of CO2 hydration incubated for 15 mins prior to testing by stopped flow CO2 hydration method
AID1235245Inhibition of Pseudoalteromonas haloplanktis gamma-CA after 15 mins by stopped-flow/Co2 hydration assay2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Cloning, characterization and anion inhibition studies of a new γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis.
AID1461934Inhibition of human CA2 incubated for 15 mins by stopped-flow CO2 hydration assay
AID329524Cell death rescue in rat striatal neuron N548 mutant cells relative to rotenone2007Proceedings of the National Academy of Sciences of the United States of America, Sep-04, Volume: 104, Issue:36
Inhibitors of metabolism rescue cell death in Huntington's disease models.
AID1161952Inhibition of Porphyromonas gingivalis beta-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Anion inhibition study of the β-class carbonic anhydrase (PgiCAb) from the oral pathogen Porphyromonas gingivalis.
AID1070020Inhibition of human carbonic anhydrase 2 by stopped-flow CO2 hydrase assay2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Anion inhibition studies of two new β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.
AID1161930Inhibition of human carbonic anhydrase 1 preincubated for 15 mins by stopped flow CO2 hydration method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum--the η-carbonic anhydrases.
AID587130Inhibition of human carbonic anhydrase 1 after 15 mins by CO2 hydrase assay at pH 7.52011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Purification and inhibition studies with anions and sulfonamides of an α-carbonic anhydrase from the Antarctic seal Leptonychotes weddellii.
AID1058395Inhibition of human cytosolic carbonic anhydrase 2 preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Anion inhibition studies of a β-carbonic anhydrase from Clostridium perfringens.
AID730752Inhibition of Helicobacter pylori alpha carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Anion inhibition studies of the α-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
AID1235241Inhibition of human CA2 after 15 mins by stopped-flow/Co2 hydration assay2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Cloning, characterization and anion inhibition studies of a new γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis.
AID677270Inhibition of Sulfurihydrogenibium yellowstonense YO3AOP1 alpha-carbonic anhydrase-catalyzed CO2 hydration reaction preincubated for 15 mins by stopped flow CO2 hydrase assay2012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
Anion inhibition studies of an α-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1.
AID587132Inhibition of Leptonychotes weddellii alpha-carbonic anhydrase after 15 mins by CO2 hydrase assay at pH 7.52011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Purification and inhibition studies with anions and sulfonamides of an α-carbonic anhydrase from the Antarctic seal Leptonychotes weddellii.
AID724719Inhibition of human recombinant CA10 mutant after 15 mins by stopped-flow CO2 hydration method2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
Restoring catalytic activity to the human carbonic anhydrase (CA) related proteins VIII, X and XI affords isoforms with high catalytic efficiency and susceptibility to anion inhibition.
AID758952Inhibition of human recombinant CA2 by CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
A highly catalytically active γ-carbonic anhydrase from the pathogenic anaerobe Porphyromonas gingivalis and its inhibition profile with anions and small molecules.
AID1161931Inhibition of human carbonic anhydrase 2 preincubated for 15 mins by stopped flow CO2 hydration method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum--the η-carbonic anhydrases.
AID1430528Inhibition of Burkholderia pseudomallei recombinant His-tagged carbonic anhydrase beta (256 residues) expressed in Escherichia coli BL21 (DE3) incubated for 15 mins prior to testing by stopped flow CO2 hydration method
AID730753Inhibition of human carbonic anhydrase 2 preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Anion inhibition studies of the α-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
AID1461938Inhibition of recombinant His6-tagged Francisella tularensis beta-CA (227 residues) expressed in Escherichia coli BL21(DE3) incubated for 15 mins by stopped-flow CO2 hydration assay
AID1336558Inhibition of Methanosarcina thermophila recombinant carbonic anhydrase gamma assessed as inhibition of CO2 hydration preincubated for 15 mins by Lineweaver-burk plot method
AID1070021Inhibition of Legionella pneumophila carbonic anhydrase 2 preincubated for 15 mins by stopped-flow CO2 hydrase assay2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Anion inhibition studies of two new β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.
AID1235243Inhibition of Porphyromonas gingivalis CA after 15 mins by stopped-flow/Co2 hydration assay2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Cloning, characterization and anion inhibition studies of a new γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis.
AID1336560Inhibition of Nostoc commune recombinant carbonic anhydrase gamma assessed as inhibition of CO2 hydration preincubated for 15 mins by Lineweaver-burk plot method
AID1269931Inhibition of Colwellia psychrerythraea gamma carbonic anhydrase expressed in Escherichia coli incubated for 15 mins prior to testing by stopped flow CO2 hydration method2016Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
Cloning, characterization and anion inhibition studies of a γ-carbonic anhydrase from the Antarctic bacterium Colwellia psychrerythraea.
AID724721Inhibition of human recombinant wild type CA2 by stopped-flow CO2 hydration method2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
Restoring catalytic activity to the human carbonic anhydrase (CA) related proteins VIII, X and XI affords isoforms with high catalytic efficiency and susceptibility to anion inhibition.
AID1336561Inhibition of Pseudoalteromonas haloplanktis recombinant carbonic anhydrase gamma assessed as inhibition of CO2 hydration preincubated for 15 mins by Lineweaver-burk plot method
AID1058389Inhibition of Clostridium perfringens carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Anion inhibition studies of a β-carbonic anhydrase from Clostridium perfringens.
AID714400Inhibition of human cytosolic carbonic anhydrase 2 preincubated for 15 mins by stopped flow CO2 hydration assay2012Bioorganic & medicinal chemistry letters, Dec-01, Volume: 22, Issue:23
Anion inhibition studies of the fastest carbonic anhydrase (CA) known, the extremo-CA from the bacterium Sulfurihydrogenibium azorense.
AID1336559Inhibition of Porphyromonas gingivalis recombinant carbonic anhydrase gamma assessed as inhibition of CO2 hydration preincubated for 15 mins by Lineweaver-burk plot method
AID598728Inhibition of recombinant human carbonic anhydrase 2 after 15 mins by stopped flow CO2 hydration assay at pH 8.32011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Inhibition studies with anions and small molecules of two novel β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium.
AID329498Toxicity in drosophila Huntington's disease model2007Proceedings of the National Academy of Sciences of the United States of America, Sep-04, Volume: 104, Issue:36
Inhibitors of metabolism rescue cell death in Huntington's disease models.
AID1182904Induction of cell proliferation in osteoblasts (unknown origin) at 10 uM after 48 hrs by MTT assay relative to untreated control2014Bioorganic & medicinal chemistry letters, Aug-15, Volume: 24, Issue:16
Lactones from Ficus auriculata and their effects on the proliferation function of primary mouse osteoblasts in vitro.
AID1235244Inhibition of Nostoc commune CA after 15 mins by stopped-flow/Co2 hydration assay2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Cloning, characterization and anion inhibition studies of a new γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis.
AID1161950Inhibition of human carbonic anhydrase 2 preincubated for 15 mins by stopped flow CO2 hydration method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Anion inhibition study of the β-class carbonic anhydrase (PgiCAb) from the oral pathogen Porphyromonas gingivalis.
AID1593557Inhibition of cytosolic nucleotidase in MaMel.65-CD73 cell cytosolic extract (unknown origin) at 5 mM using AMP as substrate preincubated for 5 mins followed by substrate addition and measured after 60 mins in presence of levamisole by malachite green oxa2019Journal of medicinal chemistry, 04-11, Volume: 62, Issue:7
Structure-Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5'-Nucleotidase (CD73) Inhibitors.
AID1237475Inhibition of human carbonic anhydrase-2 by CO2 hydration reaction based colorimetric stopped-flow method2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Structure and inhibition studies of a type II beta-carbonic anhydrase psCA3 from Pseudomonas aeruginosa.
AID329496Cell death rescue in rat striatal neuron N548 mutant cells2007Proceedings of the National Academy of Sciences of the United States of America, Sep-04, Volume: 104, Issue:36
Inhibitors of metabolism rescue cell death in Huntington's disease models.
AID677271Inhibition of Helicobacter pylori alpha-carbonic anhydrase-catalyzed CO2 hydration reaction preincubated for 15 mins by stopped flow CO2 hydrase assay2012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
Anion inhibition studies of an α-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1.
AID730368Inhibition of Helicobacter pylori beta-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Kinetic and anion inhibition studies of a β-carbonic anhydrase (FbiCA 1) from the C4 plant Flaveria bidentis.
AID1237477Inhibition of Pseudomonas aeruginosa PAO1 type-2 beta-carbonic anhydrase psCA3 expressed in Escherichia coli Tuner BL21 (DE3) cells pre-incubated for 15 mins at pH 8.3 and 293K by CO2 hydration reaction based colorimetric stopped-flow method2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Structure and inhibition studies of a type II beta-carbonic anhydrase psCA3 from Pseudomonas aeruginosa.
AID1070022Inhibition of Legionella pneumophila carbonic anhydrase 1 preincubated for 15 mins by stopped-flow CO2 hydrase assay2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Anion inhibition studies of two new β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.
AID1235242Inhibition of archaeon Methanosarcina thermophila gamma-CA after 15 mins by stopped-flow/Co2 hydration assay2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Cloning, characterization and anion inhibition studies of a new γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis.
AID758950Inhibition of Methanosarcina thermophila recombinant gamma-CA by CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
A highly catalytically active γ-carbonic anhydrase from the pathogenic anaerobe Porphyromonas gingivalis and its inhibition profile with anions and small molecules.
AID598726Inhibition of recombinant human carbonic anhydrase 1 after 15 mins by stopped flow CO2 hydration assay at pH 8.32011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Inhibition studies with anions and small molecules of two novel β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium.
AID724722Inhibition of human recombinant wild type CA1 by stopped-flow CO2 hydration method2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
Restoring catalytic activity to the human carbonic anhydrase (CA) related proteins VIII, X and XI affords isoforms with high catalytic efficiency and susceptibility to anion inhibition.
AID1336557Inhibition of human recombinant carbonic anhydrase 2 assessed as inhibition of CO2 hydration preincubated for 15 mins by Lineweaver-burk plot method
AID763569Inhibition of human carbonic anhydrase-1 at 20 degC preincubated for 15 mins by stopped-flow CO2 hydrase assay2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Anion inhibition studies of the α-carbonic anhydrase from the protozoan pathogen Trypanosoma cruzi, the causative agent of Chagas disease.
AID329522Cell death rescue of neuronal cells in drosophila Huntington's disease model2007Proceedings of the National Academy of Sciences of the United States of America, Sep-04, Volume: 104, Issue:36
Inhibitors of metabolism rescue cell death in Huntington's disease models.
AID714401Inhibition of human cytosolic carbonic anhydrase 1 preincubated for 15 mins by stopped flow CO2 hydration assay2012Bioorganic & medicinal chemistry letters, Dec-01, Volume: 22, Issue:23
Anion inhibition studies of the fastest carbonic anhydrase (CA) known, the extremo-CA from the bacterium Sulfurihydrogenibium azorense.
AID647373Inhibition of Astrosclera willeyana recombinant GST-tagged astrosclerin 3 expressed in Escherichia coli BL21-DE3-RIPL cells preincubated for 15 mins measured for 10 to 100 secs by stopped flow CO2 hydration assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
Anion inhibition studies of an α-carbonic anhydrase from the living fossil Astrosclera willeyana.
AID598732Inhibition of Salmonella Typhimurium carbonic anhydrase 2 after 15 mins by stopped flow CO2 hydration assay at pH 8.32011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Inhibition studies with anions and small molecules of two novel β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium.
AID1430527Inhibition of Burkholderia pseudomallei recombinant carbonic anhydrase gamma incubated for 15 mins prior to testing by stopped flow CO2 hydration method
AID587131Inhibition of human carbonic anhydrase 2 after 15 mins by CO2 hydrase assay at pH 7.52011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Purification and inhibition studies with anions and sulfonamides of an α-carbonic anhydrase from the Antarctic seal Leptonychotes weddellii.
AID758948Inhibition of Porphyromonas gingivalis recombinant CA by CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
A highly catalytically active γ-carbonic anhydrase from the pathogenic anaerobe Porphyromonas gingivalis and its inhibition profile with anions and small molecules.
AID763567Inhibition of Brucella suis beta carbonic anhydrase-1 at 20 degC by stopped-flow CO2 hydrase assay2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Anion inhibition studies of the α-carbonic anhydrase from the protozoan pathogen Trypanosoma cruzi, the causative agent of Chagas disease.
AID1161932Inhibition of recombinant Plasmodium falciparum eta-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum--the η-carbonic anhydrases.
AID763568Inhibition of human carbonic anhydrase-2 at 20 degC preincubated for 15 mins by stopped-flow CO2 hydrase assay2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Anion inhibition studies of the α-carbonic anhydrase from the protozoan pathogen Trypanosoma cruzi, the causative agent of Chagas disease.
AID329523Toxicity in rat striatal neuronal N548 mutant cells2007Proceedings of the National Academy of Sciences of the United States of America, Sep-04, Volume: 104, Issue:36
Inhibitors of metabolism rescue cell death in Huntington's disease models.
AID724718Inhibition of human recombinant CA11 mutant after 15 mins by stopped-flow CO2 hydration method2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
Restoring catalytic activity to the human carbonic anhydrase (CA) related proteins VIII, X and XI affords isoforms with high catalytic efficiency and susceptibility to anion inhibition.
AID1161951Inhibition of Porphyromonas gingivalis gamma-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration method2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Anion inhibition study of the β-class carbonic anhydrase (PgiCAb) from the oral pathogen Porphyromonas gingivalis.
AID730373Inhibition of human cytosolic carbonic anhydrase-2 preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Kinetic and anion inhibition studies of a β-carbonic anhydrase (FbiCA 1) from the C4 plant Flaveria bidentis.
AID329497Toxicity in Caenorhabditis elegans Huntington's disease model2007Proceedings of the National Academy of Sciences of the United States of America, Sep-04, Volume: 104, Issue:36
Inhibitors of metabolism rescue cell death in Huntington's disease models.
AID598731Inhibition of Salmonella Typhimurium carbonic anhydrase 1 after 15 mins by stopped flow CO2 hydration assay at pH 8.32011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Inhibition studies with anions and small molecules of two novel β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium.
AID714403Inhibition of Sulfurihydrogenibium azorense alpha-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay2012Bioorganic & medicinal chemistry letters, Dec-01, Volume: 22, Issue:23
Anion inhibition studies of the fastest carbonic anhydrase (CA) known, the extremo-CA from the bacterium Sulfurihydrogenibium azorense.
AID1336562Inhibition of Burkholderia pseudomallei recombinant His-tagged carbonic anhydrase gamma expressed in Escherichia coli BL21 (DE3) assessed as inhibition of CO2 hydration preincubated for 15 mins by Lineweaver-burk plot method
AID1312218Inhibition of Plasmodium falciparum full length recombinant His-fused Eta-carbonic anhydrase domain preincubated for 15 mins by stopped-flow CO2 hydrase assay2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Anion inhibition profiles of the complete domain of the η-carbonic anhydrase from Plasmodium falciparum.
AID552785Inhibition of Streptococcus pneumoniae beta-carbonic anhydrase after 15 mins by stopped flow CO2 hydration assay2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Inhibition of the β-carbonic anhydrase from Streptococcus pneumoniae by inorganic anions and small molecules: Toward innovative drug design of antiinfectives?
AID730754Inhibition of human carbonic anhydrase 1 preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Anion inhibition studies of the α-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
AID724720Inhibition of human recombinant CA8 mutant after 15 mins by stopped-flow CO2 hydration method2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
Restoring catalytic activity to the human carbonic anhydrase (CA) related proteins VIII, X and XI affords isoforms with high catalytic efficiency and susceptibility to anion inhibition.
AID1461935Inhibition of Burkholderia pseudomallei beta-CA incubated for 15 mins by stopped-flow CO2 hydration assay
AID1182903Induction of cell proliferation in osteoblasts (unknown origin) at 1 uM after 48 hrs by MTT assay relative to untreated control2014Bioorganic & medicinal chemistry letters, Aug-15, Volume: 24, Issue:16
Lactones from Ficus auriculata and their effects on the proliferation function of primary mouse osteoblasts in vitro.
AID1182905Induction of cell proliferation in osteoblasts (unknown origin) at 100 uM after 48 hrs by MTT assay relative to untreated control2014Bioorganic & medicinal chemistry letters, Aug-15, Volume: 24, Issue:16
Lactones from Ficus auriculata and their effects on the proliferation function of primary mouse osteoblasts in vitro.
AID730372Inhibition of Flaveria bidentis beta-carbonic anhydrase-1 preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Kinetic and anion inhibition studies of a β-carbonic anhydrase (FbiCA 1) from the C4 plant Flaveria bidentis.
AID763566Inhibition of Brucella suis beta carbonic anhydrase-2 at 20 degC by stopped-flow CO2 hydrase assay2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Anion inhibition studies of the α-carbonic anhydrase from the protozoan pathogen Trypanosoma cruzi, the causative agent of Chagas disease.
AID329499Cell death rescue of ASH neuronal cells in Caenorhabditis elegans Huntington's disease model2007Proceedings of the National Academy of Sciences of the United States of America, Sep-04, Volume: 104, Issue:36
Inhibitors of metabolism rescue cell death in Huntington's disease models.
AID650231Osteoblastic proliferative activity in rat MC3T3-E1 cells at 10'-2 mM by MTT assay2012Bioorganic & medicinal chemistry letters, Mar-01, Volume: 22, Issue:5
New cyclic peptides with osteoblastic proliferative activity from Dianthus superbus.
AID730751Inhibition of Vibrio cholerae alpha carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Anion inhibition studies of the α-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
AID763565Inhibition of recombinant Trypanosoma cruzi CL Brener alpha carbonic anhydrase expressed in baculovirus infected SF9 cells at 20 degC preincubated for 15 mins by stopped-flow CO2 hydrase assay2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Anion inhibition studies of the α-carbonic anhydrase from the protozoan pathogen Trypanosoma cruzi, the causative agent of Chagas disease.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6,654)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902263 (34.01)18.7374
1990's1453 (21.84)18.2507
2000's960 (14.43)29.6817
2010's1469 (22.08)24.3611
2020's509 (7.65)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 79.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index79.90 (24.57)
Research Supply Index9.02 (2.92)
Research Growth Index4.60 (4.65)
Search Engine Demand Index151.33 (26.88)
Search Engine Supply Index2.05 (0.95)

This Compound (79.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1,007 (13.88%)5.53%
Reviews286 (3.94%)6.00%
Case Studies175 (2.41%)4.05%
Observational8 (0.11%)0.25%
Other5,781 (79.66%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (203)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Effectiveness of Casein Phosphopeptide Amorphous Calcium Phosphate (MI Varnish) and 5% Sodium Fluoride Plus Xylitol (PreviDent Varnish) on Non Cavitated Interproximal Lesions. Randomised Clinical Trial [NCT03925740]Phase 490 participants (Anticipated)Interventional2019-01-01Active, not recruiting
Remineralization of Molar Incisor Hypomineralization (MIH) With a Hydroxyapatite Toothpaste - an in Situ Study [NCT05485662]15 participants (Anticipated)Interventional2022-09-06Recruiting
Effect of Casein Phosphopeptide Amorphous Calcium Phosphate Fluoride Varnish on Remineralization of White Spot Lesion in Primary Teeth (Randomized Clinical Trial) [NCT03865680]Phase 2180 participants (Actual)Interventional2019-04-28Completed
Randomized, Examiner Blind, Clinical Study Investigating the Efficacy of a Stannous Fluoride Dentifrice in Improving Gingival Health After 3 Weeks Use [NCT04050722]Phase 4130 participants (Actual)Interventional2019-10-07Completed
Effect of a Triclosan Containing Dentifrice on Oral Bacteria and Postoperative Complications Following Third Molar Surgery [NCT01292343]141 participants (Actual)Interventional2008-02-29Completed
An 8-Week Clinical Study to Evaluate the Efficacy of Two Oral Hygiene Regimens in the Reduction of Dentin Hypersensitivity After Non-surgical Periodontal Treatment: Randomized Clinical Trial [NCT02461030]Phase 460 participants (Actual)Interventional2014-08-31Completed
Effectiveness of Different Fluoride Varnishes on Salivary Bacteria Levels in Children With Early Childhood Caries [NCT03625310]88 participants (Actual)Interventional2016-11-30Completed
Evaluation of the Fluoride Dose Response of a Modified In Situ Caries Model [NCT03383783]Phase 328 participants (Actual)Interventional2017-12-19Completed
Evaluation of Remineralization Potential of Preventive Regimens Containing Herbal-based Compared to Fluoride-based Toothpastes in High Caries Risk Patients With Initial Carious Lesions: Randomized Clinical Trial [NCT04446390]32 participants (Actual)Interventional2021-01-01Active, not recruiting
Assessment of a Potassium Oxalate-Containing Formulation for the Relief of Dentinal Hypersensitivity [NCT01345292]226 participants (Actual)Interventional2011-04-30Completed
A Randomized, 8 Week Clinical Study to Evaluate the Efficacy of an Experimental Stannous Fluoride Dentifrice in the Relief of Dentinal Hypersensitivity [NCT03310268]185 participants (Actual)Interventional2017-11-18Completed
Postoperative Pain After Application of Silver Diamine Fluoride Verses Sodium Fluoride Varnish in Treatment of Carious Primary Teeth (A Randomized Clinical Trial) [NCT03554980]Phase 446 participants (Anticipated)Interventional2018-12-01Not yet recruiting
A Method Development Clinical Study Investigating the Efficacy of an Experimental Oral Rinse in Providing Long Term Relief From Dentinal Hypersensitivity [NCT03238352]Phase 289 participants (Actual)Interventional2017-08-07Completed
Discoloration of Carious Primary Teeth After Application of Silver Diamine Fluoride Versus Sodium Fluoride Varnish: A Randomized Clinical Trial [NCT03557996]Phase 442 participants (Anticipated)Interventional2018-12-01Not yet recruiting
The PET-EVAR Study - Predicting Endoleaks Following Endovascular Aortic Aneurysm Repair Using 18F-Sodium Fluoride [NCT04577716]102 participants (Actual)Observational2021-04-01Active, not recruiting
18F Sodium Fluoride PET/CT in Acute Aortic Syndrome [NCT03647566]76 participants (Actual)Observational2018-10-01Completed
"Immediate And Sustained Treatment Response Of Commercially Available BioMin F, Colgate Sensitive Pro-Relief And Sensodyne Rapid Action Dentifrices In Dentin Hypersensitivity - A Randomized Clinical Trial" [NCT04249336]Phase 3140 participants (Actual)Interventional2019-09-27Completed
Clinical Study to Evaluate the Effectiveness of a Cognitive Behavioral Intervention (CBI) Adjunctive to a Smart Powered Toothbrush on the Oral Health of Adolescents [NCT05782348]150 participants (Anticipated)Interventional2023-02-06Recruiting
Anti-Inflammatory Efficacy of Ginger Containing Dentifrice in the Control of Biofilm Induced Gingivitis: a 3 Months Randomized Parallel Clinical Trial [NCT05868200]Phase 380 participants (Actual)Interventional2022-02-12Completed
Clinical Effectiveness of Silver Diamine Fluoride on Arresting Caries Lesions in Children [NCT05872542]Phase 460 participants (Anticipated)Interventional2023-06-01Recruiting
Pilot Study -- Oral Microbiome and Dental Plaque Control With Livionex(R) in Children Undergoing Hematopoietic Stem Cell Transplantation (HSCT) [NCT02617407]Phase 475 participants (Anticipated)Interventional2016-08-02Recruiting
PET Imaging as a Biomarker of Systemic Treatment Response for Men With Metastatic Castration-Resistant Prostate Cancer [NCT02169063]0 participants (Actual)Interventional2015-12-31Withdrawn
Different Concentrations of Potassium Nitrate in In-office Tooth Bleaching Sensitivity: a Randomized Clinical Trial [NCT03323372]Phase 256 participants (Actual)Interventional2016-12-21Completed
Efficacy of Silver Diamine Fluoride (SDF) and Fluoride Varnish in Arresting and Preventing Dental Caries in Primary School Children: Randomized Controlled Clinical Trial [NCT03480516]300 participants (Actual)Interventional2017-09-01Completed
"Combined One Stop Shop NaF/FDG PET/MRI Evaluation of Response to Xofigo® in mCRPC Patients: A Pilot Study" [NCT02429804]Phase 14 participants (Actual)Interventional2015-04-30Terminated(stopped due to Accrual factor)
Triclosan as Adjunctive Therapy in the Plaque Control in Children From Generalized Aggressive Periodontitis Families. A Controlled and Randomized Clinical Trial. [NCT03642353]Phase 440 participants (Actual)Interventional2016-01-30Completed
Essential Oils With and Without Alcohol: in Vivo Antibacterial Effect [NCT03146390]Phase 420 participants (Anticipated)Interventional2017-05-02Recruiting
A Prospective, Open Label, Randomized Control Trial to Study the Effect of Different Remineralizing Agents on White Spot Lesions and Dental Plaque During Orthodontic Retention [NCT04788550]30 participants (Anticipated)Interventional2021-03-17Recruiting
Probiotics That Moderate pH and Antagonize Pathogens to Promote Oral Health [NCT02999230]170 participants (Actual)Interventional2017-02-22Active, not recruiting
Cost Effectiveness of Sodium Fluoride Varnish Application in Prevention of Dental Caries in School Children Between Age of 6 and 7 Years [NCT03571815]328 participants (Actual)Interventional2015-01-02Completed
Non-invasive Detection of Bicuspid Aortic Valve-Related Thoracic Aortopathy [NCT04083118]95 participants (Actual)Observational2019-04-01Completed
Comparison of Clinpro™ 5000 1.1% Sodium Fluoride Anti-Cavity Toothpaste, Clinpro™ Tooth Crème, and MI-Paste Plus for the Prevention and Reduction of White Spot Lesions in Orthodontic Treatment [NCT03440996]90 participants (Actual)Interventional2011-01-14Completed
Comparative Evaluation of Remineralizing Efficacy of Fluoride Varnish and Its Combination Varnishes on White Spot Lesions in Children With ECC: A Randomized Clinical Trial [NCT03360266]60 participants (Actual)Interventional2016-03-21Completed
Comparison of the Remineralization Potential of an Optimized Fluoride Dentifrice With a Control Fluoride Dentifrice Using an in Situ Caries Model [NCT06010732]Phase 365 participants (Anticipated)Interventional2023-10-02Recruiting
18F-Sodium Fluoride (18F-NaF) PET-CT Imaging to Identify Vulnerable Plaques in Patients With Diabetes [NCT03530176]98 participants (Actual)Interventional2015-01-01Completed
Twelve Week Safety/Clinical/Microbiological Efficacy of Experimental Mouthwashes [NCT05121909]Phase 4274 participants (Actual)Interventional2021-11-15Completed
Effect of Dissolving Xylitol Chewable Tablets Versus Xylitol Chewing Gum on Salivary pH and Bacterial Count in Geriatric Bedridden Patients : Randomized Clinical Trial [NCT03877705]Early Phase 198 participants (Anticipated)Interventional2019-09-01Not yet recruiting
Effect of Low-level Light Therapy Associated With Potassium Nitrate in the Control of Post-bleaching Dental Sensitivity: a Randomized, Double-blind, Split-mouth, Controlled Trial [NCT03434782]Phase 150 participants (Actual)Interventional2017-04-24Completed
Clinical Efficacy of Giomer Versus Sodium Fluoride Varnish for Management of Hypersensitivity: Randomized Control Trail [NCT03818945]Phase 4104 participants (Anticipated)Interventional2019-03-01Recruiting
Retention of Fluoride Formed on Enamel by Fluoride Gel or Varnish Application and Its Release to Dental Biofilm Fluid - in Vivo Study [NCT02486458]Early Phase 162 participants (Actual)Interventional2015-04-30Completed
Comparison of Sodium Fluoride Positron Emission Tomography and Magnetic Resonance Imaging of Spine and Sacroiliac Joints for Detection of Inflammatory Lesions in Patients Affected by Spondyloarthritis [NCT02869100]26 participants (Actual)Interventional2013-01-31Completed
"Effect of Single Rinsing With Three Different Types of Mouthwash on VSC Levels in Morning Breath; Randomized Clinical Trial, Double-blind Cross-sectional Study" [NCT04279106]36 participants (Actual)Interventional2018-09-03Completed
Effect of Weekly Professional Oral Care, During 12 Months, on the Composition of the Oral Flora and Related Variables in Dependent Elderly Residents [NCT02627469]68 participants (Actual)Interventional2007-08-31Completed
Safety and Clinical Efficacy of Mouth Rinses in Type 1 and Type 2 Diabetics: Effect on Oral Soft Tissue, Plaque and Gingivitis [NCT04449952]Phase 4154 participants (Actual)Interventional2019-12-02Completed
Efficacy, Cost-efficacy and Parental Acceptability of Using Diammine Silver Fluoride in Arresting Enamel Caries Lesions on Babies' Occlusal Surfaces [NCT02789202]100 participants (Anticipated)Interventional2014-10-31Active, not recruiting
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases [NCT00375830]Phase 2114 participants (Actual)Interventional2006-01-31Completed
Methodology of Application and Immediate Effect of the Essential Oils and 0.2% Chlorhexidine on Oral Biofilm: Immersion Versus Mouthwash. [NCT02267239]Phase 415 participants (Anticipated)Interventional2014-10-31Recruiting
Assessment of Unstable Carotid Plaque Using PET and MR Imaging in Patient Referred to Endarterectomy: The CAROTEP Study [NCT03353103]Phase 220 participants (Anticipated)Interventional2018-09-03Recruiting
EFFECTIVENESS OF A HOMECARE DESENSITIZER FOR PATIENTS WITH DENTIN HYPERSENSITIVITY [NCT02128633]Phase 2/Phase 3126 participants (Actual)Interventional2009-11-30Completed
The Role of Detergents in the Pathogenesis of Eosinophilic Esophagitis [NCT05482256]12 participants (Actual)Interventional2022-09-12Active, not recruiting
A Randomized Clinical Trial on the Use of Sodium Fluoride Varnish and Silver Diamine Fluoride Solution for Arresting Active Dental Caries in Preschool Children [NCT02426619]Phase 2/Phase 3371 participants (Actual)Interventional2012-09-30Completed
Comparison of the Clinical Efficacy From the Retention Phase of Fluoride Delivery of Fluoride Toothpastes Using an in Situ Caries Model [NCT00708123]Phase 360 participants (Actual)Interventional2007-11-30Completed
SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial [NCT04802408]Phase 2/Phase 3200 participants (Anticipated)Interventional2021-10-01Recruiting
Therapeutic Effect of Two Fluoride Varnishes on White Spot Lesions: a Clinical Study [NCT00723515]Phase 445 participants (Actual)Interventional2007-02-28Completed
Evaluation of the Anticaries Efficacy of Various Dentifrice Formulations Using an In-situ Model [NCT06140758]12 participants (Anticipated)Interventional2023-07-31Active, not recruiting
A Randomized Clinical Trial to Investigate Salivary Flow and pH Following Use of Essential-Oil Containing Mouthwashes [NCT06136455]Phase 4164 participants (Anticipated)Interventional2023-11-13Not yet recruiting
A Randomized, Controlled Clinical Study to Evaluate the Efficacy of a Range of Dental/Denture Products for Improved Oral Health, Compared to Existing Oral Hygiene, in a Population of Partial Denture Wearers With Generalized Mild-moderate Plaque-induced Gi [NCT04290624]Phase 458 participants (Actual)Interventional2020-10-14Completed
Arrest of Interproximal Caries Lesion in Primary Molars With 38% Silver Diamine Fluoride Solution and 5% Sodium Fluoride Varnish: A Randomized Clinical Trial [NCT05791669]Phase 345 participants (Actual)Interventional2021-08-01Completed
Assessment of Symptomatic and Asymptomatic Carotid Plaques Using Hybrid Imaging 18F-sodium Fluoride PET/MR [NCT02726984]15 participants (Actual)Interventional2016-01-15Completed
Antiviral Efficacy and Acceptability of Therapeutic Antiseptic Mouth Rinses for Inactivation of COVID SARS-2 Virus [NCT04748783]Phase 22 participants (Actual)Interventional2021-03-26Terminated(stopped due to Funding withdrawn)
Validation of Imaging-Based Biomarkers of Treatment Response in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide [NCT02677376]7 participants (Actual)Observational2016-06-27Completed
Effectiveness of the Use of Desensitizing Dentifrices Based on Nanocrystals of Hydroxyapatite / 5% Potassium Nitrate / 1450ppm Sodium Monofluorophosphate and Potassium Nitrate 5% / 1426ppm Sodium Floride in the Treatment of Dentine Hypersensitivity. Test [NCT04156152]32 participants (Anticipated)Interventional2020-04-10Not yet recruiting
Clinical and Microbiological Effects of Three Different Mouth Rinses Made of Sodium Fluoride, Guava Leaves Extract or Pomegranate Peel Extract on Dental Plaque in Children [NCT06013735]40 participants (Actual)Interventional2020-02-17Completed
Assessment of Effect of an Experimental Pregabalin Gel in Reducing Post-operative Tooth Sensitivity Surgery Caused by Bleaching With 35% Hydrogen Peroxide [NCT06180707]Phase 375 participants (Anticipated)Interventional2024-01-05Not yet recruiting
A Randomized, Controlled, Examiner-Blind Clinical Study Investigating the Effects of a Dentifrice Containing 0.454% w/w Stannous Fluoride on Gingivitis Treatment and Plaque Reduction When Used Twice Daily for 12 Weeks [NCT06143670]160 participants (Anticipated)Interventional2023-11-29Recruiting
Clinical Study to Compare Dental Plaque Control [NCT00758394]Phase 329 participants (Actual)Interventional2007-09-30Completed
The Effect of Subclinical Leaflet Thrombosis and Prosthesis Type on Transcatheter Aortic Valve Degeneration [NCT05758662]180 participants (Anticipated)Observational2023-04-30Not yet recruiting
The Anticariogenic Effect of Miswak (Silvadora Persica) and Grape Seed Extract [NCT04136639]30 participants (Actual)Interventional2019-06-01Completed
Prevention of Dental Caries Lesions With Fluoride Varnish in Erupting First Permanent Molars [NCT02592278]Phase 4180 participants (Actual)Interventional2015-03-31Completed
An Observational Pilot Study of 18F-Sodium Fluoride (Na18F) Whole Body PET Scans in Patients for Whom 99m Tc MDP Bone Scans Would Normally be Indicated. [NCT00922519]9,999 participants (Anticipated)Observational2009-06-30Recruiting
A Phase 2, Multicenter Evaluation of 18F-Fluoride PET as a Pharmacodynamic Biomarker for Dasatinib, a Src Kinase Inhibitor, in Men With Castration-Resistant Prostate Cancer and Bone Metastases (BMS #180-279) [NCT00936975]Phase 218 participants (Actual)Interventional2009-09-30Completed
A Randomized Controlled Clinical Trial to Evaluate Late First to Mid-Second Trimester Introduction of Advanced Daily Oral Hygiene on Gingivitis and Maternity Outcomes [NCT01549587]746 participants (Actual)Interventional2012-02-29Completed
Clinical Efficacy of Different Remineralizing Agents in Treatment of White Spot Lesions Among a Group of Egyptian Children : A Randomized Clinical Trial [NCT05064137]30 participants (Anticipated)Interventional2022-03-31Not yet recruiting
Effectiveness of Silver Diamine Fluoride Versus Sodium Fluoride Varnish With Parental Behavior Modification for Arresting Early Childhood Caries: A Randomized Clinical Trial [NCT05761041]Phase 3140 participants (Actual)Interventional2022-03-28Completed
Comparison of the Clinical Effectiveness of 8% Arginine/1450 Ppm Sodium Monofluorophosphate Versus 5% Potassium Nitrate/2500 Ppm Sodium Fluoride in Dentin Hypersensitivity Therapy: A Randomized Controlled Clinical Trial [NCT02829879]Phase 350 participants (Anticipated)Interventional2015-12-31Recruiting
Investigation of Dental Plaque and Gingival Index [NCT00759031]Phase 319 participants (Actual)Interventional2008-02-29Completed
Total Salivary Fluoride Concentration of Healthy Adult Subjects Following Toothbrushing With Different Formulations of Fluoridated Toothpastes With and Without Post-brushing Water Rinsing. A Double Blinded Randomised Controlled Trial [NCT02740803]120 participants (Actual)Interventional2016-04-30Completed
Phase II Trial of Radium-223 in Biochemically Recurrent Prostate Cancer [NCT04206319]Phase 226 participants (Anticipated)Interventional2020-09-22Recruiting
F-18 NaF PET for Detection of Bone Metastases in Men With Prostate Cancer: Exploratory Study [NCT00956163]Early Phase 150 participants (Actual)Interventional2010-03-31Completed
Immediate Effect and Substantivity of the Essential Oils Without Alcohol on the Oral Biofilm in Situ. A Randomized Clinical Trial [NCT02946814]Phase 420 participants (Anticipated)Interventional2016-10-31Not yet recruiting
A Randomised Controlled Trial Investigating a Comparison of Fluoride Varnish vs Self-Etching Dentine Bonding Agent in the Reduction of Cervical Dentine Sensitivity in Patients Attending a General Dental Practice in West Sussex, UK. [NCT02919202]26 participants (Actual)Interventional2016-10-26Completed
A Phase 2 Study of Bevacizumab, Erlotinib and Atezolizumab in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) Associated or Sporadic Papillary Renal Cell Cancer [NCT04981509]Phase 265 participants (Anticipated)Interventional2022-06-10Recruiting
The Influence of Periodontal Treatment on Gingival Inflammatory Response of the Type II Diabetic Patient [NCT01881074]74 participants (Actual)Observational2012-06-30Completed
Randomized Clinical Trial on Resin Infiltration Versus Fluoride Varnish Treatment of Early Smooth-surface Caries Lesions in Deciduous Teeth [NCT01881100]81 participants (Actual)Interventional2011-01-31Completed
18F- Sodium Fluoride PET Imaging as a Replacement for Bone Scintigraphy [NCT01930812]Phase 3286 participants (Actual)Interventional2014-07-31Completed
Cariostatic and Remineralizing Effects of Three Different Dental Varnishes (A Clinical Trial) [NCT04887389]Phase 4115 participants (Anticipated)Interventional2021-08-01Active, not recruiting
Alcohol-free Essential Oils Containing Mouthrinse Efficacy on 3-day Supragingival Plaque Regrowth: a Randomized Crossover Clinical Trial [NCT02894593]21 participants (Actual)Interventional2015-01-31Completed
The Effect of Toothpaste Containing Aloe Vera on Clinical and Microbiological Out Comes With Measuring IL_1 β in Gingival Crevicular Fluid: a Randomized Controlled Crossover Clinical Trial [NCT04662385]Phase 224 participants (Actual)Interventional2020-03-13Completed
A Randomized, Controlled, Examiner-Blind Clinical Study Investigating the Effects of a Dentifrice Containing 67% Sodium Bicarbonate When Used Twice Daily for 12 Weeks on Gingivitis Treatment and Plaque Removal [NCT05654662]204 participants (Actual)Interventional2023-02-20Completed
Clinical and Cost-effectiveness of Fluoride Varnish Versus Resin Based Fissure Sealant in Newly Erupted Permanent Molars in Group of Egyptian Children : A Randomized Clinical Trial ( Part 1) [NCT04603573]91 participants (Anticipated)Interventional2021-07-10Recruiting
Clinical Evaluation of the Effectiveness of Immediate Relief Obtained With Desensitizing Creams - A Controlled, Randomized, Triple Masked, Split-Mouth Clinical Trial [NCT02018783]138 participants (Actual)Interventional2013-04-30Completed
Effectiveness of Biannual Application of Silver Nitrate Solution Followed by Sodium Fluoride Varnish in Arresting Early Childhood Caries in Preschool Children: a 30-month, Randomised, Double-blind, Non-inferiority Trial [NCT02019160]Phase 31,070 participants (Actual)Interventional2014-09-30Completed
The Effectiveness of Biomimetic Materials in Preventing Enamel Demineralization During Fixed Appliance Orthodontic Treatment: a Randomized Clinical Trial [NCT05940701]65 participants (Actual)Interventional2023-01-15Active, not recruiting
Metagenomic and Metatranscriptomic Analysis of Clinical Plaque Samples [NCT05138978]Phase 234 participants (Actual)Interventional2017-10-06Completed
Glass Ionomer Sealant Versus Fluoride Varnish Application to Prevent Occlusal Caries Among Preschool Children - a Randomized Controlled Trial [NCT04163354]348 participants (Anticipated)Interventional2018-04-11Enrolling by invitation
Impact of Basic Periodontal Therapy in the Levels of Porphyromonas Gingivalis and Aggregatibacter Actinomycetemcomitans Subgingival and Its Association With Vascular Function [NCT02716259]120 participants (Anticipated)Interventional2016-03-31Recruiting
Sodium Fluoride, Chlorhexidine and Vancomycin Effect in the Inhibition of Mutans Streptococci in Children With Dental Caries: a Randomized, Double-Blind Clinical Trial [NCT00612469]69 participants (Actual)Interventional2005-10-31Completed
Assessment of the Oral Tissue Tolerance of a Potassium Oxalate Containing Mouthrinse [NCT01009554]96 participants (Actual)Interventional2009-10-31Completed
Clinical Efficacy of Fluoride Toothpastes Using an in Situ Caries Model [NCT01005966]Phase 365 participants (Actual)Interventional2008-11-30Completed
Evaluation of Sodium Fluoride PET in the Identification of Bone Metastases in Patients Having Undergone a Choline PET for Occult Recurrence of Prostatic Adenocarcinoma [NCT02876991]110 participants (Anticipated)Interventional2016-02-29Recruiting
Preventing Early Childhood Caries With Silver Diamine Fluoride - a Randomised Clinical Trial [NCT04075474]Phase 2730 participants (Anticipated)Interventional2020-10-27Recruiting
18F-fluoride (18F-NaF) Positron Emission Tomography (PET) for Identification of Ruptured and High-Risk Coronary Atherosclerotic Plaques [NCT02607748]Phase 441 participants (Actual)Interventional2015-11-13Completed
Mouth Rinses Efficacy on Salivary SARS-CoV-2 Viral Load: A Randomized Clinical Trial [NCT04721457]Phase 490 participants (Actual)Interventional2021-01-03Completed
Association of Two Desensitizing Protocols to Control Dentinal Hypersensitivity in Non-carious Lesions: A Randomized, Double-blind Clinical Trial. [NCT04642001]24 participants (Actual)Interventional2019-08-07Completed
Efficacy of Salivary Bacteria and Post Brushing [NCT00981825]Phase 322 participants (Actual)Interventional2007-10-31Completed
Plaque Removal Efficacy of Four Dentifrices in a Single Brushing Model [NCT03285984]56 participants (Actual)Interventional2012-03-27Completed
Antiplaque Effect of Essential Oils and 0.2% Chlorhexidine on an in Situ Model of Oral Biofilm Growth. A Randomized Clinical Trial [NCT02946801]Phase 420 participants (Anticipated)Interventional2016-11-30Not yet recruiting
Six Month Clinical Efficacy of Virtually Supervised Mouthwash and Interdental Brushes: Effect on Plaque, Gingivitis and Oral Microbiome [NCT05756673]Phase 4292 participants (Actual)Interventional2023-02-09Completed
Randomized Clinical Trial to Evaluate the Efficacy of Nano-hydroxyapatite Combined With the Potassium Nitrate for the Treatment of Dental Sensitivity [NCT02895321]Phase 435 participants (Anticipated)Interventional2016-03-31Completed
A Randomized, Crossover, Controlled, Maximal Use Study to Determine the Pharmacokinetics of L-arginine After Exaggerated Oral Use of COL101 in Healthy Adult Subjects [NCT06182267]Phase 130 participants (Anticipated)Interventional2023-11-27Active, not recruiting
Investigation of Clinical Efficacy of a New Mouthwash on Reducing Dental Plaque and Helping Prevent Gum Problems as Compared to a Control Mouthwash - a Six-month Study in Italy [NCT05821712]Phase 380 participants (Actual)Interventional2021-03-08Completed
Evaluation of a Test Mouthwash and Dentifrice Regimen in an In-situ Model of Dental Erosion [NCT01128972]Phase 236 participants (Actual)Interventional2009-08-31Completed
Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer [NCT01541358]2 participants (Actual)Interventional2012-05-31Terminated(stopped due to Low accrual and no funding)
Effectiveness of Nano-hydroxyapetite Care Paste in Reducing Dentinhypersenstitivity: A Double Blind Randomized Control Trial [NCT02936830]Phase 463 participants (Actual)Interventional2016-10-31Completed
Compare the Clinical Efficacy of Prototype Toothpastes [NCT00926029]Phase 398 participants (Actual)Interventional2008-01-31Completed
NaF PET/CT Repeatability, Responsiveness, and Response Assessment in Patients With Metastatic Castrate-resistant Prostate Cancer to Bone Treated With Either an Antimicrotubule Directed Agent or Androgen Receptor (AR)-Directed Therapies [NCT01516866]58 participants (Actual)Observational2011-11-30Completed
Effectiveness of Remineralization Agents on the Prevention of Dental Bleaching Induced Sensitivity [NCT04855279]64 participants (Actual)Interventional2019-01-07Completed
The Effect of Fluoride Varnish, Casein Phosphopeptide-Amorphous Calcium Phosphate, and Resin Infiltration in the Treatment of White Spot Lesions After Orthodontic Therapy: A Randomized Controlled Trial [NCT06051981]Phase 488 participants (Anticipated)Interventional2023-10-31Not yet recruiting
Effectiveness of Using Nano-Silver Fluoride Varnish Versus Sodium Fluoride Varnish in Management of Cervical Dentin Hypersensitivity in Adult Patients: A Randomized Clinical Trial. [NCT04731766]42 participants (Anticipated)Interventional2021-11-01Not yet recruiting
Minimally Invasive Treatment Approach for Early Childhood Caries Using Silver Diammine Fluoride and Sodium Fluoride With Functionalized Tricalcium Phosphate and Their Effects on Oral Health Related Quality of Life: A Pragmatic Randomized Control Trial [NCT05772039]Phase 472 participants (Anticipated)Interventional2022-01-18Enrolling by invitation
Caries-preventing Effect of a Hydroxyapatite-toothpaste in Adults [NCT04756557]192 participants (Actual)Interventional2021-01-01Completed
F-18 Sodium Fluoride PET/CT Guided Robotic Arm-assisted Pain Palliation in Chronic Nociceptive Low Backache [NCT05560165]30 participants (Anticipated)Interventional2022-01-01Recruiting
Determination of the Antiplaque/Antigingivitis Efficacy of Essential Oil Containing Mouthrinses In a Six-Month Study [NCT02980497]370 participants (Actual)Interventional2013-09-30Completed
Evaluate Clinical Research From Commerical Oral Care Products [NCT00759187]Phase 325 participants (Actual)Interventional2008-01-31Completed
F18 NaF PET/CT and Whole Body and Axial MRI for the Detection of Metastases in Patients With Biochemical Recurrence of Prostate Cancer [NCT01967862]54 participants (Actual)Interventional2013-12-31Completed
21 Day Clinical Efficacy of Essential Oil Containing Mouth Rinses: Effect on Reducing Existing Gingivitis and Plaque [NCT02233998]158 participants (Actual)Interventional2014-08-31Completed
The Effect of Light-cured Fluoride Varnish to Remineralize Post-orthodontic White Spot Lesions and Change the Oral Microbiome: a Double-blind, Split-mouth Randomized Clinical Trial [NCT04528134]120 participants (Anticipated)Interventional2022-02-07Recruiting
Prospective Cohort Study: Efficacy of the Use of 38% Silver Diamine Fluoride and 5% Sodium Fluoride Varnish in Patients 4 to 12 Years for the Treatment of Caries and Its Association With Other Aspects of Relevance [NCT05638217]199 participants (Actual)Observational2022-11-07Completed
In-situ Evaluation of Anti-caries Technology [NCT01650493]29 participants (Actual)Observational2012-06-30Completed
Comparison of 18-F Sodium Fluoride Uptake in Culprit Plaques Between Acute Coronary Syndrome and Stable Angina [NCT01665248]20 participants (Actual)Interventional2012-08-31Terminated
Assessment of the Cytotoxic and Genotoxic Effect of Toothpastes With Different Forms of Fluoride on the Buccal Mucosa [NCT05596149]80 participants (Anticipated)Interventional2022-11-01Recruiting
Fluoride Bioavailability in Saliva After Use of Prescription and Over-the-counter Toothpastes Followed by Fluoride Mouthrinses [NCT05601154]Early Phase 120 participants (Anticipated)Interventional2023-03-23Enrolling by invitation
A Comparative Study on the Cost-effectiveness of Four Methods in Preventing Fissure Caries in Permanent Teeth [NCT01829334]Phase 2329 participants (Actual)Interventional2006-06-30Completed
The Effectiveness of Brushing and Flossing Sequence on Control of Plaque and Gingival Inflammation-A Randomized Controlled Clinical Trial in Klinik Pergigian, MMMC, Melaka [NCT03989427]30 participants (Actual)Interventional2019-05-20Completed
The Effectiveness of Sealants in Prevention of Occlusal Caries on Primary Molars [NCT01438866]Phase 4148 participants (Actual)Interventional2011-10-31Completed
Phase 2 Efficacy Evaluation Of Advantage Anti-Caries Varnish [NCT03082196]Phase 2284 participants (Actual)Interventional2017-03-30Completed
Comparing Chlorhexidine Gluconate Rinse, Sodium Fluoride Rinse, Water Rinse, and Chewing Gum in Regard to Streptococcus Mutans Reduction [NCT02598778]Phase 212 participants (Actual)Interventional2015-11-01Terminated(stopped due to Study discontinued early due to time constraints and lack of selectivity in agar used in the identification of the target (Streptococcus mutans). Only 12 participants out of a planned 40 were enrolled.)
Remineralization Effect of NaF, NaF With TCP, NaF With CPP-ACP, and NaF With CXP Varnishes on Newly Erupted First Permanent Molars: a Randomised Controlled Trial [NCT04124887]40 participants (Actual)Interventional2017-02-03Completed
Twelve Week Clinical Efficacy of Virtually Supervised Mouth Rinse and Flossing: Effect on Plaque, Gingivitis, and Microbiome [NCT05600231]Phase 4284 participants (Actual)Interventional2022-04-18Completed
Avaliação da Carga do vírus SARS-CoV-2 na Cavidade Oral e na Saliva após desinfecção Com soluções Antimicrobianas Orais e dentifrícios. [NCT04537962]202 participants (Actual)Interventional2020-07-14Completed
Open-label Clinical Trial on the Safety and Efficacy of 18F-sodium Fluoride (NaF) PET Imaging in Patients in Need of a Standard 99mTc Bone Scintigraphy [NCT04842071]Phase 32,500 participants (Anticipated)Interventional2008-01-01Recruiting
Clinical and Cost-effectiveness of Fluoride Varnish Versus Resin Based Sealant in Newly Erupted Permanent Molars in Group of Egyptian Children: A Randomized Clinical Trial(Part 2). [NCT04793256]91 participants (Anticipated)Interventional2021-04-30Not yet recruiting
A Randomized, Open-Label, Crossover, Controlled, Multi-center Clinical Study to Assess the Diagnostic Performance and Safety of 18F-NaF-PET/CT in Bone Metastases of Malignant Tumors Compared With 99mTc⁃MDP-BS±SPECT [NCT05614518]Phase 3280 participants (Actual)Interventional2021-03-29Completed
NUPRO Sensodyne Prophylaxis Paste With NovaMin for the Treatment of Dentin Hypersensitivity. [NCT01669785]139 participants (Actual)Interventional2012-03-31Completed
Comparison of the Salivary Levels of Streptococcus Mutans in Pediatric Patients With Early Childhood Caries After the Application of Silver Diamine Fluoride or 5% Sodium Fluoride Varnish [NCT03089567]Early Phase 10 participants (Actual)Interventional2017-09-15Withdrawn(stopped due to Study was not conducted. No participants were enrolled)
A Prospective Randomized Controlled Trial for Prevention of Enamel White Spot Lesions During Fixed Orthodontic Treatment [NCT04342858]Phase 299 participants (Actual)Interventional2017-09-15Active, not recruiting
An in Situ Study on the Impact of Fluoride Dose and Concentration in Milk on Its Anti-caries Efficacy [NCT01665911]28 participants (Actual)Interventional2012-08-31Completed
Two-Week Clinical Safety and Saliva Flow Quantification [NCT05645705]Phase 4270 participants (Actual)Interventional2022-11-28Completed
Evaluation of the Efficacy of Fluoride Therapies on Hypersensitive Carious Lesions in Primary Teeth [NCT04804423]Phase 2/Phase 330 participants (Actual)Interventional2020-01-13Completed
A Placebo Controlled Study to Evaluate the Effectiveness of Experimental Foaming Gel Toothpastes Using an In-situ Erosion Remineralization Model [NCT01657903]56 participants (Actual)Interventional2011-11-30Completed
Clinical Investigation Examining the Anticaries Efficacy of Three Dentifrices (1.5% Arginine in a Calcium Base, 8.0% Arginine in a Calcium Base, and 0.32% Sodium Fluoride in a Silica Base): a Two-year Caries Clinical Study [NCT05560945]Phase 36,000 participants (Actual)Interventional2019-04-15Completed
Evaluation of Remineralizing Efficacy of Grape Seed Extract Oil Versus Fluoride Mouthwash in Management of Post-Orthodontic White Spot Lesions: Randomized Clinical Trial [NCT04357093]40 participants (Anticipated)Interventional2021-02-28Not yet recruiting
Digital PET/CT Using [Ga-68]PSMA vs. [F-18]NaF for Evaluation of Osseous Metastatic Involvement in Prostate Cancer Patients [NCT05527483]40 participants (Anticipated)Observational2022-04-21Recruiting
A Proof of Concept Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in the Relief of Dentinal Hypersensitivity [NCT01831817]Phase 2140 participants (Actual)Interventional2013-01-31Completed
A Six Month Clinical Study Based in the US to Evaluate the Efficacy and Tolerability of Sodium Bicarbonate Toothpaste [NCT02207907]Phase 2247 participants (Actual)Interventional2014-08-31Completed
MI Varnish and MI Paste Plus in a Caries Prevention and Remineralization Study [NCT02424097]Phase 440 participants (Actual)Interventional2013-05-31Completed
The Effect of Fluoride in an Experimental Dentifrice on Remineralization of Erosive Lesions In-Situ [NCT01641237]Phase 372 participants (Actual)Interventional2012-03-31Completed
The Effect of Experimental Dentifrices on Remineralization of Caries Lesions In-situ [NCT02195583]62 participants (Actual)Interventional2014-06-30Completed
A Clinical Study to Evaluate the Efficacy of Two Dentifrices for Dentine Hypersensitivity [NCT02371616]304 participants (Actual)Interventional2014-09-29Completed
A Clinical Study to Evaluate the Efficacy of Pre-procedural and Pre-surgical Rinsing With an Antimicrobial Agent in Reducing Bacteria in Dental Aerosols and in the Oral Cavity [NCT02319668]Phase 438 participants (Actual)Interventional2015-02-01Completed
A Pharmacodynamic Study Using NaF PET/CT Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Metastatic Castrate Resistant Prostate Cancer to Bone [NCT01816048]Phase 28 participants (Actual)Interventional2013-05-31Terminated(stopped due to Study supporter (Takeda) ended study drug for prostate cancer; enrollment ended prematurely.)
Exploring Caregivers' Experiences Related to the Use of a Smart Toothbrush by Children With Autism Spectrum Disorder [NCT05552144]17 participants (Actual)Observational2022-08-24Completed
Evaluation of Two Different Toothpastes for the Clinical Management of Extrinsic Stains: Randomized Clinical Trial. [NCT04904978]40 participants (Actual)Interventional2021-05-28Completed
Study to Investigate the Initial Stages of Enamel Erosion in Vivo [NCT02533466]30 participants (Actual)Interventional2015-10-01Completed
Clinical Study to Assess Therapeutic Delay and Resolution of Induced Gingivitis [NCT05731778]Phase 426 participants (Actual)Interventional2018-12-22Completed
A Six Month Clinical Study Based in the US to Evaluate the Efficacy and Tolerability of Sodium Bicarbonate Toothpaste and Its Effect on Opportunistic or Resistant Organisms [NCT02207400]Phase 2246 participants (Actual)Interventional2014-08-25Completed
Ecological Effect of 8% Arginine Dentifrice on Oral Microbiota of Caries-Free and Caries-active Populations [NCT02988349]42 participants (Actual)Interventional2013-10-31Completed
A Randomized, Examiner Blind, Crossover, in Situ Erosion Study to Investigate the Efficacy of an Experimental Dentifrice in Remineralization of Previously Softened Enamel Compared to a Placebo Dentifrice [NCT03296072]Phase 362 participants (Actual)Interventional2017-11-13Completed
Comparing Three Caries Prevention Products on Dentinal Hypersensitivity - A Pilot Study [NCT02136576]39 participants (Actual)Interventional2014-05-31Completed
Quantitative Clinical Assessment of Bifluorid 10 Versus Varnish Fluoride on The Exposed Hypersensitive Cervical Dentin in Adult Patient: A Randomized Clinical Trial [NCT04485299]Phase 2/Phase 368 participants (Anticipated)Interventional2020-10-31Not yet recruiting
Whitening Action of a Hydrogen Peroxide/Sodium Fluoride Containing Mouth Rinse: A 2 Week Randomized Controlled Trial [NCT02151058]227 participants (Actual)Interventional2014-06-30Completed
Evaluation of Plaque Fluid Fluoride Retention From Fluoride Toothpastes [NCT00708305]Phase 365 participants (Actual)Interventional2008-06-30Completed
A Comparison Between a Toothpaste With Micro Crystals of Hydroxyapatite and a Toothpaste With 1450 Ppm of Fluoride in the Home Remineralization of White Spot Lesions: a Clinical Trial. [NCT04908293]40 participants (Actual)Interventional2021-05-28Completed
A Phase 2 Randomized, Double-blind, Active-controlled Multi-center Clinical Trial to Assess the Safety and the Anti-caries Efficacy of COL 101 (Arginine) Non-fluoride Dentifrices With 1.5%, 4.0% and 8.0% Arginine Each in Comparison With 0.24% Sodium Fluor [NCT04750902]Phase 22,000 participants (Actual)Interventional2021-01-21Active, not recruiting
Silver Diamine Fluoride: Novel Addition to the Prophylactic Bundle for Dental Management of Radiation-Induced Dental Caries in Oral and Pharyngeal Cancer Patients [NCT05403125]60 participants (Anticipated)Interventional2022-06-01Not yet recruiting
Short- and Long Term Antibacterial Effects of a Single Rinse With Different Mouthwashes: a Randomized Clinical Trial [NCT05178823]Phase 4171 participants (Actual)Interventional2017-06-01Completed
A Randomized Clinical Study of the Safety and Effectiveness of Two Dentinal Hypersensitivity Treatments Used With Normal Oral Hygiene [NCT02221349]30 participants (Actual)Interventional2014-08-31Completed
Effect of Evolocumab on Coronary Artery Plaque Volume and Composition by Coronary CTA (CCTA) and Microcalcification by F18-NaF PET: A Phase 3 Study [NCT03689946]Phase 355 participants (Actual)Interventional2019-03-19Completed
Clinical Investigation of a Toothpaste Containing Stannous Fluoride as Compared to Colgate Fluoride Toothpaste in Reducing Plaque and Gingivitis - a Three Month Study [NCT04033575]Phase 488 participants (Actual)Interventional2019-03-06Completed
NUPRO(r) Sensodyne Prophylaxis Paste With NovaMin(r) for the Treatment of Dentin Hypersensitivity. [NCT01610167]151 participants (Actual)Interventional2011-09-30Completed
Effect of a Dentifrice Containing Calcium Glycerophosphate and Fluoride on the pH of Dental Biofilm in Vivo [NCT00875212]Phase 112 participants (Actual)Interventional2006-01-31Completed
Non-invasive and Minimal Intervention in Dental Caries Management: Randomized Clinical Study [NCT04373356]30 participants (Anticipated)Interventional2020-07-01Not yet recruiting
Comparison Of The Caries-Protective Effect Of Fluoride Varnish (Duraphat®) With Treatment As Usual In Nursery School Attendees Receiving Preventive Oral Health Support Through The Childsmile Oral Health Improvement Programme: An RCT [NCT01674933]Phase 41,610 participants (Anticipated)Interventional2012-10-31Completed
A Randomized Controlled Trial on the Remineralization Agents Used for the Treatment of White Spot Lesions [NCT04827966]12 participants (Actual)Interventional2022-09-01Terminated(stopped due to Funding issues)
Effectiveness of Self-assembling Peptide (P11-4) and Nano-silver Fluoride Varnish in Management of Enamel White Spot Lesions in Young People (Randomized Controlled Clinical Trial) [NCT04929509]66 participants (Anticipated)Interventional2020-12-05Recruiting
Effect of Sodium Fluoride at 1.1%, Associated or Not With the Low-level Light Therapy in the Prevention of Post-bleaching Sensitivity: a Randomized, Double-blind, Controlled Trial [NCT03044171]Phase 125 participants (Actual)Interventional2016-08-01Completed
Evaluation of the Response of Caries Lesions in Dentin After Application of Silver Diamine Fluoride Gel: A Case Series [NCT05395065]235 participants (Actual)Observational2022-07-11Active, not recruiting
Compare the Clinical Efficacy of Prototype Toothpastes. [NCT00761930]Phase 3103 participants (Actual)Interventional2008-03-31Completed
A Proof of Concept Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in the Relief of Dentinal Hypersensitivity [NCT01691560]Phase 2140 participants (Actual)Interventional2012-08-31Completed
A Randomized Clinical Trial to Investigate Two-Week Clinical Safety, Changes in Salivary Flow and pH Following Use of an Anticavity Low pH Mouthwash [NCT06010758]Phase 4163 participants (Actual)Interventional2023-07-17Completed
The Effect of Sodium Fluoride Application on the Prevention of Radiation Caries in Nasopharyngeal Carcinoma Patients: A Prospective, Open, Randomized Controlled Phase II Trial [NCT06174012]Phase 2135 participants (Anticipated)Interventional2023-12-15Not yet recruiting
Effectiveness of Silver Diamine Fluoride in Preventing Occlusal Caries in Primary Teeth of Preschool Children: a 30-month Randomized Clinical Trial [NCT05084001]Phase 2/Phase 3769 participants (Anticipated)Interventional2020-03-01Recruiting
A Clinical Study Investigating the Efficacy of a Mouthwash in Providing Long Term Relief From Dentinal Hypersensitivity [NCT02226562]Phase 2191 participants (Actual)Interventional2014-09-02Completed
A Randomised, Controlled Trial to Assess the Effect of Different Modes of Fluoride Delivery on Enamel Demineralisation, During Orthodontic Treatment With Fixed Appliances [NCT05005689]Phase 4130 participants (Anticipated)Interventional2023-10-20Recruiting
The Clinical Investigation of Colgate Total Toothpaste as Compared to Parodontax Toothpaste and Colgate Cavity Protection Toothpaste in Controlling Established Plaque and Gingivitis. (A Six Month Study) [NCT02080273]Phase 4135 participants (Actual)Interventional2013-03-31Completed
Remineralization of Dentine Caries Using Nanosilver Fluoride and Casein Phosphopeptides-amorphous Calcium Phosphate (A Randomized Clinical Trial) [NCT04930458]135 participants (Anticipated)Interventional2021-08-10Recruiting
A Study to Evaluate the Effect of a 67% Sodium Bicarbonate Containing Toothpaste on Chlorhexidine Digluconate Tooth Staining [NCT01962493]Phase 4160 participants (Actual)Interventional2013-09-30Completed
Efficacy of Shoplaq® Disclosing Toothpaste in Removing Dental Plaque: A Randomized Controlled Clinical Trial. [NCT03287011]50 participants (Anticipated)Interventional2017-09-11Recruiting
[NCT02384044]30 participants (Actual)Interventional2015-02-28Completed
Clinical Evaluation of Efficacy of Shield Force Plus Varnish Versus Sodium Fluoride on Cervical Dentin Hypersensitivity on Adult Patients: A Randomized Clinical Trial [NCT04484844]Phase 2/Phase 368 participants (Anticipated)Interventional2020-10-31Not yet recruiting
Effectiveness of Self-assembling Peptide (p11-4) in Conjunction With Fluoride Varnish in the Management of White Spot Lesions in Primary Teeth (Randomized Controlled Clinical Trial) [NCT05721586]24 participants (Actual)Interventional2020-06-01Completed
A Real-World Evidence Study Evaluating Oral Health Related Quality of Life Following the Use of Antisensitivity Toothpaste for Dentine Hypersensitivity Management [NCT04964063]655 participants (Actual)Interventional2021-08-31Completed
A Study to Measure the Effect of Dentifrice Usage Regime on Delivery and Efficacy of Fluoride Using an In Situ Caries Model [NCT01563172]Phase 465 participants (Actual)Interventional2009-01-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

TrialOutcome
NCT00375830 (9) [back to overview]Cohort 3 - Total Skeletal Lesions Identified, Tc-99m MDP WBBS vs 18F-NaF / 18F-FDG PET/MRI
NCT00375830 (9) [back to overview]Cohort 1 - 18F-NaF PET/CT vs 18F-FDG PET/CT
NCT00375830 (9) [back to overview]Cohort 1 - NaF PET/CT vs 99mTc-MDP Bone Scintigraphy
NCT00375830 (9) [back to overview]Cohort 2 - 18F-NaF/18F-FDG PET/CT vs Whole-body MRI for Detection of Extraskeletal Lesions
NCT00375830 (9) [back to overview]Cohort 2 - 18F-NaF/18F-FDG vs 99mTc-MDP Bone Scintigraphy for Detection of Skeletal Lesions
NCT00375830 (9) [back to overview]Cohort 2 - 18F-NaF/18F-FDG vs Whole-body MRI for Detection of Skeletal Lesions
NCT00375830 (9) [back to overview]Cohort 2 - Overall Sensitivity and Accuracy for 18F-NaF/18F-FDG vs Whole-body MRI
NCT00375830 (9) [back to overview]Cohort 2 - Overall Sensitivity and Accuracy for 18F-NaF/18F-FDG vs Whole-body MRI/99mTc-MDP Bone Scintigraphy
NCT00375830 (9) [back to overview]Cohort 3 - Skeletal Lesions Identified by 99mTc MDP WBBS vs 18F-NaF / 18F-FDG PET/MRI
NCT00708123 (3) [back to overview]Mean %SMHR of Enamel Specimens Exposed to NaF/Carbopol Toothpaste (1400 ppmF), NaF Toothpaste (1350ppmF), NaMFP/NaF Toothpaste (1450ppmF), NaF Toothpaste (250ppmF) and Placebo Toothpaste (0ppmF)
NCT00708123 (3) [back to overview]Adjusted Mean Change From Baseline in Enamel Fluoride Uptake
NCT00708123 (3) [back to overview]Mean Percentage Surface Microhardness Recovery (%SMHR) of Enamel Specimens Exposed to NaF/Carbopol Toothpaste (1400 ppmF), NaF Toothpaste (1350ppmF) Compared to NaMFP/NaF Toothpaste (1450ppmF)
NCT00708305 (7) [back to overview]Natural Log Transformed AUC for Fluoride Concentration in Plaque Fluid Between 0-4 Hours
NCT00708305 (7) [back to overview]Change From Baseline in Fluoride Concentration at 1 Hour Post Brushing With Study Treatments
NCT00708305 (7) [back to overview]Natural Log Transformed Area Under the Fluoride Concentration in Plaque Fluid by Time Curve (AUC) Between 0-4 Hours
NCT00708305 (7) [back to overview]Change From Baseline in Fluoride Concentration at 4 Hours Post Brushing With Study Treatments
NCT00708305 (7) [back to overview]Change From Baseline in Fluoride Concentration at 30 Minutes Post Brushing With Study Treatments
NCT00708305 (7) [back to overview]Change From Baseline in Fluoride Concentration at 2 Hours Post Brushing With Study Treatments
NCT00708305 (7) [back to overview]Change From Baseline in Fluoride Concentration at 15 Minutes After Brushing With Study Treatments
NCT00758394 (1) [back to overview]Dental Plaque Index
NCT00759031 (1) [back to overview]Gingival Margin Plaque Index
NCT00759187 (1) [back to overview]Dental Plaque Index
NCT00761930 (3) [back to overview]Gingivitis Score
NCT00761930 (3) [back to overview]Dental Plaque
NCT00761930 (3) [back to overview]Bleeding Index (EIBI)
NCT00875212 (2) [back to overview]Minimum pH After 14 Days of Use of Dentifrice
NCT00875212 (2) [back to overview]Minimum pH
NCT00926029 (2) [back to overview]Plaque Index
NCT00926029 (2) [back to overview]Gingivitis Index
NCT00936975 (6) [back to overview]Changes in 18F-fluoride Transport (by Patlak Flux) - Normal
NCT00936975 (6) [back to overview]Changes in 18F-fluoride Transport (by Patlak Flux) - Tumor
NCT00936975 (6) [back to overview]Changes in 18F-fluoride PET SUV - Normal Bone
NCT00936975 (6) [back to overview]Changes in 18F-fluoride Ki - Normal Bone
NCT00936975 (6) [back to overview]Changes in 18F-fluoride Ki - Tumor Bone
NCT00936975 (6) [back to overview]Changes in 18F-fluoride PET (SUV) - Tumor Bone
NCT00981825 (1) [back to overview]CFU (Colony Forming Units)
NCT01005966 (3) [back to overview]Change From Baseline in Enamel Fluoride Uptake Potential
NCT01005966 (3) [back to overview]Percent SMH Recovery of Enamel Specimens Exposed to NaF Toothpaste (1426ppmF), NaF Toothpaste (675ppmF), NaMFP/NaF Toothpaste (1400ppm F) and Placebo (0ppmF)
NCT01005966 (3) [back to overview]Percent Surface Microhardness (SMH) Recovery of Enamel Specimens Exposed to NaF Toothpaste (1426ppmF) and AmF Toothpaste (1400ppmF)
NCT01009554 (64) [back to overview]Mean Stain Area for Gingival Sites at 4 Weeks
NCT01009554 (64) [back to overview]Mean Stain Area for Gingival Sites at 6 Weeks
NCT01009554 (64) [back to overview]Mean Stain Intensity For Interproximal (Mesial and Distal) Sites at 6 Weeks
NCT01009554 (64) [back to overview]Mean Stain Area for Body Sites at 6 Weeks
NCT01009554 (64) [back to overview]Mean Stain Intensity for Gingival Sites at 6 Weeks
NCT01009554 (64) [back to overview]Mean Stain Area for Facial Sites at 4 Weeks
NCT01009554 (64) [back to overview]Mean Stain Intensity for Gingival Sites at 4 Weeks
NCT01009554 (64) [back to overview]Mean Stain Intensity for Facial Sites at 6 Weeks
NCT01009554 (64) [back to overview]Mean Stain Intensity for Facial Sites at 4 Weeks
NCT01009554 (64) [back to overview]Mean Stain Intensity for Body Sites at 8 Weeks
NCT01009554 (64) [back to overview]Mean Stain Intensity for Body Sites at 6 Weeks
NCT01009554 (64) [back to overview]Mean Stain Intensity for Body Sites at 4 Weeks
NCT01009554 (64) [back to overview]Mean Stain Area Over All Tooth Sites at 8 Weeks
NCT01009554 (64) [back to overview]Mean Stain Area Over All Tooth Sites at 6 Weeks
NCT01009554 (64) [back to overview]Mean Stain Area Over All Tooth Sites at 4 Weeks
NCT01009554 (64) [back to overview]Mean Stain Intensity for Facial Sites at 8 Weeks
NCT01009554 (64) [back to overview]Mean Stain Intensity for Lingual Sites at 8 Weeks
NCT01009554 (64) [back to overview]Mean Stain Intensity for Lingual Sites at 6 Weeks
NCT01009554 (64) [back to overview]Mean Stain Area for Lingual Sites at 8 Weeks
NCT01009554 (64) [back to overview]Mean Stain Area for Lingual Sites at 6 Weeks
NCT01009554 (64) [back to overview]Mean Stain Area for Lingual Sites at 4 Weeks
NCT01009554 (64) [back to overview]Mean Stain Area for Interproximal (Mesial and Distal) Sites at 8 Weeks
NCT01009554 (64) [back to overview]Mean Stain Area for Gingival Sites at 8 Weeks
NCT01009554 (64) [back to overview]Mean Stain Area for Interproximal (Mesial and Distal) Sites at 6 Weeks
NCT01009554 (64) [back to overview]Mean Stain Intensity for Lingual Sites at 4 Weeks
NCT01009554 (64) [back to overview]Change in Tooth Color as Represented by Δb at 4 Weeks Post Baseline From the CIElab Assessment
NCT01009554 (64) [back to overview]Change in Tooth Color as Represented by Δb at 6 Weeks Post Baseline From the CIElab Assessment
NCT01009554 (64) [back to overview]Change in Tooth Color as Represented by Δb at 8 Weeks Post Baseline From the CIElab Assessment
NCT01009554 (64) [back to overview]Change in Tooth Color as Represented by ΔE at 4 Weeks Post Baseline From the CIElab Assessment
NCT01009554 (64) [back to overview]Change in Tooth Color as Represented by ΔE at 6 Weeks Post Baseline From the CIElab Assessment
NCT01009554 (64) [back to overview]Change in Tooth Color as Represented by ΔE at 8 Weeks Post Baseline From the CIElab Assessment
NCT01009554 (64) [back to overview]Change in Tooth Color as Represented by ΔL at 4 Weeks Post Baseline From the CIElab Assessment
NCT01009554 (64) [back to overview]Change in Tooth Color as Represented by ΔL at 6 Weeks Post Baseline From the CIElab Assessment
NCT01009554 (64) [back to overview]Change in Tooth Color as Represented by ΔL at 8 Weeks Post Baseline From the CIElab Assessment
NCT01009554 (64) [back to overview]Mean Stain Area for Body Sites at 4 Weeks
NCT01009554 (64) [back to overview]Mean Stain Intensity Over All Tooth Sites at 4 Weeks
NCT01009554 (64) [back to overview]Mean Stain Intensity Over All Tooth Sites at 6 Weeks
NCT01009554 (64) [back to overview]Mean Stain Intensity Over All Tooth Sites at 8 Weeks
NCT01009554 (64) [back to overview]Mean Stain Score for Body Sites at 4 Weeks
NCT01009554 (64) [back to overview]Mean Stain Score for Body Sites at 6 Weeks
NCT01009554 (64) [back to overview]Mean Stain Score for Body Sites at 8 Weeks
NCT01009554 (64) [back to overview]Mean Stain Score for Facial Sites at 4 Weeks
NCT01009554 (64) [back to overview]Mean Stain Score for Facial Sites at 6 Weeks
NCT01009554 (64) [back to overview]Mean Stain Intensity For Interproximal (Mesial and Distal) Sites at 8 Weeks
NCT01009554 (64) [back to overview]Mean Stain Score for Gingival Sites at 4 Weeks
NCT01009554 (64) [back to overview]Mean Stain Score for Gingival Sites at 6 Weeks
NCT01009554 (64) [back to overview]Mean Stain Score for Gingival Sites at 8 Weeks
NCT01009554 (64) [back to overview]Mean Stain Score for Interproximal (Mesial and Distal) Sites at 4 Weeks
NCT01009554 (64) [back to overview]Mean Stain Score for Interproximal (Mesial and Distal) Sites at 6 Weeks
NCT01009554 (64) [back to overview]Mean Stain Score for Interproximal (Mesial and Distal) Sites at 8 Weeks
NCT01009554 (64) [back to overview]Mean Stain Score for Lingual Sites at 4 Weeks
NCT01009554 (64) [back to overview]Mean Stain Score for Lingual Sites at 6 Weeks
NCT01009554 (64) [back to overview]Mean Stain Score for Lingual Sites at 8 Weeks
NCT01009554 (64) [back to overview]Mean Stain Score Over All Tooth Sites at 4 Weeks
NCT01009554 (64) [back to overview]Mean Stain Score Over All Tooth Sites at 6 Weeks
NCT01009554 (64) [back to overview]Mean Stain Score Over All Tooth Sites at 8 Weeks
NCT01009554 (64) [back to overview]Mean Stain Score for Facial Sites at 8 Weeks
NCT01009554 (64) [back to overview]Mean Stain Intensity For Interproximal (Mesial and Distal) Sites at 4 Weeks
NCT01009554 (64) [back to overview]Mean Stain Intensity for Gingival Sites at 8 Weeks
NCT01009554 (64) [back to overview]Mean Stain Area for Body Sites at 8 Weeks
NCT01009554 (64) [back to overview]Mean Stain Area for Interproximal (Mesial and Distal) Sites at 4 Weeks
NCT01009554 (64) [back to overview]Mean Stain Area for Facial Sites at 6 Weeks
NCT01009554 (64) [back to overview]Mean Stain Area for Facial Sites at 8 Weeks
NCT01009554 (64) [back to overview]Oral Tissue Tolerance
NCT01128972 (6) [back to overview]Adjusted Mean Percent SMH Recovery of Enamel Specimens Exposed to Test Dentifrice +Sterile Water Rinse and Reference Dentifrice +Sterile Water Rinse
NCT01128972 (6) [back to overview]Adjusted Mean Percentage SMH Recovery of Enamel Specimens Exposed to Test Dentifrice + Test MR Relative to Following Treatment Regimens: 1) Test Dentifrice +Test MR 2) Test Dentifrice + Sterile Water 3) Reference Dentifrice +Sterile Water
NCT01128972 (6) [back to overview]Adjusted Mean Percentage Surface Microhardness (SMH) Recovery of Enamel Specimens Exposed to Test Dentifrice + Test MR Relative to: 1)Test Dentifrice+Sterile Water Rinse 2)Reference Dentifrice+Sterile Water Rinse 3)Placebo Dentifrice+ Sterile Water Rinse
NCT01128972 (6) [back to overview]Adjusted Mean Percent NER of Enamel Specimens Exposed to a Treatment Regimen of Placebo Dentifrice + Test MR Relative to: 1) Test Dentifrice +Test MR 2) Test Dentifrice + Sterile Water Rinse 3) Reference Dentifrice +Sterile Water Rinse
NCT01128972 (6) [back to overview]Adjusted Mean Percent NER of Enamel Specimens Exposed to Test Dentifrice +Sterile Water Rinse and Reference Dentifrice +Sterile Water Rinse
NCT01128972 (6) [back to overview]Adjusted Mean Percent Net Erosion Resistance (NER) of Enamel Specimens Exposed to Test Dentifrice + Test MR Relative to: 1) Test Dentifrice+ Sterile Water Rinse 2) Reference Dentifrice+ Sterile Water Rinse 3) Placebo Dentifrice+ Sterile Water Rinse
NCT01345292 (8) [back to overview]Mean Cold Air Stimulus VAS Score at Week 4
NCT01345292 (8) [back to overview]Mean Tactile Sensitivity Score at Week 2
NCT01345292 (8) [back to overview]Mean Tactile Sensitivity Score at Week 4
NCT01345292 (8) [back to overview]Mean Tactile Sensitivity VAS Score at Week 4
NCT01345292 (8) [back to overview]Mean Tactile Sensitivity Visual Analog Scale (VAS) Score at Week 2
NCT01345292 (8) [back to overview]Global Subjective VAS Score at Week 2
NCT01345292 (8) [back to overview]Global Subjective VAS Score at Week 4
NCT01345292 (8) [back to overview]Mean Cold Air Stimulus VAS Score at Week 2
NCT01541358 (3) [back to overview]Sensitivity of F-18 NaF PET/CT to Detect Bone Lesions in Patients With Suspected Skeletal Malignancy
NCT01541358 (3) [back to overview]Total Number of Lesions Identified by F-18 NaF PET/CT in Patients With Suspected Skeletal Malignancy
NCT01541358 (3) [back to overview]Specificity of F-18 NaF PET/CT to Detect Bone Lesions in Patients With Suspected Skeletal Malignancy
NCT01549587 (6) [back to overview]Change From Baseline in Löe-Silness Gingivitis Index
NCT01549587 (6) [back to overview]Change From Baseline in Löe-Silness Gingivitis Index
NCT01549587 (6) [back to overview]Neonate Birth Weight (Grams)
NCT01549587 (6) [back to overview]Change From Baseline in Löe-Silness Gingivitis Index
NCT01549587 (6) [back to overview]Preterm Birth (Gestational Age < 37 Weeks)
NCT01549587 (6) [back to overview]Gestational Age (Weeks)
NCT01563172 (10) [back to overview]Percentage Surface Micro-hardness Recovery (% SMH), of Brushing for 45 Seconds With 0.5g of Experimental Dentifrice vs. Brushing for 45 Seconds With 1.5g of Experimental Dentifrice.
NCT01563172 (10) [back to overview]Percentage Surface Micro Hardness (% SMH) Recovery , of Brushing for 2 Minutes vs. Brushing for 45 Seconds With 0.5g of Experimental Dentifrice.
NCT01563172 (10) [back to overview]Percent Surface Micro-hardness (% SMH) Recovery, of Brushing for 2 Minutes With 1.5g of Experimental Dentifrice vs. Brushing for 2 Minutes With 1.5g of an Control Dentifrice.
NCT01563172 (10) [back to overview]Enamel Fluoride Uptake (EFU) After Brushing for 45 Seconds With 0.5g of Experimental Dentifrice vs. Brushing for 45 Seconds With 1.5g of Experimental Dentifrice.
NCT01563172 (10) [back to overview]Enamel Fluoride Uptake (EFU) After Brushing for 2 Minutes With 0.5g of Experimental Dentifrice vs. Brushing for 2 Minutes With 1.5g of Experimental Dentifrice.
NCT01563172 (10) [back to overview]Percentage Surface Micro Hardness Recovery (% SMH), of Brushing for 2 Minutes Versus (vs.) Brushing for 45 Seconds With 1.5g of Experimental Dentifrice.
NCT01563172 (10) [back to overview]Enamel Fluoride Uptake (EFU) After Brushing for 2 Minutes vs. Brushing for 45 Seconds With 1.5g of Experimental Dentifrice.
NCT01563172 (10) [back to overview]Enamel Fluoride Uptake (EFU) After Brushing for 2 Minutes vs. Brushing for 45 Seconds With 0.5g of Experimental Dentifrice.
NCT01563172 (10) [back to overview]Enamel Fluoride Uptake (EFU) After Brushing for 2 Minutes With 1.5g of Experimental Dentifrice vs. Brushing for 2 Minutes With 1.5g of Control Dentifrice.
NCT01563172 (10) [back to overview]Percentage Surface Micro Hardness (% SMH) Recovery, of Brushing for 2 Minutes With 0.5g of Experimental Dentifrice vs. Brushing for 2 Minutes With 1.5g of Experimental Dentifrice.
NCT01610167 (5) [back to overview]Extended Sensitivity Relief. Air Blast Sensitivity.
NCT01610167 (5) [back to overview]Extended Sensitivity Relief. Tactile Sensitivity.
NCT01610167 (5) [back to overview]Immediate Sensitivity Relief. Tactile Sensitivity.
NCT01610167 (5) [back to overview]Immediate Sensitivity Relief. Air Blast Sensitivity.
NCT01610167 (5) [back to overview]Adverse Events.
NCT01641237 (4) [back to overview]Percentage Surface Microhardness Recovery (%SMHR) Dose Response Relationship
NCT01641237 (4) [back to overview]Percentage Relative Erosion Resistance
NCT01641237 (4) [back to overview]Enamel Fluoride Uptake (Corrected Data)
NCT01641237 (4) [back to overview]%SMHR
NCT01657903 (4) [back to overview]Relative Erosion Resistance (RER) of Enamel Specimens Post 4 Hours of Treatment Exposure
NCT01657903 (4) [back to overview]SMH Recovery of Enamel Specimens Post 2 Hours of Treatment Exposure
NCT01657903 (4) [back to overview]Surface Microhardness (SMH) Recovery of Enamel Specimens Post 4 Hours of Treatment Exposure
NCT01657903 (4) [back to overview]RER of Enamel Specimens Post 2 Hours of Treatment Exposure
NCT01665911 (3) [back to overview]Enamel Fluoride Uptake Per Each of Five Arms
NCT01665911 (3) [back to overview]% Acid Resistance Score Per Each of Five Arms
NCT01665911 (3) [back to overview]% Surface Microhardness (SMH) Recovery Score Per Each of Five Arms
NCT01669785 (10) [back to overview]Post-prophylaxis Sensitivity Relief (Self-Assessment)
NCT01669785 (10) [back to overview]Sensitivity Relief (Self-Assessment)
NCT01669785 (10) [back to overview]Post- Scaling Sensitivity Relief (Self-Assessment)
NCT01669785 (10) [back to overview]Long-term Sensitivity Relief (Tactile Sensitivity)
NCT01669785 (10) [back to overview]Long-term Sensitivity Relief (Self-Assessment)
NCT01669785 (10) [back to overview]Long-term Sensitivity Relief (Schiff Air Blast Sensitivity)
NCT01669785 (10) [back to overview]Immediate Sensitivity Relief (Tactile Sensitivity)
NCT01669785 (10) [back to overview]Baseline Pre-Prophy Assessment (Tactile Sensitivity)
NCT01669785 (10) [back to overview]Baseline Pre-Prophy Assessment (Air Blast Sensitivity)
NCT01669785 (10) [back to overview]Immediate Sensitivity Relief (Schiff Air Blast Sensitivity)
NCT01691560 (6) [back to overview]Change From Baseline in Evaporative Air Sensitivity Response on a Visual Rating Scale (VRS) at Week 4
NCT01691560 (6) [back to overview]Change From Baseline in Evaporative Air Sensitivity Response on VRS at Week 8
NCT01691560 (6) [back to overview]Change From Baseline in Tactile Sensitivity Pain Response (g) at Week 4
NCT01691560 (6) [back to overview]Change From Baseline in Tactile Sensitivity Pain Response (g) at Week 8
NCT01691560 (6) [back to overview]Change From Baseline in Evaporative Air Sensitivity Pain Response on Schiff Sensitivity Scale at Week 8
NCT01691560 (6) [back to overview]Change From Baseline in Evaporative Air Sensitivity Pain Response on Schiff Sensitivity Scale at Week 4
NCT01816048 (2) [back to overview]Number of Subjects Who Experience Adverse Events While on Treatment With TAK 700
NCT01816048 (2) [back to overview]Number of Participants With Change in the Number of Circulating Tumor Cells Using the Cell Search System (Veridex, LLC) Obtained Prior to Beginning Treatment With TAK 700, After Completing One Cycle and After Completing 3 Cycles
NCT01831817 (8) [back to overview]Mean Change From Baseline in Visual Rating Scale Score at Week 4
NCT01831817 (8) [back to overview]Median Change From Baseline in Tactile Sensitivity at Week 8
NCT01831817 (8) [back to overview]Mean Change From Baseline in Visual Rating Scale Score at Week 8
NCT01831817 (8) [back to overview]Median Change From Baseline in Tactile Sensitivity at Week 4
NCT01831817 (8) [back to overview]Mean Change From Baseline in Dentine Hypersensitivity Experience Questionnaire (DHEQ) Total Score at Week 8
NCT01831817 (8) [back to overview]Mean Change From Baseline in Dentine Hypersensitivity Experience Questionnaire Total Score at Week 4
NCT01831817 (8) [back to overview]Mean Change From Baseline in Schiff Sensitivity Score at Week 4
NCT01831817 (8) [back to overview]Mean Change From Baseline in Schiff Sensitivity Score at Week 8
NCT01962493 (8) [back to overview]Overall Facial MLSI at Week 6
NCT01962493 (8) [back to overview]Overall MLSI at Week 3
NCT01962493 (8) [back to overview]Overall Interproximal MLSI at Week 6
NCT01962493 (8) [back to overview]Overall Interproximal MLSI at Week 3
NCT01962493 (8) [back to overview]Overall Gingival and Interproximal MLSI at Week 3
NCT01962493 (8) [back to overview]Overall Facial MLSI at Week 3
NCT01962493 (8) [back to overview]Modified Lobene Stain Index (MLSI) at Week 6
NCT01962493 (8) [back to overview]Overall Gingival and Interproximal MLSI at Week 6
NCT01967862 (1) [back to overview]Number of Eligible Patients With Positive CT Scan/Bone Scan, MRI and PET Scan.
NCT02080273 (8) [back to overview]Dental Plaque Score
NCT02080273 (8) [back to overview]Gingivitis Scores
NCT02080273 (8) [back to overview]Gingivitis Scores
NCT02080273 (8) [back to overview]Gingivitis Scores
NCT02080273 (8) [back to overview]Gingivitis Scores
NCT02080273 (8) [back to overview]Dental Plaque Score
NCT02080273 (8) [back to overview]Dental Plaque Score
NCT02080273 (8) [back to overview]Dental Plaque Score
NCT02136576 (1) [back to overview]Dentinal Hypersensitivity
NCT02151058 (9) [back to overview]Lobene Stain Index Area Scores at Day 4
NCT02151058 (9) [back to overview]Lobene Stain Index Area Scores at Day 8
NCT02151058 (9) [back to overview]Lobene Stain Index Composite Score at Day 15
NCT02151058 (9) [back to overview]Lobene Stain Index Intensity Scores at Day 8
NCT02151058 (9) [back to overview]Lobene Stain Index Intensity Scores at Day 4
NCT02151058 (9) [back to overview]Lobene Stain Index Intensity Scores at Day 15
NCT02151058 (9) [back to overview]Lobene Stain Index Composite Score at Day 8
NCT02151058 (9) [back to overview]Lobene Stain Index Composite Score at Day 4
NCT02151058 (9) [back to overview]Lobene Stain Index Area Scores at Day 15
NCT02195583 (4) [back to overview]Percentage Comparative Acid Resistance (% CAR)
NCT02195583 (4) [back to overview]Enamel Fluoride Uptake
NCT02195583 (4) [back to overview]Percentage Net Acid Resistance (% NAR)
NCT02195583 (4) [back to overview]Percentage Surface Microhardness Recovery (% SMHR)
NCT02207400 (7) [back to overview]Modified Gingival Index (MGI) at 24 Weeks
NCT02207400 (7) [back to overview]Bacterial Count at Baseline, After 6, 12, 24 and 32 Weeks
NCT02207400 (7) [back to overview]Bleeding Index (BI) at 6, 12 and 24 Weeks
NCT02207400 (7) [back to overview]Modified Gingival Index (MGI)) at 6 and 12 Weeks.
NCT02207400 (7) [back to overview]Number of Gingival Bleeding Sites at 6 and 12 Weeks
NCT02207400 (7) [back to overview]Plaque Control (Overall and Interproximal Dental Plaque Scores) at 6, 12 and 24 Weeks.
NCT02207400 (7) [back to overview]Number of Gingival Bleeding Sites at 24 Weeks
NCT02207907 (6) [back to overview]Number of Gingival Bleeding Sites at 24 Weeks
NCT02207907 (6) [back to overview]Bleeding Index at 6, 12 and 24 Weeks
NCT02207907 (6) [back to overview]Modified Gingival Index (MGI) at 24 Weeks
NCT02207907 (6) [back to overview]Modified Gingival Index (MGI) at 6 and 12 Weeks.
NCT02207907 (6) [back to overview]Number of Gingival Bleeding Sites at 6 and 12 Weeks.
NCT02207907 (6) [back to overview]Plaque Control (Overall and Interproximal Dental Plaque Scores) Using Turesky Modification of Quigley &Amp; Hein Plaque Index at 6, 12 and 24 Weeks.
NCT02221349 (2) [back to overview]Change From Baseline Air Challenge
NCT02221349 (2) [back to overview]Change From Baseline Visual Analog Scale
NCT02226562 (6) [back to overview]Mean Change From Baseline in Tactile Threshold at Week 4
NCT02226562 (6) [back to overview]Mean Change From Baseline in Schiff Sensitivity Score at Week 8
NCT02226562 (6) [back to overview]Mean Change From Baseline in Schiff Sensitivity Score at Week 4
NCT02226562 (6) [back to overview]Mean Change From Baseline in VRS at Week 4
NCT02226562 (6) [back to overview]Mean Change From Baseline in Tactile Threshold at Week 8
NCT02226562 (6) [back to overview]Mean Change From Baseline in Visual Rating Scale (VRS) at Week 8
NCT02233998 (9) [back to overview]Change From Baseline in the Percentage of Healthy Sites (Modified Gingival Index (MGI) Scores of 0 or 1) at Week 3
NCT02233998 (9) [back to overview]Change From Baseline in the Percentage of Non-Bleeding Sites (Gingival Bleeding Index (BI) Scores of 0) at Week 3
NCT02233998 (9) [back to overview]Change From Baseline in the Percentage of Problem Sites (Plaque Index (PI) Scores of ≥ 2) at Week 3
NCT02233998 (9) [back to overview]Change From Baseline in the Percentage of Problem Sites (Modified Gingival Index (MGI) Scores of ≥ 3) at Week 3
NCT02233998 (9) [back to overview]Whole Mouth Mean Modified Gingival Index (MGI) at Week 3
NCT02233998 (9) [back to overview]Whole Mouth Mean Plaque Index (PI) at Week 3
NCT02233998 (9) [back to overview]Whole Mouth Mean Gingival Bleeding Index (BI) at Week 3
NCT02233998 (9) [back to overview]Change From Baseline in the Percentage of Virtually Plaque-Free Sites (Plaque Index (PI) Scores of 0 or 1) at Week 3
NCT02233998 (9) [back to overview]Change From Baseline in the Percentage of Problem Sites (Plaque Index (PI) Scores of ≥ 3) at Week 3
NCT02319668 (4) [back to overview]Area Under the Curve (AUC) for the Total Number of Plaque Bacteria in the Mouth Post Implant Surgery
NCT02319668 (4) [back to overview]Total Number of Detectable Plaque Bacteria Sampled at Implant Surgery (at Pre-rinse, Pre, Mid and Post Implant Surgery) and Post Implant Surgery (at Day 1 and 7)
NCT02319668 (4) [back to overview]Total Number of Recoverable Viable Bacteria in the Aerosol Generated During Dental Prophylaxis
NCT02319668 (4) [back to overview]Total Number of Detectable Plaque Bacteria Sampled 3 Days Post Implant Surgery
NCT02371616 (4) [back to overview]Mean Change From Baseline in Evaporative Air Sensitivity as Measured by Visual Analogue Score (VAS) at Week 8
NCT02371616 (4) [back to overview]Mean Change From Baseline in Evaporative Air Sensitivity as Measured by Schiff Sensitivity Score at Week 4 and Week 8
NCT02371616 (4) [back to overview]Change From Baseline in Tactile Threshold at Week 4 and Week 8
NCT02371616 (4) [back to overview]Mean Change From Baseline in Evaporative Air Sensitivity as Measured by Visual Analogue Score (VAS) at Week 4
NCT02384044 (2) [back to overview]Change From Baseline for Air Challenge
NCT02384044 (2) [back to overview]Change From Baseline Visual Analog Scale
NCT02424097 (2) [back to overview]Change in White Spot Lesions Count - Enamel Decalcification Index (EDI)
NCT02424097 (2) [back to overview]Change in International Caries Detection and Assessment System (ICDAS II) to Score for Smooth Surfaces White Spot Lesions (WSL)
NCT02533466 (10) [back to overview]Change From Pre-acid Challenge (Baseline) Tooth Impression Grading Score Following 4 Hours Post Acid Challenge
NCT02533466 (10) [back to overview]Change From Pre-acid Challenge (Baseline) Tooth Impression Grading Score Following 7 Hours Post Acid Challenge
NCT02533466 (10) [back to overview]Change From Pre-acid Challenge (Baseline) Tooth Impression Grading Score Immediately Following an Acid Challenge
NCT02533466 (10) [back to overview]Change From Baseline in Buffering Capacity at 30 Mins Post Dietary Acid Challenge
NCT02533466 (10) [back to overview]Change From Baseline in Buffering Capacity 7 Hours Post Dietary Acid Challenge
NCT02533466 (10) [back to overview]Change From Baseline of pH Measurement 7 Hours Post Dietary Acid Challenge
NCT02533466 (10) [back to overview]Change From Baseline of pH Measurement at 30 Mins Post Dietary Acid Challenge
NCT02533466 (10) [back to overview]Change From Pre-acid Challenge (Baseline) Tooth Impression Grading Score Following 2 Hours Post Acid Challenge.
NCT02533466 (10) [back to overview]Change From Baseline of Salivary Calcium Concentration at 30 Mins Post Dietary Acid Challenge
NCT02533466 (10) [back to overview]Change From Baseline of Salivary Calcium Concentration 7 Hours Post Dietary Acid Challenge
NCT02598778 (2) [back to overview]Change in Salivary Streptococcus Mutans Levels After 30 Second Oral Rinse Time (Chlorhexidine Gluconate, Sodium Fluoride, or Deionized Water) or 2 Minute Chew Time (Paraffin Wax Chewing Gum)
NCT02598778 (2) [back to overview]Change in Salivary Streptococcus Mutans Levels After 30 Second Oral Rinse Time (Chlorhexidine Gluconate, Sodium Fluoride, or Deionized Water) or 2 Minute Chew Time (Paraffin Wax Chewing Gum)
NCT02988349 (2) [back to overview]The Change of Relative Activities of Microbial Enzymes After Intervention as Determined by Laboratory Enzymatic Assays
NCT02988349 (2) [back to overview]The Change of Abundance of Specific Oral Microbes After Intervention as Assessed by 16S rRNA Sequencing
NCT03082196 (4) [back to overview]Dental Caries for Primary Molars Sound at Baseline
NCT03082196 (4) [back to overview]Child Response to Fifth Treatment
NCT03082196 (4) [back to overview]Dental Caries for All Primary Teeth Sound at Baseline
NCT03082196 (4) [back to overview]Child Response to First Treatment
NCT03238352 (2) [back to overview]Change From Baseline in Tactile Threshold
NCT03238352 (2) [back to overview]Change From Baseline in Schiff Sensitivity Score
NCT03285984 (2) [back to overview]Mean Change From Baseline (Pre-brushing to Post Brushing) in Turesky Score After Single Supervised Use for Test Products 1, 2, 3 and 4 After 4 Weeks
NCT03285984 (2) [back to overview]Mean Change From Baseline (Pre-brushing to Post-brushing) in Turesky Score After Single Supervised Use (Test Product 1 Versus [vs] Test Product 4) After 4 Weeks
NCT03296072 (6) [back to overview]% RER (Comparison of 1150 Ppm Fluoride and 5% KNO3 Dentifrice Relative to Comparator Containing 1100 Ppm Fluoride)
NCT03296072 (6) [back to overview]% Relative Erosion Resistance (RER; Comparison of 1150 Ppm Fluoride and 5% KNO3 Dentifrice Relative to a Fluoride Free Placebo Dentifrice to Inhibit Demineralization of Enamel)
NCT03296072 (6) [back to overview]EFU (Comparison of 1150 Ppm Fluoride and 5% KNO3 Dentifrice Relative to Comparator Containing 1100 Ppm Fluoride)
NCT03296072 (6) [back to overview]Enamel Fluoride Uptake (EFU; Comparison of 1150 Ppm Fluoride and 5% KNO3 Dentifrice Relative to a Fluoride Free Placebo Dentifrice to Promote Fluoride Uptake in Enamel)
NCT03296072 (6) [back to overview]% Surface Micro Hardness Recovery (SMHR; Comparison of 1150 Ppm Fluoride and 5% KNO3 Dentifrice Relative to a Fluoride Free Placebo Dentifrice to Enhance Remineralization of Enamel)
NCT03296072 (6) [back to overview]% SMHR (Comparison of 1150 Ppm Fluoride and 5% KNO3 Dentifrice Relative to Comparator Containing 1100 Ppm Fluoride)
NCT03310268 (2) [back to overview]Change From Baseline in Schiff Sensitivity Score After 8 Weeks of Treatment
NCT03310268 (2) [back to overview]Change From Baseline in Tactile Threshold After 8 Weeks of Treatment
NCT03383783 (7) [back to overview]Transverse Microradiography (TMR) - Maximum Mineral Density at the Surface-zone
NCT03383783 (7) [back to overview]Transverse Microradiography (TMR) - Lesion Depth - L
NCT03383783 (7) [back to overview]Percentage Surface Microhardness Recovery (%SMH)
NCT03383783 (7) [back to overview]Net Acid Resistance (NAR)
NCT03383783 (7) [back to overview]Enamel Fluoride Uptake (EFU)
NCT03383783 (7) [back to overview]Comparative Acid Resistance (CAR)
NCT03383783 (7) [back to overview]Transverse Microradiography (TMR) - Integrated Mineral Loss - ∆Z
NCT03989427 (2) [back to overview]Change From Baseline in Mean BPI Index Scores at 2 Weeks
NCT03989427 (2) [back to overview]Change From Baseline in Mean RMNPI Index Score at 2 Weeks
NCT04050722 (6) [back to overview]Mean Overall Turesky Modification of the Quigley & Hein Plaque Index (TPI) Score at Week 2 and Week 3
NCT04050722 (6) [back to overview]Mean Number of Bleeding Sites (NBS) at Week 2 and Week 3
NCT04050722 (6) [back to overview]Mean Modified Gingival Index (MGI) at Week 2 and Week 3
NCT04050722 (6) [back to overview]Mean Interproximal Turesky Modification of the Quigley & Hein Plaque Index (TPI) at Week 2 and Week 3
NCT04050722 (6) [back to overview]Whole Mouth Mean Bleeding Index (BI) at Week 3
NCT04050722 (6) [back to overview]Whole Mouth Mean Bleeding Index (BI) at Week 2
NCT04249336 (3) [back to overview]Percent Change in Mean Scores of Pain Response From Baseline on Visual Analog Scale Using Water Jet Stimulus
NCT04249336 (3) [back to overview]Percent Change in Mean Scores of Pain Response From Baseline on Visual Analog Scale Using Mechanical Stimulus
NCT04249336 (3) [back to overview]Percent Change in Mean Score of Pain Response From Baseline on Schiff Cold Air Sensitivity Scale Using Air Blast Stimulus
NCT04290624 (10) [back to overview]Mean Oral Hygiene Index (OHI) at Week 6 and Week 12
NCT04290624 (10) [back to overview]Mean BI at Week 6
NCT04290624 (10) [back to overview]Mean Modified Gingival Index (MGI) at Week 6 and Week 12
NCT04290624 (10) [back to overview]Mean Number of Bleeding Sites (NBS) at Week 6 and Week 12
NCT04290624 (10) [back to overview]Mean Overall Turesky Plaque Index (TPI) at Week 6 and Week 12
NCT04290624 (10) [back to overview]Mean Partial Denture Cleanliness Index (PDCI) at Week 6 and 12
NCT04290624 (10) [back to overview]Mean Calculus Index (CI) at Week 6 and Week 12
NCT04290624 (10) [back to overview]Mean Interproximal TPI at Week 6 and Week 12
NCT04290624 (10) [back to overview]Mean Bleeding Index (BI) at Week 12
NCT04290624 (10) [back to overview]Mean Oral Debris Index (ODI) at Week 6 and Week 12

Cohort 3 - Total Skeletal Lesions Identified, Tc-99m MDP WBBS vs 18F-NaF / 18F-FDG PET/MRI

Participants in Cohort 3 received 99mTc-methylene diphosphonate (MDP) whole-body bone scintigraphy (WBBS) and 18F-sodium fluoride (NaF) / 18F-fluorodeoxyglucose (FDG) positron emission tomography / magnetic imaging resonance (PET/MRI) scans. On the basis of the scans, the total number skeletal lesions identified in the participants was determined. The outcome is reported as the total number skeletal lesions identified by each scan methodology, a number without dispersion. (NCT00375830)
Timeframe: 30 days

Interventionlesions (Number)
Cohort 3 - 99mTc-methyl Diphosphonate (MDP) Bone Scan81
Cohort 3 - 18F-NaF / 18F-FDG PET/MRI140

[back to top]

Cohort 1 - 18F-NaF PET/CT vs 18F-FDG PET/CT

The medical value of 18F-sodium fluoride (NaF) positron emission tomography / computed tomography (PET/CT) vs 18F-fluorodeoxyglucose (FDG) positron emission tomography / computed tomography (PET/CT) was assessed on the basis of the radiation oncologist's medical assessment of image quality and detected extent of disease, for each participant diagnosed with osseous (skeletal) metastases. Per protocol, the data were collected and the outcome is reported for Cohort 1 only. The outcome is reported as the number of participants for whom the medical value of the image was superior for 18-NaF PET/CT compared to 18F-FDG PET/CT, the same between both scans, or inferior for 18-NaF PET/CT compared to 18F-FDG PET/CT. The outcome result is represented as a number without dispersion. (NCT00375830)
Timeframe: 30 days

InterventionParticipants (Count of Participants)
18F-NaF > 18F-FDG18F-NaF = 18F-FDG18F-NaF < 18F-FDG
Cohort 1 Pilot-WB-MRI & Combined 18F-NaF-CT/18F-FDG-PET Scans300

[back to top]

Cohort 1 - NaF PET/CT vs 99mTc-MDP Bone Scintigraphy

"The medical value of 18F-sodium fluoride (NaF) positron emission tomography / computed tomography (PET/CT) vs 99mTc-methylene diphosphonate (MDP) bone scintigraphy was assessed on the basis of the radiation oncologist's medical assessment of image quality and detected extent of disease, for each participant. Per protocol, the data were collected and the outcome is reported for Cohort 1 only. The outcome is reported as the number of participants for whom the medical value of the image was superior for 18F-NaF vs 99mTc-MDP bone scintigraphy (18F-NaF > 99mTc-MDP), the same between both scans (18F-NaF = 99mTc-MDP), or inferior for 18F-NaF vs 99mTc-MDP bone scintigraphy (18F-NaF < 99mTc-MDP)." (NCT00375830)
Timeframe: 30 days

InterventionParticipants (Count of Participants)
18F-NaF > 99mTc-MDP18F-NaF = 99mTc-MDP18F-NaF < 99mTc-MDP
Cohort 1 Pilot-WB-MRI & Combined 18F-NaF-CT/18F-FDG-PET Scans1000

[back to top]

Cohort 2 - 18F-NaF/18F-FDG PET/CT vs Whole-body MRI for Detection of Extraskeletal Lesions

"Sensitivity; positive predictive value (PPV); and accuracy for the detection of extraskeletal lesions was assessed for 18F-sodium fluoride (NaF) / 18F-fluorodeoxyglucose (FDG) positron emission tomography / computed tomography (PET/CT) and for whole body magnetic imaging resonance (WB-MRI).~Sensitivity is a percentage that defines the proportion of true positive participants with the disease in a total group of participants.~PPV is the probability that participants with a positive screening test truly have the disease.~Accuracy is the proportion of true results (both true positives and true negatives) among the total number of cases examined.~Per protocol, the data were collected and the outcome is reported for Cohort 2 only. Sensitivity, PPV, and accuracy are reported as a percentage, a number without dispersion. Higher numbers represent better detection." (NCT00375830)
Timeframe: 30 days

,
Interventionpercentage of particpants (Number)
SensitivityPositive predictive valueAccuracy
Cohort 2 - Combined 18F-NaF-CT/18F-FDG-PET Scan92.981.376.5
Cohort 2 - Whole Body-MRI Scan92.986.782.4

[back to top]

Cohort 2 - 18F-NaF/18F-FDG vs 99mTc-MDP Bone Scintigraphy for Detection of Skeletal Lesions

Sensitivity and accuracy for the detection of skeletal lesions was assessed for 18F-sodium fluoride (NaF) / 18F-fluorodeoxyglucose (FDG) positron emission tomography / computed tomography (PET/CT) and for 99mTc-methylene diphosphonate (MDP) bone scintigraphy. Per protocol, the data were collected and the outcome is reported for Cohort 2 only. Sensitivity and accuracy are reported as a percentage, a number without dispersion. Higher numbers represent better detection. (NCT00375830)
Timeframe: 30 days

,
Interventionpercentage of participants (Number)
SensitivityAccuracy
Cohort 2 - 99mTc-MDP Bone Scintigraphy Scan64.665.9
Cohort 2 Combined 18F-NaF-CT/18F-FDG-PET Scan96.289.8

[back to top]

Cohort 2 - 18F-NaF/18F-FDG vs Whole-body MRI for Detection of Skeletal Lesions

Sensitivity and accuracy for the detection of skeletal lesions was assessed for 18F-sodium fluoride (NaF) / 18F-fluorodeoxyglucose (FDG) positron emission tomography / computed tomography (PET/CT) and for whole body magnetic imaging resonance (WB-MRI). Per protocol, the data were collected and the outcome is reported for Cohort 2 only. Sensitivity and accuracy are reported as a percentage, a number without dispersion. Higher numbers represent better detection. (NCT00375830)
Timeframe: 30 days

,
Interventionpercentage of particpants (Number)
SensitivityAccuracy
Cohort 2 - Combined 18F-NaF-CT/18F-FDG-PET Scan96.289.8
Cohort 2 - WB-MRI Scan81.474.7

[back to top]

Cohort 2 - Overall Sensitivity and Accuracy for 18F-NaF/18F-FDG vs Whole-body MRI

Overall sensitivity and accuracy for the detection of tumor lesions was assessed for 18F-sodium fluoride (NaF) / 18F-fluorodeoxyglucose (FDG) positron emission tomography / computed tomography (PET/CT) and for whole body magnetic imaging resonance (WB-MRI). Per protocol, the data were collected and the outcome is reported for Cohort 2 only. Sensitivity and accuracy are reported as a percentage, a number without dispersion. Higher numbers represent better detection. (NCT00375830)
Timeframe: 30 days

,
Interventionpercentage of participants (Number)
SensitivityAccuracy
Cohort 2 - Combined 18F-NaF-CT/18F-FDG-PET Scan95.787.6
Cohort 2 - Whole Body Magnetic Resonance Imaging (WB-MRI) Scan83.376.0

[back to top]

Cohort 2 - Overall Sensitivity and Accuracy for 18F-NaF/18F-FDG vs Whole-body MRI/99mTc-MDP Bone Scintigraphy

Overall sensitivity and accuracy for the detection of tumor lesions was assessed for 18F-sodium fluoride (NaF) / 18F-fluorodeoxyglucose (FDG) positron emission tomography / computed tomography (PET/CT) and for 99mTc-methylene diphosphonate (MDP) bone scintigraphy. Per protocol, the data were collected and the outcome is reported for Cohort 2 only. Sensitivity and accuracy are reported as a percentage, a number without dispersion. Higher numbers represent better detection. (NCT00375830)
Timeframe: 30 days

,
Interventionpercentage of participants (Number)
SensitivityAccuracy
Cohort 2 Combined 18F-NaF-CT/18F-FDG-PET Scan95.787.6
Cohort 2 WB-MRI & 99mTc-MDP Bone Scintigraphy91.683.0

[back to top]

Cohort 3 - Skeletal Lesions Identified by 99mTc MDP WBBS vs 18F-NaF / 18F-FDG PET/MRI

Participants in Cohort 3 received 99mTc-methylene diphosphonate (MDP) whole-body bone scintigraphy (WBBS) and 18F-sodium fluoride (NaF) / 18F-fluorodeoxyglucose (FDG) positron emission tomography / magnetic imaging resonance (PET/MRI) scans. On the basis of the scans, participants with skeletal lesions were identified. The outcome is reported as the number of Cohort 3 participants for whom skeletal lesions were identified by each scan methodology, a number without dispersion. (NCT00375830)
Timeframe: 30 days

InterventionParticipants (Count of Participants)
Cohort 3 - 99mTc-methyl Diphosphonate (MDP) Bone Scan37
Cohort 3 - 18F-NaF / 18F-FDG PET/MRI45

[back to top]

Mean %SMHR of Enamel Specimens Exposed to NaF/Carbopol Toothpaste (1400 ppmF), NaF Toothpaste (1350ppmF), NaMFP/NaF Toothpaste (1450ppmF), NaF Toothpaste (250ppmF) and Placebo Toothpaste (0ppmF)

%SMHR test was used to assess mineralization status of enamel specimens using a Wilson 2100 Hardness tester. %SMHR was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents rehardening of enamel surface. %SMHR was calculated from indentation values of enamel specimens at baseline (B), after intra-oral exposure (R) and after in-vitro demineralization (D) using formula: [(D-R)/ (D-B)]*100. (NCT00708123)
Timeframe: Baseline to 14 days

Intervention%SMHR (Least Squares Mean)
NaF/Carbopol Toothpaste (1400 Ppm F)33.54
NaF Toothpaste (1350ppm F)35.23
NaF Toothpaste (250 Ppm F)24.98
NaMFP/NaF Toothpaste (1450 Ppm F)29.57
Placebo Toothpaste (0 Ppm F)22.05

[back to top]

Adjusted Mean Change From Baseline in Enamel Fluoride Uptake

Enamel fluoride uptake was determined using the microdrill enamel biopsy technique. The amount of fluoride uptake by enamel was calculated based on the amount of fluoride (F) divided by the area of the enamel cores and expressed as ug F/cm2. The difference between treatments was calculated with respect to fluoride uptake by enamel. (NCT00708123)
Timeframe: Baseline to 14 days

Interventionµg*F/cm^2 (Least Squares Mean)
NaF/ Carbopol Toothpaste (1400 Ppm F)1283.13
NaF Toothpaste (1350ppm F)1333.09
NaF Toothpaste (250 Ppm F)680.20
NaMFP/NaF Toothpaste (1450 Ppm F)1086.39
Placebo Toothpaste (0 Ppm F)435.58

[back to top]

Mean Percentage Surface Microhardness Recovery (%SMHR) of Enamel Specimens Exposed to NaF/Carbopol Toothpaste (1400 ppmF), NaF Toothpaste (1350ppmF) Compared to NaMFP/NaF Toothpaste (1450ppmF)

%SMHR test was used to assess mineralization status of enamel specimens using a Wilson 2100 Hardness tester. %SMHR was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents rehardening of enamel surface. %SMHR was calculated from indentation values of enamel specimens at baseline (B), after intra-oral exposure (R) and after in-vitro demineralization (D) using formula: [(D-R)/ (D-B)]*100. (NCT00708123)
Timeframe: Baseline to 14 days

Intervention%SMHR (Least Squares Mean)
NaF/Carbopol Toothpaste (1400 Ppm F)33.54
NaF Toothpaste (1350 Ppm F)35.23
NaMFP/NaF Toothpaste (1450 Ppm F)29.57

[back to top]

Natural Log Transformed AUC for Fluoride Concentration in Plaque Fluid Between 0-4 Hours

To evaluate fluoride content, plaque samples were collected from the interproximal surfaces of the posterior teeth of participants using a standardized approach. Plaque fluid fluoride were calculated using a micro analytical method and in comparison to a standard fluoride curve constructed on the same day of the analysis. AUC was determined from 0-4 hours using trapezoidal rule and natural log transformation was applied.due to failure of assumption of normal distribution of data. (NCT00708305)
Timeframe: Plaque samples collected at 15 minutes, 30 minutes, 1 hour, 2 hours and 4 hours post single application of treatment

Interventionln(μg*F*minutes/cm^2) (Log Mean)
NaF Toothpaste(1450ppmF)0.54
NaF Toothpaste (1400ppmF)0.54
NaMFP/NaF Toothpaste (1450ppmF)0.05
Placebo Toothpaste (0ppmF)-0.90

[back to top]

Change From Baseline in Fluoride Concentration at 1 Hour Post Brushing With Study Treatments

Change from baseline at any time point for a treatment period was calculated as the median post brushing fluoride value at a time point minus the median baseline (pre-brushing) fluoride value for a treatment period. (NCT00708305)
Timeframe: Plaque samples were collected at baseline, 1 hour post single application of study treatment

Interventionμg*F/g (Median)
NaF Toothpaste(1450ppmF)0.20
NaF Toothpaste (1400ppmF)0.22
NaMFP/NaF Toothpaste (1450ppmF)0.12
Placebo Toothpaste (0ppmF)0.01

[back to top]

Natural Log Transformed Area Under the Fluoride Concentration in Plaque Fluid by Time Curve (AUC) Between 0-4 Hours

To evaluate fluoride content, plaque samples were collected from the interproximal surfaces of the posterior teeth of participants using a standardized approach. Plaque fluid fluoride were calculated using a micro analytical method and in comparison to a standard fluoride curve constructed on the same day of the analysis. AUC was determined from 0-4hours using trapezoidal rule and natural log transformation was applied due to failure of assumption of normal distribution of data. (NCT00708305)
Timeframe: Plaque samples collected at 15 minutes, 30 minutes, 1 hour, 2 hours and 4 hours post single application of treatment

Interventionln(μg*F*minutes/cm^2) (Least Squares Mean)
NaF Toothpaste(1450 Ppm F)0.54
NaF Toothpaste (1400 Ppm F)0.54

[back to top]

Change From Baseline in Fluoride Concentration at 4 Hours Post Brushing With Study Treatments

Change from baseline at any time point for a treatment period was calculated as the median post brushing fluoride value at a time point minus the median baseline (pre-brushing) fluoride value for a treatment period. (NCT00708305)
Timeframe: Plaque samples were collected at baseline, 4 hours post single application of study treatment

Interventionμg*F/g (Median)
NaF Toothpaste(1450ppmF)0.04
NaF Toothpaste (1400ppmF)0.04
NaMFP/NaF Toothpaste (1450ppmF)0.02
Placebo Toothpaste (0ppmF)-0.01

[back to top]

Change From Baseline in Fluoride Concentration at 30 Minutes Post Brushing With Study Treatments

Change from baseline at any time point for a treatment period was calculated as the median post brushing fluoride value at a time point minus the median baseline (pre-brushing) fluoride value for a treatment period. (NCT00708305)
Timeframe: Plaque samples were collected at baseline, 30 minutes post single application of study treatment

Interventionμg*F/g (Median)
NaF Toothpaste(1450ppmF)0.71
NaF Toothpaste (1400ppmF)0.72
NaMFP/NaF Toothpaste (1450ppmF)0.28
Placebo Toothpaste (0ppmF)0.02

[back to top]

Change From Baseline in Fluoride Concentration at 2 Hours Post Brushing With Study Treatments

Change from baseline at any time point for a treatment period was calculated as the median post brushing fluoride value at a time point minus the median baseline (pre-brushing) fluoride value for a treatment period. (NCT00708305)
Timeframe: Plaque samples were collected at baseline, 2 hour post single application of study treatment

Interventionμg*F/g (Median)
NaF Toothpaste(1450ppmF)0.09
NaF Toothpaste (1400ppmF)0.09
NaMFP/NaF Toothpaste (1450ppmF)0.07
Placebo Toothpaste (0ppmF)0.00

[back to top]

Change From Baseline in Fluoride Concentration at 15 Minutes After Brushing With Study Treatments

Change from baseline at any time point for a treatment period was calculated as the median post brushing fluoride value at a time point minus the median baseline (pre-brushing) fluoride value for a treatment period. (NCT00708305)
Timeframe: Plaque samples were collected at baseline, 15 minutes post single application of study treatment

Interventionμg*F/g (Median)
NaF Toothpaste(1450ppmF)2.00
NaF Toothpaste (1400ppmF)1.56
NaMFP/NaF Toothpaste (1450ppmF)0.76
Placebo Toothpaste (0ppmF)0.03

[back to top]

Dental Plaque Index

plaque units measured on a scale between 0 to 5. 0 = No plaque; 5 = 2/3 of Tooth covered in plaque. (NCT00758394)
Timeframe: 4-Day

InterventionUnits on a scale (Mean)
Fluoride - A3.12
Fluoride/Triclosan - B2.90
Triclosan/Fluoride/Arginine2.92
Triclosan/Fluoride/Cavistat2.94

[back to top]

Gingival Margin Plaque Index

Scale 0 to 100% of tooth gingival margin covered by plaque. (0=no plaque, 100%=100% of the tooth's gingival margin is covered in plaque). The lower the score less dental plaque is present along the gum line and therefore the better the performance of the study treatment. (NCT00759031)
Timeframe: 1 day

InterventionUnits on a scale (Mean)
Fluoride15.4
Triclosan + Fluoride12.81

[back to top]

Dental Plaque Index

Scale 0 to 5 (zero= no plaque to 5 = plaque covering 2/3 or more of the crown of the tooth) (NCT00759187)
Timeframe: 4-Day

InterventionUnits on a scale (Mean)
Fluoride2.79
Fluoride/Triclosan2.82
Chlorhexidine Gluconate1.99

[back to top]

Gingivitis Score

"Gingivitis score (GI)= Units on a scale 0 to 3 (0 = no inflammation,~1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing. 3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding. GI scored=sum of GI scores divided by the number of sites (gingival gum line around the tooth)scored." (NCT00761930)
Timeframe: 6 weeks

InterventionUnits on a scale (Mean)
A- Placebo Comparator0.942
B - Active Comparator0.722
C - Experimental Toothpaste0.705

[back to top]

Dental Plaque

Quigley Hein Method: Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth. Plaque score= sum of all scores divided by the number of sites (teeth) scored. (NCT00761930)
Timeframe: 6 weeks

InterventionUnits on a scale (Mean)
A- Placebo Comparator2.273
B - Active Comparator1.806
C - Experimental Toothpaste2.041

[back to top]

Bleeding Index (EIBI)

Eastman Interdental Bleeding Index Scores (EIBI) measures the number of interdental spaces that bleed, divided by number of interdental spaces studied to yield a score with a minimum of O and a maximum of 1 (0=no bleeding & 1= bleeding) The number of spots between teeth that bleed are divided by number of spots between teeth that are scored and may be expressed as a percent when multiplied by 100. (NCT00761930)
Timeframe: 6 weeks

InterventionUnits on a scale (Mean)
A- Placebo Comparator0.325
B - Active Comparator0.164
C - Experimental Toothpaste0.141

[back to top]

Minimum pH After 14 Days of Use of Dentifrice

measurement of pH obtained as described before. However, this time the biofilm was exposed to the dentifrices for a longer period (14 days). (NCT00875212)
Timeframe: 14 days

InterventionpH (Mean)
Control4.78
Calcium Glycerophosphate5.24
Fluoride5.25
Calcium Glycerophosphate and Fluoride5.44

[back to top]

Minimum pH

The dental biofilm pH was measured in vivo with the microtouch method, using a palladium microelectrode + reference electrode. Data represents the mean values of the lowest pH observed each time after the use of sucrose. (NCT00875212)
Timeframe: at 1 minute (minimum fermenting pH) or at 7 minutes

InterventionpH (Mean)
Control5.40
Calcium Glycerophosphate5.48
Fluoride5.25
Calcium Glycerophosphate and Fluoride5.70

[back to top]

Plaque Index

Plaque Index score scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque,3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth) (NCT00926029)
Timeframe: 6 weeks

InterventionUnits on a scale (Mean)
Placebo Control0.91
Positive Control0.84
Experimental1.77

[back to top]

Gingivitis Index

Gingivitis score- scale 0 to 3 (0 = no inflammation,1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing. 3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding) (NCT00926029)
Timeframe: 6 Weeks

InterventionUnits on a scale (Mean)
Placebo Control0.63
Positive Control0.51
Experimental0.98

[back to top]

Changes in 18F-fluoride Transport (by Patlak Flux) - Normal

Investigation of changes in regional fluoride incorporation as measured by 18F-fluoride transport (Patlak flux) in normal bone. Palak flux is an indicator of blood flow and an indirect marker of angiogenesis. (NCT00936975)
Timeframe: Baseline and 12 weeks

InterventionmL/min/mL (Mean)
Overall0.01

[back to top]

Changes in 18F-fluoride Transport (by Patlak Flux) - Tumor

Investigation of changes in regional fluoride incorporation as measured by 18F-fluoride transport (Patlak flux) in Tumor. This measurement uses the Patlak method for determining the influx constant. (NCT00936975)
Timeframe: Baseline and 12 weeks

InterventionmL/min/mL (Mean)
Overall-0.01

[back to top]

Changes in 18F-fluoride PET SUV - Normal Bone

Investigation of changes between baseline and 12 weeks in regional fluoride incorporation as measured by 18F-fluoride PET (SUV) in normal bone as measured by SUVmax (NCT00936975)
Timeframe: Baseline and 12 weeks

InterventionSUVmax (Mean)
18F-Fluoride PET0.31

[back to top]

Changes in 18F-fluoride Ki - Normal Bone

Investigation of changes between baseline and 12 weeks in regional fluoride incorporation as measured by 18F-fluoride PET (Ki) in normal bone. Ki represents the net uptake of fluoride to the bone mineral compartment and reflects the level of osteoblastic activity in bone (NCT00936975)
Timeframe: Baseline and 12 weeks

InterventionmL/min/mL (Mean)
18F-Fluoride PET0.0

[back to top]

Changes in 18F-fluoride Ki - Tumor Bone

Investigation of changes between baseline and 12 weeks in regional fluoride incorporation as measured by 18F-fluoride PET (Ki) in tumor bone. Ki represents the net uptake of fluoride to the bone mineral compartment and reflects the level of osteoblastic activity in bone (NCT00936975)
Timeframe: Baseline and 12 weeks

InterventionmL/min/mL (Mean)
18F-Fluoride PET-0.02

[back to top]

Changes in 18F-fluoride PET (SUV) - Tumor Bone

Investigation of changes between baseline and 12 weeks in regional fluoride incorporation as measured by 18F-fluoride PET in tumor bone as measured by SUVmax (NCT00936975)
Timeframe: Baseline and 12 weeks

InterventionSUVmax (Mean)
18F-Fluoride PET-6.67

[back to top]

CFU (Colony Forming Units)

Total number of salivary bacterial colony forming units (lower number = less colonies present) (NCT00981825)
Timeframe: 4 hours

Interventionnumber of colony forming units (Mean)
Fluoride Toothpaste (Control)7.18
Triclosan/Fluoride Toothpaste6.94

[back to top]

Change From Baseline in Enamel Fluoride Uptake Potential

Enamel fluoride uptake was determined using the microdrill enamel biopsy technique. The amount of fluoride uptake by enamel was calculated based on the amount of fluoride (F) divided by the area of the enamel cores. The difference between treatments was calculated with respect to fluoride uptake by enamel. (NCT01005966)
Timeframe: Baseline to 14 days

Interventionmicrograms (μg)* F/centimeters(cm)^2 (Mean)
NaF Toothpaste (1426ppmF)2342.35
AmF Toothpaste (1400ppmF)2305.11
Na MFP/NaF Toothpaste (1450ppmF)1809.74
NaF Toothpaste (675ppmF)1649.44
Placebo Toothpaste (0ppmF)462.95

[back to top]

Percent SMH Recovery of Enamel Specimens Exposed to NaF Toothpaste (1426ppmF), NaF Toothpaste (675ppmF), NaMFP/NaF Toothpaste (1400ppm F) and Placebo (0ppmF)

SMH test was used to assess the changes in mineralization status of enamel specimens using a Wilson 2100 Hardness tester. SMH was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents rehardening of enamel surface. Differences in percent SMH recovery due to study and reference toothpastes were calculated. (NCT01005966)
Timeframe: Baseline to 14 days

InterventionPercentage SMHR (Mean)
NaF Toothpaste (1426ppmF)38.05
AmF Toothpaste (1400ppmF)41.06
NaMFP/NaF Toothpaste (1450ppmF)33.48
NaF Toothpaste (675ppmF)29.08
Placebo Toothpaste (0ppmF)14.49

[back to top]

Percent Surface Microhardness (SMH) Recovery of Enamel Specimens Exposed to NaF Toothpaste (1426ppmF) and AmF Toothpaste (1400ppmF)

SMH recovery test was used to assess the changes in mineralization status of enamel specimens using a Wilson 2100 Hardness tester. SMH was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents rehardening of enamel surface. Difference in percent SMH recovery was calculated by comparing study NaF toothpaste (1426ppmF) with reference AmF toothpaste (1400ppmF). (NCT01005966)
Timeframe: Baseline to 14 days

InterventionPercentage SMHR (Mean)
NaF Toothpaste (1426ppmF)38.05
AmF Toothpaste (1400ppmF)41.06

[back to top]

Mean Stain Area for Gingival Sites at 4 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). The gingival regions were scored for area according to the following criteria. Stain area for gingival regions were scored as 0=no stain present, natural tooth color; 1=thin line of stain, may be discontinuous; 2=thick line or band of stain; 3=stain covers entire area. (NCT01009554)
Timeframe: 4 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.186
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.263

[back to top]

Mean Stain Area for Gingival Sites at 6 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). The gingival regions were scored for area according to the following criteria. Stain area for gingival regions were scored as 0=no stain present, natural tooth color; 1=thin line of stain, may be discontinuous; 2=thick line or band of stain; 3=stain covers entire area. (NCT01009554)
Timeframe: 6 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.184
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.352

[back to top]

Mean Stain Intensity For Interproximal (Mesial and Distal) Sites at 6 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). The interproximal (mesial and distal) regions were scored for intensity according to the following criteria. The intensity of yellow-brown stains occurring in each region is unrelated to the area covered with stained pellicle. The regions were assessed on a 4-point ordinal scale as 0=no stain, 1=faint stain (can be seen with close examination), 2=moderate stain (clearly visible and aesthetically unacceptable), 3=heavy, dark stain (obvious and aesthetically unacceptable). (NCT01009554)
Timeframe: 6 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.205
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.379

[back to top]

Mean Stain Area for Body Sites at 6 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). The body regions were scored for area according to the following criteria. Stain area for the body of the tooth was scored as 0=no stain present, natural tooth color, 1=stain limited to pits and grooves; 2=stain outside pits/grooves, up to 10% of surface affected; 3=stain outside pits/grooves, over 10% of surface affected. (NCT01009554)
Timeframe: 6 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.076
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.100

[back to top]

Mean Stain Intensity for Gingival Sites at 6 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). The gingival regions were scored for intensity according to the following criteria. The intensity of yellow-brown stains occurring in each region is unrelated to the area covered with stained pellicle. The gingival regions were assessed on a 4-point ordinal scale as 0=no stain, 1=faint stain (can be seen with close examination), 2=moderate stain (clearly visible and aesthetically unacceptable), 3=heavy, dark stain (obvious and aesthetically unacceptable). (NCT01009554)
Timeframe: 6 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.180
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.358

[back to top]

Mean Stain Area for Facial Sites at 4 Weeks

The facial surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for area according to the following criteria. Stain area for mesial, gingival, and distal regions were scored as 0=no stain present, natural tooth color; 1=thin line of stain, may be discontinuous; 2=thick line or band of stain; 3=stain covers entire area and for the body of tooth as 0=no stain present, natural tooth color, 1=stain limited to pits and grooves; 2=stain outside pits/grooves, up to 10% of surface affected; 3=stain outside pits/grooves, over 10% of surface affected. (NCT01009554)
Timeframe: 4 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.032
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.033

[back to top]

Mean Stain Intensity for Gingival Sites at 4 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). The gingival regions were scored for intensity according to the following criteria. The intensity of yellow-brown stains occurring in each region is unrelated to the area covered with stained pellicle. The gingival regions were assessed on a 4-point ordinal scale as 0=no stain, 1=faint stain (can be seen with close examination), 2=moderate stain (clearly visible and aesthetically unacceptable), 3=heavy, dark stain (obvious and aesthetically unacceptable). (NCT01009554)
Timeframe: 4 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.180
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.252

[back to top]

Mean Stain Intensity for Facial Sites at 6 Weeks

The facial surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for intensity according to the following criteria. The intensity of yellow-brown stains occurring in each region is unrelated to the area covered with stained pellicle. All four regions were assessed on a 4-point ordinal scale as 0=no stain, 1=faint stain (can be seen with close examination), 2=moderate stain (clearly visible and aesthetically unacceptable), 3=heavy, dark stain (obvious and aesthetically unacceptable). (NCT01009554)
Timeframe: 6 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.054
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.065

[back to top]

Mean Stain Intensity for Facial Sites at 4 Weeks

The facial surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for intensity according to the following criteria. The intensity of yellow-brown stains occurring in each region is unrelated to the area covered with stained pellicle. All four regions were assessed on a 4-point ordinal scale as 0=no stain, 1=faint stain (can be seen with close examination), 2=moderate stain (clearly visible and aesthetically unacceptable), 3=heavy, dark stain (obvious and aesthetically unacceptable). (NCT01009554)
Timeframe: 4 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.027
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.025

[back to top]

Mean Stain Intensity for Body Sites at 8 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). The body regions were scored for intensity according to the following criteria. The intensity of yellow-brown stains occurring in each region is unrelated to the area covered with stained pellicle. The body regions were assessed on a 4-point ordinal scale as 0=no stain, 1=faint stain (can be seen with close examination), 2=moderate stain (clearly visible and aesthetically unacceptable), 3=heavy, dark stain (obvious and aesthetically unacceptable). (NCT01009554)
Timeframe: 8 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.063
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.112

[back to top]

Mean Stain Intensity for Body Sites at 6 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). The body regions were scored for intensity according to the following criteria. The intensity of yellow-brown stains occurring in each region is unrelated to the area covered with stained pellicle. The body regions were assessed on a 4-point ordinal scale as 0=no stain, 1=faint stain (can be seen with close examination), 2=moderate stain (clearly visible and aesthetically unacceptable), 3=heavy, dark stain (obvious and aesthetically unacceptable). (NCT01009554)
Timeframe: 6 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.075
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.100

[back to top]

Mean Stain Intensity for Body Sites at 4 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). The body regions were scored for intensity according to the following criteria. The intensity of yellow-brown stains occurring in each region is unrelated to the area covered with stained pellicle. The body regions were assessed on a 4-point ordinal scale as 0=no stain, 1=faint stain (can be seen with close examination), 2=moderate stain (clearly visible and aesthetically unacceptable), 3=heavy, dark stain (obvious and aesthetically unacceptable). (NCT01009554)
Timeframe: 4 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.058
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.045

[back to top]

Mean Stain Area Over All Tooth Sites at 8 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for area according to the following criteria. Stain area for mesial, gingival, and distal regions were scored as 0=no stain present, natural tooth color; 1=thin line of stain, may be discontinuous; 2=thick line or band of stain; 3=stain covers entire area and for the body of tooth as 0=no stain present, natural tooth color, 1=stain limited to pits and grooves; 2=stain outside pits/grooves, up to 10% of surface affected; 3=stain outside pits/grooves, over 10% of surface affected. (NCT01009554)
Timeframe: 8 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.188
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.383

[back to top]

Mean Stain Area Over All Tooth Sites at 6 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for area according to the following criteria. Stain area for mesial, gingival, and distal regions were scored as 0=no stain present, natural tooth color; 1=thin line of stain, may be discontinuous; 2=thick line or band of stain; 3=stain covers entire area and for the body of tooth as 0=no stain present, natural tooth color, 1=stain limited to pits and grooves; 2=stain outside pits/grooves, up to 10% of surface affected; 3=stain outside pits/grooves, over 10% of surface affected. (NCT01009554)
Timeframe: 6 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.166
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.303

[back to top]

Mean Stain Area Over All Tooth Sites at 4 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for area according to the following criteria. Stain area for mesial, gingival, and distal regions were scored as 0=no stain present, natural tooth color; 1=thin line of stain, may be discontinuous; 2=thick line or band of stain; 3=stain covers entire area and for the body of tooth as 0=no stain present, natural tooth color, 1=stain limited to pits and grooves; 2=stain outside pits/grooves, up to 10% of surface affected; 3=stain outside pits/grooves, over 10% of surface affected. (NCT01009554)
Timeframe: 4 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.162
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.196

[back to top]

Mean Stain Intensity for Facial Sites at 8 Weeks

The facial surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for intensity according to the following criteria. The intensity of yellow-brown stains occurring in each region is unrelated to the area covered with stained pellicle. All four regions were assessed on a 4-point ordinal scale as 0=no stain, 1=faint stain (can be seen with close examination), 2=moderate stain (clearly visible and aesthetically unacceptable), 3=heavy, dark stain (obvious and aesthetically unacceptable). (NCT01009554)
Timeframe: 8 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.042
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.144

[back to top]

Mean Stain Intensity for Lingual Sites at 8 Weeks

The lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for intensity according to the following criteria. The intensity of yellow-brown stains occurring in each region is unrelated to the area covered with stained pellicle. All four regions were assessed on a 4-point ordinal scale as 0=no stain, 1=faint stain (can be seen with close examination), 2=moderate stain (clearly visible and aesthetically unacceptable), 3=heavy, dark stain (obvious and aesthetically unacceptable). (NCT01009554)
Timeframe: 8 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.314
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.596

[back to top]

Mean Stain Intensity for Lingual Sites at 6 Weeks

The lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for intensity according to the following criteria. The intensity of yellow-brown stains occurring in each region is unrelated to the area covered with stained pellicle. All four regions were assessed on a 4-point ordinal scale as 0=no stain, 1=faint stain (can be seen with close examination), 2=moderate stain (clearly visible and aesthetically unacceptable), 3=heavy, dark stain (obvious and aesthetically unacceptable). (NCT01009554)
Timeframe: 6 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.279
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.541

[back to top]

Mean Stain Area for Lingual Sites at 8 Weeks

The lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for area according to the following criteria. Stain area for mesial, gingival, and distal regions were scored as 0=no stain present, natural tooth color; 1=thin line of stain, may be discontinuous; 2=thick line or band of stain; 3=stain covers entire area and for the body of tooth as 0=no stain present, natural tooth color, 1=stain limited to pits and grooves; 2=stain outside pits/grooves, up to 10% of surface affected; 3=stain outside pits/grooves, over 10% of surface affected. (NCT01009554)
Timeframe: 8 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.325
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.598

[back to top]

Mean Stain Area for Lingual Sites at 6 Weeks

The lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for area according to the following criteria. Stain area for mesial, gingival, and distal regions were scored as 0=no stain present, natural tooth color; 1=thin line of stain, may be discontinuous; 2=thick line or band of stain; 3=stain covers entire area and for the body of tooth as 0=no stain present, natural tooth color, 1=stain limited to pits and grooves; 2=stain outside pits/grooves, up to 10% of surface affected; 3=stain outside pits/grooves, over 10% of surface affected. (NCT01009554)
Timeframe: 6 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.277
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.533

[back to top]

Mean Stain Area for Lingual Sites at 4 Weeks

The lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for area according to the following criteria. Stain area for mesial, gingival, and distal regions were scored as 0=no stain present, natural tooth color; 1=thin line of stain, may be discontinuous; 2=thick line or band of stain; 3=stain covers entire area and for the body of tooth as 0=no stain present, natural tooth color, 1=stain limited to pits and grooves; 2=stain outside pits/grooves, up to 10% of surface affected; 3=stain outside pits/grooves, over 10% of surface affected. (NCT01009554)
Timeframe: 4 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.293
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.359

[back to top]

Mean Stain Area for Interproximal (Mesial and Distal) Sites at 8 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). The interproximal (mesial and distal) regions were scored for area according to the following criteria. Stain area for mesial and distal regions were scored as 0=no stain present, natural tooth color; 1=thin line of stain, may be discontinuous; 2=thick line or band of stain; 3=stain covers entire area. (NCT01009554)
Timeframe: 8 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.218
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.483

[back to top]

Mean Stain Area for Gingival Sites at 8 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). The gingival regions were scored for area according to the following criteria. Stain area for gingival regions were scored as 0=no stain present, natural tooth color; 1=thin line of stain, may be discontinuous; 2=thick line or band of stain; 3=stain covers entire area. (NCT01009554)
Timeframe: 8 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.250
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.444

[back to top]

Mean Stain Area for Interproximal (Mesial and Distal) Sites at 6 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). The interproximal (mesial and distal) regions were scored for area according to the following criteria. Stain area for mesial and distal regions were scored as 0=no stain present, natural tooth color; 1=thin line of stain, may be discontinuous; 2=thick line or band of stain; 3=stain covers entire area. (NCT01009554)
Timeframe: 6 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.206
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.383

[back to top]

Mean Stain Intensity for Lingual Sites at 4 Weeks

The lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for intensity according to the following criteria. The intensity of yellow-brown stains occurring in each region is unrelated to the area covered with stained pellicle. All four regions were assessed on a 4-point ordinal scale as 0=no stain, 1=faint stain (can be seen with close examination), 2=moderate stain (clearly visible and aesthetically unacceptable), 3=heavy, dark stain (obvious and aesthetically unacceptable). (NCT01009554)
Timeframe: 4 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.282
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.344

[back to top]

Change in Tooth Color as Represented by Δb at 4 Weeks Post Baseline From the CIElab Assessment

The tooth color of the four maxillary incisor teeth (teeth #7-10, facial surface) was measured instrumentally using the MHT SpectroShade System. Assessments were made under standardized lighting conditions after participants brushed their teeth with water. The aperture tip was placed perpendicularly to the facial surface of the tooth and the color measured using the CIElab color system. The change in the individual b* color parameter was calculated. The Δb was calculated per tooth and then averaged over the teeth for a participant. (NCT01009554)
Timeframe: 4 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.077
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)-0.117

[back to top]

Change in Tooth Color as Represented by Δb at 6 Weeks Post Baseline From the CIElab Assessment

The tooth color of the four maxillary incisor teeth (teeth #7-10, facial surface) was measured instrumentally using the MHT SpectroShade System. Assessments were made under standardized lighting conditions after participants brushed their teeth with water. The aperture tip was placed perpendicularly to the facial surface of the tooth and the color measured using the CIElab color system. The change in the individual b* color parameter was calculated. The Δb was calculated per tooth and then averaged over the teeth for a participant. (NCT01009554)
Timeframe: 6 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.123
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)-0.212

[back to top]

Change in Tooth Color as Represented by Δb at 8 Weeks Post Baseline From the CIElab Assessment

The tooth color of the four maxillary incisor teeth (teeth #7-10, facial surface) was measured instrumentally using the MHT SpectroShade System. Assessments were made under standardized lighting conditions after participants brushed their teeth with water. The aperture tip was placed perpendicularly to the facial surface of the tooth and the color measured using the CIElab color system. The change in the individual b* color parameter was calculated. The Δb was calculated per tooth and then averaged over the teeth for a participant. (NCT01009554)
Timeframe: 8 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.107
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)-0.107

[back to top]

Change in Tooth Color as Represented by ΔE at 4 Weeks Post Baseline From the CIElab Assessment

The tooth color of the four maxillary incisor teeth (teeth #7-10, facial surface) was measured instrumentally using the MHT SpectroShade System. Assessments were made under standardized lighting conditions after participants brushed their teeth with water. The aperture tip was placed perpendicularly to the facial surface of the tooth and the color measured using the CIElab color system. The changes in the individual L*, a*, and b* color parameters were calculated to determine quantitatively the improvements in tooth lightness, redness, and yellowness, respectively. An overall change in tooth color was calculated using the CIE color equation ΔE = [(ΔL*)^2 + (Δa*)^2 + (Δb*)^2]^1/2. The ΔE was calculated per tooth and then averaged over the teeth for a participant. (NCT01009554)
Timeframe: 4 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.875
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.882

[back to top]

Change in Tooth Color as Represented by ΔE at 6 Weeks Post Baseline From the CIElab Assessment

The tooth color of the four maxillary incisor teeth (teeth #7-10, facial surface) was measured instrumentally using the MHT SpectroShade System. Assessments were made under standardized lighting conditions after participants brushed their teeth with water. The aperture tip was placed perpendicularly to the facial surface of the tooth and the color measured using the CIElab color system. The changes in the individual L*, a*, and b* color parameters were calculated to determine quantitatively the improvements in tooth lightness, redness, and yellowness, respectively. An overall change in tooth color was calculated using the CIE color equation ΔE = [(ΔL*)^2 + (Δa*)^2 + (Δb*)^2]^1/2. The ΔE was calculated per tooth and then averaged over the teeth for a participant. (NCT01009554)
Timeframe: 6 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.805
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)1.040

[back to top]

Change in Tooth Color as Represented by ΔE at 8 Weeks Post Baseline From the CIElab Assessment

The tooth color of the four maxillary incisor teeth (teeth #7-10, facial surface) was measured instrumentally using the MHT SpectroShade System. Assessments were made under standardized lighting conditions after participants brushed their teeth with water. The aperture tip was placed perpendicularly to the facial surface of the tooth and the color measured using the CIElab color system. The changes in the individual L*, a*, and b* color parameters were calculated to determine quantitatively the improvements in tooth lightness, redness, and yellowness, respectively. An overall change in tooth color was calculated using the CIE color equation ΔE = [(ΔL*)^2 + (Δa*)^2 + (Δb*)^2]^1/2. The ΔE was calculated per tooth and then averaged over the teeth for a participant. (NCT01009554)
Timeframe: 8 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.909
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)1.035

[back to top]

Change in Tooth Color as Represented by ΔL at 4 Weeks Post Baseline From the CIElab Assessment

The tooth color of the four maxillary incisor teeth (teeth #7-10, facial surface) was measured instrumentally using the MHT SpectroShade System. Assessments were made under standardized lighting conditions after participants brushed their teeth with water. The aperture tip was placed perpendicularly to the facial surface of the tooth and the color measured using the CIElab color system. The change in the individual L* color parameter was calculated. The ΔL was calculated per tooth and then averaged over the teeth for a participant. (NCT01009554)
Timeframe: 4 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.013
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.054

[back to top]

Change in Tooth Color as Represented by ΔL at 6 Weeks Post Baseline From the CIElab Assessment

The tooth color of the four maxillary incisor teeth (teeth #7-10, facial surface) was measured instrumentally using the MHT SpectroShade System. Assessments were made under standardized lighting conditions after participants brushed their teeth with water. The aperture tip was placed perpendicularly to the facial surface of the tooth and the color measured using the CIElab color system. The change in the individual L* color parameter was calculated. The ΔL was calculated per tooth and then averaged over the teeth for a participant. (NCT01009554)
Timeframe: 6 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.071
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)-0.090

[back to top]

Change in Tooth Color as Represented by ΔL at 8 Weeks Post Baseline From the CIElab Assessment

The tooth color of the four maxillary incisor teeth (teeth #7-10, facial surface) was measured instrumentally using the MHT SpectroShade System. Assessments were made under standardized lighting conditions after participants brushed their teeth with water. The aperture tip was placed perpendicularly to the facial surface of the tooth and the color measured using the CIElab color system. The change in the individual L* color parameter was calculated. The ΔL was calculated per tooth and then averaged over the teeth for a participant. (NCT01009554)
Timeframe: 8 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.158
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)-0.043

[back to top]

Mean Stain Area for Body Sites at 4 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). The body regions were scored for area according to the following criteria. Stain area for the body of the tooth was scored as 0=no stain present, natural tooth color, 1=stain limited to pits and grooves; 2=stain outside pits/grooves, up to 10% of surface affected; 3=stain outside pits/grooves, over 10% of surface affected. (NCT01009554)
Timeframe: 4 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.064
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.056

[back to top]

Mean Stain Intensity Over All Tooth Sites at 4 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for intensity according to the following criteria. The intensity of yellow-brown stains occurring in each region is unrelated to the area covered with stained pellicle. All four regions were assessed on a 4-point ordinal scale as 0=no stain, 1=faint stain (can be seen with close examination), 2=moderate stain (clearly visible and aesthetically unacceptable), 3=heavy, dark stain (obvious and aesthetically unacceptable). (NCT01009554)
Timeframe: 4 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.154
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.184

[back to top]

Mean Stain Intensity Over All Tooth Sites at 6 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for intensity according to the following criteria. The intensity of yellow-brown stains occurring in each region is unrelated to the area covered with stained pellicle. All four regions were assessed on a 4-point ordinal scale as 0=no stain, 1=faint stain (can be seen with close examination), 2=moderate stain (clearly visible and aesthetically unacceptable), 3=heavy, dark stain (obvious and aesthetically unacceptable). (NCT01009554)
Timeframe: 6 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.164
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.302

[back to top]

Mean Stain Intensity Over All Tooth Sites at 8 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for intensity according to the following criteria. The intensity of yellow-brown stains occurring in each region is unrelated to the area covered with stained pellicle. All four regions were assessed on a 4-point ordinal scale as 0=no stain, 1=faint stain (can be seen with close examination), 2=moderate stain (clearly visible and aesthetically unacceptable), 3=heavy, dark stain (obvious and aesthetically unacceptable). (NCT01009554)
Timeframe: 8 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.181
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.375

[back to top]

Mean Stain Score for Body Sites at 4 Weeks

The mean stain score (0-9) per participant was determined by multiplying the individual area and intensity scores from each region and summing them then dividing by the number of sites scored. The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). Stain area for the body of the tooth was scored on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain outside pits/grooves, over 10% of surface affected). The intensity of yellow-brown stains occurring in each region was assessed on a 4-point ordinal scale (0=no stain; 3=heavy, dark stain). (NCT01009554)
Timeframe: 4 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.132
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.112

[back to top]

Mean Stain Score for Body Sites at 6 Weeks

The mean stain score (0-9) per participant was determined by multiplying the individual area and intensity scores from each region and summing them then dividing by the number of sites scored. The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). Stain area for the body of the tooth was scored on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain outside pits/grooves, over 10% of surface affected). The intensity of yellow-brown stains occurring in each region was assessed on a 4-point ordinal scale (0=no stain; 3=heavy, dark stain). (NCT01009554)
Timeframe: 6 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.160
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.215

[back to top]

Mean Stain Score for Body Sites at 8 Weeks

The mean stain score (0-9) per participant was determined by multiplying the individual area and intensity scores from each region and summing them then dividing by the number of sites scored. The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). Stain area for the body of the tooth was scored on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain outside pits/grooves, over 10% of surface affected). The intensity of yellow-brown stains occurring in each region was assessed on a 4-point ordinal scale (0=no stain; 3=heavy, dark stain). (NCT01009554)
Timeframe: 8 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.143
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.258

[back to top]

Mean Stain Score for Facial Sites at 4 Weeks

The mean stain score (0-9) per participant was determined by multiplying the individual area and intensity scores from each region and summing them then dividing by the number of sites scored. The facial surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for area and intensity according to the following criteria. Stain area for mesial, gingival, and distal regions were scored on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain covers entire area) and for the body of tooth on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain outside pits/grooves, over 10% of surface affected). The intensity of yellow-brown stains occurring in each region was assessed on a 4-point ordinal scale (0=no stain; 3=heavy, dark stain). (NCT01009554)
Timeframe: 4 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.063
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.058

[back to top]

Mean Stain Score for Facial Sites at 6 Weeks

The mean stain score (0-9) per participant was determined by multiplying the individual area and intensity scores from each region and summing them then dividing by the number of sites scored. The facial surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for area and intensity according to the following criteria. Stain area for mesial, gingival, and distal regions were scored on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain covers entire area) and for the body of tooth on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain outside pits/grooves, over 10% of surface affected). The intensity of yellow-brown stains occurring in each region was assessed on a 4-point ordinal scale (0=no stain; 3=heavy, dark stain). (NCT01009554)
Timeframe: 6 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.118
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.140

[back to top]

Mean Stain Intensity For Interproximal (Mesial and Distal) Sites at 8 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). The interproximal (mesial and distal) regions were scored for intensity according to the following criteria. The intensity of yellow-brown stains occurring in each region is unrelated to the area covered with stained pellicle. The regions were assessed on a 4-point ordinal scale as 0=no stain, 1=faint stain (can be seen with close examination), 2=moderate stain (clearly visible and aesthetically unacceptable), 3=heavy, dark stain (obvious and aesthetically unacceptable). (NCT01009554)
Timeframe: 8 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.210
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.475

[back to top]

Mean Stain Score for Gingival Sites at 4 Weeks

The mean stain score (0-9) per participant was determined by multiplying the individual area and intensity scores from each region and summing them then dividing by the number of sites scored. The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). Stain area for gingival regions were scored on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain covers entire area) and for the body of tooth on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain outside pits/grooves, over 10% of surface affected). The intensity of yellow-brown stains occurring in each region was assessed on a 4-point ordinal scale (0=no stain; 3=heavy, dark stain). (NCT01009554)
Timeframe: 4 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.383
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.521

[back to top]

Mean Stain Score for Gingival Sites at 6 Weeks

The mean stain score (0-9) per participant was determined by multiplying the individual area and intensity scores from each region and summing them then dividing by the number of sites scored. The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). Stain area for gingival regions were scored on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain covers entire area) and for the body of tooth on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain outside pits/grooves, over 10% of surface affected). The intensity of yellow-brown stains occurring in each region was assessed on a 4-point ordinal scale (0=no stain; 3=heavy, dark stain). (NCT01009554)
Timeframe: 6 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.395
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.732

[back to top]

Mean Stain Score for Gingival Sites at 8 Weeks

The mean stain score (0-9) per participant was determined by multiplying the individual area and intensity scores from each region and summing them then dividing by the number of sites scored. The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). Stain area for gingival regions were scored on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain covers entire area) and for the body of tooth on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain outside pits/grooves, over 10% of surface affected). The intensity of yellow-brown stains occurring in each region was assessed on a 4-point ordinal scale (0=no stain; 3=heavy, dark stain). (NCT01009554)
Timeframe: 8 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.526
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.920

[back to top]

Mean Stain Score for Interproximal (Mesial and Distal) Sites at 4 Weeks

The mean stain score (0-9) per participant was determined by multiplying the individual area and intensity scores from each region and summing them then dividing by the number of sites scored. The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). Stain area for mesial and distal regions were scored on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain covers entire area). The intensity of yellow-brown stains occurring in each region was assessed on a 4-point ordinal scale (0=no stain; 3=heavy, dark stain). (NCT01009554)
Timeframe: 4 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.408
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.463

[back to top]

Mean Stain Score for Interproximal (Mesial and Distal) Sites at 6 Weeks

The mean stain score (0-9) per participant was determined by multiplying the individual area and intensity scores from each region and summing them then dividing by the number of sites scored. The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). Stain area for mesial and distal regions were scored on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain covers entire area). The intensity of yellow-brown stains occurring in each region was assessed on a 4-point ordinal scale (0=no stain; 3=heavy, dark stain). (NCT01009554)
Timeframe: 6 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.427
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.776

[back to top]

Mean Stain Score for Interproximal (Mesial and Distal) Sites at 8 Weeks

The mean stain score (0-9) per participant was determined by multiplying the individual area and intensity scores from each region and summing them then dividing by the number of sites scored. The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). Stain area for mesial and distal regions were scored on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain covers entire area). The intensity of yellow-brown stains occurring in each region was assessed on a 4-point ordinal scale (0=no stain; 3=heavy, dark stain). (NCT01009554)
Timeframe: 8 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.451
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.994

[back to top]

Mean Stain Score for Lingual Sites at 4 Weeks

The mean stain score (0-9) per participant was determined by multiplying the individual area and intensity scores from each region and summing them then dividing by the number of sites scored. The lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for area and intensity according to the following criteria. Stain area for mesial, gingival, and distal regions were scored on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain covers entire area) and for the body of tooth on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain outside pits/grooves, over 10% of surface affected). The intensity of yellow-brown stains occurring in each region was assessed on a 4-point ordinal scale (0=no stain; 3=heavy, dark stain). (NCT01009554)
Timeframe: 4 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.596
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.716

[back to top]

Mean Stain Score for Lingual Sites at 6 Weeks

The mean stain score (0-9) per participant was determined by multiplying the individual area and intensity scores from each region and summing them then dividing by the number of sites scored. The lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for area and intensity according to the following criteria. Stain area for mesial, gingival, and distal regions were scored on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain covers entire area) and for the body of tooth on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain outside pits/grooves, over 10% of surface affected). The intensity of yellow-brown stains occurring in each region was assessed on a 4-point ordinal scale (0=no stain; 3=heavy, dark stain). (NCT01009554)
Timeframe: 6 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.586
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)1.106

[back to top]

Mean Stain Score for Lingual Sites at 8 Weeks

The mean stain score (0-9) per participant was determined by multiplying the individual area and intensity scores from each region and summing them then dividing by the number of sites scored. The lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for area and intensity according to the following criteria. Stain area for mesial, gingival, and distal regions were scored on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain covers entire area) and for the body of tooth on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain outside pits/grooves, over 10% of surface affected). The intensity of yellow-brown stains occurring in each region was assessed on a 4-point ordinal scale (0=no stain; 3=heavy, dark stain). (NCT01009554)
Timeframe: 8 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.677
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)1.244

[back to top]

Mean Stain Score Over All Tooth Sites at 4 Weeks

The mean stain score (0-9) per participant was determined by multiplying the individual area and intensity scores from each region and summing them then dividing by the number of sites scored. The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for area and intensity according to the following criteria. Stain area for mesial, gingival, and distal regions were scored on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain covers entire area) and for the body of tooth on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain outside pits/grooves, over 10% of surface affected). The intensity of yellow-brown stains occurring in each region was assessed on a 4-point ordinal scale (0=no stain; 3=heavy, dark stain). (NCT01009554)
Timeframe: 4 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.329
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.386

[back to top]

Mean Stain Score Over All Tooth Sites at 6 Weeks

The mean stain score (0-9) per participant was determined by multiplying the individual area and intensity scores from each region and summing them then dividing by the number of sites scored. The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for area and intensity according to the following criteria. Stain area for mesial, gingival, and distal regions were scored on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain covers entire area) and for the body of tooth on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain outside pits/grooves, over 10% of surface affected). The intensity of yellow-brown stains occurring in each region was assessed on a 4-point ordinal scale (0=no stain; 3=heavy, dark stain). (NCT01009554)
Timeframe: 6 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.349
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.621

[back to top]

Mean Stain Score Over All Tooth Sites at 8 Weeks

The mean stain score (0-9) per participant was determined by multiplying the individual area and intensity scores from each region and summing them then dividing by the number of sites scored. The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for area and intensity according to the following criteria. Stain area for mesial, gingival, and distal regions were scored on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain covers entire area) and for the body of tooth on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain outside pits/grooves, over 10% of surface affected). The intensity of yellow-brown stains occurring in each region was assessed on a 4-point ordinal scale (0=no stain; 3=heavy, dark stain). (NCT01009554)
Timeframe: 8 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.394
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.791

[back to top]

Mean Stain Score for Facial Sites at 8 Weeks

The mean stain score (0-9) per participant was determined by multiplying the individual area and intensity scores from each region and summing them then dividing by the number of sites scored. The facial surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for area and intensity according to the following criteria. Stain area for mesial, gingival, and distal regions were scored on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain covers entire area) and for the body of tooth on a 4-point ordinal scale (0=no stain present, natural tooth color; 3=stain outside pits/grooves, over 10% of surface affected). The intensity of yellow-brown stains occurring in each region was assessed on a 4-point ordinal scale (0=no stain; 3=heavy, dark stain). (NCT01009554)
Timeframe: 8 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.097
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.319

[back to top]

Mean Stain Intensity For Interproximal (Mesial and Distal) Sites at 4 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). The interproximal (mesial and distal) regions were scored for intensity according to the following criteria. The intensity of yellow-brown stains occurring in each region is unrelated to the area covered with stained pellicle. The regions were assessed on a 4-point ordinal scale as 0=no stain, 1=faint stain (can be seen with close examination), 2=moderate stain (clearly visible and aesthetically unacceptable), 3=heavy, dark stain (obvious and aesthetically unacceptable). (NCT01009554)
Timeframe: 4 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.192
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.224

[back to top]

Mean Stain Intensity for Gingival Sites at 8 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). The gingival regions were scored for intensity according to the following criteria. The intensity of yellow-brown stains occurring in each region is unrelated to the area covered with stained pellicle. The gingival regions were assessed on a 4-point ordinal scale as 0=no stain, 1=faint stain (can be seen with close examination), 2=moderate stain (clearly visible and aesthetically unacceptable), 3=heavy, dark stain (obvious and aesthetically unacceptable). (NCT01009554)
Timeframe: 8 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.241
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.438

[back to top]

Mean Stain Area for Body Sites at 8 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). The body regions were scored for area according to the following criteria. Stain area for the body of the tooth was scored as 0=no stain present, natural tooth color, 1=stain limited to pits and grooves; 2=stain outside pits/grooves, up to 10% of surface affected; 3=stain outside pits/grooves, over 10% of surface affected. (NCT01009554)
Timeframe: 8 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.067
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.124

[back to top]

Mean Stain Area for Interproximal (Mesial and Distal) Sites at 4 Weeks

The facial and lingual surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). The interproximal (mesial and distal) regions were scored for area according to the following criteria. Stain area for mesial and distal regions were scored as 0=no stain present, natural tooth color; 1=thin line of stain, may be discontinuous; 2=thick line or band of stain; 3=stain covers entire area. (NCT01009554)
Timeframe: 4 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.202
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.236

[back to top]

Mean Stain Area for Facial Sites at 6 Weeks

The facial surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for area according to the following criteria. Stain area for mesial, gingival, and distal regions were scored as 0=no stain present, natural tooth color; 1=thin line of stain, may be discontinuous; 2=thick line or band of stain; 3=stain covers entire area and for the body of tooth as 0=no stain present, natural tooth color, 1=stain limited to pits and grooves; 2=stain outside pits/grooves, up to 10% of surface affected; 3=stain outside pits/grooves, over 10% of surface affected. (NCT01009554)
Timeframe: 6 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.059
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.075

[back to top]

Mean Stain Area for Facial Sites at 8 Weeks

The facial surfaces of the maxillary and mandibular anterior teeth (teeth #6-11 and #22-27) were scored using the Macpherson Modification of the Lobene Stain Index. Each surface was divided into 4 regions (gingival, mesial, distal, and body). All four regions were scored for area according to the following criteria. Stain area for mesial, gingival, and distal regions were scored as 0=no stain present, natural tooth color; 1=thin line of stain, may be discontinuous; 2=thick line or band of stain; 3=stain covers entire area and for the body of tooth as 0=no stain present, natural tooth color, 1=stain limited to pits and grooves; 2=stain outside pits/grooves, up to 10% of surface affected; 3=stain outside pits/grooves, over 10% of surface affected. (NCT01009554)
Timeframe: 8 weeks

Interventionunits on a scale (Least Squares Mean)
Crest® Regular Toothpaste0.047
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.160

[back to top]

Oral Tissue Tolerance

Oral tissue tolerance was assessed by oral tissue adverse events for which the relationship to treatment was considered as possible, probable, or very likely. If the relationship to treatment was missing, the adverse event was categorized as a treatment-related adverse event. (NCT01009554)
Timeframe: through 8 weeks

,
Interventionpercentage of participants (Number)
Participants with ≥ one treatment-related AESensitivity of teeth
11794-050 (1.5% Potassium Oxalate & pH 4.2 Mouth Rinse)0.00.0
Crest® Regular Toothpaste2.12.1

[back to top]

Adjusted Mean Percent SMH Recovery of Enamel Specimens Exposed to Test Dentifrice +Sterile Water Rinse and Reference Dentifrice +Sterile Water Rinse

SMH test was used to assess mineralization status of enamel specimens using a Wilson 2100 Hardness tester. SMH was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents rehardening of enamel surface. Percent SMH recovery was calculated from indentation values of enamel specimens at baseline (B), after in-situ hardening (R) and after first erosive challenge (E1) using formula: [(E1-R)/ (E1-B)]*100. (NCT01128972)
Timeframe: Baseline, 4 hours post treatment in each treatment period

InterventionPercent SMH (Least Squares Mean)
Test Dentifrice + Sterile Water Rinse38.02
Reference Dentifrice + Sterile Water Rinse30.88

[back to top]

Adjusted Mean Percentage SMH Recovery of Enamel Specimens Exposed to Test Dentifrice + Test MR Relative to Following Treatment Regimens: 1) Test Dentifrice +Test MR 2) Test Dentifrice + Sterile Water 3) Reference Dentifrice +Sterile Water

SMH test was used to assess mineralization status of enamel specimens using a Wilson 2100 Hardness tester. SMH was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents rehardening of enamel surface. Percent SMH recovery was calculated from indentation values of enamel specimens at baseline (B), after in-situ hardening (R) and after first erosive challenge (E1) using formula: [(E1-R)/ (E1-B)]*100. (NCT01128972)
Timeframe: Baseline, 4 hours post treatment in each treatment period

InterventionPercent SMH (Least Squares Mean)
Placebo Dentifrice + Test MR37.75
Test Dentifrice + Test MR42.14
Test Dentifrice + Sterile Water Rinse38.02
Reference Dentifrice + Sterile Water Rinse30.88
Placebo Dentifrice + Sterile Water Rinse30.57

[back to top]

Adjusted Mean Percentage Surface Microhardness (SMH) Recovery of Enamel Specimens Exposed to Test Dentifrice + Test MR Relative to: 1)Test Dentifrice+Sterile Water Rinse 2)Reference Dentifrice+Sterile Water Rinse 3)Placebo Dentifrice+ Sterile Water Rinse

SMH test was used to assess mineralization status of enamel specimens using a Wilson 2100 Hardness tester. SMH was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents rehardening of enamel surface. Percent SMH recovery was calculated from indentation values of enamel specimens at baseline (B), after in-situ hardening (R) and after first erosive challenge (E1) using formula: [(E1-R)/ (E1-B)]*100. (NCT01128972)
Timeframe: Baseline, 4 hours post treatment in each treatment period.

InterventionPercent SMH (Least Squares Mean)
Test Dentifrice + Test MR42.14
Test Dentifrice + Sterile Water Rinse38.02
Reference Dentifrice + Sterile Water Rinse30.88
Placebo Dentifrice + Sterile Water Rinse30.57

[back to top]

Adjusted Mean Percent NER of Enamel Specimens Exposed to a Treatment Regimen of Placebo Dentifrice + Test MR Relative to: 1) Test Dentifrice +Test MR 2) Test Dentifrice + Sterile Water Rinse 3) Reference Dentifrice +Sterile Water Rinse

Enamel specimens were exposed to dietary erosive challenge and set of five indentations within each specimen was measured. Decrease in the indentation length compared to the baseline indicates hardening of enamel surface. Enamel specimens were exposed to second erosion challenge to determine NER which compared the indentations values of enamel specimens at baseline (B), first erosive (E1) and second erosive challenge (E2). Percent NER was calculated by formula: [(E1-E2)/ (E1-B)]*100. Smaller the negative NER, better is treatment regimen in imparting resistance to enamel. (NCT01128972)
Timeframe: Baseline, 4 hours post treatment in each treatment period

InterventionPercent NER (Least Squares Mean)
Placebo Dentifrice + Test MR-3.76
Test Dentifrice + Test MR-2.88
Test Dentifrice + Sterile Water Rinse-14.54
Reference Dentifrice + Sterile Water Rinse-29.48
Placebo Dentifrice + Sterile Water Rinse-40.05

[back to top]

Adjusted Mean Percent NER of Enamel Specimens Exposed to Test Dentifrice +Sterile Water Rinse and Reference Dentifrice +Sterile Water Rinse

Enamel specimens were exposed to dietary erosive challenge and set of five indentations within each specimen was measured. Decrease in the indentation length compared to the baseline indicates hardening of enamel surface. Enamel specimens were exposed to second erosion challenge to determine NER which compared the indentations values of enamel specimens at baseline (B), first erosive (E1) and second erosive challenge (E2). Percent NER was calculated by formula: [(E1-E2)/ (E1-B)]*100. Smaller the negative NER, better is treatment regimen in imparting resistance to enamel. (NCT01128972)
Timeframe: Baseline, 4 hours post treatment in each treatment period

InterventionPercent NER (Least Squares Mean)
Test Dentifrice + Sterile Water Rinse-2.88
Reference Dentifrice + Sterile Water Rinse-29.48

[back to top]

Adjusted Mean Percent Net Erosion Resistance (NER) of Enamel Specimens Exposed to Test Dentifrice + Test MR Relative to: 1) Test Dentifrice+ Sterile Water Rinse 2) Reference Dentifrice+ Sterile Water Rinse 3) Placebo Dentifrice+ Sterile Water Rinse

Enamel specimens were exposed to dietary erosive challenge and set of five indentations within each specimen was measured. Decrease in the indentation length compared to the baseline indicates hardening of enamel surface. Enamel specimens were exposed to second erosion challenge to determine NER which compared the indentations values of enamel specimens at baseline (B), first erosive (E1) and second erosive challenge (E2). Percent NER was calculated by formula: [(E1-E2)/ (E1-B)]*100. Smaller the negative NER, better is treatment regimen in imparting resistance to enamel. (NCT01128972)
Timeframe: Baseline, 4 hours post treatment in each treatment period

InterventionPercent NER (Least Squares Mean)
Test Dentifrice + Test MR-2.88
Test Dentifrice + Sterile Water Rinse-14.54
Reference Dentifrice + Sterile Water Rinse-29.48
Placebo Dentifrice + Sterile Water Rinse-40.05

[back to top]

Mean Cold Air Stimulus VAS Score at Week 4

Tooth sensitivity was measured using a Cold Air Stimulus. When being assessed, participants rated their perception of the pain/discomfort experienced when cold air was directed at the exposed root of each tooth by marking a single vertical line on a VAS scale from 0 to 100 mm, where 0 = No Pain/Discomfort and 100 = Intense Pain/Discomfort. The dental recorder measured the length of the line from 0 to the participant's line and recorded the VAS score in mm. The score for each participant was calculated by averaging the scores for all study teeth for that participant. (NCT01345292)
Timeframe: 4 weeks

Interventionunits on a scale (mm) (Least Squares Mean)
Negative Control (Crest Regular Toothpaste)39.54
Positive Control (Sensodyne Toothpaste)28.36
12027-027 (1.40% Potassium Oxalate Mouth Rinse)29.30

[back to top]

Mean Tactile Sensitivity Score at Week 2

Tooth sensitivity was measured using a Yeaple probe. The force at which discomfort was felt by the participant was recorded on a scale of 10-80 grams. The score for each participant was calculated by averaging the scores for all study teeth for that participant. (NCT01345292)
Timeframe: 2 weeks

Interventiongrams of force (Least Squares Mean)
Negative Control (Crest Regular Toothpaste)10.10
Positive Control (Sensodyne Toothpaste)13.16
12027-027 (1.40% Potassium Oxalate Mouth Rinse)12.51

[back to top]

Mean Tactile Sensitivity Score at Week 4

Tooth sensitivity was measured using a Yeaple probe. The force at which discomfort was felt by the participant was recorded on a scale of 10-80 grams. The score for each participant was calculated by averaging the scores for all study teeth for that participant. (NCT01345292)
Timeframe: 4 weeks

Interventiongrams of force (Least Squares Mean)
Negative Control (Crest Regular Toothpaste)10.39
Positive Control (Sensodyne Toothpaste)21.83
12027-027 (1.40% Potassium Oxalate Mouth Rinse)18.72

[back to top]

Mean Tactile Sensitivity VAS Score at Week 4

Tooth sensitivity was measured using a VAS. At each visit, participants rated their perception of the pain/discomfort experienced from the Yeaple probe by marking a single vertical line on a VAS scale from 0 to 100 mm, where 0 = No Pain/Discomfort and 100 = Intense Pain/Discomfort. The dental recorder measured the length of the line from 0 to the participant's line and recorded the VAS score in mm. The investigator recorded a VAS score of 0 mm for participants who did not experience discomfort at the maximum force of 80 grams. The score for each participant was calculated by averaging the scores for all study teeth for that participant. (NCT01345292)
Timeframe: 4 weeks

Interventionunits on a scale (mm) (Least Squares Mean)
Negative Control (Crest Regular Toothpaste)39.49
Positive Control (Sensodyne Toothpaste)30.94
12027-027 (1.40% Potassium Oxalate Mouth Rinse)29.32

[back to top]

Mean Tactile Sensitivity Visual Analog Scale (VAS) Score at Week 2

Tooth sensitivity was measured using a VAS. At each visit, participants rated their perception of the pain/discomfort experienced from the Yeaple probe by marking a single vertical line on a VAS scale from 0 to 100 mm, where 0 = No Pain/Discomfort and 100 = Intense Pain/Discomfort. The dental recorder measured the length of the line from 0 to the participant's line and recorded the VAS score in mm. The investigator recorded a VAS score of 0 mm for participants who did not experience discomfort at the maximum force of 80 grams. The score for each participant was calculated by averaging the scores for all study teeth for that participant. (NCT01345292)
Timeframe: 2 weeks

Interventionunits on a scale (mm) (Least Squares Mean)
Negative Control (Crest Regular Toothpaste)41.59
Positive Control (Sensodyne Toothpaste)39.52
12027-027 (1.40% Potassium Oxalate Mouth Rinse)37.16

[back to top]

Global Subjective VAS Score at Week 2

"At each visit, participants rated their perception of the pain/discomfort experienced by marking a single vertical line on a VAS scale from 0 to 100 mm, where 0 = No Pain/Discomfort and 100 = Intense Pain/Discomfort. Participants were instructed as follows: Please rate the intensity of the pain/discomfort you have experienced in the last two weeks when drinking cold/hot beverages and/or foods, eating sweet and sour foods, breathing cold air, brushing your teeth or performing any habits/behaviors that solicit your dentinal hypersensitivity pain/discomfort since you first started using the product. The dental recorder measured the length of the line from 0 to the participant's line and recorded the VAS score in mm." (NCT01345292)
Timeframe: 2 weeks

Interventionunits on a scale (mm) (Least Squares Mean)
Negative Control (Crest Regular Toothpaste)44.94
Positive Control (Sensodyne Toothpaste)43.68
12027-027 (1.40% Potassium Oxalate Mouth Rinse)43.64

[back to top]

Global Subjective VAS Score at Week 4

"At each visit, participants rated their perception of the pain/discomfort experienced by marking a single vertical line on a VAS scale from 0 to 100 mm, where 0 = No Pain/Discomfort and 100 = Intense Pain/Discomfort. Participants were instructed as follows: Please rate the intensity of the pain/discomfort you have experienced in the last two weeks when drinking cold/hot beverages and/or foods, eating sweet and sour foods, breathing cold air, brushing your teeth or performing any habits/behaviors that solicit your dentinal hypersensitivity pain/discomfort since you first started using the product. The dental recorder measured the length of the line from 0 to the participant's line and recorded the VAS score in mm." (NCT01345292)
Timeframe: 4 weeks

Interventionunits on a scale (mm) (Least Squares Mean)
Negative Control (Crest Regular Toothpaste)41.32
Positive Control (Sensodyne Toothpaste)32.79
12027-027 (1.40% Potassium Oxalate Mouth Rinse)35.19

[back to top]

Mean Cold Air Stimulus VAS Score at Week 2

Tooth sensitivity was measured using a Cold Air Stimulus. When being assessed, participants rated their perception of the pain/discomfort experienced when cold air was directed at the exposed root of each tooth by marking a single vertical line on a VAS scale from 0 to 100 mm, where 0 = No Pain/Discomfort and 100 = Intense Pain/Discomfort. The dental recorder measured the length of the line from 0 to the participant's line and recorded the VAS score in mm. The score for each participant was calculated by averaging the scores for all study teeth for that participant. (NCT01345292)
Timeframe: 2 weeks

Interventionunits on a scale (mm) (Least Squares Mean)
Negative Control (Crest Regular Toothpaste)43.65
Positive Control (Sensodyne Toothpaste)38.74
12027-027 (1.40% Potassium Oxalate Mouth Rinse)40.22

[back to top]

Sensitivity of F-18 NaF PET/CT to Detect Bone Lesions in Patients With Suspected Skeletal Malignancy

"Sensitivity is the ability of a test to correctly identify those with the disease (true positive rate). This study determined how many lesions were detected by F18 NaF PET/CT compared to the known results. The calculation for sensitivity is TP / (TP+FN), where:~TP = true positive (the lesion was accurately detected on both F18 NaF and comparison study) FN = false negative (the lesion was not detected on the PET/CT but was detected on the comparison study)~The result is expressed as the percentage of confirmed lesions across all participants that were also detected by F18 NaF PET/CT." (NCT01541358)
Timeframe: an estimated average of 2 hours

Interventionpercentage of sensitivity (Number)
Diagnostic (Fluorine F 18 Sodium Fluoride PET/CT)14

[back to top]

Total Number of Lesions Identified by F-18 NaF PET/CT in Patients With Suspected Skeletal Malignancy

F-18 NaF is a positron emission tomography (PET) bone imaging agent that targets changes in the bone. The fluoride ions are taken up in areas of the bone that have increased bone remodeling (bone repair) and increased blood flow, which is indicative of diseases such as cancer. (NCT01541358)
Timeframe: an estimated average of 2 hours

Interventionlesions detected by F18 NaF (Number)
Diagnostic (Fluorine F 18 Sodium Fluoride PET/CT)1

[back to top]

Specificity of F-18 NaF PET/CT to Detect Bone Lesions in Patients With Suspected Skeletal Malignancy

"Specificity is the ability of a test to correctly determine the absence of disease (true negative). This study determined how accurately F18 NaF PET/CT performed at detecting the absence of disease.~The calculation for specificity is TN / (TN + FP), where:~TN = the participant was a true negative (the lesion was not detected on F18 NaF PET/CT and the patient does not have the disease) FP = the participant was a false positive (the lesion was falsely detected on the F18 NaF PET/CT and the patient does not have the disease) The result is expressed as a percentage." (NCT01541358)
Timeframe: an estimated average of 2 hours

Interventionpercentage of specificity (Number)
Diagnostic (Fluorine F 18 Sodium Fluoride PET/CT)100

[back to top]

Change From Baseline in Löe-Silness Gingivitis Index

"Score Criteria 0 Normal gingiva.~Mild inflammation - slight change in color, slight edema. No bleeding on probing.~Moderate inflammation - redness, edema, and glazing. Bleeding on probing.~Severe inflammation - marked redness, edema. Ulceration. Tendency to spontaneous bleeding." (NCT01549587)
Timeframe: 3 months

Interventionscore on a scale (Least Squares Mean)
Regular Oral Hygiene0.141
Advanced Oral Hygiene Plus Counseling0.154

[back to top]

Change From Baseline in Löe-Silness Gingivitis Index

"Score Criteria 0 Normal gingiva.~Mild inflammation - slight change in color, slight edema. No bleeding on probing.~Moderate inflammation - redness, edema, and glazing. Bleeding on probing.~Severe inflammation - marked redness, edema. Ulceration. Tendency to spontaneous bleeding." (NCT01549587)
Timeframe: 2 months

Interventionscore on a scale (Least Squares Mean)
Regular Oral Hygiene0.124
Advanced Oral Hygiene Plus Counseling0.137

[back to top]

Neonate Birth Weight (Grams)

(NCT01549587)
Timeframe: At delivery

Interventiongrams (Least Squares Mean)
Regular Oral Hygiene3095.97
Advanced Oral Hygiene Plus Counseling3167.80

[back to top]

Change From Baseline in Löe-Silness Gingivitis Index

"Score Criteria 0 Normal gingiva.~Mild inflammation - slight change in color, slight edema. No bleeding on probing.~Moderate inflammation - redness, edema, and glazing. Bleeding on probing.~Severe inflammation - marked redness, edema. Ulceration. Tendency to spontaneous bleeding." (NCT01549587)
Timeframe: 1 month

Interventionscore on a scale (Least Squares Mean)
Regular Oral Hygiene0.112
Advanced Oral Hygiene Plus Counseling0.125

[back to top]

Preterm Birth (Gestational Age < 37 Weeks)

(NCT01549587)
Timeframe: At delivery

InterventionParticipants (Count of Participants)
Regular Oral Hygiene32
Advanced Oral Hygiene Plus Counseling21

[back to top]

Gestational Age (Weeks)

log[42.9-gestational age] (NCT01549587)
Timeframe: At delivery

Interventionlog weeks (Least Squares Mean)
Regular Oral Hygiene1.3988
Advanced Oral Hygiene Plus Counseling1.3271

[back to top]

Percentage Surface Micro-hardness Recovery (% SMH), of Brushing for 45 Seconds With 0.5g of Experimental Dentifrice vs. Brushing for 45 Seconds With 1.5g of Experimental Dentifrice.

SMH recovery test was used to assess the changes in mineralization status of enamel specimens using a Wilson 2100 Hardness tester. SMH recovery was performed in-vitro and determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents re-hardening of enamel surface. % SMH recovery was calculated from indentation length (μm) of sound enamel specimen at baseline (B), indentation length (μm) after in vitro demineralization (D1), indentation length (μm) after intra-oral exposure (R): [D1-R/D1-B] ×100. (NCT01563172)
Timeframe: At Baseline and at Day 14

Intervention% SMH (Least Squares Mean)
Experimental Dentifrice 0.5g, 45 Seconds Brushing Group25.05
Experimental Dentifrice 1.5g, 45 Seconds Brushing Group34.66

[back to top]

Percentage Surface Micro Hardness (% SMH) Recovery , of Brushing for 2 Minutes vs. Brushing for 45 Seconds With 0.5g of Experimental Dentifrice.

SMH recovery test was used to assess the changes in mineralization status of enamel specimens using a Wilson 2100 Hardness tester. SMH recovery was performed in-vitro and determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents re-hardening of enamel surface. % SMH recovery was calculated from indentation length (μm) of sound enamel specimen at baseline (B), indentation length (μm) after in vitro demineralization (D1), indentation length (μm) after intra-oral exposure (R): [D1-R/D1-B] ×100. (NCT01563172)
Timeframe: At Baseline and at Day 14

Intervention% SMH (Least Squares Mean)
Experimental Dentifrice 0.5g, 2 Minutes Brushing Group30.75
Experimental Dentifrice 0.5g, 45 Seconds Brushing Group25.05

[back to top]

Percent Surface Micro-hardness (% SMH) Recovery, of Brushing for 2 Minutes With 1.5g of Experimental Dentifrice vs. Brushing for 2 Minutes With 1.5g of an Control Dentifrice.

SMH recovery test was used to assess the changes in mineralization status of enamel specimens using a Wilson 2100 Hardness tester. SMH recovery was performed in-vitro and determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents re-hardening of enamel surface. % SMH recovery was calculated from indentation length (μm) of sound enamel specimen at baseline (B), indentation length (μm) after in vitro demineralization (D1), indentation length (μm) after intra-oral exposure (R): [D1-R/D1-B] ×100. (NCT01563172)
Timeframe: At Baseline and at Day 14

Intervention% SMH (Least Squares Mean)
Experimental Dentifrice 1.5g, 2 Minutes Brushing Group41.61
Contol Group26.23

[back to top]

Enamel Fluoride Uptake (EFU) After Brushing for 45 Seconds With 0.5g of Experimental Dentifrice vs. Brushing for 45 Seconds With 1.5g of Experimental Dentifrice.

EFU was measured by using micro-drill analysis of the enamel specimens carried out after 14 days of intra-oral exposure for each of the toothpaste treatments. The amount of fluoride-uptake by enamel was calculated based on the amount of fluoride divided by the area of the enamel cores. (NCT01563172)
Timeframe: At Day 14

Interventionμg×F/cm2 (Least Squares Mean)
Experimental Dentifrice 0.5g, 45 Seconds Brushing Group1337.72
Experimental Dentifrice 1.5g, 45 Seconds Brushing Group1912.51

[back to top]

Enamel Fluoride Uptake (EFU) After Brushing for 2 Minutes With 0.5g of Experimental Dentifrice vs. Brushing for 2 Minutes With 1.5g of Experimental Dentifrice.

EFU was measured by using micro-drill analysis of the enamel specimens carried out after 14 days of intra-oral exposure for each of the toothpaste treatments. The amount of fluoride-uptake by enamel was calculated based on the amount of fluoride divided by the area of the enamel cores. (NCT01563172)
Timeframe: At Day 14

Interventionμg×F/cm2 (Least Squares Mean)
Experimental Dentifrice 0.5g, 2 Minutes Brushing Group1603.63
Experimental Dentifrice 1.5g, 2 Minutes Brushing Group2426.51

[back to top]

Percentage Surface Micro Hardness Recovery (% SMH), of Brushing for 2 Minutes Versus (vs.) Brushing for 45 Seconds With 1.5g of Experimental Dentifrice.

SMH recovery test was used to assess the changes in mineralization status of enamel specimens using a Wilson 2100 Hardness tester. SMH recovery was performed in-vitro and determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents re-hardening of enamel surface. % SMH recovery was calculated from indentation length (micrometer [μm]) of sound enamel specimen at baseline (B), indentation length (μm) after in vitro demineralization (D1), indentation length (μm) after intra-oral exposure (R): [D1-R/D1-B] ×100. (NCT01563172)
Timeframe: At Baseline and at Day 14

Intervention% SMH (Least Squares Mean)
Experimental Dentifrice 1.5g, 2 Minutes Brushing Group41.61
Experimental Dentifrice 1.5g, 45 Seconds Brushing Group34.66

[back to top]

Enamel Fluoride Uptake (EFU) After Brushing for 2 Minutes vs. Brushing for 45 Seconds With 1.5g of Experimental Dentifrice.

EFU was measured by using micro-drill analysis of the enamel specimens carried out after 14 days of intra-oral exposure for each of the toothpaste treatments. The amount of fluoride-uptake by enamel was calculated based on the amount of fluoride divided by the area of the enamel cores. (NCT01563172)
Timeframe: At Day 14

Interventionmicrograms (μg)×F/centimeters(cm)2 (Least Squares Mean)
Experimental Dentifrice 1.5g, 2 Minutes Brushing Group2426.51
Experimental Dentifrice 1.5g, 45 Seconds Brushing Group1912.51

[back to top]

Enamel Fluoride Uptake (EFU) After Brushing for 2 Minutes vs. Brushing for 45 Seconds With 0.5g of Experimental Dentifrice.

EFU was measured by using micro-drill analysis of the enamel specimens carried out after 14 days of intra-oral exposure for each of the toothpaste treatments. The amount of fluoride-uptake by enamel was calculated based on the amount of fluoride divided by the area of the enamel cores. (NCT01563172)
Timeframe: At Day 14

Interventionμg×F/cm2 (Least Squares Mean)
Experimental Dentifrice 0.5g, 2 Minutes Brushing Group1603.63
Experimental Dentifrice 0.5g, 45 Seconds Brushing Group1337.72

[back to top]

Enamel Fluoride Uptake (EFU) After Brushing for 2 Minutes With 1.5g of Experimental Dentifrice vs. Brushing for 2 Minutes With 1.5g of Control Dentifrice.

EFU was measured by using micro-drill analysis of the enamel specimens carried out after 14 days of intra-oral exposure for each of the toothpaste treatments. The amount of fluoride-uptake by enamel was calculated based on the amount of fluoride divided by the area of the enamel cores. (NCT01563172)
Timeframe: At Day 14

Interventionμg×F/cm2 (Least Squares Mean)
Experimental Dentifrice 1.5g, 2 Minutes Brushing Group2426.51
Contol Group1132.18

[back to top]

Percentage Surface Micro Hardness (% SMH) Recovery, of Brushing for 2 Minutes With 0.5g of Experimental Dentifrice vs. Brushing for 2 Minutes With 1.5g of Experimental Dentifrice.

SMH recovery test was used to assess the changes in mineralization status of enamel specimens using a Wilson 2100 Hardness tester. SMH recovery was performed in-vitro and determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents re-hardening of enamel surface. % SMH recovery was calculated from indentation length (μm) of sound enamel specimen at baseline (B), indentation length (μm) after in vitro demineralization (D1), indentation length (μm) after intra-oral exposure (R): [D1-R/D1-B] ×100. (NCT01563172)
Timeframe: At Baseline and at Day 14

Intervention% SMH (Least Squares Mean)
Experimental Dentifrice 0.5g, 2 Minutes Brushing Group30.75
Experimental Dentifrice 1.5g, 2 Minutes Brushing Group41.61

[back to top]

Extended Sensitivity Relief. Air Blast Sensitivity.

Assessment of cold air sensitivity. Cold air sensitivity measurements performed using a cold air blast and sensitivity scored on the four (4) point Schiff scale with 0 equal to no discomfort or awareness of sensitivity and 3 equal to severe pain from sensitive teeth. (NCT01610167)
Timeframe: 28 days (+/- 2 days) post treatment.

Interventionunits on a scale (Mean)
NUPRO Sensodyne Prophy Paste w/ Novamin-0.94
NUPRO Sensodyne Prophy Paste w/ Novamin(r) w/ Fluoride.-0.95
NUPRO(r) Classic Prophy Paste0.03

[back to top]

Extended Sensitivity Relief. Tactile Sensitivity.

"Assessment of sensitivity score via tactile stimulation 28 days post treatment. Tactile sensitivity measured using a Yeaple probe recording tactile pressure in grams before nerve stimulation. Point of nerve stimulation identified by patient with yes response as pressure is increased in 10 gram increments. Measured sensitivity is reported as difference from baseline examination." (NCT01610167)
Timeframe: 28 days (+/- 2 days) post treatment.

Interventiongrams (Mean)
NUPRO Sensodyne Prophy Paste w/ Novamin10.19
NUPRO Sensodyne Prophy Paste w/ Novamin(r) w/ Fluoride.11.07
NUPRO(r) Classic Prophy Paste1.15

[back to top]

Immediate Sensitivity Relief. Tactile Sensitivity.

"Assessment of sensitivity via tactile stimulation immediately after treatment. Tactile sensitivity measured using a Yeaple probe recording tactile pressure in grams before nerve stimulation. Point of nerve stimulation identified by patient with a yes response as pressure is increased in 10 gram increments. Tactile sensitivity is reported as the change from baseline after treatment." (NCT01610167)
Timeframe: Immediately after treatment.

Interventiongrams (Mean)
NUPRO Sensodyne Prophy Paste w/ Novamin12.36
NUPRO Sensodyne Prophy Paste w/ Novamin(r) w/ Fluoride.10.46
NUPRO(r) Classic Prophy Paste0.60

[back to top]

Immediate Sensitivity Relief. Air Blast Sensitivity.

Sensitivity measurements performed using a cold air blast and sensitivity scored on the four (4) point Schiff scale with 0 equal to no discomfort or awareness of sensitivity and 3 equal to severe pain from sensitive teeth. Score is reported as the change from baseline after treatment. (NCT01610167)
Timeframe: Immediately after treatment.

Interventionunits on a scale (Mean)
NUPRO Sensodyne Prophy Paste w/ Novamin-0.87
NUPRO Sensodyne Prophy Paste w/ Novamin(r) w/ Fluoride.-0.86
NUPRO(r) Classic Prophy Paste0.00

[back to top]

Adverse Events.

Assessment of adverse events that may occur as a result of treatment (typically includes any kind of allergic reation to paste). (NCT01610167)
Timeframe: Immediately after treatment to 28 days (+/- 2 days) post treatment.

InterventionNumber of adverse events. (Number)
NUPRO Sensodyne Prophy Paste w/ Novamin0
NUPRO Sensodyne Prophy Paste w/ Novamin(r) w/ Fluoride.0
NUPRO(r) Classic Prophy Paste0

[back to top]

Percentage Surface Microhardness Recovery (%SMHR) Dose Response Relationship

SMHR test was used to assess the changes in mineralization status of enamel specimens using a Wilson 2100 Hardness tester. SMHR was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents rehardening of enamel surface. Percent SMHR was calculated from indentation values of enamel specimens at baseline (B), after in-situ hardening (R) and after first erosive challenge (E1) using formula: [(E1-R)/ (E1-B)]*100. (NCT01641237)
Timeframe: Baseline to 4 hours

Intervention%SMHR (Mean)
NaF Dentifrice (1426 ppmF)30.89
NaF Dentifrice (1150 ppmF)28.71
NaF Dentifrice (250 ppmF)25.28
Placebo Dentifrice (0 ppmF)21.03

[back to top]

Percentage Relative Erosion Resistance

Changes in mineral content of enamel specimens exposed to dietary erosive challenge were determined by measuring the length of the indentations. Decrease in the indentation length compared to the baseline indicates hardening of enamel surface. Enamel specimens were exposed to second erosion challenge to determine relative erosion resistance which compared the indentations values of enamel specimens at baseline (B), first erosive (E1) and second erosive challenge (E2). Percent relative erosion resistance was calculated by formula: [(E1-E2)/ (E1-B)]*100. (NCT01641237)
Timeframe: Baseline to 4 hours

Intervention% Relative Erosion Resistance (Mean)
NaF Dentifrice (1426 ppmF)-38.83
NaF Dentifrice (1150 ppmF)-39.75
NaF Dentifrice (250 ppmF)-50.40
Placebo Dentifrice (0 ppmF)-71.21

[back to top]

Enamel Fluoride Uptake (Corrected Data)

Enamel fluoride uptake was determined using the microdrill enamel biopsy technique. The amount of fluoride uptake by enamel was calculated based on amount of fluoride divided by area of the enamel cores. Data analysis was based on corrected data. (NCT01641237)
Timeframe: Baseline to 4 hours

Interventionmicrograms*F/centimeters^2 (Mean)
NaF Dentifrice (1426 ppmF)3.13
NaF Dentifrice (1150 ppmF)3.07
NaF Dentifrice (250 ppmF)2.09
Placebo Dentifrice (0 ppmF)1.47

[back to top]

%SMHR

SMHR test was used to assess the changes in mineralization status of enamel specimens using a Wilson 2100 Hardness tester. SMHR was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents rehardening of enamel surface. Percent SMHR was calculated from indentation values of enamel specimens at baseline (B), after in-situ hardening (R) and after first erosive challenge (E1) using formula: [(E1-R)/ (E1-B)]*100. (NCT01641237)
Timeframe: Baseline to 4 hours

Intervention%SMHR (Mean)
NaF Dentifrice (1426 ppmF)30.9
NaF Dentifrice (1150 ppmF)28.7
NaF Dentifrice (250 ppmF)25.3
Placebo Dentifrice (0 ppmF)21.0

[back to top]

Relative Erosion Resistance (RER) of Enamel Specimens Post 4 Hours of Treatment Exposure

Enamel specimens were exposed to dietary erosive challenge and set of five indentations within each specimen was measured. Decrease in the indentation length compared to the baseline indicates hardening of enamel surface. Enamel specimens were exposed to second erosion challenge to determine RER which compared the indentations values of enamel specimens at baseline (B), first erosive (E1) and second erosive challenge (E2). Percent RER was calculated by formula: [(E1-E2)/ (E1-B)]*100. Smaller the negative RER, better is treatment regimen in imparting resistance to enamel. (NCT01657903)
Timeframe: Baseline, 4 hours post treatment in each treatment period

InterventionPercentage RER (Least Squares Mean)
NaF/KNO3 Toothpaste 1-36.66
NaF/KNO3 Toothpaste 2-36.53
NaF/KNO3 Toothpaste 3-36.98
No Fluoride/KNO3 Toothpaste-77.82

[back to top]

SMH Recovery of Enamel Specimens Post 2 Hours of Treatment Exposure

SMH test was used to assess mineralization status of enamel specimens using a Wilson 2100 Hardness tester. SMH was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents rehardening of enamel surface. Percent SMH recovery was calculated from indentation values of enamel specimens at baseline (B), after in-situ hardening (R) and after first erosive challenge (E1) using formula: [(E1- R)/ (E1-B)]*100. A higher percentage values indicate a better outcome. (NCT01657903)
Timeframe: Baseline, 2 hours post treatment in each treatment period

InterventionPercentage SMH (Least Squares Mean)
NaF/KNO3 Toothpaste 128.96
NaF/KNO3 Toothpaste 228.92
NaF/KNO3 Toothpaste 328.30
No Fluoride/KNO3 Toothpaste17.90

[back to top]

Surface Microhardness (SMH) Recovery of Enamel Specimens Post 4 Hours of Treatment Exposure

SMH test was used to assess mineralization status of enamel specimens using a Wilson 2100 Hardness tester. SMH was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents rehardening of enamel surface. Percent SMH recovery was calculated from indentation values of enamel specimens at baseline (B), after in-situ hardening (R) and after first erosive challenge (E1) using formula: [(E1- R)/ (E1-B)]*100. A higher percentage values indicate a better outcome. (NCT01657903)
Timeframe: Baseline, 4 hours post treatment in each treatment period

InterventionPercentage SMH (Least Squares Mean)
NaF/KNO3 Toothpaste 132.24
NaF/KNO3 Toothpaste 232.32
NaF/KNO3 Toothpaste 334.53
No Fluoride/KNO3 Toothpaste22.87

[back to top]

RER of Enamel Specimens Post 2 Hours of Treatment Exposure

Enamel specimens were exposed to dietary erosive challenge and set of five indentations within each specimen was measured. Decrease in the indentation length compared to the baseline indicates hardening of enamel surface. Enamel specimens were exposed to second erosion challenge to determine RER which compared the indentations values of enamel specimens at baseline (B), first erosive (E1) and second erosive challenge (E2). Percent RER was calculated by formula: [(E1-E2)/ (E1-B)]*100. Smaller the negative RER, better is treatment regimen in imparting resistance to enamel. (NCT01657903)
Timeframe: Baseline, 2 hours post treatment in each treatment period

Intervention% RER (Least Squares Mean)
NaF/KNO3 Toothpaste 1-43.76
NaF/KNO3 Toothpaste 2-43.33
NaF/KNO3 Toothpaste 3-41.88
No Fluoride/KNO3 Toothpaste-85.88

[back to top]

Enamel Fluoride Uptake Per Each of Five Arms

Enamel fluoride uptake is a measure of fluoridation of a caries lesion (NCT01665911)
Timeframe: Three Weeks per each of five arms

Interventionmicrogram fluoride per square cm (Least Squares Mean)
0 mg fluoride in 200 ml milk1.5 mg fluoride in 100 ml milk1.5 mg fluoride in 200 ml milk3.0 mg fluoride in 100 ml milk3.0 mg fluoride in 200 ml milk
All Participants1.22.42.123.092.67

[back to top]

% Acid Resistance Score Per Each of Five Arms

% Acid Resistance is a measure of acid resistance of the remineralized caries lesion which is calculated as (D1-D2)/(D1-B)*100%, where B is the indentation length of sound enamel specimen at baseline, D1 is an indentation length after first in vitro demineralization, D2 is an indentation length after second in vitro demineralization. (NCT01665911)
Timeframe: Three Weeks per each of five arms

Interventionpercent (Least Squares Mean)
0 mg fluoride in 200 ml milk1.5 mg fluoride in 100 ml milk1.5 mg fluoride in 200 ml milk3.0 mg fluoride in 100 ml milk3.0 mg fluoride in 200 ml milk
All Participants-3.42.6-0.25.46.0

[back to top]

% Surface Microhardness (SMH) Recovery Score Per Each of Five Arms

"surface microhardness recovery is a measure of caries lesion remineralization and is calculated using the following equation:~SMHr=(D1-R)/(D1-B)×100 B = indentation length of sound enamel specimen at baseline D1 = indentation length after first in vitro demineralization R = indentation length after intra-oral exposure (rehardening)." (NCT01665911)
Timeframe: Three Weeks per each of five arms

Interventionpercent (Least Squares Mean)
0 mg fluoride in 200 ml milk1.5 mg fluoride in 100 ml milk1.5 mg fluoride in 200 ml milk3.0 mg fluoride in 100 ml milk3.0 mg fluoride in 200 ml milk
All Participants202422.526.725.4

[back to top]

Post-prophylaxis Sensitivity Relief (Self-Assessment)

"All subjects completed a questionnaire titled How sensitive are your teeth? to assess their whole-mouth tooth sensitivity immediately following the timed, 1-minute prophylaxis paste application.~The questionnaire contained a 4-item verbal descriptor scale as follows:~Score 0= no discomfort or awareness of sensitivity; 1=mild discomfort/pain from sensitive teeth;2=moderate discomfort/pain from sensitive teeth; 3=severe pain from sensitive teeth.~The higher the score, the higher the hypersensitivity.~Subjects were required to have two sensitive teeth which are not adjacent to each other and preferably in different quadrants. Scores were obtained by taking the average over the scores for the evaluated teeth." (NCT01669785)
Timeframe: Immediately following post-prophylaxis treatment.

Interventionunits on a scale (Mean)
Group A1.00
Group B0.90
Group C1.09

[back to top]

Sensitivity Relief (Self-Assessment)

"All subjects completed a questionnaire titled How sensitive are your teeth? to assess their whole-mouth tooth sensitivity prior to the baseline assessments.~The questionnaire contained a 4-item verbal descriptor scale as follows:~Score 0= no discomfort or awareness of sensitivity; 1=mild discomfort/pain from sensitive teeth; 2=moderate discomfort/pain from sensitive teeth; 3=severe pain from sensitive teeth.~The higher the score, the higher the hypersensitivity.~Subjects were required to have two sensitive teeth which are not adjacent to each other and preferably in different quadrants. Scores were obtained by taking the average over the scores for the evaluated teeth." (NCT01669785)
Timeframe: Pre-Treatment

Interventionunits on a scale (Mean)
Group A0.82
Group B0.67
Group C0.76

[back to top]

Post- Scaling Sensitivity Relief (Self-Assessment)

"All subjects completed a questionnaire titled How sensitive are your teeth? to assess their whole-mouth tooth sensitivity immediately following the scaling procedure.~The questionnaire contained a 4-item verbal descriptor scale as follows:~Score 0= no discomfort or awareness of sensitivity; 1=mild discomfort/pain from sensitive teeth; 2=moderate discomfort/pain from sensitive teeth; 3=severe pain from sensitive teeth.~The higher the score, the higher the hypersensitivity.~Subjects were required to have two sensitive teeth which are not adjacent to each other and preferably in different quadrants. Scores were obtained by taking the average over the scores for the evaluated teeth." (NCT01669785)
Timeframe: Post-scaling procedure,immediate

Interventionunits on a scale (Mean)
Group A1.31
Group B0.98
Group C1.28

[back to top]

Long-term Sensitivity Relief (Tactile Sensitivity)

"Assessment of sensitivity score via tactile measurements long term after treatment.~Tactile hypersensitivity is measured with an electronic force sensing probel (Yeaple probe). Grams of force needed to elicit pain are recorded as hypersensitivity score for the tooth. Grams of force needed to elicit pain are recorded as hypersensitivity score for the tooth. 10 to 50 grams of force are applied to the hypersensitive tooth until pain is elicited. The higher the score (the more grams of force needed to elicit a response of pain), the lower the hypersensitivity.~Subjects were required to have two sensitive teeth which are not adjacent to each other and preferably in different quadrants. Scores were obtained by taking the average over the scores for the evaluated teeth." (NCT01669785)
Timeframe: 28 days (+/- 2 days) post treatment.

Interventiongrams (Mean)
Group A19.89
Group B16.51
Group C12.07

[back to top]

Long-term Sensitivity Relief (Self-Assessment)

"All subjects completed a questionnaire titled How sensitive are your teeth? to assess their whole-mouth tooth sensitivity 28 days following prophylaxis treatment.~The questionnaire contained a 4-item verbal descriptor scale as follows:~Score 0= no discomfort or awareness of sensitivity;1=mild discomfort/pain from sensitive teeth; 2=moderate discomfort/pain from sensitive teeth; 3=severe pain from sensitive teeth.~The higher the score, the higher the hypersensitivity.~Subjects were required to have two sensitive teeth which are not adjacent to each other and preferably in different quadrants. Scores were obtained by taking the average over the scores for the evaluated teeth." (NCT01669785)
Timeframe: 28 days post-prophylaxis treatment.

Interventionunits on a scale (Mean)
Group A0.60
Group B0.50
Group C0.72

[back to top]

Long-term Sensitivity Relief (Schiff Air Blast Sensitivity)

"Assessment of sensitivity score Schiff air blast measurements long term after treatment.~Air blast hypersensitivity is measured using the Schiff Cold Air Sensitivity scale (0-3). The scale is scored as follows:~0=Subject does not respond to stimulus; 1= Subject responds to stimulus but does not request discontinuation of stimulus; 2=Subject responds to stimulus and requests discontinuation or moves from air stimulus; 3=Subject responds to stimulus, considers it painful and requests discontinuation.~Subjects were required to have two sensitive teeth which are not adjacent to each other and preferably in different quadrants. Scores were obtained by taking the average over the scores for the evaluated teeth." (NCT01669785)
Timeframe: 28 days (+/- 2 days) post treatment.

Interventionunits on a scale (Mean)
Group A0.87
Group B1.11
Group C1.67

[back to top]

Immediate Sensitivity Relief (Tactile Sensitivity)

"Assessment of sensitivity score via tactile and air blast measurements immediately after treatment. Tactile hypersensitivity is measured with an electronic force sensing probel (Yeaple probe). Grams of force needed to elicit pain are recorded as hypersensitivity score for the tooth. Grams of force needed to elicit pain are recorded as hypersensitivity score for the tooth. 10, 20, 30, 40 up to 50 grams of force are applied to the hypersensitive tooth until pain is elicited. The higher the score (the more grams of force needed to elicit a response of pain), the lower the hypersensitivity.~Subjects were required to have two sensitive teeth which are not adjacent to each other and preferably in different quadrants. Scores were obtained by taking the average over the scores for the evaluated teeth." (NCT01669785)
Timeframe: Immediately after treatment .

Interventiongrams (Mean)
Group A19.61
Group B16.67
Group C12.01

[back to top]

Baseline Pre-Prophy Assessment (Tactile Sensitivity)

"Pre-prophy procedure baseline assessment is measured with an electronic force sensing probe (Yeaple probe). Grams of force needed to elicit pain are recorded as hypersensitivity score for the tooth. 10,20,30,40, up to 50 grams of force are applied to the hypersensitive tooth until pain is elicited. The higher the score (the more grams of force needed to elicit a response of pain), the lower the hypersensitiv~Subjects were required to have two sensitive teeth which are not adjacent to each other and preferably in different quadrants. Scores were obtained by taking the average over the scores for the evaluated teeth." (NCT01669785)
Timeframe: Pre-treatment measurement

Interventiongrams (Mean)
Group A10.56
Group B10.00
Group C10.98

[back to top]

Baseline Pre-Prophy Assessment (Air Blast Sensitivity)

"Pre-prophy procedure baseline assessment using Schiff Cold Air Sensitivity scale (0-3).~Air blast hypersensitivity is measured using the Schiff Cold Air Sensitivty scale (0-3). The scale is scored as follows:~0=Subject does not respond to stimulus; 1= Subject responds to stimulus but does not request discontinuation of stimulus; 2=Subject responds to stimulus and requests discontinuation or moves from air stimulus; 3=Subject responds to stimulus, considers it painful and requests discontinuation.~The higher the score, the higher the hypersensitivity.~Subjects were required to have two sensitive teeth which are not adjacent to each other and preferably in different quadrants. Scores were obtained by taking the average over the scores for the evaluated teeth." (NCT01669785)
Timeframe: Pre-treatment measurement

Interventionunits on a scale (Mean)
Group A1.72
Group B1.70
Group C1.65

[back to top]

Immediate Sensitivity Relief (Schiff Air Blast Sensitivity)

"Assessment of sensitivity score via air blast measurements immediately after treatment.~Air blast hypersensitivity is measured using the Schiff Cold Air Sensitivity scale (0-3). The scale is scored as follows:~0=Subject does not respond to stimulus; 1= Subject responds to stimulus but does not request discontinuation of stimulus; 2=Subject responds to stimulus and requests discontinuation or moves from air stimulus; 3=Subject responds to stimulus, considers it painful and requests discontinuation.~Subjects were required to have two sensitive teeth which are not adjacent to each other and preferably in different quadrants. Scores were obtained by taking the average over the scores for the evaluated teeth." (NCT01669785)
Timeframe: Immediately after treatment .

Interventionunits on a scale (Mean)
Group A0.88
Group B0.97
Group C1.72

[back to top]

Change From Baseline in Evaporative Air Sensitivity Response on a Visual Rating Scale (VRS) at Week 4

Participants rated the intensity of their response to the stimulus using a 10 point Visual rating scale of 1 (no Pain) to 10 (intense pain). (NCT01691560)
Timeframe: Baseline to 4 weeks post administration of study treatment

InterventionScore on a scale (Least Squares Mean)
5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate-1.22
Sodium Monofluorophosphate-1.07
Sodium Fluoride-1.35
0% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate-1.25

[back to top]

Change From Baseline in Evaporative Air Sensitivity Response on VRS at Week 8

Participants rated the intensity of their response to the stimulus using a 10 point VRS of 1 (no Pain) to 10 (intense pain). (NCT01691560)
Timeframe: Baseline to 8 weeks post administration of study treatment

InterventionScore on a scale (Least Squares Mean)
5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate-1.76
Sodium Monofluorophosphate-1.22
Sodium Fluoride-1.31
0% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate-2.06

[back to top]

Change From Baseline in Tactile Sensitivity Pain Response (g) at Week 4

Response to increasing force on hypersensitive teeth was evaluated using a Yeaple Probe pain response scale. In tactile sensitivity assessment, an increasing force is applied to hypersensitive tooth until a yes response was recorded or the maximum force was reached. (NCT01691560)
Timeframe: Baseline to 4 weeks post administration of study treatment

Interventiongrams (Mean)
5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate7.31
Sodium Monofluorophosphate6.32
Sodium Fluoride4.09
0% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate3.64

[back to top]

Change From Baseline in Tactile Sensitivity Pain Response (g) at Week 8

Response to increasing force on hypersensitive teeth was evaluated using a Yeaple Probe pain response scale. In tactile sensitivity assessment, an increasing force is applied to hypersensitive tooth until a yes response was recorded or the maximum force was reached. (NCT01691560)
Timeframe: Baseline to 8 weeks post administration of study treatment

Interventiongrams (Mean)
5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate10.15
Sodium Monofluorophosphate5.88
Sodium Fluoride4.39
0% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate11.97

[back to top]

Change From Baseline in Evaporative Air Sensitivity Pain Response on Schiff Sensitivity Scale at Week 8

Response to a constant jet of air applied to hypersensitive teeth was evaluated using a Schiff Sensitivity pain response scale. According to this analog scale, pain response for each individual stimulated tooth ranged from 0 to 3; 0 - participant does not respond to air stimulation, 1 - participant responds to air stimulus but does not request discontinuation of stimulus, 2 - participant responds to air stimulus and request discontinuation of stimulus, 3 - participant responds to air stimulus, considers stimulus to be painful and request discontinuation of stimulus. (NCT01691560)
Timeframe: Baseline to 8 weeks post administration of study treatment

InterventionScore on a scale (Least Squares Mean)
5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate-0.55
Sodium Monofluorophosphate-0.43
Sodium Fluoride-0.43
0% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate-0.92

[back to top]

Change From Baseline in Evaporative Air Sensitivity Pain Response on Schiff Sensitivity Scale at Week 4

Response to a constant jet of air applied to hypersensitive teeth was evaluated using a Schiff Sensitivity pain response scale. According to this analog scale, pain response for each individual stimulated tooth ranged from 0 to 3; 0 - participant does not respond to air stimulation, 1 - participant responds to air stimulus but does not request discontinuation of stimulus, 2 - participant responds to air stimulus and request discontinuation of stimulus, 3 - participant responds to air stimulus, considers stimulus to be painful and request discontinuation of stimulus. (NCT01691560)
Timeframe: Baseline to 4 weeks post administration of study treatment

InterventionScore on a scale (Least Squares Mean)
5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate-0.36
Sodium Monofluorophosphate-0.43
Sodium Fluoride-0.40
0% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate-0.45

[back to top]

Number of Subjects Who Experience Adverse Events While on Treatment With TAK 700

The number of subjects experiencing adverse events per CTCAE 4.0 while on treatment. (NCT01816048)
Timeframe: Up to 12 months

Interventionparticipants (Number)
TAK-7008

[back to top] [back to top]

Mean Change From Baseline in Visual Rating Scale Score at Week 4

"The intensity of response to stimulus will be rated using a 10 point scale where 1 denotes No Pain and 10 denotes Intense Pain." (NCT01831817)
Timeframe: Baseline and 4 weeks post administration of study treatment

,,,
InterventionScore on a scale (Mean)
BaselineWeek 4Mean change from baseline at Week 4
0% Calcium Sodium Phosphosilicate/Sodium Monofluorophosphate6.695.72-0.97
5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate6.665.45-1.20
Sodium Fluoride6.926.38-0.54
Sodium Monofluorophosphate6.415.39-1.03

[back to top]

Median Change From Baseline in Tactile Sensitivity at Week 8

Response to tactile sensitivity using a Yeaple probe which allowed application of a known force to the dentin surface, starting at 10g and rising in increments of 10g until the tactile threshold or maximum force was reached. The tactile threshold for each tooth was determined by asking the subject whether the sensation caused discomfort. The pressure setting at which the subject gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth. At baseline, the maximum force used was 20g; at all subsequent visits, it was 80g. (NCT01831817)
Timeframe: Baseline and 8 weeks post administration of study treatment

,,,
Interventiongrams (Median)
BaselineWeek 8Median change from baseline at Week 8
0% Calcium Sodium Phosphosilicate/Sodium Monofluorophosphate10.0015.005.00
5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate10.0015.005.00
Sodium Fluoride10.0010.000.00
Sodium Monofluorophosphate10.0010.000.00

[back to top]

Mean Change From Baseline in Visual Rating Scale Score at Week 8

"The intensity of response to stimulus will be rated using a 10 point scale where 1 denotes No Pain and 10 denotes Intense Pain." (NCT01831817)
Timeframe: Baseline and 8 weeks post administration of study treatment

,,,
InterventionScore on a scale (Mean)
BaselineWeek 8Mean change from baseline at Week 8
0% Calcium Sodium Phosphosilicate/Sodium Monofluorophosphate6.694.46-2.24
5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate6.714.65-2.06
Sodium Fluoride6.926.07-0.86
Sodium Monofluorophosphate6.415.70-0.71

[back to top]

Median Change From Baseline in Tactile Sensitivity at Week 4

Response to tactile sensitivity using a Yeaple probe which allowed application of a known force to the dentin surface, starting at 10g and rising in increments of 10g until the tactile threshold or maximum force was reached. The tactile threshold for each tooth was determined by asking the subject whether the sensation caused discomfort. The pressure setting at which the subject gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth. At baseline, the maximum force used was 20g; at all subsequent visits, it was 80g. (NCT01831817)
Timeframe: Baseline and 4 weeks post administration of study treatment

,,,
Interventiongrams (Median)
BaselineWeek 4Median change from baseline at Week 4
0% Calcium Sodium Phosphosilicate/Sodium Monofluorophosphate10.0010.000.00
5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate10.0010.000.00
Sodium Fluoride10.0010.000.00
Sodium Monofluorophosphate10.0010.000.00

[back to top]

Mean Change From Baseline in Dentine Hypersensitivity Experience Questionnaire (DHEQ) Total Score at Week 8

DHEQ Total score is an overall summary measure for the impact of dentine hypersensitivity on everyday life. Total score is calculated as the sum of 34 questions (each with a possible score of 1 to 7). The scale of responses range from 34 to 238. Higher values imply a worse outcome i.e. an increase in impact on dentine hypersensitivity on everyday life. Lower values imply a better outcome i.e. a decrease in impact on dentine hypersensitivity on everyday life. (NCT01831817)
Timeframe: Baseline and 8 weeks post administration of study treatment

,,,
InterventionScore on a scale (Mean)
BaselineChange from baseline at Week 8
0% Calcium Sodium Phosphosilicate/Sodium Monofluorophosphate132.55-7.97
5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate134.33-6.43
Sodium Fluoride133.89-10.86
Sodium Monofluorophosphate120.09-3.88

[back to top]

Mean Change From Baseline in Dentine Hypersensitivity Experience Questionnaire Total Score at Week 4

DHEQ Total score is an overall summary measure for the impact of dentine hypersensitivity on everyday life. Total score is calculated as the sum of 34 questions (each with a possible score of 1 to 7). The scale of responses range from 34 to 238. Higher values imply a worse outcome i.e. an increase in impact on dentine hypersensitivity on everyday life. Lower values imply a better outcome i.e. a decrease in impact on dentine hypersensitivity on everyday life. (NCT01831817)
Timeframe: Baseline and 4 weeks post administration of study treatment

,,,
InterventionScore on a scale (Mean)
BaselineMean change from baseline at Week 4
0% Calcium Sodium Phosphosilicate/Sodium Monofluorophosphate132.55-4.39
5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate136.53-3.91
Sodium Fluoride133.89-7.50
Sodium Monofluorophosphate121.09-3.80

[back to top]

Mean Change From Baseline in Schiff Sensitivity Score at Week 4

Response to a constant jet of air applied to hypersensitive teeth was evaluated using a Schiff Sensitivity pain response scale. According to this analog scale, pain response for each individual stimulated tooth ranged from 0 to 3; 0 - participant did not respond to air stimulation, 1 - participant responded to air stimulus but did not request discontinuation of stimulus, 2 - participant responded to air stimulus and requested discontinuation of stimulus, 3 - participant responded to air stimulus, considered stimulus to be painful and request discontinuation of stimulus. (NCT01831817)
Timeframe: Baseline and 4 weeks post administration of study treatment

,,,
InterventionScore on a scale (Mean)
BaselineWeek 4Mean change from baseline at Week 4
0% Calcium Sodium Phosphosilicate/Sodium Monofluorophosphate2.411.94-0.47
5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate2.391.83-0.56
Sodium Fluoride2.382.31-0.07
Sodium Monofluorophosphate2.402.31-0.09

[back to top]

Mean Change From Baseline in Schiff Sensitivity Score at Week 8

Response to a constant jet of air applied to hypersensitive teeth was evaluated using a Schiff Sensitivity pain response scale. According to this analog scale, pain response for each individual stimulated tooth ranged from 0 to 3; 0 - participant did not respond to air stimulation, 1 - participant responded to air stimulus but did not request discontinuation of stimulus, 2 - participant responded to air stimulus and requested discontinuation of stimulus, 3 - participant responded to air stimulus, considered stimulus to be painful and request discontinuation of stimulus. (NCT01831817)
Timeframe: Baseline and 8 weeks post administration of study treatment

,,,
InterventionScore on a Scale (Mean)
BaselineWeek 8Mean change from baseline at Week 8
0% Calcium Sodium Phosphosilicate/Sodium Monofluorophosphate2.411.56-0.85
5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate2.401.60-0.81
Sodium Fluoride2.382.440.07
Sodium Monofluorophosphate2.402.410.01

[back to top]

Overall Facial MLSI at Week 6

An assessment of the area and intensity of dental stain on the study teeth was performed using the MLSI after usage of 0.2% w/v chlorhexidine digluconate mouthwash for 6 weeks. The intensity of stain was scored on a scale of 0 to 3 (0 - no stain, 1- light stain, 2 - moderate stain, 3 - heavy stain). The area of stain was scored on the following scale: 0 - no stain; 1 - stain up to 1/3 of the area affected; 2- stain between 1/3 and 2/3 of the area affected; and 3 - stain more than 2/3 of area affected. Intensity X Area was thus analyzed on a scale of 0 (best score) to 9 (worst score). (NCT01962493)
Timeframe: Week 6 post treatment administration

InterventionScore on a Scale (Mean)
NaHCO3/NaF Toothpaste + Chlorhexidine Digluconate Mouthwash0.67
NaF Toothpaste + Chlorhexidine Digluconate Mouthwash0.96

[back to top]

Overall MLSI at Week 3

An assessment of the area and intensity of dental stain on the study teeth was performed using the MLSI after usage of 0.2% w/v chlorhexidine digluconate mouthwash for 3 weeks. The intensity of stain was scored on a scale of 0 to 3 (0 - no stain, 1- light stain, 2 - moderate stain, 3 - heavy stain). The area of stain was scored on the following scale: 0 - no stain; 1 - stain up to 1/3 of the area affected; 2- stain between 1/3 and 2/3 of the area affected; and 3 - stain more than 2/3 of area affected. Intensity X Area was thus analyzed on a scale of 0 (best score) to 9 (worst score). (NCT01962493)
Timeframe: Week 3 post treatment administration

InterventionScore on a Scale (Mean)
NaHCO3/NaF Toothpaste + Chlorhexidine Digluconate Mouthwash0.46
NaF Toothpaste + Chlorhexidine Digluconate Mouthwash0.59

[back to top]

Overall Interproximal MLSI at Week 6

An assessment of the area and intensity of dental stain on the study teeth was performed using the MLSI after usage of 0.2% w/v chlorhexidine digluconate mouthwash for 6 weeks. The intensity of stain was scored on a scale of 0 to 3 (0 - no stain, 1- light stain, 2 - moderate stain, 3 - heavy stain). The area of stain was scored on the following scale: 0 - no stain; 1 - stain up to 1/3 of the area affected; 2- stain between 1/3 and 2/3 of the area affected; and 3 - stain more than 2/3 of area affected. Intensity X Area was thus analyzed on a scale of 0 (best score) to 9 (worst score). (NCT01962493)
Timeframe: Week 6 post treatment administration

InterventionScore on a Scale (Mean)
NaHCO3/NaF Toothpaste + Chlorhexidine Digluconate Mouthwash1.44
NaF Toothpaste + Chlorhexidine Digluconate Mouthwash1.87

[back to top]

Overall Interproximal MLSI at Week 3

An assessment of the area and intensity of dental stain on the study teeth was performed using the MLSI after usage of 0.2% w/v chlorhexidine digluconate mouthwash for 3 weeks. The intensity of stain was scored on a scale of 0 to 3 (0 - no stain, 1- light stain, 2 - moderate stain, 3 - heavy stain). The area of stain was scored on the following scale: 0 - no stain; 1 - stain up to 1/3 of the area affected; 2- stain between 1/3 and 2/3 of the area affected; and 3 - stain more than 2/3 of area affected. Intensity X Area was thus analyzed on a scale of 0 (best score) to 9 (worst score). (NCT01962493)
Timeframe: Week 3 post treatment administration

InterventionScore on a Scale (Mean)
NaHCO3/NaF Toothpaste + Chlorhexidine Digluconate Mouthwash0.66
NaF Toothpaste + Chlorhexidine Digluconate Mouthwash0.87

[back to top]

Overall Gingival and Interproximal MLSI at Week 3

An assessment of the area and intensity of dental stain on the study teeth was performed using the MLSI after usage of 0.2% w/v chlorhexidine digluconate mouthwash for 3 weeks. The intensity of stain was scored on a scale of 0 to 3 (0 - no stain, 1- light stain, 2 - moderate stain, 3 - heavy stain). The area of stain was scored on the following scale: 0 - no stain; 1 - stain up to 1/3 of the area affected; 2- stain between 1/3 and 2/3 of the area affected; and 3 - stain more than 2/3 of area affected. Intensity X Area was thus analyzed on a scale of 0 (best score) to 9 (worst score). (NCT01962493)
Timeframe: Week 3 post treatment administration

InterventionScore on a Scale (Mean)
NaHCO3/NaF Toothpaste + Chlorhexidine Digluconate Mouthwash0.56
NaF Toothpaste + Chlorhexidine Digluconate Mouthwash0.73

[back to top]

Overall Facial MLSI at Week 3

An assessment of the area and intensity of dental stain on the study teeth was performed using the MLSI after usage of 0.2% w/v chlorhexidine digluconate mouthwash for 3 weeks. The intensity of stain was scored on a scale of 0 to 3 (0 - no stain, 1- light stain, 2 - moderate stain, 3 - heavy stain). The area of stain was scored on the following scale: 0 - no stain; 1 - stain up to 1/3 of the area affected; 2- stain between 1/3 and 2/3 of the area affected; and 3 - stain more than 2/3 of area affected. Intensity X Area was thus analyzed on a scale of 0 (best score) to 9 (worst score). (NCT01962493)
Timeframe: Week 3 post treatment administration

InterventionScore on a Scale (Mean)
NaHCO3/NaF Toothpaste + Chlorhexidine Digluconate Mouthwash0.27
NaF Toothpaste + Chlorhexidine Digluconate Mouthwash0.41

[back to top]

Modified Lobene Stain Index (MLSI) at Week 6

An assessment of the area and intensity of dental stain on the study teeth was performed using the MLSI after usage of 0.2% w/v chlorhexidine digluconate mouthwash for 6 weeks. The intensity of stain was scored on a scale of 0 to 3 (0 - no stain, 1- light stain, 2 - moderate stain, 3 - heavy stain). The area of stain was scored on the following scale: 0 - no stain; 1 - stain up to 1/3 of the area affected; 2- stain between 1/3 and 2/3 of the area affected; and 3 - stain more than 2/3 of area affected. Intensity X Area was thus analyzed on a scale of 0 (best score) to 9 (worst score). (NCT01962493)
Timeframe: Week 6 post treatment administration

InterventionScore on a Scale (Mean)
NaHCO3/NaF Toothpaste + Chlorhexidine Digluconate Mouthwash0.97
NaF Toothpaste + Chlorhexidine Digluconate Mouthwash1.22

[back to top]

Overall Gingival and Interproximal MLSI at Week 6

An assessment of the area and intensity of dental stain on the study teeth was performed using the MLSI after usage of 0.2% w/v chlorhexidine digluconate mouthwash for 6 weeks. The intensity of stain was scored on a scale of 0 to 3 (0 - no stain, 1- light stain, 2 - moderate stain, 3 - heavy stain). The area of stain was scored on the following scale: 0 - no stain; 1 - stain up to 1/3 of the area affected; 2- stain between 1/3 and 2/3 of the area affected; and 3 - stain more than 2/3 of area affected. Intensity X Area was thus analyzed on a scale of 0 (best score) to 9 (worst score). (NCT01962493)
Timeframe: Week 6 post treatment administration

InterventionScore on a Scale (Mean)
NaHCO3/NaF Toothpaste + Chlorhexidine Digluconate Mouthwash1.18
NaF Toothpaste + Chlorhexidine Digluconate Mouthwash1.52

[back to top]

Number of Eligible Patients With Positive CT Scan/Bone Scan, MRI and PET Scan.

Count of eligible patients with positive CT chest, abdomen, pelvis scan, positive WB/axial MRI, positive F-18 NaF PET/CT and positive Bone scan for detection of metastatic disease. (NCT01967862)
Timeframe: Up to 12 months

InterventionParticipants (Count of Participants)
Positive CT ScanPositive Bone ScanPositive MRIPositive PET
Diagnostic (CT, Bone Scan, WB/Axial MRI, F18 NaF PET/CT)001217

[back to top]

Dental Plaque Score

Dental Plaque (Quigley-Hein, Turesky Modification Index) Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth) (NCT02080273)
Timeframe: 3 months post treatment use

Interventionunits on a scale (Mean)
Colgate Cavity Protection Toothpaste3.31
Colgate Total Toothpaste2.45
Parodontax3.45

[back to top]

Gingivitis Scores

Gingivitis scale (Loe & Silness Gingival Index) Units on a scale 0 to 3 (0 = no inflammation, 1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing. 3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding) (NCT02080273)
Timeframe: baseline

Interventionunits on a scale (Mean)
Colgate Cavity Protection Toothpaste1.77
Colgate Total Toothpaste1.78
Parodontax1.77

[back to top]

Gingivitis Scores

Gingivitis scale (Loe & Silness Gingival Index) Units on a scale 0 to 3 (0 = no inflammation, 1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing. 3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding) (NCT02080273)
Timeframe: 6 months post treatment use

Interventionunits on a scale (Mean)
Colgate Cavity Protection Toothpaste1.57
Colgate Total Toothpaste0.95
Parodontax1.47

[back to top]

Gingivitis Scores

Gingivitis scale (Loe & Silness Gingival Index) Units on a scale 0 to 3 (0 = no inflammation, 1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing. 3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding) (NCT02080273)
Timeframe: 3 weeks post treatment use

Interventionunits on a scale (Mean)
Colgate Cavity Protection Toothpaste1.76
Colgate Total Toothpaste1.65
Parodontax1.67

[back to top]

Gingivitis Scores

Gingivitis scale (Loe & Silness Gingival Index) Units on a scale 0 to 3 (0 = no inflammation, 1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing. 3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding) (NCT02080273)
Timeframe: 3 months post treatment use

Interventionunits on a scale (Mean)
Colgate Cavity Protection Toothpaste1.63
Colgate Total Toothpaste1.27
Parodontax1.67

[back to top]

Dental Plaque Score

Dental Plaque (Quigley-Hein, Turesky Modification Index) Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth) (NCT02080273)
Timeframe: baseline

Interventionunits on a scale (Mean)
Colgate Cavity Protection Toothpaste3.53
Colgate Total Toothpaste3.55
Parodontax3.59

[back to top]

Dental Plaque Score

Dental Plaque (Quigley-Hein, Turesky Modification Index) Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth) (NCT02080273)
Timeframe: 6 months post treatment use

Interventionunits on a scale (Mean)
Colgate Cavity Protection Toothpaste3.40
Colgate Total Toothpaste1.65
Parodontax3.23

[back to top]

Dental Plaque Score

Dental Plaque (Quigley-Hein, Turesky Modification Index) Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth) (NCT02080273)
Timeframe: 3 weeks post treatment use

Interventionunits on a scale (Mean)
Colgate Cavity Protection Toothpaste3.46
Colgate Total Toothpaste2.98
Parodontax3.50

[back to top]

Dentinal Hypersensitivity

"The primary analysis will be to compare the dentinal hypersensitivity between the 3 groups.~Air test: A 1 second blast of air from the air-water syringe was applied to the tooth.~Water test: Three drops of ice water were be placed on the tooth.~Schiff Score~Investigator observed participant reaction to test and scored on following scale:~0-Tooth/Subject does not respond to stimulus.~Tooth/Subject responds to stimulus, but does not request discontinuation of stimulus.~Tooth/Subject responds to stimulus and requests discontinuation or moves from stimulus.~Tooth/Subject responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus~VAS (visual analog scale):~The participant reported sensitivity on a scale of 0-10. 0 being no pain and 10 being worst pain imaginable." (NCT02136576)
Timeframe: 8 weeks after baseline

,,
Interventionunits on a scale (Median)
Air SchiffAir VASWater SchiffWater VAS
Clinpro 50000212
Crest Cavity Protection & MI Paste Plus1212
Sensodyne1314

[back to top]

Lobene Stain Index Area Scores at Day 4

Tooth stain surface was assessed by using scores on the Lobene Stain Index scored 0 - 3, where 0= no stain, 1 = covering up to 1/3 of the region, 2 = covering > 1/3 to 2/3 of the region, and 3 = covering > 2/3 of the region. (NCT02151058)
Timeframe: 4 Days

Interventionunits on a scale (Least Squares Mean)
Negative Control1.621
Crest 3D1.538
Investigative Mouth Rinse1.502

[back to top]

Lobene Stain Index Area Scores at Day 8

Tooth stain surface was assessed by using scores on the Lobene Stain Index scored 0 - 3, where 0= no stain, 1 = covering up to 1/3 of the region, 2 = covering > 1/3 to 2/3 of the region, and 3 = covering > 2/3 of the region. (NCT02151058)
Timeframe: 8 Days

Interventionunits on a scale (Least Squares Mean)
Negative Control1.615
Crest 3D1.439
Investigative Mouth Rinse1.265

[back to top]

Lobene Stain Index Composite Score at Day 15

"Tooth stain surface and stain intensity were assessed by using scores on the Lobene Stain Index (two part visual scale), scored 0 - 3. Where 0 = no stain, 1 = light stain, 2 = moderate stain and 3 = heavy stain. The second part of the scale examined the surface of the tooth on a scale of 0-3, where 0= no stain, 1 = covering up to 1/3 of the region, 2 = covering > 1/3 to 2/3 of the region and 3 = covering > 2/3 of the region.~The mean composite score (0-9) was determined by multiplying the individual tooth stain surface and stain intensity scores and summing then dividing by the number of regions scored for the subject (or tooth)." (NCT02151058)
Timeframe: 15 Days

Interventionunits on a scale (Least Squares Mean)
Negative Control2.568
Crest 3D1.909
Investigative Mouth Rinse1.575

[back to top]

Lobene Stain Index Intensity Scores at Day 8

Tooth stain surface was assessed by using scores on the Lobene Stain Index scored 0 - 3, where 0= no stain, 1 = light stain, 2 = moderate stain, and 3 = heavy stain. (NCT02151058)
Timeframe: 8 Days

Interventionunits on a scale (Least Squares Mean)
Negative Control1.668
Crest 3D1.438
Investigative Mouth Rinse1.355

[back to top]

Lobene Stain Index Intensity Scores at Day 4

Tooth stain surface was assessed by using scores on the Lobene Stain Index scored 0 - 3, where 0= no stain, 1 = light stain, 2 = moderate stain, and 3 = heavy stain. (NCT02151058)
Timeframe: 4 Days

Interventionunits on a scale (Least Squares Mean)
Negative Control1.651
Crest 3D1.527
Investigative Mouth Rinse1.483

[back to top]

Lobene Stain Index Intensity Scores at Day 15

Tooth stain surface was assessed by using scores on the Lobene Stain Index scored 0 - 3, where 0= no stain, 1 = light stain, 2 = moderate stain, and 3 = heavy stain. (NCT02151058)
Timeframe: 15 Days

Interventionunits on a scale (Least Squares Mean)
Negative Control1.671
Crest 3D1.396
Investigative Mouth Rinse1.206

[back to top]

Lobene Stain Index Composite Score at Day 8

"Tooth stain surface and stain intensity were assessed by using scores on the Lobene Stain Index (two part visual scale), scored 0 - 3. Where 0 = no stain, 1 = light stain, 2 = moderate stain and 3 = heavy stain. The second part of the scale examined the surface of the tooth on a scale of 0-3, where 0= no stain, 1 = covering up to 1/3 of the region, 2 = covering > 1/3 to 2/3 of the region and 3 = covering > 2/3 of the region.~The mean composite score (0-9) was determined by multiplying the individual tooth stain surface and stain intensity scores and summing then dividing by the number of regions scored for the subject (or tooth)." (NCT02151058)
Timeframe: 8 Days

Interventionunits on a scale (Least Squares Mean)
Negative Control2.536
Crest 3D2.023
Investigative Mouth Rinse1.852

[back to top]

Lobene Stain Index Composite Score at Day 4

"Tooth stain surface and stain intensity were assessed by using scores on the Lobene Stain Index (two part visual scale), scored 0 - 3. Where 0 = no stain, 1 = light stain, 2 = moderate stain and 3 = heavy stain. The second part of the scale examined the surface of the tooth on a scale of 0-3, where 0= no stain, 1 = covering up to 1/3 of the region, 2 = covering > 1/3 to 2/3 of the region and 3 = covering > 2/3 of the region.~The mean composite score (0-9) was determined by multiplying the individual tooth stain surface and stain intensity scores and summing then dividing by the number of regions scored for the subject (or tooth)." (NCT02151058)
Timeframe: 4 Days

Interventionunits on a scale (Least Squares Mean)
Negative Control2.527
Crest 3D2.242
Investigative Mouth Rinse2.200

[back to top]

Lobene Stain Index Area Scores at Day 15

Tooth stain surface was assessed by using scores on the Lobene Stain Index scored 0 - 3, where 0= no stain, 1 = covering up to 1/3 of the region, 2 = covering > 1/3 to 2/3 of the region, and 3 = covering > 2/3 of the region. (NCT02151058)
Timeframe: 15 Days

Interventionunits on a scale (Least Squares Mean)
Negative Control1.629
Crest 3D1.382
Investigative Mouth Rinse1.131

[back to top]

Percentage Comparative Acid Resistance (% CAR)

Changes in the mineral content of the four centrally-located enamel specimens were evaluated using the SMH Test. The SMH was measured using a Wilson 2100 Hardness Tester. The baseline SMH was measured prior to the in vitro acid challenge. SMH was measured again after the in vitro acid challenge, after the in situ remineralization test, and again after the second in vitro acid challenge. The % CAR was calculated using the equation: % CAR= [(D2-R)/(D1-B)]*100 where B= Indentation length (μm) of sound enamel at baseline; R= Indentation length (μm) of enamel after in situ remineralization; D1= Indentation length (μm) after first acid challenge; D2= Indentation length (μm) after second acid challenge. (NCT02195583)
Timeframe: Baseline to 4 hours

InterventionPercentage of CAR (Least Squares Mean)
Sodium Fluoride (1426 Ppm)45.00
Sodium Fluoride (1150 Ppm)45.23
Sodium Fluoride (250 Ppm)45.44
Sodium Fluoride (1426 Ppm) + Zinc Base A40.29
Sodium Fluoride (1426 Ppm) + Zinc Base B42.21
Sodium Fluoride (0 Ppm)75.41

[back to top]

Enamel Fluoride Uptake

The microdrill enamel biopsy technique was used to analyze the fluoride uptake by enamel. Each enamel specimen was mounted on the long axis of a drill attached to a microdrill and drilled to a depth of approximately 100 micrometer (μm) through the entire lesion (four cores per specimen). The enamel powder pooled from four drilling sample was then immediately analyzed for fluoride content using fluoride specific electrode and pH/ion meter. The amount of fluoride-uptake by enamel was calculated based on the amount of fluoride divided by the area of the enamel cores and expressed as microgram per square centimeter (μg/cm^2). (NCT02195583)
Timeframe: Baseline to 4 hours

Interventionmicrogram per square centimeter(μg/cm^2) (Least Squares Mean)
Sodium Fluoride (1426 Ppm)2.94
Sodium Fluoride (1150 Ppm)2.70
Sodium Fluoride (250 Ppm)1.85
Sodium Fluoride (1426 Ppm) + Zinc Base A2.62
Sodium Fluoride (1426 Ppm) + Zinc Base B2.37
Sodium Fluoride (0 Ppm)0.98

[back to top]

Percentage Net Acid Resistance (% NAR)

Changes in the mineral content of the four centrally-located enamel specimens were evaluated using the SMH Test. The SMH was measured using a Wilson 2100 Hardness Tester. The baseline SMH was measured prior to the in vitro acid challenge. SMH was measured again after the in vitro acid challenge, after the in situ remineralization test, and again after the second in vitro acid challenge. The % NAR was calculated using the equation: % NAR= [(D1-D2)/(D1-B)]*100 where B= Indentation length (μm) of sound enamel at baseline; D1= Indentation length (μm) after first acid challenge and D2= Indentation length (μm) after second acid challenge. (NCT02195583)
Timeframe: Baseline to 4 hours

InterventionPercentage of NAR (Least Squares Mean)
Sodium Fluoride (1426 Ppm)-12.54
Sodium Fluoride (1150 Ppm)-13.45
Sodium Fluoride (250 Ppm)-17.81
Sodium Fluoride (1426 Ppm) + Zinc Base A-17.60
Sodium Fluoride (1426 Ppm) + Zinc Base B-18.98
Sodium Fluoride (0 Ppm)-50.60

[back to top]

Percentage Surface Microhardness Recovery (% SMHR)

Changes in the mineral content of the four centrally-located enamel specimens were evaluated using the Surface Microhardness (SMH) Test. The SMH was measured using a Wilson 2100 Hardness Tester. The baseline SMH was determined prior to the in vitro acid challenge. SMH was determined again after the in vitro acid challenge, after the in situ remineralization test, and again after the second in vitro acid challenge. The extent of remineralization was calculated as the % recovery in SMH using the equation: % SMHR= [(D1-R)/(D1-B)]*100 Where B = indentation length (μm) of sound enamel at baseline; D1 = indentation length (μm) after first acid challenge; R = indentation length (μm) after in situ remineralization. (NCT02195583)
Timeframe: Baseline to 4 hours

InterventionPercentage of SMHR (Least Squares Mean)
Sodium Fluoride (1426 Ppm)32.49
Sodium Fluoride (1150 Ppm)31.81
Sodium Fluoride (250 Ppm)27.56
Sodium Fluoride (1426 Ppm) + Zinc Base A22.62
Sodium Fluoride (1426 Ppm) + Zinc Base B23.22
Sodium Fluoride (0 Ppm)24.78

[back to top]

Modified Gingival Index (MGI) at 24 Weeks

MGI was assessed on facial and lingual surfaces at two sites on each tooth (papillae and margin). The scoring of the MGI was performed under dental office conditions using a standard dental light for illuminating the oral cavity. Compressed air, water and mouth mirrors were available to each examiner. This procedure was performed by a single examiner. The MGI scoring system is as follows: 0 = absence of inflammation; 1 = mild inflammation; slight change in color, little change in color; little change in texture of any portion of the marginal or papillary gingival unit; 2 = mild inflammation; criteria as above but involving the entire marginal or papillar gingival units; 3= moderate inflammation; glazing, redness, edema, and/ or hypertrophy of the marginal or papillary gingival unit; 4 = severe inflammation; marked redness, edema and/or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, congestion, or ulceration (NCT02207400)
Timeframe: 24 weeks

InterventionUnits on a scale (Mean)
Sodium Bicarbonate and Sodium Fluoride Dentifrice1.26
Sodium Fluoride Dentifrice1.93

[back to top]

Bacterial Count at Baseline, After 6, 12, 24 and 32 Weeks

Microbiological samples were collected at baseline, 6 weeks, 12 weeks, 24 weeks and 32 weeks. Plaque was harvested from contra-lateral 1st molar teeth, where no restorations are present, using a sterile paper point. The paper point was immersed into 4 ml of Calgon Ringer's solution in a sterile bijou and kept on ice until they can be taken to the laboratory for processing (within 24 hours). (NCT02207400)
Timeframe: Baseline, 6, 12, 24 and 32 weeks

,
Interventioncolony forming units per sample (Mean)
Staph Count at Baseline (n=24, 26)Steph Count at 6 weeks (n=24, 26)Steph Count at 12 weeks (n=24, 26)Steph Count at 24 weeks (n=23, 25)Steph Count at 32 weeks (n=21, 21)Yeast Count at Baseline (n=24, 26)Yeast Count at 6 weeks (n=23, 26)Yeast Count at 12 weeks (n=24, 25)Yeast Count at 24 weeks (n=17, 22)Yeast Count at 32 weeks (n= 14, 14)Coliform count at Baseline (n= 24, 26)Coliform count at 6 weeks (n= 24, 26)Coliform count at 12 weeks (n= 24, 26)Coliform count at 24 weeks (n=23, 25)Coliform count at 32 weeks (n=21, 21)E. Coli count at Baseline (n=24, 26)E. Coli count at 6 weeks (n=24, 26)E. Coli count at 12 weeks (n=24, 26)E. Coli count at 24 weeks (n=23, 25)E. Coli count at 32 weeks (n=21, 21)
Sodium Bicarbonate and Sodium Fluoride Dentifrice0.20.11.80.60.2203.4287.3668.91479.62743.53.92.610.98.110.900.10.10.30.6
Sodium Fluoride Dentifrice0.203.20.20.1647.8784.3411.31522.31206.43.85.726.912.617.80000.20

[back to top]

Bleeding Index (BI) at 6, 12 and 24 Weeks

BI was performed by a single examiner using a color coded periodontal probe. The probe was engaged approximately 1mm into the gingival crevice. A moderate pressure was used whilst sweeping from interproximal to interproximal along the sulcular epithelium. The BI scoring system used is as follows: 0= No bleeding after 30 seconds; 1= Bleeding upon probing after 30 seconds; 2= Immediate bleeding observed (NCT02207400)
Timeframe: 6, 12 and 24 weeks

,
InterventionUnits on a Scale (Mean)
BI Score Score at 6 weeksBI Score Score at 12 weeksBI Score Score at 24 weeks
Sodium Bicarbonate and Sodium Fluoride Dentifrice0.150.190.17
Sodium Fluoride Dentifrice0.300.280.31

[back to top]

Modified Gingival Index (MGI)) at 6 and 12 Weeks.

MGI was assessed on facial and lingual surfaces at two sites on each tooth (papillae and margin). The scoring of the MGI was performed under dental office conditions using a standard dental light for illuminating the oral cavity. Compressed air, water and mouth mirrors were available to each examiner. This procedure was performed by a single examiner. The MGI scoring system is as follows: 0 = absence of inflammation; 1 = mild inflammation; slight change in color, little change in color; little change in texture of any portion of the marginal or papillary gingival unit; 2 = mild inflammation; criteria as above but involving the entire marginal or papillar gingival units; 3= moderate inflammation; glazing, redness, edema, and/ or hypertrophy of the marginal or papillary gingival unit; 4 = severe inflammation; marked redness, edema and/or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, congestion, or ulceration (NCT02207400)
Timeframe: 6 and 12 weeks

,
InterventionUnits on a scale (Mean)
MGI at 6 weeksMGI at 12 weeks
Sodium Bicarbonate and Sodium Fluoride Dentifrice1.501.50
Sodium Fluoride Dentifrice1.961.94

[back to top]

Number of Gingival Bleeding Sites at 6 and 12 Weeks

BI was performed by a single examiner using a color coded periodontal probe. The probe was engaged approximately 1mm into the gingival crevice. A moderate pressure was used whilst sweeping from interproximal to interproximal along the sulcular epithelium. The BI scoring system used is as follows: 0= No bleeding after 30 seconds; 1= Bleeding upon probing after 30 seconds; 2= Immediate bleeding observed (NCT02207400)
Timeframe: Baseline, 6 and 12 weeks

,
InterventionNumber of bleeding sites (Mean)
Number of Bleeding Sites at BaselineNumber of Bleeding Sites at 6 weeksNumber of Bleeding Sites at 12 weeks
Sodium Bicarbonate and Sodium Fluoride Dentifrice29.7612.2615.73
Sodium Fluoride Dentifrice29.0523.2323.86

[back to top]

Plaque Control (Overall and Interproximal Dental Plaque Scores) at 6, 12 and 24 Weeks.

The dental examiner had used the Turesky Modification of the Quigley Hein Index to assess plaque on all gradable teeth. Interproximal Dental Plaque Scores were analyzed in the same way as for Overall scores but just based on mesiofacial, facial, distofacial, mesiolingual, lingual and distolingual surfaces. Dental Plaque (Quigley-Hein, Turesky Modification Index) Units on a scale 0 to 5: 0= No plaque; 1= Slight flecks of plaque at the cervical margin of the tooth; 2= A thin continuous band of plaque (1 mm or smaller) at the cervical margin of the tooth; 3= A band of plaque wider than 1 mm but covering less than 1/3 of the crown of the tooth; 4= Plaque covering at least 1/3 but less than 2/3 of the crown of the tooth; 5= Plaque covering 2/3 or more of the crown of the tooth. (NCT02207400)
Timeframe: 6, 12 and 24 weeks

,
InterventionUnits on a scale (Mean)
Overall Plaque Score at 6 weeksOverall Plaque Score at 12 weeksOverall Plaque Score at 24 weeksInterproximal Plaque Score at 6 weeksInterproximal Plaque Score at 12 weeksInterproximal Plaque Score at 24 weeks
Sodium Bicarbonate and Sodium Fluoride Dentifrice2.562.542.472.782.762.71
Sodium Fluoride Dentifrice3.012.902.923.193.103.11

[back to top]

Number of Gingival Bleeding Sites at 24 Weeks

The Bleeding Index was performed by a single examiner using a color coded periodontal probe. The probe was engaged approximately 1 millimetre (mm) into the gingival crevice. A moderate pressure was used whilst sweeping from interproximal to interproximal along the sulcular epithelium. The BI scoring system used is as follows: 0= No bleeding after 30 seconds; 1= Bleeding upon probing after 30 seconds; 2= Immediate bleeding observed (NCT02207400)
Timeframe: 24 weeks

InterventionNumber of bleeding sites (Mean)
Sodium Bicarbonate and Sodium Fluoride Dentifrice13.24
Sodium Fluoride Dentifrice24.90

[back to top]

Number of Gingival Bleeding Sites at 24 Weeks

Number of gingival bleeding sites were measured as bleeding index via a single examiner using a color coded periodontal probe. The probe was engaged approximately 1 millimetre (mm) into the gingival crevice. A moderate pressure was used whilst sweeping from interproximal to interproximal along the sulcular epithelium. The BI scoring system used to measure bleeding sites is as follows: 0= No bleeding after 30 seconds; 1= Bleeding upon probing after 30 seconds; 2= Immediate bleeding observed. A bleeding site was considered as a BI score of 1 or 2. (NCT02207907)
Timeframe: Baseline, 24 weeks

,
Interventionnumber of gingival bleeding sites (Mean)
Number of Bleeding Sites at BaselineNumber of Bleeding sites after 24 weeks
0% Sodium Bicarbonate Dentrifice45.8436.39
Sodium Bicarbonate Dentrifice45.1318.67

[back to top]

Bleeding Index at 6, 12 and 24 Weeks

The Bleeding Index was performed by a single examiner using a color coded periodontal probe. The probe was engaged approximately 1 millimetre (mm) into the gingival crevice. A moderate pressure was used whilst sweeping from interproximal to interproximal along the sulcular epithelium. The BI scoring system to be used is as follows: 0= No bleeding after 30 seconds; 1= Bleeding upon probing after 30 seconds; 2= Immediate bleeding observed (NCT02207907)
Timeframe: Baseline, 6, 12 and 24 weeks

,
InterventionUnits on a Scale (Mean)
Bleeding Index Score at BaselineBleeding Index Score after 6 weeksBleeding Index Score after 12 weeksBleeding Index Score after 24 weeks
0% Sodium Bicarbonate Dentrifice0.470.410.350.37
Sodium Bicarbonate Dentrifice0.450.250.210.19

[back to top]

Modified Gingival Index (MGI) at 24 Weeks

The Modified Gingival Index (MGI) was assessed on facial and lingual surfaces at two sites on each tooth (papillae and margin). The scoring of the MGI was performed under dental office conditions using a standard dental light for illuminating the oral cavity. Compressed air, water and mouth mirrors were available to each examiner. This procedure was performed by a single examiner. The MGI scoring system is as follows: 0 = absence of inflammation; 1 = mild inflammation; slight change in color, little change in color; little change in texture of any portion of the marginal or papillary gingival unit; 2 = mild inflammation; criteria as above but involving the entire marginal or papillar gingival units; 3= moderate inflammation; glazing, redness, edema, and/ or hypertrophy of the marginal or papillary gingival unit; 4 = severe inflammation; marked redness, edema and/or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, congestion, or ulceration (NCT02207907)
Timeframe: Baseline, 24 weeks

,
InterventionUnits on a scale (Mean)
Modified Gingival Index at BaselineModified Gingival Index after 24 weeks
0% Sodium Bicarbonate Dentrifice2.542.43
Sodium Bicarbonate Dentrifice2.532.23

[back to top]

Modified Gingival Index (MGI) at 6 and 12 Weeks.

MGI was assessed on facial and lingual surfaces at two sites on each tooth (papillae and margin). The scoring of the MGI was performed under dental office conditions using a standard dental light for illuminating the oral cavity. Compressed air, water and mouth mirrors were available to each examiner. This procedure was performed by a single examiner. The MGI scoring system is as follows: 0 = absence of inflammation; 1 = mild inflammation; slight change in color, little change in color; little change in texture of any portion of the marginal or papillary gingival unit; 2 = mild inflammation; criteria as above but involving the entire marginal or papillar gingival units; 3= moderate inflammation; glazing, redness, edema, and/ or hypertrophy of the marginal or papillary gingival unit; 4 = severe inflammation; marked redness, edema and/or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, congestion, or ulceration (NCT02207907)
Timeframe: Baseline, 6 and 12 weeks

,
InterventionUnits on a scale (Mean)
Modified Gingival Index at BaselineModified Gingival Index after 6 weeksModified Gingival Index after 12 weeks
0% Sodium Bicarbonate Dentrifice2.542.452.40
Sodium Bicarbonate Dentrifice2.532.282.24

[back to top]

Number of Gingival Bleeding Sites at 6 and 12 Weeks.

Number of gingival bleeding sites were measured as bleeding index via a single examiner using a color coded periodontal probe. The probe was engaged approximately 1 millimetre (mm) into the gingival crevice. A moderate pressure was used whilst sweeping from interproximal to interproximal along the sulcular epithelium. The BI scoring system used to measure bleeding sites is as follows: 0= No bleeding after 30 seconds; 1= Bleeding upon probing after 30 seconds; 2= Immediate bleeding observed. A bleeding site was considered as a BI score of 1 or 2. (NCT02207907)
Timeframe: Baseline, 6 and 12 weeks

,
Interventionnumber of gingival bleeding sites (Mean)
Number of Bleeding Sites at BaselineNumber of Bleeding Sites after 6 weeksNumber of Bleeding sites after 12 weeks
0% Sodium Bicarbonate45.8440.2734.23
Sodium Bicarbonate Dentrifice45.1325.4020.83

[back to top]

Plaque Control (Overall and Interproximal Dental Plaque Scores) Using Turesky Modification of Quigley &Amp; Hein Plaque Index at 6, 12 and 24 Weeks.

The dental examiner used the Turesky Modification of the Quigley Hein Index to assess plaque on all gradable teeth. The plaque was first disclosed using a dye solution. Participants then rinsed with disclosing solution according to instructions. They had expectorated and rinsed with 10 mL of water for 10 seconds and expectorated again. Plaque was assessed with each tooth being divided into 6 areas including the mesiofacial, facial, distofacial, mesiolingual, lingual and distolingual surfaces. Disclosed plaque was scored as follows: 0= No plaque; 1= Slight flecks of plaque at the cervical margin of the tooth; 2= A thin continuous band of plaque (1 mm or smaller) at the cervical margin of the tooth; 3= A band of plaque wider than 1 mm but covering less than 1/3 of the crown of the tooth; 4= Plaque covering at least 1/3 but less tan 2/3 of the crown of the tooth; 5= Plaque covering 2/3 or more of the crown of the tooth (NCT02207907)
Timeframe: Baseline, 6,12 and 24 weeks

,
InterventionUnits on a scale (Mean)
Overall Plaque Score at BaselineOverall Plaque Score after 6 weeksOverall Plaque Score after 12 weeksOverall Plaque Score after 24 weeksInterproximal Plaque Score at BaselineInterproximal Plaque Score after 6 weeksInterproximal Plaque Score after 12 weeksInterproximal Plaque Score after 24 weeks
0% Sodium Bicarbonate Dentrifice3.002.982.922.953.083.053.013.03
Sodium Bicarbonate Dentrifice3.042.652.552.523.122.732.642.61

[back to top]

Change From Baseline Air Challenge

The Schiff Sensitivity Scale was assessed for each test tooth via an evaporative air challenge. The examiner recorded the Schiff Index score corresponding to the response to the air challenge. The Schiff Index Sensitivity scale is scored as follows: 0: tooth/subject did not respond to stimulus, 1: tooth/subject responds to stimulus, but does not request discontinuation of stimulus, 2: tooth/subjects responds to stimulus and requests discontinuation or moves from stimulus, 3: tooth/subject responds to stimulus considers stimulus to be painful, and requests discontinuation of the stimulus. The higher the Schiff score, the more sensitive the tooth. The mean change from Baseline was calculated for this measure. (NCT02221349)
Timeframe: 60 days

InterventionUnits on a scale (Mean)
Oxalate Liquid & Gel Plus SnF2 Paste-1.643
Oxalate Liquid & Gel Plus NaF Paste-1.500

[back to top]

Change From Baseline Visual Analog Scale

Visual Analog Scale (VAS) - subjects are asked to look at a VAS and designate the level of hypersensitivity they experienced as a result of the thermal and water challenges using a continuum scale of 0 = No tooth pain up to 100 = Worst tooth pain ever experienced. (NCT02221349)
Timeframe: 60 days

InterventionUnits on a scale (Mean)
Oxalate Liquid & Gel Plus SnF2 Paste-29.82
Oxalate Liquid & Gel Plus NaF Paste-24.67

[back to top]

Mean Change From Baseline in Tactile Threshold at Week 4

The examiner assessed the response to tactile sensitivity using a Yeaple probe which allowed application of a known force to the dentin surface, starting at 10g and rising in increments of 10g until the tactile threshold or maximum force was reached. The tactile threshold for each tooth was determined by asking the subject whether the sensation caused discomfort. The pressure setting at which the subject gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth. At baseline, the maximum force used was 20g; at all subsequent visits, it was 80g. (NCT02226562)
Timeframe: Baseline to 4 week

InterventionGram (g) (Mean)
Dentifrice Plus Oral Rinse14.11
Dentifrice Alone0.74

[back to top]

Mean Change From Baseline in Schiff Sensitivity Score at Week 8

The examiner indicated the participant's response to an evaporaitve air stimulus for each tooth using the Schiff Sensitivity Scale scored as follows - 0: Participant does not respond to air stimulation; 1: responds to air stimulus but does not request discontinuation of stimulus; 2: Participant responds to air stimulus and requests discontinuation or moves from stimulus; 3: Participant responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. A reduction in Schiff Sensitivity score is indicative of an imrpovement in sensitivity. (NCT02226562)
Timeframe: Baseline to 8 week

InterventionScore on scale (Least Squares Mean)
Dentifrice Plus Oral Rinse-1.47
Dentifrice Alone-0.37

[back to top]

Mean Change From Baseline in Schiff Sensitivity Score at Week 4

The examiner indicated the participant's response to an evaporaitve air stimulus for each tooth using the Schiff Sensitivity Scale scored as follows - 0: Participant does not respond to air stimulation; 1: responds to air stimulus but does not request discontinuation of stimulus; 2: Participant responds to air stimulus and requests discontinuation or moves from stimulus; 3: Participant responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. A reduction in Schiff Sensitivity score is indicative of an imrpovement in sensitivity. (NCT02226562)
Timeframe: Baseline to 4 week

InterventionScores on scale (Mean)
Dentifrice Plus Oral Rinse-0.94
Dentifrice Alone-0.31

[back to top]

Mean Change From Baseline in VRS at Week 4

Participants rated the intensity of their response to an evaporative air stimulus using a 10 point VRS scale with 1 indicating 'no pain' and 10 indicating 'Intense pain'. A reduction in the score is indicative of an improvement in sensitivity. (NCT02226562)
Timeframe: Baseline to 4 week

InterventionScore on scale (Mean)
Dentifrice Plus Oral Rinse-1.64
Dentifrice Alone-0.86

[back to top]

Mean Change From Baseline in Tactile Threshold at Week 8

The examiner assessed the response to tactile sensitivity using a Yeaple probe which allowed application of a known force to the dentin surface, starting at 10g and rising in increments of 10g until the tactile threshold or maximum force was reached. The tactile threshold for each tooth was determined by asking the subject whether the sensation caused discomfort. The pressure setting at which the subject gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth. At baseline, the maximum force used was 20g; at all subsequent visits, it was 80g. (NCT02226562)
Timeframe: Baseline to 8 week

InterventionGram(g) (Mean)
Dentifrice Plus Oral Rinse31.32
Dentifrice Alone3.74

[back to top]

Mean Change From Baseline in Visual Rating Scale (VRS) at Week 8

Participants rated the intensity of their response to an evaporative air stimulus using a 10 point VRS scale with 1 indicating 'no pain' and 10 indicating 'Intense pain'. A reduction in the score is indicative of an improvement in sensitivity. (NCT02226562)
Timeframe: Baseline to 8 week

InterventionScore on scale (Mean)
Dentifrice Plus Oral Rinse-3.05
Dentifrice Alone-1.05

[back to top]

Change From Baseline in the Percentage of Healthy Sites (Modified Gingival Index (MGI) Scores of 0 or 1) at Week 3

Gingivitis was assessed on the buccal and lingual marginal gingivae and interdental papillae of all scorable teeth according to the following scale: 0: Normal (absence of inflammation), 1: Mild inflammation (slight change in color, little change in texture) of any portion of the gingival unit, 2: Mild inflammation of the entire gingival unit, 3: Moderate inflammation (moderate glazing, redness, edema, and/or hypertrophy) of the gingival unit, and 4: Severe inflammation marked redness, edema and/ or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, congestion, or ulceration. The score for each participant was the change from baseline in the percentage of sites with an MGI score of 0 or 1 at Week 3. (NCT02233998)
Timeframe: Baseline to 3 Weeks

Interventionpercentage of MGI scores of 0 or 1 (Mean)
Negative Control (W002194-221P)5.5
19292-116A27.5
11965-05924.3

[back to top]

Change From Baseline in the Percentage of Non-Bleeding Sites (Gingival Bleeding Index (BI) Scores of 0) at Week 3

Bleeding was assessed using a periodontal probe with a 0.5 mm diameter tip which was inserted into the gingival crevice, and swept from distal to mesial, around the tooth at an angle of approximately 60 degrees, while in contact with the sulcular epithelium. Each of 4 gingival areas (disto-buccal, midbuccal, mid-lingual, and mesio-lingual) around each tooth was assessed. After approximately 30 seconds, bleeding at each gingival unit was recorded according to the following scale: 0: Absence of bleeding after 30 seconds, 1: Bleeding after 30 seconds, and 2: Immediate bleeding. The score for each participant was the change from baseline in the percentage of sites with a BI score of 0 at Week 3. (NCT02233998)
Timeframe: Baseline to 3 Weeks

Interventionpercentage of BI scores of 0 (Mean)
Negative Control (W002194-221P)0.3
19292-116A2.5
11965-0592.1

[back to top]

Change From Baseline in the Percentage of Problem Sites (Plaque Index (PI) Scores of ≥ 2) at Week 3

Plaque area was measured based on the Turesky modification of the Quigley-Hein Plaque Index and was scored on six surfaces (distobuccal, midbuccal, mesiobuccal, distolingual, midlingual, and mesiolingual) of all scorable teeth, following disclosing, according to the following scale: 0: No plaque, 1: Separate flecks or discontinuous band of plaque at the gingival (cervical) margin, 2: Thin (up to 1 mm), continuous band of plaque at the gingival margin, 3: Band of plaque wider than 1 mm but less than 1/3 of surface, 4: Plaque covering 1/3 or more, but less than 2/3 of surface, 5: Plaque covering 2/3 or more of surface. The score for each participant was the change from baseline (i.e., Baseline Score minus Week 3 Score) in the percentage of sites with a PI score ≥2 at Week 3. (NCT02233998)
Timeframe: Baseline to 3 Weeks

Interventionpercentage of PI scores of >= 2 (Mean)
Negative Control (W002194-221P)3.2
19292-116A20.9
11965-05918.3

[back to top]

Change From Baseline in the Percentage of Problem Sites (Modified Gingival Index (MGI) Scores of ≥ 3) at Week 3

Gingivitis was assessed on the buccal and lingual marginal gingivae and interdental papillae of all scorable teeth according to the following scale: 0: Normal (absence of inflammation), 1: Mild inflammation (slight change in color, little change in texture) of any portion of the gingival unit, 2: Mild inflammation of the entire gingival unit, 3: Moderate inflammation (moderate glazing, redness, edema, and/or hypertrophy) of the gingival unit, and 4: Severe inflammation marked redness, edema and/ or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, congestion, or ulceration. The score for each participant was the change from baseline (i.e., Baseline Score minus Week 3 Score) in the percentage of sites with an MGI score ≥3 at Week 3. (NCT02233998)
Timeframe: Baseline to 3 Weeks

Interventionpercentage of MGI scores of >= 3 (Mean)
Negative Control (W002194-221P)-0.6
19292-116A0.9
11965-0590.3

[back to top]

Whole Mouth Mean Modified Gingival Index (MGI) at Week 3

Gingivitis was assessed on the buccal and lingual marginal gingivae and interdental papillae of all scorable teeth according to the following scale: 0: Normal (absence of inflammation), 1: Mild inflammation (slight change in color, little change in texture) of any portion of the gingival unit, 2: Mild inflammation of the entire gingival unit, 3: Moderate inflammation (moderate glazing, redness, edema, and/or hypertrophy) of the gingival unit, and 4: Severe inflammation marked redness, edema and/ or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, congestion, or ulceration. The score for each participant was calculated by averaging their tooth site scores at Week 3. (NCT02233998)
Timeframe: 3 Weeks

Interventionunits on a scale (Least Squares Mean)
Negative Control (W002194-221P)2.004
19292-116A1.770
11965-0591.807

[back to top]

Whole Mouth Mean Plaque Index (PI) at Week 3

Plaque area was measured based on the Turesky modification of the Quigley-Hein Plaque Index and was scored on six surfaces (distobuccal, midbuccal, mesiobuccal, distolingual, midlingual, and mesiolingual) of all scorable teeth, following disclosing, according to the following scale: 0: No plaque, 1: Separate flecks or discontinuous band of plaque at the gingival (cervical) margin, 2: Thin (up to 1 mm), continuous band of plaque at the gingival margin, 3: Band of plaque wider than 1 mm but less than 1/3 of surface, 4: Plaque covering 1/3 or more, but less than 2/3 of surface, 5: Plaque covering 2/3 or more of surface. The score for each participant was calculated by averaging their tooth site scores at Week 3. (NCT02233998)
Timeframe: 3 Weeks

Interventionunits on a scale (Least Squares Mean)
Negative Control (W002194-221P)2.434
19292-116A1.965
11965-0592.055

[back to top]

Whole Mouth Mean Gingival Bleeding Index (BI) at Week 3

Bleeding was assessed using a periodontal probe with a 0.5 mm diameter tip which was inserted into the gingival crevice, and swept from distal to mesial, around the tooth at an angle of approximately 60 degrees, while in contact with the sulcular epithelium. Each of 4 gingival areas (disto-buccal, midbuccal, mid-lingual, and mesio-lingual) around each tooth was assessed. After approximately 30 seconds, bleeding at each gingival unit was recorded according to the following scale: 0: Absence of bleeding after 30 seconds, 1: Bleeding after 30 seconds, and 2: Immediate bleeding. The score for each participant was calculated by averaging their tooth site scores at Week 3. (NCT02233998)
Timeframe: 3 Weeks

Interventionunits on a scale (Least Squares Mean)
Negative Control (W002194-221P)0.098
19292-116A0.067
11965-0590.072

[back to top]

Change From Baseline in the Percentage of Virtually Plaque-Free Sites (Plaque Index (PI) Scores of 0 or 1) at Week 3

Plaque area was measured based on the Turesky modification of the Quigley-Hein Plaque Index and was scored on six surfaces (distobuccal, midbuccal, mesiobuccal, distolingual, midlingual, and mesiolingual) of all scorable teeth, following disclosing, according to the following scale: 0: No plaque, 1: Separate flecks or discontinuous band of plaque at the gingival (cervical) margin, 2: Thin (up to 1 mm), continuous band of plaque at the gingival margin, 3: Band of plaque wider than 1 mm but less than 1/3 of surface, 4: Plaque covering 1/3 or more, but less than 2/3 of surface, 5: Plaque covering 2/3 or more of surface. The score for each participant was the change from baseline in the percentage of sites with a PI score of 0 or 1 at Week 3. (NCT02233998)
Timeframe: Baseline to 3 Weeks

Interventionpercentage of PI scores of 0 or 1 (Mean)
Negative Control (W002194-221P)3.2
19292-116A20.9
11965-05918.3

[back to top]

Change From Baseline in the Percentage of Problem Sites (Plaque Index (PI) Scores of ≥ 3) at Week 3

Plaque area was measured based on the Turesky modification of the Quigley-Hein Plaque Index and was scored on six surfaces (distobuccal, midbuccal, mesiobuccal, distolingual, midlingual, and mesiolingual) of all scorable teeth, following disclosing, according to the following scale: 0: No plaque, 1: Separate flecks or discontinuous band of plaque at the gingival (cervical) margin, 2: Thin (up to 1 mm), continuous band of plaque at the gingival margin, 3: Band of plaque wider than 1 mm but less than 1/3 of surface, 4: Plaque covering 1/3 or more, but less than 2/3 of surface, 5: Plaque covering 2/3 or more of surface. The score for each participant was the change from baseline (i.e., Baseline Score minus Week 3 Score) in the percentage of sites with a PI score ≥3 at Week 3. (NCT02233998)
Timeframe: Baseline to 3 Weeks

Interventionpercentage of PI scores of >= 3 (Mean)
Negative Control (W002194-221P)0.1
19292-116A23.5
11965-05918.9

[back to top]

Area Under the Curve (AUC) for the Total Number of Plaque Bacteria in the Mouth Post Implant Surgery

The examiner identified three plaque sampling sites as follows: surgical site, contralateral site to the surgical site and tongue. An individual cotton swab was used at each identified site for up to 20 seconds in order to harvest a plaque sample and immediately be placed into 1mL phosphate buffered saline in a sterile Eppendorf tube. The samples were analysed using quantitative polymerase chain reaction (qPCR) which determined the total number of bacteria in a sample by quantifying the number of 16S ribosomal ribonucleic acid (rRNA) genes in the sample. The AUC of the total count of detectable plaque bacteria was calculated using trapezoidal rule in the time range from immediately post implant surgery to 7 days post implant surgery (NCT02319668)
Timeframe: Up to 7 days post implant surgery

Interventionlog (10) CFE × Day (Mean)
Test and Reference Product8.57
Reference Product8.37

[back to top]

Total Number of Detectable Plaque Bacteria Sampled at Implant Surgery (at Pre-rinse, Pre, Mid and Post Implant Surgery) and Post Implant Surgery (at Day 1 and 7)

The examiner identified three plaque sampling sites as follows: surgical site, contralateral site to the surgical site and tongue. An individual cotton swab was used at each identified site for up to 20 seconds in order to harvest a plaque sample and immediately be placed into 1mL phosphate buffered saline in a sterile Eppendorf tube. The samples were analysed using quantitative polymerase chain reaction (qPCR) which determined the total number of bacteria in a sample by quantifying the number of 16S ribosomal ribonucleic acid (rRNA) genes in the sample. (NCT02319668)
Timeframe: At Day 0 (pre-rinse, pre, mid and post implant surgery), Day 1 and 7

,
Interventionlog (10) CFE (Mean)
At Day 0 (pre rinse), (n=19,19)At Day 0 (pre implant), (n=19, 18)At Day 0 (mid implant), (n=19, 18)At Day 0 (post implant), (n=19,18)At Day 1 (n=19, 17)At Day 7 (n=19, 17)
Reference Product7.748.017.847.817.067.38
Test and Reference Products7.557.657.587.587.447.72

[back to top]

Total Number of Recoverable Viable Bacteria in the Aerosol Generated During Dental Prophylaxis

Thick settle blood agar plates (supplemented with 5% [volume by volume v/v]) defibrinated horse blood) were used to determine the bacterial load of the aerosol. Thirty (30) minutes prior to the participants had their procedure (dental prophylaxis), a total of 5 settle plates with lids removed were placed at set positions around the dental surgery. After 30 minutes, the settle plates lids were replaced. This was repeated during the dental prophylaxis procedure using 5 fresh settle plates. All plates were then sealed with parafilm and transported for incubation in an anaerobic chamber at 37°C for 3 days. The plates were inspected daily to access growth and after 3 days removed and stored at 4°C for subsequent colony enumeration and Colony Forming Unit/mL (CFU/mL) calculation (NCT02319668)
Timeframe: At Baseline

,
Interventionlog (10) CFU/mL (Mean)
Pre prophylaxisPost prophylaxis
Reference Product0.911.33
Test and Reference Product0.941.31

[back to top]

Total Number of Detectable Plaque Bacteria Sampled 3 Days Post Implant Surgery

The examiner identified three plaque sampling sites as follows: surgical site, contralateral site to the surgical site and tongue. An individual cotton swab was used at each identified site for up to 20 seconds in order to harvest a plaque sample and immediately be placed into 1mL phosphate buffered saline in a sterile Eppendorf tube. The samples were analysed using quantitative polymerase chain reaction (qPCR) which determined the total number of bacteria in a sample by quantifying the number of 16S ribosomal ribonucleic acid (rRNA) genes in the sample. The number of bacteria in each of the three identified plaque sampling sites (surgical site, contralateral site to the surgical site and tongue) for each participant were summed to calculate the total number of bacteria for each participant. (NCT02319668)
Timeframe: At Day 3

Interventionlog(10) colony forming equivalents (CFE) (Mean)
Test and Reference Product7.63
Reference Product7.43

[back to top]

Mean Change From Baseline in Evaporative Air Sensitivity as Measured by Visual Analogue Score (VAS) at Week 8

"Evaporative air sensitivity was assessed by examiner as a response to a 1 second application of air from a triple air dental syringe applied to the exposed dentine surface of hypersensitive tooth from a distance of approximately 1centimeter. Each participants rated the intensity of their response to the stimulus using a 100 millimeter (mm) VAS, were 0 represented no pain and 100 represented the worst pain imaginable. Change from baseline was calculated as mean score at the given time point minus mean score at baseline of the two selected test teeth." (NCT02371616)
Timeframe: At Baseline and Week 8

,
Interventionscore on a scale (Mean)
At BaselineAt Week 8Change from baseline at Week 8
Comparator Dentifrice55.8930.51-25.16
Test Dentifrice53.0531.62-21.50

[back to top]

Mean Change From Baseline in Evaporative Air Sensitivity as Measured by Schiff Sensitivity Score at Week 4 and Week 8

Evaporative air sensitivity was measured by examiner as the participant's response to an evaporative air stimulus for each tooth using the Schiff Sensitivity Scale scored as follows - 0: Participant does not respond to air stimulation; 1: responds to air stimulus but does not request discontinuation of stimulus; 2: Participant responds to air stimulus and requests discontinuation or moves from stimulus; 3: Participant responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. A reduction in Schiff Sensitivity score indicate improvement in sensitivity. Change from baseline was calculated as mean score at the given time point minus mean score at baseline of the two selected test teeth. (NCT02371616)
Timeframe: At Baseline, Week 4 and Week 8

,
Interventionscore on a scale (Mean)
At BaselineAt Week 4Change from baseline at Week 4At Week 8Change from baseline at Week 8
Comparator Dentifrice2.682.11-0.571.58-1.09
Test Dentifrice2.722.13-0.591.65-1.08

[back to top]

Change From Baseline in Tactile Threshold at Week 4 and Week 8

Tactile threshold was assessed by examiner using a constant pressure probe (Yeaple probe) which allowed application of a known force to the dentine surface from 10 g to an upper threshold of 80g in increments of 10 g. The tactile threshold is the maximum pressure applied at which participant do not report any pain or discomfort. The tactile threshold for each tooth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth. Change from baseline was calculated as mean score at the given time point minus mean score at baseline of the two selected test teeth. (NCT02371616)
Timeframe: At Baseline, Week 4 and Week 8

,
Interventiongram (g) (Mean)
At BaselineAt Week 4Change from baseline at Week 4At Week 8Change from baseline at Week 8
Comparator Dentifrice12.1823.6111.4233.5821.42
Test Dentifrice12.7925.4512.7232.8820.10

[back to top]

Mean Change From Baseline in Evaporative Air Sensitivity as Measured by Visual Analogue Score (VAS) at Week 4

"Evaporative air sensitivity was assessed by examiner as a response to a 1 second application of air from a triple air dental syringe applied to the exposed dentine surface of hypersensitive tooth from a distance of approximately 1centimeter. Each participants rated the intensity of their response to the stimulus using a 100 mm VAS, were 0 represented no pain and 100 represented the worst pain imaginable. Change from baseline was calculated as mean score at the given time point minus mean score at baseline of the two selected test teeth." (NCT02371616)
Timeframe: At Baseline and Week 4

,
Interventionscore on a scale (Mean)
At Week 4Change from baseline at Week 4
Comparator Dentifrice40.60-15.24
Test Dentifrice40.71-12.12

[back to top]

Change From Baseline for Air Challenge

The Schiff Sensitivity Scale was assessed for each test tooth via an evaporative air challenge. The examiner recorded the Schiff Index score corresponding to the response to the air challenge. The Schiff Index Sensitivity scale is scored as follows- 0: tooth/subject did not respond to stimulus, 1: tooth/subject responds to stimulus, but does not request discontinuation of stimulus, 2: tooth/subject responds to stimulus and requests discontinuation or moves form stimulus, 3: tooth/subject responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. A negative change from Baseline score represents a decrease in sensitivity from baseline.The mean change from Baseline was calculated for this measure. (NCT02384044)
Timeframe: 1 Day

InterventionUnits on a scale (Mean)
Crest® Sensi-Stop™ Strips-0.800
Colgate® Sensitivity Relief Pen0.000

[back to top]

Change From Baseline Visual Analog Scale

Visual Analog Scale (VAS) - subjects are asked to look at a VAS and designate the level of hypersensitivity they experienced as a result of the thermal and water challenges using a continuum scale of 0 = No tooth pain up to 100 = Worst tooth pain ever experienced. A negative change from Baseline score represents a decrease in sensitivity from baseline. (NCT02384044)
Timeframe: 1 Day

InterventionUnits on a scale (Mean)
Crest® Sensi-Stop™ Strips-22.933
Colgate® Sensitivity Relief Pen-3.200

[back to top]

Change in White Spot Lesions Count - Enamel Decalcification Index (EDI)

"The area evaluation scheme of the Enamel Decalcification Index (EDI) divides the buccal surface of each tooth into 4 quadrants and then registers the possible existence of a white spot lesion (decalcification) in each of these 4 quadrants. For each quadrant the lesion can be scaled as: 0 = no decalcification, 1 = decalcification covering <50% of the area, 2 = decalcification covering > 50% of the area, 3 = decalcifications covering 100% of the area or severe decalcification with cavitation. Thus, for each tooth the value can range between 0 and 12.~16 teeth per subject were evaluated, for each subject the value of each tooth was added - thus the range per one subject can be between 0 and 192.~A mean over all participants in one group was calculated. A higher score means a worse outcome." (NCT02424097)
Timeframe: Baseline and 12-months

Interventionunits on a scale (Mean)
MI Paste & MI Varnish40.2
Standard of Care41.3

[back to top]

Change in International Caries Detection and Assessment System (ICDAS II) to Score for Smooth Surfaces White Spot Lesions (WSL)

"The International Caries Detection and Assessment System (ICDAS II) is a standardized method of caries lesion assessment.The score is based on apparent lesion severity, with scores from 0 to 6.The buccal surface of each tooth was divided into 4 quadrants, and for each quadrant a score was assigned with ICDAS scores: 0 = sound, 1 = first visual change in enamel, after air drying, 2 = distinct demineralization visual change in enamel, 3 = localized enamel breakdown due to caries with no visible dentin, 4 = surface with underlying dark shadow from dentin with or without enamel breakdown, 5 = distinct cavity with visible dentin, 6 = extensive cavity with visible dentin.~The ICDAS scores were calculated as the sum of the highest ICDAS scores assigned to each examined tooth per subject. 16 teeth per subject were evaluated, thus, for each subject the value can range between 0 and 96.~A mean over all participants in one group was calculated. A higher score means a worse outcome." (NCT02424097)
Timeframe: Baseline and 12-months

Interventionscore on a scale (Mean)
MI Paste & MI Varnish22.3
Standard of Care22.6

[back to top]

Change From Pre-acid Challenge (Baseline) Tooth Impression Grading Score Following 4 Hours Post Acid Challenge

"The impressions of the tooth surface were analysed using scanning electron microscopy (SEM) to investigate changes in the enamel surface topography to determine degree of early stage enamel erosion. Interrogation of the tooth surface via impressions using SEM followed by visual image analysis was used to investigate the enamel surface topography.~The Images were graded as follows:~- No signs of surface erosive wear (no evidence of the lock and key structure)~- Early signs of erosive surface changes~- Mild signs of erosive surface changes (early signs of the lock and key structure).~- Moderate signs of erosive surface changes~- Severe signs of erosive surface changes (lock and key structure and enamel pits) X - Not evaluable" (NCT02533466)
Timeframe: Baseline, 4 hours post acid challenge

InterventionScores on grading scale (Median)
Test Product3.17
Reference Product1.08

[back to top]

Change From Pre-acid Challenge (Baseline) Tooth Impression Grading Score Following 7 Hours Post Acid Challenge

"The impressions of the tooth surface were analysed using scanning electron microscopy (SEM) to investigate changes in the enamel surface topography to determine degree of early stage enamel erosion. Interrogation of the tooth surface via impressions using SEM followed by visual image analysis was used to investigate the enamel surface topography.~The Images were graded as follows:~- No signs of surface erosive wear (no evidence of the lock and key structure)~- Early signs of erosive surface changes~- Mild signs of erosive surface changes (early signs of the lock and key structure).~- Moderate signs of erosive surface changes~- Severe signs of erosive surface changes (lock and key structure and enamel pits) X - Not evaluable" (NCT02533466)
Timeframe: Baseline, 7 hours post acid challenge

InterventionScores on grading scale (Median)
Test Product2.58
Reference Product0.75

[back to top]

Change From Pre-acid Challenge (Baseline) Tooth Impression Grading Score Immediately Following an Acid Challenge

"The impressions of the tooth surface were analysed using scanning electron microscopy (SEM) to investigate changes in the enamel surface topography to determine degree of early stage enamel erosion. Interrogation of the tooth surface via impressions using SEM followed by visual image analysis was used to investigate the enamel surface topography.~The Images were graded as follows:~- No signs of surface erosive wear (no evidence of the lock and key structure)~- Early signs of erosive surface changes~- Mild signs of erosive surface changes (early signs of the lock and key structure).~- Moderate signs of erosive surface changes~- Severe signs of erosive surface changes (lock and key structure and enamel pits) X - Not evaluable" (NCT02533466)
Timeframe: Baseline, 30 minutes post dietary acid challenge

InterventionScores on grading scale (Median)
Test Product3.75
Reference Product3.17

[back to top]

Change From Baseline in Buffering Capacity at 30 Mins Post Dietary Acid Challenge

Saliva was collected and stored at 0 - 20°C. A Saliva-check Buffer Kit was used to determine the buffer capacity. The colourimetric assay yielded a coloured pattern on a paper diagnostic using a 0-12 scale where 0-5 was deemed to be very low, 6-9 was deemed low and 10-12 was deemed normal-high. (NCT02533466)
Timeframe: Baseline, 30 mins post dietary acid challenge

Interventionscores on a scale (Mean)
Test Product-1.81
Reference Product-1.50

[back to top]

Change From Baseline in Buffering Capacity 7 Hours Post Dietary Acid Challenge

Saliva was collected and stored at 0 - 20°C. A Saliva-check Buffer Kit was used to determine the buffer capacity. The colourimetric assay yielded a coloured pattern on a paper diagnostic using a 0-12 scale where 0-5 was deemed to be very low, 6-9 was deemed low and 10-12 was deemed normal-high. (NCT02533466)
Timeframe: Baseline, 7 hours post dietary acid challenge

Interventionscores on a scale (Mean)
Test Product-0.25
Reference Product-0.36

[back to top]

Change From Baseline of pH Measurement 7 Hours Post Dietary Acid Challenge

Saliva stored at 0 - 20°C was used for determining pH (NCT02533466)
Timeframe: Baseline, 7 hours post dietary acid challenge

InterventionpH units (Mean)
Test Product0.00
Reference Product0.16

[back to top]

Change From Baseline of pH Measurement at 30 Mins Post Dietary Acid Challenge

Saliva stored at 0 - 20°C was used for determining pH (NCT02533466)
Timeframe: Baseline, 30 mins post dietary acid challenge

InterventionpH units (Mean)
Test Product-0.71
Reference Product-0.51

[back to top]

Change From Pre-acid Challenge (Baseline) Tooth Impression Grading Score Following 2 Hours Post Acid Challenge.

"The impressions of the tooth surface were analysed using scanning electron microscopy (SEM) to investigate changes in the enamel surface topography to determine degree of early stage enamel erosion. Interrogation of the tooth surface via impressions using SEM followed by visual image analysis was used to investigate the enamel surface topography.~The Images were graded as follows:~- No signs of surface erosive wear (no evidence of the lock and key structure)~- Early signs of erosive surface changes~- Mild signs of erosive surface changes (early signs of the lock and key structure).~- Moderate signs of erosive surface changes~- Severe signs of erosive surface changes (lock and key structure and enamel pits) X - Not evaluable" (NCT02533466)
Timeframe: Baseline, 2 hours post acid challenge

InterventionScores on grading scale (Median)
Test Product3.83
Reference Product2.33

[back to top]

Change From Baseline of Salivary Calcium Concentration at 30 Mins Post Dietary Acid Challenge

Saliva stored at 0 - 20°C was used for determining calcium concentration (NCT02533466)
Timeframe: Baseline, 30 mins post dietary acid challenge

Interventionppm (Mean)
Test Product-12.81
Reference Product-16.29

[back to top]

Change From Baseline of Salivary Calcium Concentration 7 Hours Post Dietary Acid Challenge

Saliva stored at 0 - 20°C was used for determining calcium concentration (NCT02533466)
Timeframe: Baseline, 7 hours post dietary acid challenge

Interventionppm (Mean)
Test Product4.38
Reference Product0.00

[back to top]

Change in Salivary Streptococcus Mutans Levels After 30 Second Oral Rinse Time (Chlorhexidine Gluconate, Sodium Fluoride, or Deionized Water) or 2 Minute Chew Time (Paraffin Wax Chewing Gum)

"Oral salivary sample obtained and plated on MSB (mitis salivarius-bacitracin) agar petri dish to determine Streptococcus mutans (S. mutans) levels.~Values in each row in the Outcome Measure Data Table represent percentage change (increase denoted by positive number, decrease denoted by negative number) in S. mutans colonies from baseline (pre rinse/chew) sample for a single participant within that particular Arm/Group. Row titles have been arbitrarily identified as 'First Participant', 'Second Participant', 'Third Participant' and 'Fourth Participant.' No values are shown for 'Third Participant' and 'Fourth Participant' for the Chlorhexidine gluconate (0.12%) and Deionized water Arm/Group since only 2 participants were enrolled within each group. One result is obtained from each pre and post sample combination (percentage change)." (NCT02598778)
Timeframe: Sample obtained at baseline (pre rinse/chew) and immediately after treatment (post rinse/chew). Timed for 30 seconds (oral rinses) or 2 minutes (chewing gum)

,
InterventionPercentage change in S. mutans colonies (Number)
First ParticipantSecond ParticipantThird ParticipantFourth Participant
Paraffin Wax Chewing Gum (Sugar-free)53.1388.89161.54176.26
Sodium Fluoride (0.05%)-75-100-100-100

[back to top]

Change in Salivary Streptococcus Mutans Levels After 30 Second Oral Rinse Time (Chlorhexidine Gluconate, Sodium Fluoride, or Deionized Water) or 2 Minute Chew Time (Paraffin Wax Chewing Gum)

"Oral salivary sample obtained and plated on MSB (mitis salivarius-bacitracin) agar petri dish to determine Streptococcus mutans (S. mutans) levels.~Values in each row in the Outcome Measure Data Table represent percentage change (increase denoted by positive number, decrease denoted by negative number) in S. mutans colonies from baseline (pre rinse/chew) sample for a single participant within that particular Arm/Group. Row titles have been arbitrarily identified as 'First Participant', 'Second Participant', 'Third Participant' and 'Fourth Participant.' No values are shown for 'Third Participant' and 'Fourth Participant' for the Chlorhexidine gluconate (0.12%) and Deionized water Arm/Group since only 2 participants were enrolled within each group. One result is obtained from each pre and post sample combination (percentage change)." (NCT02598778)
Timeframe: Sample obtained at baseline (pre rinse/chew) and immediately after treatment (post rinse/chew). Timed for 30 seconds (oral rinses) or 2 minutes (chewing gum)

,
InterventionPercentage change in S. mutans colonies (Number)
First ParticipantSecond Participant
Chlorhexidine Gluconate (0.12%)-100-100
Deionized Water-39.29-46.15

[back to top]

The Change of Relative Activities of Microbial Enzymes After Intervention as Determined by Laboratory Enzymatic Assays

Saliva and dental plaque samples will be collected and microbial enzyme activity will be quantified in the lab. Measures include relative enzyme activity of arginine deiminase, urease and lactase dehydrogenase as determined by standard laboratory enzymatic assay protocols. (NCT02988349)
Timeframe: baseline ,2 week

,
Interventionenzyme activity (μmol/min/g) (Mean)
baseline: ADS activity in supragingival plaquebaseline: ADS activity in subgingival plaquebaseline: ADS activity in saliva plaquebaseline: urease activity in supragingival plaquebaseline: urease activity in subgingival plaquebaseline: urease activity in salivabaseline: LDH activity in supragingival plaquebaseline: LDH activity in subgingival plaquebaseline: LDH activity in saliva2 week: ADS activity in supragingival plaque2 week: ADS activity in subgingival plaque2 week: ADS activity in saliva2 week: urease activity in supragingival plaque2 week: urease activity in subgingival plaque2 week: urease activity in saliva2 week: LDH activity in supragingival plaque2 week: LDH activity in subgingival plaque2 week: LDH activity in saliva
Caries-active Subjects0.36530.291100.234700.32070.346300.1792020.96509017.57611016.0538700.84180.736000.348500.65080.696800.2526014.09691011.64903015.268450
Caries-free Subjects0.89450.631500.758700.67950.718400.729008.8590507.2672207.5087871.07710.746500.774100.58710.733300.7324011.3470608.6641249.496731

[back to top]

The Change of Abundance of Specific Oral Microbes After Intervention as Assessed by 16S rRNA Sequencing

Saliva and dental plaque samples will be collected, and the abundance of specific oral microbes such as Streptococcus mutans, Streptococcus sanguinis will be quantified by microbial 16S rRNA sequencing. (NCT02988349)
Timeframe: baseline , 2 week

,
Interventionpercentage of bacteria (Mean)
Baseline: sm in supragingival plaqueBaseline: sm in subgingival plaqueBaseline: sm in salivaBaseline: ss in supragingival plaqueBaseline: ss in subgingival plaqueBaseline: ss in saliva2 week: sm in supragingival plaque2 week: sm in subgingival plaque2 week: sm in saliva2 week: ss in supragingival plaque2 week: ss in subgingival plaque2 week: ss in saliva
Caries-active Subjects0.146360.119560.013140.5215066671.5399133330.183240.0095266670.002840.0030066673.214863.2322333332.040286667
Caries-free Subjects0.007560.006290.006081.0077666672.0646466670.8127066670.0034066670.00330.0024933331.6551066674.5885466671.3109

[back to top]

Dental Caries for Primary Molars Sound at Baseline

The primary outcome will be the surface-level primary molar caries increment (d2-4mfs) at two years post baseline. Caries, as measured by d2-4mfs, is the total number of surfaces with decay into the enamel (2), dentin (3) or pulp (4), missing due to caries (m), or filled with amalgam, composite or other filling material (f). This scale records whether caries is detected in any of the 5 surfaces of the tooth for up to 8 primary molar teeth that were sound at baseline, and has a range of 0 to 40. Higher values indicate a greater number of caries. (NCT03082196)
Timeframe: 24 months

Interventionunits on a scale (Mean)
Test Varnish2.3
Standard Varnish3.3

[back to top]

Child Response to Fifth Treatment

Facial Images Scale which measures the child's response using a series of five happy/sad faces from a very unhappy face (5) to a very happy face (1). The minimum value is 1 which corresponds to a very happy face and the maximum value is 5 which corresponds to a very unhappy face. The possible values of the scale are 1, 2, 3, 4, or 5. (NCT03082196)
Timeframe: After fifth treatment visit

Interventionunits on a scale (Mean)
Test Varnish2.2
Standard Varnish2.1

[back to top]

Dental Caries for All Primary Teeth Sound at Baseline

"The outcome will be the surface-level primary tooth caries increment (d2-4mfs) at two years post baseline that were sound at baseline. Caries, as measured by d2-4mfs, is the total number of surfaces with decay into the enamel (2), dentin (3) or pulp (4), missing due to caries (m), or filled with amalgam, composite or other filling material (f). This scale records whether caries is detected in any of the 4 or 5 surfaces of the tooth for up to 20 primary teeth that were sound at baseline, and has a range of 0 to 88. Higher values indicate a greater number of caries.~The measure records whether caries is present on any of the 5 surfaces of the primary molars or 4 surfaces of the other teeth." (NCT03082196)
Timeframe: 24 months

Interventionunits on a scale (Mean)
Test Varnish2.0
Standard Varnish2.7

[back to top]

Child Response to First Treatment

Facial Images Scale which measures the child's response using a series of five happy/sad faces from a very unhappy face (5) to a very happy face (1). The minimum value is 1 which corresponds to a very happy face and the maximum value is 5 which corresponds to a very unhappy face. The possible values of the scale are 1, 2, 3, 4, or 5. (NCT03082196)
Timeframe: After first treatment visit

Interventionunits on a scale (Mean)
Test Varnish2.3
Standard Varnish2.5

[back to top]

Change From Baseline in Tactile Threshold

The examiner assessed the response to tactile sensitivity using a Yeaple probe which allowed the application of a known force to the dentin surface, starting at 10 grams (g) and rising in increments of 10g until the tactile threshold or maximum force was reached. The tactile threshold for each tooth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth. At baseline, the maximum force used was 20g; at all subsequent visits, it was 80g. (NCT03238352)
Timeframe: Week 8

,,
InterventionGrams (Mean)
Tactile threshold at baselineChange from baseline at Week 8
Negative Control (0.02% w/w Sodium Fluoride)10.2523.75
Placebo (0% KOX, 0 Ppm Fluoride, pH 7)10.2311.59
Test Product (1.5% KOX, 0 Ppm Fluoride, pH 7)10.3561.28

[back to top]

Change From Baseline in Schiff Sensitivity Score

The examiner assessed the participant's response to an evaporative air stimulus for each tooth using the Schiff Sensitivity Scale which was scored as follows - 0: Participant did not respond to air stimulation; 1: Participant responded to air stimulus but does not request discontinuation of stimulus; 2: Participant responded to air stimulus and requested discontinuation or moves from stimulus; 3: Participant responded to stimulus, considered stimulus to be painful, and requested discontinuation of the stimulus. A reduction in Schiff Sensitivity score will be indicative of an improvement in sensitivity. (NCT03238352)
Timeframe: Week 8

,,
InterventionScore on Scale (Mean)
Schiff score at baselineChange from baseline in Schiff score at Week 8
Negative Control (0.02% w/w Sodium Fluoride)2.68-0.75
Placebo (0% KOX, 0 Ppm Fluoride, pH 7)2.52-0.64
Test Product (1.5% KOX, 0 Ppm Fluoride, pH 7)2.59-1.94

[back to top]

Mean Change From Baseline (Pre-brushing to Post Brushing) in Turesky Score After Single Supervised Use for Test Products 1, 2, 3 and 4 After 4 Weeks

The dental examiner used Turesky Modification of the Quigley Hein Index to assess plaque on all gradable teeth.Overall plaque scores were calculated taking average over all tooth sites for participant.Plaque was first disclosed using dye solution followed by disclosing solution.They expectorated and rinsed with 10 mL of water for 10 sec,expectorated again. Plaque was assessed with each tooth being divided into 6 areas including mesiofacial,facial,distofacial,mesiolingual,lingual,distolingual surfaces.Disclosed plaque was scored for each tooth surface separately as:0 No plaque;1 Slight flecks of plaque at cervical margin of the tooth;2 A thin continuous band of plaque(1 mm or smaller) at cervical margin of tooth;3 A band of plaque wider than 1 mm but covering less than 1/3 of the crown of tooth;4 Plaque covering at least 1/3 but less than 2/3 of crown of tooth;5 Plaque covering 2/3 or more of crown of tooth.Score range 0-5.Lower scores indicate less plaque area. (NCT03285984)
Timeframe: Baseline to 4 Weeks

,,,
InterventionScore on a scale (Mean)
BaselinePost BaselineChange from Baseline after 4 weeks
Test Product 12.901.76-1.13
Test Product 22.921.78-1.14
Test Product 32.891.77-1.11
Test Product 42.861.96-0.90

[back to top]

Mean Change From Baseline (Pre-brushing to Post-brushing) in Turesky Score After Single Supervised Use (Test Product 1 Versus [vs] Test Product 4) After 4 Weeks

The dental examiner used Turesky Modification of the Quigley Hein Index to assess plaque on all gradable teeth.Overall plaque scores were calculated taking average over all tooth sites for participant.Plaque was first disclosed using dye solution followed by disclosing solution.They expectorated and rinsed with 10 milliliters (mL) water for 10 seconds (sec),expectorated again. Plaque was assessed with each tooth being divided into 6 areas including mesiofacial,facial,distofacial,mesiolingual,lingual,distolingual surfaces.Disclosed plaque was scored for each tooth surface separately as:0 No plaque;1 Slight flecks of plaque at cervical margin of the tooth;2 A thin continuous band of plaque(1 mm or smaller) at cervical margin of tooth;3 A band of plaque wider than 1 mm but covering less than 1/3 of the crown of tooth;4 Plaque covering at least 1/3 but less than 2/3 of crown of tooth;5 Plaque covering 2/3 or more of crown of tooth.Score range 0-5.Lower scores indicate less plaque area. (NCT03285984)
Timeframe: Baseline to 4 Weeks

,
InterventionScore on a scale (Mean)
BaselinePost BaselineChange from Baseline
Test Product 12.901.76-1.13
Test Product 42.861.96-0.90

[back to top]

% RER (Comparison of 1150 Ppm Fluoride and 5% KNO3 Dentifrice Relative to Comparator Containing 1100 Ppm Fluoride)

The %RER was calculated to assess the ability of treated enamel specimens to provide a combined benefit in terms of enhanced remineralization and acid resistance of the enamel. The mean indent length (micrometer) from five Knoop microindentations within each specimen was measured at baseline (B), after the first erosive challenge (E1), and after the second erosive challenge (E2) (E2 is measured for after both 2 and 4 hours of remineralization). An increase in the indentation length compared to the baseline indicates softening of the enamel surface while decrease in the indentation length represents re-hardening of enamel surface. The %RER was calculated as : %RER = [(E1-E2)/ (E1-B)]*100. Higher values of %RER indicate greater resistance to erosion, thus higher values are more favorable. (NCT03296072)
Timeframe: After 4 hrs following single exposure of treatment

InterventionPercentage RER (Least Squares Mean)
Test Product-23.65
Comparator Product-34.63

[back to top]

% Relative Erosion Resistance (RER; Comparison of 1150 Ppm Fluoride and 5% KNO3 Dentifrice Relative to a Fluoride Free Placebo Dentifrice to Inhibit Demineralization of Enamel)

The %RER was calculated to assess the ability of treated enamel specimens to provide a combined benefit in terms of enhanced remineralization and acid resistance of the enamel. The mean indent length (micrometer) from five Knoop microindentations within each specimen was measured at baseline (B), after the first erosive challenge (E1), and after the second erosive challenge (E2) (E2 is measured for after both 2 and 4 hours of remineralization). An increase in the indentation length compared to the baseline indicates softening of the enamel surface while decrease in the indentation length represents re-hardening of enamel surface. The %RER was calculated as : %RER = [(E1-E2)/ (E1-B)]*100. Higher values of %RER indicate greater resistance to erosion, thus higher values are more favorable. (NCT03296072)
Timeframe: After 4 hrs following single exposure of treatment

InterventionPercentage RER (Least Squares Mean)
Test Product-23.65
Placebo Product-56.94

[back to top]

EFU (Comparison of 1150 Ppm Fluoride and 5% KNO3 Dentifrice Relative to Comparator Containing 1100 Ppm Fluoride)

The EFU was measured to determine the amount of fluoride incorporation into the model erosive lesions. Each enamel specimen drilled to a depth of approximately 100 μm using a microdrill, through the entire lesion (four cores per specimen). The enamel powder pooled from four drilling samples was then, dissolved in a known volume of perchloric acid and immediately analyzed for fluoride content using a calibrated fluoride specific electrode. The amount of fluoride-uptake by enamel was calculated based on the amount of fluoride divided by the area of the enamel cores and expressed as microgram fluoride per square centimeter (μgF/cm^2). Higher values of EFU indicate greater incorporation of fluoride into the enamel and are thus more favorable. (NCT03296072)
Timeframe: After 4 hrs following single exposure of treatment

InterventionMicrogram fluoride per square centimeter (Least Squares Mean)
Test Product2.98
Comparator Product2.01

[back to top]

Enamel Fluoride Uptake (EFU; Comparison of 1150 Ppm Fluoride and 5% KNO3 Dentifrice Relative to a Fluoride Free Placebo Dentifrice to Promote Fluoride Uptake in Enamel)

The EFU was measured to determine the amount of fluoride incorporation into the model erosive lesions. Each enamel specimen drilled to a depth of approximately 100 μm using a microdrill, through the entire lesion (four cores per specimen). The enamel powder pooled from four drilling samples was then, dissolved in a known volume of perchloric acid and immediately analyzed for fluoride content using a calibrated fluoride specific electrode. The amount of fluoride-uptake by enamel was calculated based on the amount of fluoride divided by the area of the enamel cores and expressed as microgram fluoride per square centimeter (μgF/cm^2). Higher values of EFU indicate greater incorporation of fluoride into the enamel and are thus more favorable. (NCT03296072)
Timeframe: After 4 hrs following single exposure of treatment

InterventionMicrogram fluoride per square centimeter (Least Squares Mean)
Test Product2.98
Placebo Product1.17

[back to top]

% Surface Micro Hardness Recovery (SMHR; Comparison of 1150 Ppm Fluoride and 5% KNO3 Dentifrice Relative to a Fluoride Free Placebo Dentifrice to Enhance Remineralization of Enamel)

The %SMHR was calculated to assess the changes in mineralization status of enamel specimens. The mean indent length (micrometer) from five Knoop microindentations within each specimen was measured at baseline (B), after the first erosive challenge (E1), and after 2 and 4 hours intraoral phase (R). An increase in the indentation length compared to the baseline indicates softening of the enamel surface while decrease in the indentation length represents re-hardening of enamel surface. The %SMHR was calculated as : %SMHR = [(E1-R)/(E1-B)]*100. Greater values of %SMHR indicate that greater remineralization has occurred, thus higher values are more favorable. (NCT03296072)
Timeframe: After 4 hrs following single exposure of treatment

InterventionPercentage SMHR (Least Squares Mean)
Test Product29.67
Placebo Product21.98

[back to top]

% SMHR (Comparison of 1150 Ppm Fluoride and 5% KNO3 Dentifrice Relative to Comparator Containing 1100 Ppm Fluoride)

The %SMHR was calculated to assess the changes in mineralization status of enamel specimens. The mean indent length (micrometer) from five Knoop microindentations within each specimen was measured at baseline (B), after the first erosive challenge (E1), and after 2 and 4 hours intraoral phase (R). An increase in the indentation length compared to the baseline indicates softening of the enamel surface while decrease in the indentation length represents re-hardening of enamel surface. The %SMHR was calculated as: %SMHR = [(E1-R)/(E1-B)]*100. Greater values of %SMHR indicate that greater remineralization has occurred, thus higher values are more favorable. (NCT03296072)
Timeframe: After 4 hrs following single exposure of treatment

InterventionPercentage SMHR (Least Squares Mean)
Test Product29.67
Comparator Product22.10

[back to top]

Change From Baseline in Schiff Sensitivity Score After 8 Weeks of Treatment

The examiner assessed the participant's response to an evaporative air stimulus for each tooth using the Schiff Sensitivity Scale which was scored as follows - 0: Participant did not respond to air stimulation; 1: Participant responded to air stimulus but does not request discontinuation of stimulus; 2: Participant responded to air stimulus and requested discontinuation or moves from stimulus; 3: Participant responded to stimulus, considered stimulus to be painful, and requested discontinuation of the stimulus. A reduction in Schiff Sensitivity score will be indicative of an improvement in sensitivity. (NCT03310268)
Timeframe: Baseline, Week 8

,,
InterventionScore on Scale (Mean)
Schiff score at baselineSchiff score at Week 8Change from baseline in Schiff score at Week 8
Negative Control (1400 Ppm Fluoride as SMFP)2.231.50-0.72
Positive Control (SnCl2 and 0.15% NaF [1450 Ppm Fluoride])2.181.70-0.48
Test Product (0.454% SnF2 and 0.072% NaF [1450 Ppm Fluoride])2.221.69-0.53

[back to top]

Change From Baseline in Tactile Threshold After 8 Weeks of Treatment

The examiner assessed the response to tactile sensitivity using a Yeaple probe which allowed the application of a known force to the dentin surface, starting at 10 grams (g) and rising in increments of 10g until the tactile threshold or maximum force was reached. The tactile threshold for each tooth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth. At baseline, the maximum force used was 20g; at all subsequent visits, it was 80g. (NCT03310268)
Timeframe: Week 8

,,
InterventionGrams (Mean)
Tactile threshold at baselineTactile threshold at Week 8Change from baseline at Week 8
Negative Control (1400 Ppm Fluoride as SMFP)11.4236.4925.00
Positive Control (SnCl2 and 0.15% NaF [1450 Ppm Fluoride])11.8033.9322.31
Test Product (0.454% SnF2 and 0.072% NaF [1450 Ppm Fluoride])11.1328.5217.38

[back to top]

Transverse Microradiography (TMR) - Maximum Mineral Density at the Surface-zone

"Lesions will be analyzed after in situ demineralization and the following three parameters calculated:~Integrated Mineral Loss - ∆Z= [(lesion depth x 87) - area under the curve*]~Lesion Depth - L (83% mineral i.e. 95% of the mineral content of sound enamel)~Maximum mineral density at the surface-zone - SZmax (arbitrary unit from TMR software)" (NCT03383783)
Timeframe: Enamel specimens will be evaluated after 14 days of intra-oral exposure

InterventionSZmax (Mean)
Bovine Specimens 0 Ppm F62.17
Bovine Specimens 250 Ppm F62.54
Bovine Specimens 500 Ppm F67.13
Bovine Specimens 1100 Ppm F65.93
Human Specimens 0 Ppm F61.22
Human Specimens 250 Ppm F62.99
Human Specimens 500 Ppm F61.38
Human Specimens 1100 Ppm F63.66

[back to top]

Transverse Microradiography (TMR) - Lesion Depth - L

"Lesions will be analyzed after in situ demineralization and the following three parameters calculated:~Integrated Mineral Loss - ∆Z= [(lesion depth x 87) - area under the curve*]~Lesion Depth - L (83% mineral i.e. 95% of the mineral content of sound enamel)~Maximum mineral density at the surface-zone - SZmax" (NCT03383783)
Timeframe: Enamel specimens will be evaluated after 14 days of intra-oral exposure

InterventionMicrometers (Mean)
Bovine Specimens 0 Ppm F52.01
Bovine Specimens 250 Ppm F41.74
Bovine Specimens 500 Ppm F34.85
Bovine Specimens 1100 Ppm F27.31
Human Specimens 0 Ppm F60.73
Human Specimens 250 Ppm F42.12
Human Specimens 500 Ppm F37.38
Human Specimens 1100 Ppm F36.02

[back to top]

Percentage Surface Microhardness Recovery (%SMH)

"The extent of remineralization will be calculated based on the method of [Gelhard et al., 1979].~SMH recovery = (D1-R)/(D1-B) ×100 B = indentation length (µm) of sound enamel specimen at baseline D1 = indentation length (µm) after in vitro demineralization R = indentation length (µm) after intra-oral exposure." (NCT03383783)
Timeframe: Enamel specimens will be evaluated after 14 days of intra-oral exposure

InterventionPercent Surface Microhardness Recovery (Mean)
Bovine Specimens 0 Ppm F13.96
Bovine Specimens 250 Ppm F30.59
Bovine Specimens 500 Ppm F40.74
Bovine Specimens 1100 Ppm F48.28
Human Specimens 0 Ppm F7.42
Human Specimens 250 Ppm F16.27
Human Specimens 500 Ppm F21.59
Human Specimens 1100 Ppm F26.75

[back to top]

Net Acid Resistance (NAR)

"The %NAR will be calculated by the method of Corpron [Corpron et al., 1986]:~Net Acid Resistance = [(D1-D2) / (D1-B)] * 100 B= Indentation length (µm) of sound enamel at baseline D1= Indentation length (µm) after first in vitro demineralization D2= Indentation length (µm) after second in vitro demineralization" (NCT03383783)
Timeframe: Enamel specimens will be evaluated after 14 days of intra-oral exposure

Intervention% Net Acid Resistance (Mean)
Bovine Specimens 0 Ppm F-22.68
Bovine Specimens 250 Ppm F11.43
Bovine Specimens 500 Ppm F18.66
Bovine Specimens 1100 Ppm F31.79
Human Specimens 0 Ppm F-18.60
Human Specimens 250 Ppm F1.99
Human Specimens 500 Ppm F8.31
Human Specimens 1100 Ppm F16.87

[back to top]

Enamel Fluoride Uptake (EFU)

The amount of fluoride-uptake by enamel will be calculated based on the amount of fluoride divided by the area of the enamel cores and expressed as µg F/cm2. (NCT03383783)
Timeframe: Enamel specimens will be evaluated after 14 days of intra-oral exposure

Interventionµg F/cm^2 (Mean)
Bovine Specimens 0 Ppm F0.96
Bovine Specimens 250 Ppm F2.25
Bovine Specimens 500 Ppm F2.69
Bovine Specimens 1100 Ppm F2.98
Human Specimens 0 Ppm F0.96
Human Specimens 250 Ppm F2.14
Human Specimens 500 Ppm F2.50
Human Specimens 1100 Ppm F2.73

[back to top]

Comparative Acid Resistance (CAR)

"Using the data from the four centrally located enamel specimens, the equation used will compare explicitly the reduction in SMH brought by the first and second acid challenges:~Comparative Acid Resistance = [(D2-R) / (D1-B)] * 100 B= Indentation length (µm) of sound enamel at baseline R= Indentation length (µm) of enamel after in situ remineralization D1= Indentation length (µm) after first in vitro demineralization D2= Indentation length (µm) after second in vitro demineralization" (NCT03383783)
Timeframe: Enamel specimens will be evaluated after 14 days of intra-oral exposure

Intervention% Comparative Acid Resistance (Mean)
Bovine Specimens 0 Ppm F36.42
Bovine Specimens 250 Ppm F19.20
Bovine Specimens 500 Ppm F22.16
Bovine Specimens 1100 Ppm F16.27
Human Specimens 0 Ppm F25.82
Human Specimens 250 Ppm F14.31
Human Specimens 500 Ppm F13.33
Human Specimens 1100 Ppm F9.71

[back to top]

Transverse Microradiography (TMR) - Integrated Mineral Loss - ∆Z

"Lesions will be analyzed after in situ demineralization and the following three parameters calculated:~Integrated Mineral Loss - ∆Z= [(lesion depth x 87) - area under the curve*]~Lesion Depth - L (83% mineral i.e. 95% of the mineral content of sound enamel)~Maximum mineral density at the surface-zone - SZmax" (NCT03383783)
Timeframe: Enamel specimens will be evaluated after 14 days of intra-oral exposure

InterventionIntegrated Mineral Loss - ∆Z (Mean)
Bovine Specimens 0 Ppm F1240
Bovine Specimens 250 Ppm F902
Bovine Specimens 500 Ppm F664
Bovine Specimens 1100 Ppm F684
Human Specimens 0 Ppm F1526
Human Specimens 250 Ppm F912
Human Specimens 500 Ppm F901
Human Specimens 1100 Ppm F859

[back to top]

Change From Baseline in Mean BPI Index Scores at 2 Weeks

Bleeding on probing (BOP) is an objective indicator of inflammation. BPI (Bleeding Point Index) is a validated index used to measure BOP. BOP is determined at the buccal, lingual and proximal surfaces of all teeth using BPI scores. BPI scores are measured at baseline and 2 weeks, followed by a wash out period of one week. BPI score is measured again at baseline and 2 weeks after cross over in intervention. Change in BPI scores will give the estimation of effect of the intervention. BPI score- minimum value is 0% and Maximum is 100% of bleeding surfaces in each individual patient with teeth. A positive error means that the predicted value is larger than the true value, and a negative error means that the predicted value is less than the true value. The mean error should be close to zero. Sometimes it will be negative or positive depending on the population.. Higher mean score is poor outcome. However, higher reduction in mean score compared to baseline is better outcome. (NCT03989427)
Timeframe: Baseline and 2 weeks

Interventionscore on a scale (Mean)
Brushing First and Flossing Later (BF)0.396
Flossing First and Brushing Later (FB)-1.028

[back to top]

Change From Baseline in Mean RMNPI Index Score at 2 Weeks

"Rustogi Modified Navy Plaque Index(RMNPI) is a self validated tool to assess dental plaque accumulation on the teeth surfaces. RMNPI scores are used to assess change in plaque scores at baseline and at the end of 2 weeks .This will be followed by a 1 week wash out period. Then there is a cross over in the intervention. RMNPI scores are measured again from Baseline and 2 weeks. Maximum number of surfaces examined are 504 per person. A Minimum value of 0 and maximum value of 1 can be calculated in each patient.~Higher mean score is a worse outcome. However,higher percent reduction in mean score when compared to baseline is better outcome." (NCT03989427)
Timeframe: Baseline and 2 weeks

Interventionscore on a scale (Mean)
Brushing First and Flossing Later (BF)0.042
Flossing First and Brushing Later (FB)0.101

[back to top]

Mean Overall Turesky Modification of the Quigley & Hein Plaque Index (TPI) Score at Week 2 and Week 3

TPI assessed supra-gingival plaques on facial and lingual surfaces of all evaluable teeth. Each tooth divided into 3 areas;3 scores recorded facially (mesiofacial,facial,distofacial) and 3 scores lingually (mesiolingual,lingual,distolingual) generating a total of 6 scores per tooth. Plaque was identified using disclosing solution followed by rinsing with tap water(10 milliliters for 10 seconds) and scored as per given scoring criteria:0-no plaque,1-separate flecks of plaque at cervical margin,2-thin continuous band of plaque (up to 1mm) at cervical margin,3-band of plaque wider than 1mm but covering less than(<)1/3 of tooth surface,4-plaque covering more than or equal to (>=)1/3 but <2/3 of tooth surface,5-plaque covering >=2/3 of tooth surface. Lower scores indicate better results. Mean Overall TPI score for each participant was derived from total TPI score over all tooth sites divided by number of tooth sites scored. Overall mean calculated for all participants was reported. (NCT04050722)
Timeframe: Week 2 and Week 3

,
Interventionscore on a scale (Mean)
At Week 2At Week 3
Colgate Cavity Protection (Negative Control Dentifrice)2.812.76
Sensodyne Repair and Protect (Test Dentifrice)2.352.33

[back to top]

Mean Number of Bleeding Sites (NBS) at Week 2 and Week 3

Number of bleeding sites were derived from the bleeding index (BI). BI method used to assess gingival bleeding as a measure of gingival health for facial and lingual/palatal gingival surfaces of all evaluable teeth, six sites per tooth (mesiobuccal, buccal, distobuccal, mesiolingual/palatal, lingual/palatal, and distolingual/palatal). Examiner inserted a round-end probe app. 1 mm into gingival sulcus (at app. 60 degrees) and moved around tooth, from distal interproximal area to mesial interproximal area, gently stretching gingival epithelium. Gingival bleeding was assessed 30 seconds after probing. Assessments were performed 1 quadrant at a time; BI scores were recorded as per given scoring criteria: 0=absence of bleeding on probing,1=bleeding observed within 30 seconds of probing,2=bleeding observed immediately on probing. Lower scores indicate better results. A bleeding site was a site scored as 1 or 2. Mean of all bleeding sites was calculated and reported. (NCT04050722)
Timeframe: Week 2 and Week 3

,
Interventionnumber of bleeding sites (Mean)
At Week 2At Week 3
Colgate Cavity Protection (Negative Control Dentifrice)31.728.0
Sensodyne Repair and Protect (Test Dentifrice)21.019.7

[back to top]

Mean Modified Gingival Index (MGI) at Week 2 and Week 3

MGI used to assess for visual symptoms of gingivitis (redness, texture, edema) for all evaluable teeth, four sites per tooth (facial surface - papilla and margin; lingual/palatal surface - papilla and margin). MGI scores were recorded as per given scoring criteria: 0- Absence of inflammation, 1- Mild inflammation: slight change in color, little change in texture of any portion of marginal or papillary gingival unit, 2- Mild inflammation: criteria as [1] but involving entire marginal or papillary gingival unit, 3- Moderate inflammation: glazing, redness, edema, and/or hypertrophy of marginal or papillary gingival unit, 4- Severe inflammation: marked redness, edema and/or hypertrophy of marginal or papillary gingival unit, spontaneous bleeding, congestion, or ulceration. Lower scores indicate better results. Mean whole mouth MGI score for each participant was derived from total MGI score divided by number of tooth sites scored. Overall mean calculated for all participants was reported. (NCT04050722)
Timeframe: Week 2 and Week 3

,
Interventionscore on a scale (Mean)
At Week 2At Week 3
Colgate Cavity Protection (Negative Control Dentifrice)2.182.15
Sensodyne Repair and Protect (Test Dentifrice)2.082.05

[back to top]

Mean Interproximal Turesky Modification of the Quigley & Hein Plaque Index (TPI) at Week 2 and Week 3

TPI assessed supra-gingival plaques on facial and lingual surfaces of all evaluable teeth. Each tooth was divided into 3 areas; 3 scores were recorded facially (mesiofacial,facial,distofacial) and 3 scores lingually (mesiolingual,lingual,distolingual) generating a total of 6 scores per tooth. Plaque was identified using disclosing solution followed by rinsing with tap water(10 milliliters for 10 seconds) and scored as per given scoring criteria: 0-no plaque,1-separate flecks of plaque at cervical margin,2-thin continuous band of plaque(up to 1 mm)at cervical margin,3-band of plaque wider than 1mm but covering <1/3 of tooth surface,4-plaque covering >=1/3 but <2/3 of tooth surface,5-plaque covering >=2/3 of tooth surface. Lower scores indicate better results. Mean Interproximal TPI score for each participant was derived from total TPI score over all interproximal tooth sites divided by number of interproximal tooth sites scored. Mean calculated for all participants was reported. (NCT04050722)
Timeframe: Week 2 and Week 3

,
Interventionscore on a scale (Mean)
At Week 2At Week 3
Colgate Cavity Protection (Negative Control Dentifrice)2.902.88
Sensodyne Repair and Protect (Test Dentifrice)2.482.47

[back to top]

Whole Mouth Mean Bleeding Index (BI) at Week 3

BI method used to assess gingival bleeding as measure of gingival health for facial and lingual/palatal gingival surfaces of all evaluable teeth, six sites per tooth (mesiobuccal, buccal, distobuccal, mesiolingual/palatal, lingual/palatal, and distolingual/palatal). Examiner inserted a round-end probe approximately(app.) 1millimeter(mm) into gingival sulcus (at app 60 degrees) and moved around tooth, from distal interproximal area to mesial interproximal area, gently stretching gingival epithelium. Gingival bleeding was assessed 30 seconds after probing. Assessments performed 1 quadrant at a time; BI scores recorded as per given scoring criteria: 0=absence of bleeding on probing,1=bleeding observed within 30 seconds of probing,2=bleeding observed immediately on probing. Lower scores indicate better results. Mean whole mouth BI score for each participant was derived from total BI score divided by number of tooth sites scored. Overall mean calculated for all participants was reported. (NCT04050722)
Timeframe: Week 3

Interventionscore on a scale (Mean)
Sensodyne Repair and Protect (Test Dentifrice)0.14
Colgate Cavity Protection (Negative Control Dentifrice)0.20

[back to top]

Whole Mouth Mean Bleeding Index (BI) at Week 2

BI method used to assess gingival bleeding as a measure of gingival health for facial and lingual/palatal gingival surfaces of all evaluable teeth, six sites per tooth (mesiobuccal, buccal, distobuccal, mesiolingual/palatal, lingual/palatal, and distolingual/palatal). Examiner inserted a round-end probe app. 1 mm into gingival sulcus (at app. 60 degrees) and moved around tooth, from distal interproximal area to mesial interproximal area, gently stretching gingival epithelium. Gingival bleeding was assessed 30 seconds after probing. Assessments were performed 1 quadrant at a time; BI scores were recorded as per given scoring criteria: 0=absence of bleeding on probing,1=bleeding observed within 30 seconds of probing,2=bleeding observed immediately on probing. Lower scores indicate better results. Mean whole mouth BI score for each participant was derived from total BI score divided by number of tooth sites scored. Overall mean calculated for all participants was reported. (NCT04050722)
Timeframe: Week 2

Interventionscore on a scale (Mean)
Sensodyne Repair and Protect (Test Dentifrice)0.15
Colgate Cavity Protection (Negative Control Dentifrice)0.22

[back to top]

Percent Change in Mean Scores of Pain Response From Baseline on Visual Analog Scale Using Water Jet Stimulus

Visual Analogue Scale was used to measure the intensity of pain due to dentin hypersensitivity using Water Jet Stimulus. Patient's response of pain was assessed on vertical line of 0 to 10cm by asking him to move finger on the line and stop it where he felt pain. Score range from; 0 (no pain at 0cm), 1(mild pain at 1cm), 2(mild pain at 2cm), 3(mild pain at 3cm), 4(moderate pain at 4cm), 5(moderate pain at 5cm), 6(moderate pain at 6cm), 7(severe pain at 7cm), 8(severe pain at 8cm), 9(severe pain at 9cm),10(worst imaginable pain at 10cm). Percent change in mean scores = (one minute score-Baseline score) / Baseline score (NCT04249336)
Timeframe: (Base line to 1 minute) (Base line to 5 minutes)(Base line to day 3)(Base line to week 4)

,,,
Interventionpercentage of change in mean scores (Mean)
1-minute5-minutesDay-3Week-4
BioMin F22273067
Colgate Sensitive Pro Relief52563457
Colgate Total18211829
Sensodyne Rapid Action46523255

[back to top]

Percent Change in Mean Scores of Pain Response From Baseline on Visual Analog Scale Using Mechanical Stimulus

Visual Analogue Scale was used to measure the intensity of pain due to dentin hypersensitivity using mechanical stimulus. Patient's response of pain was assessed on vertical line of 0 to 10cm by asking him to move finger on the line and stop it where he felt pain. Score range from; 0 (no pain at 0cm), 1(mild pain at 1cm), 2(mild pain at 2cm), 3(mild pain at 3cm), 4(moderate pain at 4cm), 5(moderate pain at 5cm), 6(moderate pain at 6cm), 7(severe pain at 7cm), 8(severe pain at 8cm), 9(severe pain at 9cm),10(worst imaginable pain at 10cm). Percent change in mean scores = (one minute score-Baseline score) / Baseline score (NCT04249336)
Timeframe: (Base line to 1 minute) (Base line to 5 minutes)(Base line to day 3)(Base line to week 4)

,,,
Interventionpercentage of change in mean scores (Mean)
1-minute5-minutesDay-3Week-4
BioMin F25272859
Colgate Sensitive Pro Relief56613866
Colgate Total16201827
Sensodyne Rapid Action46513257

[back to top]

Percent Change in Mean Score of Pain Response From Baseline on Schiff Cold Air Sensitivity Scale Using Air Blast Stimulus

"SCHIFF cold air sensitivity scale was used to measure the intensity of pain due to dentin hypersensitivity using air blast stimulus. Patients' response of pain was assessed by the doctor according to following score range from; 0(no response of pain), 1 (pain response but no request of discontinuity of stimulus), 2(pain response with request of discontinuity of stimulus), 3(Immediate pain response for discontinuity of stimulus). Percent change in mean scores = ( one minute score-Baseline score) / Baseline score" (NCT04249336)
Timeframe: (Base line to 1 minute) (Base line to 5 minutes)(Base line to day 3)(Base line to week 4)

,,,
Interventionpercentage of change in mean scores (Mean)
1- minute5-minutesDay-3Week-4
BioMin F18272258
Colgate Sensitive Pro Relief45562455
Colgate Total15191022
Sensodyne Rapid Action37512545

[back to top]

Mean Oral Hygiene Index (OHI) at Week 6 and Week 12

OHI was calculated as sum score of mean CI and mean ODI. CI scoring:0=no calculus present,1=supragingival calculus covering not >1/3 of exposed tooth surface,2=supragingival calculus covering >1/3 but not >2/3 of exposed tooth surface/presence of individual flecks of subgingival calculus around cervical portion of tooth/both,3=supragingival calculus covering >2/3 of exposed tooth surface/continuous band of subgingival calculus around cervical portion of tooth/both. ODI scoring:0=no debris/stain present,1= supragingival calculus covering not >1/3 of exposed tooth surface,2=supragingival calculus covering>1/3 but not >2/3 of exposed tooth surface/presence of individual flecks of subgingival calculus around cervical portion of tooth/both,3=supragingival calculus covering >2/3 of exposed tooth surface/continuous band of subgingival calculus around cervical portion of tooth/ both. Thus, total OHI score range was 0 to 6. Higher score indicates worst outcome. (NCT04290624)
Timeframe: Week 6 and Week 12

,
InterventionScore on a scale (Mean)
Week 6Week 12
Intervention Group0.300.30
Non-intervention Group0.690.64

[back to top]

Mean BI at Week 6

The BI assesses the number of bleeding points elicited on probing as a measure of gingival condition. To perform the assessment, a probe was inserted into the gingival crevice to a depth of approximately 1 mm and then run around the tooth (at approximately 60 degrees to the long axis of the tooth) gently stretching the epithelium while sweeping from interproximal to interproximal along the sulcular epithelium. Three scores were recorded bucally/labially (distal, body, mesial sites) and 3 scores lingually/palatally (distal, body, mesial sites). All scorable teeth in 1 quadrant were probed first (approximately 30 seconds) before recording the number of gingival units which bled. The BI scoring included 3-point scale ranged from 0 to 2, where 0=no bleeding, 1=bleeding within 30 seconds of probing, 2=bleeding immediately on probing. Sites with a score of 1 or 2 were classified as 'bleeding' sites. Higher score indicates worst outcome. (NCT04290624)
Timeframe: Week 6

InterventionScore on a scale (Mean)
Intervention Group0.45
Non-intervention Group0.76

[back to top]

Mean Modified Gingival Index (MGI) at Week 6 and Week 12

The MGI focuses on the visual symptoms of gingivitis (redness, texture, edema). The MGI was assessed for the facial and lingual/palatal gingiva of all evaluable teeth, four sites per tooth (facial surface - papilla and margin; lingual/palatal surface - papilla and margin). The MGI scoring included 5-point scale ranged from 0 to 4, where 0=Absence of inflammation, 1=Mild inflammation: slight change in color, little change in texture of any portion of the marginal or papillary gingival unit, 2=Mild inflammation: criteria as (1) but involving the entire marginal or papillary gingival unit, 3=Moderate inflammation: glazing, redness, edema, and/or hypertrophy of the marginal or papillary gingival unit, 4=Severe inflammation: marked redness, edema and/or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, congestion, or ulceration. Higher score indicates worst outcome. (NCT04290624)
Timeframe: Week 6 and Week 12

,
InterventionScore on a scale (Mean)
Week 6Week 12
Intervention Group1.521.50
Non-intervention Group1.921.86

[back to top]

Mean Number of Bleeding Sites (NBS) at Week 6 and Week 12

Number of gingival bleeding sites were measured during BI assessment. BI assesses the severity and number of bleeding points elicited on probing as a measure of gingival condition. To perform the assessment, a probe was inserted approximately 1 mm into the gingival sulcus (at approximately 60 degrees) and moved around the tooth, from the distal interproximal area to the mesial interproximal area, gently stretching the gingival epithelium. Sites which showed signs of bleeding immediately on probing or within 30 seconds of probing were classified as a bleeding sites. (NCT04290624)
Timeframe: Week 6 and Week 12

,
InterventionNumber of sites (Mean)
Week 6Week 12
Intervention Group53.152.9
Non-intervention Group81.780.8

[back to top]

Mean Overall Turesky Plaque Index (TPI) at Week 6 and Week 12

Supra-gingival plaque was assessed on the facial and lingual/palatal surfaces of all scorable teeth, six sites per tooth using TPI which indicated plaque accumulation in the gingival area of the tooth. Each tooth surface was divided into 3 areas; three scores were recorded facially (mesiofacial, facial, distofacial) and three scores lingually (mesiolin-gual, lingual and distolingual) generating a total of six scores per tooth. The plaque was disclosed and scored on a 6-point scale ranged from 0 to 5 where: 0=No plaque, 1=Separate flecks of plaque at the cervical margin, 2=Thin continuous band of plaque (up to 1 mm) at the cervical margin, 3=Band of plaque wider than 1 mm but covering less than (<) 1/3 of the tooth surface, 4=Plaque covering greater than or equal to (>=) 1/3 but < 2/3 of the tooth surface, 5=Plaque covering >= 2/3 of the tooth surface. Higher score indicates worst outcome. (NCT04290624)
Timeframe: Week 6 and Week 12

,
InterventionScore on a scale (Mean)
Week 6Week 12
Intervention Group2.122.07
Non-intervention Group2.973.02

[back to top]

Mean Partial Denture Cleanliness Index (PDCI) at Week 6 and 12

"The cleanliness of the partial denture was evaluated based on the modification of the Clinical Categorization of Denture Cleanliness Index. A suitable dental probe was used to gently scrape the surfaces of the RPD and the PDCI was scored. All surfaces of the RPD were assessed and the highest score applicable was recorded. PDCI scoring system included 5-point scale ranged from 0 to 4, where 0=No visible plaque; no matter adherent to the dental probe on light scraping, 1=No visible plaque; matter adherent to the dental probe on light scraping, 2=Deposits of plaque just visible on careful examination without need to confirm by scraping, 3=Deposits of plaque clearly visible, 4=Gross plaque deposits (velvet appearance). Higher score indicates worst outcome." (NCT04290624)
Timeframe: Week 6 and Week 12

,
InterventionScore on a scale (Mean)
Week 6Week 12
Intervention Group1.21.1
Non-intervention Group1.71.9

[back to top]

Mean Calculus Index (CI) at Week 6 and Week 12

The extent of calculus on each tooth surface (buccal and lingual) was determined by visual examination. Only definite deposits of hard calculus were recorded. The CI was assessed on the facial and lingual surfaces of each scorable tooth. The CI for each participant was calculated as the mean score of all tooth surfaces (facial/lingual). CI scoring included 4-point scale ranged from 0 to 3 where: 0=No calculus present, 1=Supragingival calculus covering not greater than (>) 1/3 of exposed tooth surface, 2=Supragingival calculus covering > 1/3 but not > 2/3 of exposed tooth surface or presence of individual flecks of Subgingival calculus around cervical portion of tooth or both, 3= supragingival calculus covering > 2/3 of exposed tooth surface or a continuous band of Subgingival calculus around cervical portion of tooth or both. Higher score indicates worst outcome. (NCT04290624)
Timeframe: Week 6 and Week 12

,
InterventionScore on a scale (Mean)
Week 6Week 12
Intervention Group0.080.10
Non-intervention Group0.190.18

[back to top]

Mean Interproximal TPI at Week 6 and Week 12

Supra-gingival plaque was assessed on the facial and lingual/palatal surfaces of all scorable teeth, six sites per tooth using TPI which indicated plaque accumulation in the gingival area of the tooth. Each tooth surface was divided into 3 areas; three scores were recorded facially (mesiofacial, facial, distofacial) and three scores lingually (mesiolin-gual, lingual and distolingual) generating a total of six scores per tooth. The plaque was disclosed and scored on a 6-point scale ranging from 0 to 5, where 0=No plaque, 1=Separate flecks of plaque at the cervical margin, 2=Thin continuous band of plaque (up to 1 mm) at the cervical margin, 3=Band of plaque wider than 1 mm but covering < 1/3 of the tooth surface, 4=Plaque covering >= 1/3 but < 2/3 of the tooth surface, 5=Plaque covering >= 2/3 of the tooth surface. Higher score indicates worst outcome. (NCT04290624)
Timeframe: Week 6 and Week 12

,
InterventionScore on a scale (Mean)
Week 6Week 12
Intervention Group2.312.24
Non-intervention Group3.223.29

[back to top]

Mean Bleeding Index (BI) at Week 12

The BI assesses the number of bleeding points elicited on probing as a measure of gingival condition. To perform the assessment, a probe was inserted into the gingival crevice to a depth of approximately 1 millimeter [mm] and then run around the tooth (at approximately 60 degrees to the long axis of the tooth) gently stretching the epithelium while sweeping from interproximal to interproximal along the sulcular epithelium. Three scores were recorded bucally/labially (distal, body, mesial sites) and 3 scores lingually/palatally (distal, body, mesial sites). All scorable teeth in 1 quadrant were probed first (approximately 30 seconds) before recording the number of gingival units which bled. The BI scoring included 3-point scale ranged from 0 to 2, where 0=no bleeding, 1=bleeding within 30 seconds of probing, 2=bleeding immediately on probing. Sites with a score of 1 or 2 were classified as 'bleeding' sites. Higher score indicates worst outcome. (NCT04290624)
Timeframe: Week 12

InterventionScore on a scale (Mean)
Intervention Group0.45
Non-intervention Group0.76

[back to top]

Mean Oral Debris Index (ODI) at Week 6 and Week 12

The extent of oral debris (defined as soft foreign matter on the surface of teeth) on each tooth surface was determined by running the side of a number 5 explorer (Shephard's crook) probe along the buccal, labial and lingual surfaces and noting the occlusal or incisal extent of the debris as it was removed from the tooth surface. The ODI was assessed on the facial and lingual surfaces of each scorable tooth. The ODI for each participant was calculated as the mean score of all tooth surfaces (facial/lingual).ODI scoring system included 4-point scale ranged from 0 to 3 where: 0=No debris or stain present, 1=Soft debris covering not > 1/3 of the tooth surface the presence of extrinsic stains without other debris regardless of surface area covered, 2= Soft debris covering more than one third, but not more than two thirds, of the exposed tooth surface, 3=Soft debris covering more than two thirds of the exposed tooth surface. Higher score indicates worst outcome. (NCT04290624)
Timeframe: Week 6 and Week 12

,
InterventionScore on a scale (Mean)
Week 6Week 12
Intervention Group0.220.20
Non-intervention Group0.500.46

[back to top]